0001800347 false 0001800347 2021-05-27 2021-05-27 0001800347 us-gaap:CommonClassAMember 2021-05-27 2021-05-27 0001800347 us-gaap:WarrantMember 2021-05-27 2021-05-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) 
of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 1, 2021 (May 27, 2021)

 

 

 

E2open Parent Holdings, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-39272   86-1874570
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (IRS Employer Identification No.)

 

9600 Great Hills Trail, Suite 300E

Austin, TX

(address of principal executive offices)

 

78759

(zip code)

 

866-432-6736

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share   ETWO   New York Stock Exchange
Warrants to purchase one share of Class A Common Stock at an exercise price of $11.50   ETWO WT   New York Stock Exchange

 

 

 

 

  Item 1.01 Entry Into A Material Definitive Agreement.

 

On May 27, 2021, E2open Parent Holdings, Inc. (“E2open”) entered into (a) a Share Purchase Deed (the “Purchase Agreement”) by and among E2open, BluJay TopCo Limited, a private limited liability company registed in England and Wales (“BluJay”), and the sellers party thereto (collectively, the “Sellers”), (b) a Management Warranty Deed (the “Management Warranty Deed”) by and among E2open and the warrantors party thereto and (c) (b) a Tax Deed (the “Tax Deed”) by and among E2open and the warrantors party thereto. The Purchase Agreement, the Management Warranty Deed and the Tax Deed are each governed by the laws of England and Wales.

 

The Purchase Agreement and the transactions contemplated thereby were unanimously approved by the board of directors of E2open and by the board of directors of BluJay.

 

Purchase Agreement

 

Transaction

 

The Purchase Agreement provides that, upon the terms and subject to the conditions set forth in the Purchase Agreement, E2open will acquire all of the outstanding equity interests of BluJay, and BluJay will become an indirect subsidiary of E2open (the “Transaction”).

 

Upon consummation of the Transaction (“Completion”), in exchange for the equity interests of BluJay, E2open will pay to the Sellers (i) 72,383,299 shares of Class A common stock, par value USD 0.0001 per share, of E2open (the “Stock Consideration”) and (ii) cash consideration in the amount of USD 456,767,623, subject to increase for a ticking fee and adjustments for leakage and other enumerated items as provided in the Purchase Agreement.

 

Locked Box Mechanism

 

The Purchase Agreement follows a typical locked-box mechanism, pursuant to which the purchase price is fixed upfront by reference to the balance sheet position of BlueJay as at December 31, 2020 (the “Locked Box Date”), without any post-completion purchase price adjustment. E2open is also required to pay an additional consideration on a daily basis for the period between the Locked Box Date and the date of Completion at a rate of USD 63,000 per day. The purchase price will be reduced on a dollar for dollar basis if any value is extracted to or for the benefit of any sellers between the Locked Box Date and the date of Completion, which we refer to as leakage, other than for certain narrowly defined permitted leakage items specifically agreed by the Sellers and E2open and expressly provided for in the Purchase Agreement (referred to as “Permitted Leakage”).

 

Conditions to Each Party’s Obligations

 

The Completion is subject to the satisfaction or waiver of the following closing conditions: (a) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “Antitrust Condition”); (b) written confirmation from the New Zealand Overseas Investment Office or the relevant New Zealand Government Minister that a direction order has been issued allowing the Transaction pursuant to the Overseas Investment Act 2005 (New Zealand); (c) if the United Kingdom’s National Security and Investment Act 2021 (“NSI Act”) enters into force prior to Completion and the Transaction (or any part of it) becomes subject to a requirement thereunder to notify the United Kingdom Secretary of State for Business, Energy and Industrial Strategy (“BEIS”) and obtain the approval of BEIS prior to Completion, written confirmation from the BEIS approving the Transaction pursuant to the NSI Act; (d) the requisite approval by E2open’s stockholders related to the issuance of the Stock Consideration and the issuance of Class A common stock in connection with the PIPE Financing (described below) (the “Stockholder Approval Condition”); (e) the Stock Consideration having been approved for listing on the New York Stock Exchange (subject to official notice of issuance); and (f) there being no law or any governmental authority enjoining or preventing the transactions contemplated by the Purchase Agreement.

 

Termination

 

The Purchase Agreement may be terminated prior to the Completion: (i) by E2open or certain of the Sellers acting collectively if the conditions are not satisfied as of November 27, 2021, subject to extension in certain cases to February 27, 2022 (the “Longstop Date”) and (ii) prior to the Longstop Date, by E2open or certain of the Sellers acting collectively if the requisite stockholder approval is not obtained at the E2open stockholder meeting at which a vote was held to obtain such approval.

 

 

 

 

If the Purchase Agreement is terminated as a result of a failure to satisfy the Antitrust Condition, in certain cases, E2open must pay to the Sellers a termination fee equal to USD 60,000,000 (inclusive of any value added taxes).

 

If the Purchase Agreement is terminated as a result of a failure to satisfy the Stockholder Approval Condition, E2open must pay to the Sellers a termination fee equal to USD 15,000,000 (inclusive of any value added taxes).

 

Representations and Warranties, Covenants

 

The parties to the Purchase Agreement agreed to be bound by certain warranties and covenants that are customary for transactions of this type, including as to title and capacity. The warranties and covenants made by the Sellers under the Purchase Agreement will be subject to certain time limitations following Completion. The warranties and covenants made by E2open will not survive the Completion save for certain fundamental warranties and gap period covenants, which will be subject to certain time limitations following Completion.

 

E2open has agreed to customary covenants with respect to filing a proxy statement in respect of the transaction and calling and holding a meeting of E2open stockholders in order to obtain the requisite stockholder approval. E2open’s board of directors may not change its recommendation in connection with the requisite stockholder approval, unless a failure to do so would be a violation of its fiduciary duties; provided, that, in all cases E2open is required to call and hold a stockholder meeting at which a vote of the stockholders is taken with respect to the requisite stockholder approval, subject to the provisions of the Purchase Agreement.

 

Amended and Restated Investor Rights Agreement

 

In connection with the Consummation, E2open will amend its existing Investor Rights Agreement, dated as of February 4, 2021, to add certain of BluJay’s existing stockholders as parties thereto, including certain affiliates of each of Francisco Partners and Temasek Holdings (“Temasek”) and make other changes related to this transaction in the form of an Amended and Restated Investor Rights Agreement (the “A&R Investor Rights Agreement”). The A&R Investor Rights Agreement will provide each of Francisco Partners and Temasek with the right to nominate one director to E2open’s board of directors (subject to certain conditions). The A&R Investor Rights Agreement will also include registration rights in respect of the shares of Class A Common Stock of E2open held by the equityholders party thereto. In addition, Francisco Partners, Temasek, and certain of the existing equityholders of the Company will agree to a six month “lock-up” restriction with respect to their shares of Class A Common Stock of E2open.

 

A copy of the Purchase Agreement is attached as Exhibit 2.1 hereto and is incorporated herein by reference, and the foregoing description of the Purchase Agreement is qualified in its entirety by reference thereto.

 

Management Warranty Deed; Tax Deed

 

In connection with the entry into the Purchase Agreement, certain of the individual Sellers (the “Warrantors”) provide business warranties separately under the Management Warranty Deed entered into with E2open. The Warrantors’ liability under the Management Warranty Deed is limited to USD 1.00, with sole recourse being to the warranty and indemnity insurance policy, which has been obtained by E2open upon the date of entry into the Purchase Agreement and the Management Warranty Deed. Additionally, certain of the management Sellers (the “Covenantors”) entered into a Tax Deed with E2open, pursuant to which the Covenantors provide customary representations and warranties with respect to tax matters concerning BluJay. As with the Management Warranty Deed, the recourse under the tax deed is limited to USD 1.00, with sole recourse being to the warranty and indemnity policy obtained by E2open.

 

 

 

 

Under the Management Warranty Deed, the Warrantors made customary business representations and warranties for transactions of this type regarding BluJay, including with respect to capacity and authority; capitalization; subsidiaries; organizational and governing documents; solvency; financial statements and accounts; period since the Locked Box Date; indebtedness, guaranties and indemnities; real estate; non-real property assets; insurance; material contracts; compliance with laws and permits; litigation; sanctions; effect of sale on shares; intellectual property, information technology and data protection; employees; pensions; employee benefits; tax; and proxy statement information. The representations and warranties made under the Management Warranty Deed will be subject to a term set out in the Management Warranty Deed (which has been extended under the warranty and indemnity insurance policy for extended recourse)). In addition, the Warrantors and E2open agreed to be bound by certain covenants that are customary for transactions of this type in respect of the conduct, and liability in respect of, any claims made under the Management Warranty Deed.

 

A copy of the Management Warranty Deed is attached as Exhibit 2.2 hereto and is incorporated herein by reference, and the foregoing description of the Management Warranty Deed is qualified in its entirety by reference thereto. A copy of the Tax Deed is attached as Exhibit 2.3 hereto and is incorporated herein by reference, and the foregoing description of the Tax Deed is qualified in its entirety by reference thereto.

 

Support Agreement

 

In connection with the Transaction, E2open and BluJay entered into four Support Agreements, each dated May 27, 2021 (each, a “Support Agreement”), with the following stockholders of E2open (collectively, the “Supporting Stockholders”): (a) Neuberger Berman Opportunistic Capital Solutions Master Fund LP and NBOKS Co-Investment Fund I LP; (b) CC NB Sponsor 1 Holdings LLC; (c) CC Neuberger Principal Holdings I Sponsor LLC; and (d) Insight Venture Partners Growth-Buyout Coinvestment Fund (Cayman), L.P., Insight Venture Partners Growth-Buyout Coinvestment Fund (Delaware), L.P., Insight Venture Partners (Cayman) IX, L.P., Insight Venture Partners (Delaware) IX, L.P. and Insight E2open Aggregator, LLC.

 

Subject to the terms and conditions of the Support Agreements, each Supporting Stockholder has agreed, among other things and subject to the respective terms thereof, to vote its shares of Common Stock (a) in favor of the transactions contemplated by the Purchase Agreement, including the issuance of the Stock Consideration to the Sellers and amending the Certificate of Incorporation of E2open to increase the authorized number of shares of Class A Common Stock (in order to facilitate the issuance of the Stock Consideration), (b) in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of E2open at which any of the foregoing matters are submitted for consideration and vote of the stockholders of E2open if there are not sufficient votes for approval of any such matters on the date on which the meeting is held, and (c) against approval of (i) any proposal made in opposition to the Purchase Agreement or the consummation of the Transaction, (ii) any action or agreement that would to the knowledge of such Supporting Stockholder result in a breach of any covenant, representation or warranty or any other obligation or agreement of E2open contained in the Purchase Agreement, or of such Supporting Stockholder contained in its Support Agreement, and (iii) any other action that would reasonably be expected to materially impede, materially interfere with, materially delay, materially postpone or materially and adversely affect or prevent the transactions contemplated by the Purchase Agreement or its Support Agreement.

 

The Support Agreements will terminate upon the earliest to occur of the termination of the Purchase Agreement and Completion, subject to the right of the Supporting Stockholders to terminate earlier in certain limited circumstances. The Support Agreements limit the ability of the Supporting Stockholders to transfer their shares of Common Stock in a manner which results in the Supporting Stockholders ceasing to have the right to vote or direct the vote of such Common Stock, subject to certain exceptions, including that a Supporting Stockholder may transfer such Supporting Stockholder’s shares of Common Stock to certain permitted transferees.

 

A copy of each Support Agreement is attached as Exhibits 10.1, 10.2, 10.3 and 10.4 hereto and are incorporated herein by reference, and the foregoing description of the Support Agreements is qualified in its entirety by reference thereto.

 

Debt Financing

 

In connection with the signing of the Purchase Agreement, E2open entered into a commitment letter, (the “Debt Commitment Letter”), with Goldman Sachs Bank USA (“Goldman Sachs”), Credit Suisse AG and Credit Suisse Loan Funding LLC (collectively “Credit Suisse” and, together with Goldman Sachs, the “Commitment Parties”), pursuant to which the Commitment Parties have agreed, among other things, to provide USD 380 million in incremental term loans and a USD 30 million increase to the revolving credit commitments, in each case, under the Credit Agreement, dated as of February 4, 2021 (the “Credit Agreement”), by and among E2open, LLC, E2open Intermediate, LLC, each a subsidiary of E2open, the lenders party thereto and Goldman Sachs, as administrative agent, a to fund, in part, the consideration to be paid pursuant to the terms of the Purchase Agreement and to refinance certain third-party indebtedness of BluJay and to pay fees, commissions and expenses related to the foregoing (the “Debt Financing”).

 

 

 

 

PIPE Financing (Private Placement)

 

In connection with the signing of the Share Purchase Agreement, E2open entered into subscription agreements (the “Subscription Agreements”) with certain investors, including certain current equityholders of E2open (collectively, the “PIPE Investors”).

 

Pursuant to the Subscription Agreements, the PIPE Investors agreed to subscribe for and purchase, and E2open agreed to issue and sell to such investors, on the closing date, an aggregate of 28,909,022 shares of Class A Common Stock for aggregate gross proceeds of approximately $300 million (the “PIPE Financing”).

 

The closing of the PIPE Financing is contingent upon, among other things, the substantially concurrent consummation of the Transaction. The Subscription Agreements provide that E2open will grant the PIPE Investors in the PIPE Financing certain customary registration rights.

 

A copy of the form of the Subscription Agreements is attached as Exhibit 10.5 hereto and is incorporated herein by reference, and the foregoing description of the Subscription Agreements is qualified in its entirety by reference thereto.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The shares of Class A common stock to be offered and sold in connection with the PIPE Financing and the Stock Consideration have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance upon the exemption provided in Section 4(a)(2) thereof.

 

Additional Information

 

In connection with the Transaction, E2open intends to file with the Securities and Exchange Commission (the “SEC”) a preliminary proxy statement, and after the registration statement is declared effective by the SEC, E2open will mail a definitive proxy statement relating to the Transaction to its shareholders. This Current Report on Form 8-K does not contain all the information that should be considered concerning the Transaction and is not intended to form the basis of any investment decision or any other decision in respect of the Transaction. E2open’s shareholders and other interested persons are advised to read, when available, the preliminary proxy statement and the amendments thereto and the definitive proxy statement and other documents filed in connection with the Transaction, as these materials will contain important information about E2open, BluJay and the Transaction. When available, the definitive proxy statement and other relevant materials for the Transaction will be mailed to shareholders of E2open as of a record date to be established for voting on the Transaction. Shareholders will also be able to obtain copies of the preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: E2open Parent Holdings, Inc., 9600 Great Hills Trail, Suite 300E, Austin, TX 78759.

 

Participants in the Solicitation

 

E2open and its directors and executive officers may be deemed participants in the solicitation of proxies from E2open’s shareholders with respect to the Transaction. A list of the names of those directors and executive officers and a description of their interests in E2open is contained in E2open’s filings with the SEC, including in E2open’s Annual Report on Form 10-K for the year ended February 28, 2021, which was filed with the SEC and is available free of charge at the SEC’s website at www.sec.gov, or by directing a request to: E2open Parent Holdings, Inc., 9600 Great Hills Trail, Suite 300E, Austin, TX 78759. Additional information regarding the interests of such participants will be contained in the preliminary proxy statement for the Transaction when available.

 

BluJay and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of E2open in connection with the Transaction. A list of the names of such directors and executive officers and information regarding their interests in the Transaction will be included in the proxy statement for the Transaction when available.

 

No Offer or Solicitation

 

This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of E2open or BluJay, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

 

Forward-Looking Statements

 

Certain statements in this Current Report on Form 8-K may be considered forward-looking statements. Forward-looking statements generally relate to future events or E2open’s or BluJay’s future financial or operating performance. For example, projections of future growth, financial performance, and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “potential” or “continue,” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward looking statements.

 

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by E2open and its management, and BluJay and its management, as the case may be, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any subsequent definitive agreements with respect to the Transaction; (2) the outcome of any legal proceedings that may be instituted against E2open, BluJay, the combined company or others following the announcement of the Transaction and any definitive agreements with respect thereto; (3) the inability to complete the Transaction due to the failure to obtain approval of the shareholders of E2open, to obtain financing to complete the Transaction or to satisfy other conditions to closing; (4) changes to the proposed structure of the Transaction that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Transaction; (5) the ability to meet stock exchange listing standards following the consummation of the Transaction; (6) the risk that the Transaction disrupts current plans and operations of BluJay as a result of the announcement and consummation of the Transaction; (7) the ability to recognize the anticipated benefits of the Transaction, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Transaction; (9) changes in applicable laws or regulations; (10) the possibility that BluJay or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) BluJay’s estimates of expenses and profitability; and (12) other risks and uncertainties set forth in E2open’s filings with the SEC, including in the section entitled “Risk Factors” and “Forward-Looking Statements” in E2open’s Annual Report on Form 10-K for the year ended February 28, 2021.

 

Nothing in this Current Report on Form 8-K should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Neither E2open nor BluJay undertakes any duty to update these forward-looking statements.

 

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d)            Exhibits. The following exhibits are provided as part of this Form 8-K:

 

Exhibit No.   Description
2.1†   Share Purchase Deed, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc., BluJay TopCo Limited and the other parties thereto.
     
2.2†   Management Warranty Deed, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. and the other parties thereto.
     
2.3†   Tax Warranty Deed, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. and the other parties thereto.
     
10.1   Support Agreement, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. BluJay TopCo Limited, Neuberger Berman Opportunistic Capital Solutions Master Fund LP, and NBOKS Co-Investment Fund I LP
     
10.2   Support Agreement, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. BluJay TopCo Limited and CC NB Sponsor 1 Holdings LLC
     
10.3   Support Agreement, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. BluJay TopCo Limited and CC Neuberger Principal Holdings I Sponsor LLC
     
10.4   Support Agreement, dated as of May 27, 2021, by and among E2open Parent Holdings, Inc. BluJay TopCo Limited, Insight Venture Partners Growth-Buyout Coinvestment Fund (Cayman), L.P., Insight Venture Partners Growth-Buyout Coinvestment Fund (Delaware), L.P., Insight Venture Partners (Cayman) IX, L.P., Insight Venture Partners (Delaware) IX, L.P. and Insight E2open Aggregator, LLC
     
10.5   Form of Subscription Agreement.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

†      Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). E2open agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 

 

 

 

SIGNATURES

Pursuant to the Requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  E2open Parent Holdings, Inc.
     
Date: June 1, 2021 By: /s/ Laura L. Fese
    Laura L. Fese
    Executive Vice President and General Counsel

 

 

 

 

Exhibit 2.1 

 

PRIVILEGED AND CONFIDENTIAL

EXECUTION VERSION

 

27 May 2021

 

 

THE INSTITUTIONAL SELLERS

 

THE MANAGEMENT SELLERS

 

THE NON-MANAGEMENT SELLERS

 

E2open Parent Holdings, Inc.

 

and

 

BluJay Topco Limited

 

 

 

SHARE PURCHASE DEED

 

related to

 

BLUJAY TOPCO LIMITED

 

 

 

 

99 Bishopsgate
London EC2M 3XF
United Kingdom
Tel: +44.20.7710.1000

www.lw.com

 

 

 

 

 

 

CONTENTS

 

Clause   Page

 

1. DEFINITIONS AND INTERPRETATION 2
     
2. SALE OF shares 16
     
3. CONSIDERATION 16
     
4. LEAKAGE 18
     
5. CONDITIONs 22
     
6. notifications to determine payments on completion 28
     
7. PRE-COMPLETION OBLIGATIONS 29
     
8. COMPLETION 37
     
9. POST-COMPLETION OBLIGATIONS 38
     
10. WARRANTIES, UNDERTAKINGS and limitations OF THE SELLERs 38
     
11. WARRANTIES, LIMITATIONS and undertakings OF THE PURCHASER 40
     
12. RESTRICTIve covenants 43
     
13. CONFIDENTIALITY AND ANNOUNCEMENTS 44
     
14. d&o insurance 47
     
15. NON-INSTITUTIONAL sellerS’ REPRESENTATIVE 47
     
16. POWER OF ATTORNEY 47
     
17. FURTHER ASSURANCE 48
     
18. ENTIRE AGREEMENT AND REMEDIES 48
     
19. POST-COMPLETION EFFECT OF AGREEMENT 50
     
20. WAIVER AND VARIATION 50
     
21. INVALIDITY 50
     
22. ASSIGNMENT AND SUCCESSORS 50
     
23. purchaser nominee 51
     
24. PAYMENTS, SET OFF AND DEFAULT INTEREST 51
     
25. NOTICES 52
     
26. COSTS 55
     
27. RIGHTS OF THIRD PARTIES 55
     
28. COUNTERPARTS 56
     
29. GOVERNING LAW AND JURISDICTION 56
     
30. PROCESS AGENT 56
     
Schedule 1 : THE SELLERS 58
     
Schedule 2 : COMPLETION OBLIGATIONS 59

 

 

 

 

Schedule 3 : PRE-COMPLETION OBLIGATIONS 62
   
Schedule 4 : PURCHASER’S WARRANTIES 66
   
Schedule 5 : PURCHASER’S DISCLOSURES 70

 

 

 

 

THIS DEED is made on 27 May 2021.

 

BETWEEN

 

(1)         The several persons whose names and addresses are set out in Part 1 of Schedule 1 (the      “Institutional Sellers”);

 

(2)         The several persons whose names and addresses are set out in Part 2 of Schedule 1 (the      “Management Sellers”);

 

(3)        The several persons whose names and addresses are set out in Part 3 of Schedule 1 (the      “Non-Management Sellers” and together with the Institutional Sellers and the Management      Sellers, the “Sellers”);

 

(4) E2open Parent Holdings, Inc., a corporation incorporated in the State of Delaware,      whose principal office is at 9600 Great Hills Trail, Suite 300E Austin, TX, United States of      America (the “Purchaser”); and

 

(5) BluJay Topco Limited, a private limited liability company incorporated in England      and Wales with registered number 08044932 and having its registered office at Blue Tower      14th Floor, MediaCityUK, Salford Quays, United Kingdom, M50 2ST (the “Company”).

 

WHEREAS

 

(A) Each Seller holds the legal and beneficial title to such number of Shares as is set forth against its name in column 2 of Schedule 1.

 

(B) Each Seller wishes to sell the legal and beneficial title to such Shares and the Purchaser wishes to acquire (or procure that a Purchaser Nominee acquires) the legal and beneficial title to such Shares subject to the terms of this Deed.

 

(C) In connection with the transactions contemplated by this Deed, the Purchaser has entered into certain subscription agreements (the “Subscription Agreements”), dated as at the date hereof and in the Agreed Form, with certain investors party thereto (collectively, the “PIPE Investors”) pursuant to which the PIPE Investors have agreed to subscribe for and purchase, and the Purchaser has agreed to issue and sell to the PIPE Investors in a private placement, the number of shares of Class A Common Stock (defined below) provided for in the applicable Subscription Agreement (collectively the “PIPE Shares”) in exchange for the purchase price set forth therein (the aggregate purchase price under the Subscription Agreements, the “PIPE Financing Amount”, and the equity financing under the Subscription Agreements, the “PIPE Financing”), on the terms and subject to the conditions set forth in the Subscription Agreements.

 

(D) Certain stockholders of the Purchaser are entering into a voting and support agreement with the Sellers, in the Agreed Form, simultaneously with the execution of this Deed (each a “Support Agreement”), pursuant to which, among other things, such stockholders of the Purchaser have agreed to vote in favour of the transactions contemplated by this Deed.

 

(E) The Company has become a party to this Deed for the purpose of Clauses 3.6, 5.6, 5.8, 5.11, 5.13, 7.3, 7.4, 7.5, 7.6, 7.11, 7.12, 7.20, 10.3, 13, 17, 18, 25 to 30. The Company shall have no liabilities or obligations whatsoever under or in connection with this Deed or any of the matters contemplated herein other than in relation to its obligations pursuant to such Clauses.

 

1

 

 

IT IS AGREED THAT

 

1. DEFINITIONS AND INTERPRETATION

 

1.1 In this Deed, unless the context otherwise requires:

 

A Ordinary Shares” means the 60,093,051 A ordinary shares of GBP 0.01 each in the capital of the Company;

 

Additional Consideration” has the meaning given in Clause 3.1(b);

 

Affiliate” means:

 

(a) in respect of any person (other than the Temasek Seller):

 

(i) any group undertaking of that person (but, in respect of the FP Sellers, shall exclude any investee or portfolio company of it or any of its Affiliates);

 

(ii) any Fund of which that person is a general partner, trustee, nominee or manager;

 

(iii) any general partner, limited partner, trustee, nominee or manager of, or holder of interests (whether directly or indirectly) in, that person;

 

(iv) any Affiliate of any of the foregoing;

 

(v) for the purposes of Clause 4 only, and in respect of any FP Seller only, an Institutional Director appointed by such FP Seller; and

 

(vi) in respect of any Non-Institutional Seller, shall include any spouse, civil partner, co-habitee and/or lineal descendants by blood or adoption of that Non-Institutional Seller and any other person connected with that Non-Institutional Seller; and

 

(b) in respect of the Temasek Seller only:

 

(i) Temasek Holdings (Private) Limited;

 

(ii) for the purposes of Clause 4 only, and in respect of the Temasek Seller only, an Institutional Director appointed by the Temasek Seller; and

 

(iii) Temasek Holdings (Private) Limited’s direct and indirect wholly owned subsidiaries: (A) whose boards of directors or equivalent governing bodies comprise employees or nominees of Temasek Holdings (Private) Limited or Temasek Pte. Ltd. and/or wholly owned subsidiaries of Temasek Pte. Ltd.; and (B) whose principal activities are that of investment holding, financing and/or the provision of investment advisory and consultancy services; provided that, to the extent the Temasek Seller engages in a transaction which would be considered Leakage with an Affiliate in accordance with the definition of Affiliate for any Person other than the Temasek Seller, such transaction shall still be considered Leakage with respect to the Temasek Seller for all purposes hereunder, but in all cases, excluding any investee or portfolio company of the Temasek Seller or any of its Affiliates,

 

and in all cases, excluding each Group Company;

 

2

 

 

 

Agreed Form” means, in relation to a document, the form of that document which has been agreed in writing (including by e-mail) by or on behalf of the Institutional Sellers and the Purchaser to be the agreed form of such document, with such changes as the Institutional Sellers and the Purchaser may mutually agree in writing (including by e-mail) before Completion;

 

Amended Certificate of Incorporation” means the amended and restated Certificate of Incorporation of the Purchaser in the Agreed Form to make such changes as are required by the transactions contemplated by this Deed, if any;

 

Amended Investor Rights Agreement” means the Amended and Restated Investor Rights Agreement of the Purchaser, in the Agreed Form, to be entered into between (among others) the Purchaser and the Institutional Sellers on Completion;

 

Antitrust Condition” has the meaning given in Clause 5.1(a);

 

Antitrust Laws” means all Laws governing the conduct of any person in relation to restrictive or other anti-competitive agreements or practices (including cartels, pricing, resale pricing, market sharing, bid rigging, terms of trading, purchase or supply and joint ventures), abuse of dominant or monopoly market positions (whether held individually or collectively) and the control of acquisitions or mergers;

 

Articles” means the articles of association of the Company as amended or restated from time to time;

 

Authority” means any competent governmental, administrative, supervisory, regulatory, judicial, determinative, disciplinary, enforcement or tax raising body, authority, stock exchange, agency, board, department, court or tribunal of any jurisdiction and whether supranational, national, regional or local;

 

B Ordinary Shares” means the 1,334,983 B ordinary shares of GBP 0.001 each in the capital of the Company;

 

Bank Pay-Off Amount” means the amount required to:

 

(a) discharge all amounts owed by the Company and any Group Company at Completion (including all amounts of principal, interest, fees, expenses, prepayment costs and any break fees) under the Existing Facilities, together with any associated hedging arrangements; and

 

(b) release all Encumbrances in relation to the Existing Facilities (inclusive of any prepayment costs);

 

BEIS” has the meaning given in Clause 5.1(c);

 

Break Fee” has the meaning given in Clause 5.13;

 

Broader Staff Bonus” means the bonus to be paid prior to Completion to certain employees of the Group in respect of the 2021 financial year, of up to an aggregate amount (before deductions for Tax or otherwise) equal to USD 2,900,000;

 

3

 

 

Business” means the business as carried on by the Group as at the date of this Deed;

 

Business Day” means a day (other than a Saturday or Sunday) on which banks in the City of London and City of New York are open for ordinary banking business;

 

C Ordinary Shares” means the 6,949,750 C ordinary shares of GBP 0.001 each in the capital of the Company;

 

Certificate of Incorporation” means the Certificate of Incorporation of the Purchaser as in effect at the date of this Deed.

 

CFIUS” means the Committee on Foreign Investment in the United States and each member agency thereof, acting in such capacity;

 

CFIUS Authorities” means the Defense Production Act of 1950 (50 U.S.C.§ 4565), and its implementing regulations located at 31 C.F.R. Parts 800-802;

 

CFIUS Clearance” means either:

 

(a) CFIUS has concluded that the Transaction is not a “Covered Real Estate Transaction” or otherwise a “Covered Transaction” and is not subject to review under the CFIUS Authorities;

 

(b) CFIUS has issued a written notice that it has completed a review or investigation of the declaration or notice provided pursuant to the CFIUS Authorities with respect to the Transaction, and has concluded all action under the CFIUS Authorities;

 

(c) in the event that the parties have filed a declaration, CFIUS has informed the parties that it is unable to conclude action under the CFIUS Authorities with respect to the Transaction on the basis of the declaration, but CFIUS has not requested that the parties file a written notice of the Transaction, and the thirty (30) day assessment period established by CFIUS for the review of the declaration shall have elapsed; or

 

(d) if CFIUS has sent a report to the President of the United States (the “President”) requesting the President’s decision and (x) the President has announced a decision not to take any action to suspend or prohibit the proposed action or (y) having received a report from CFIUS requesting the President’s decision, the President has not taken any action after fifteen (15) days from the earlier of the date the President received such report from CFIUS or the end of the investigation period;

 

Claim” means any demand or claim made by the Purchaser against any of the Sellers, whether in contract or otherwise, under or in relation to or for any breach of any Transaction Document (other than the Management Warranty Deed or the Tax Deed which shall be subject to the limitations set out therein), including in respect of any of the Seller Warranties, save for any claims in respect of a breach of Clause 4.1;

 

Class A Common Stock” means the Class A common stock, par value USD 0.0001 per share, of the Purchaser;

 

4

 

 

Class B Non-Voting Common Stock” means the Class B common stock, par value USD 0.0001 per share, of the Purchaser;

 

Commitment” means any condition, obligation, undertaking, undertaking in lieu of reference and/or modification, which may include any structural or behavioural commitment that relates in any manner whatsoever to any undertaking or business, activities or assets:

 

(a) of any undertaking that is Controlled by the Purchaser or any member of the Purchaser Group or which is, with the Purchaser, under common Control; or

 

(b) to be transferred to the Purchaser or another member of the Purchaser Group on or after Completion;

 

Company” has the meaning given in Recital (5);

 

Company’s Bank Account” means the bank account of the Company, details of which are set out in the Consideration Allocation Schedule;

 

Company Qualified Plan” has the meaning given in Clause 7.2;

 

Completion” means completion of the sale and purchase of the Shares in accordance with Clause 8;

 

Completion Date” means the date on which Completion takes place;

 

Completion Default” has the meaning given in Clause 8.5;

 

Conditions” has the meaning given in Clause 5.1;

 

Confidential Information” has the meaning given in Clause 13.1(a);

 

Consideration” means the Ordinary Share Consideration and the Preference Share Consideration;

 

Consideration Allocation Schedule” has the meaning given in Clause 6.1;

 

Consideration Share Value” has the meaning given in Clause 3.3(a);

 

Consideration Shares” has the meaning given in Clause 3.3(a);

 

Constitutional Documents” means, with respect to an entity, its memorandum and articles of association, certificate of incorporation, by-laws, or equivalent constitutional documents;

 

Consulting Payments” has the meaning given in Clause 4.8(c);

 

Control” means the power to direct the management and policies of a person (directly or indirectly), whether through ownership of voting securities, by contract or otherwise (and the term “Controlled” shall be interpreted accordingly);

 

Credit Agreement” means the credit agreement dated 4 February 2021 entered into between, among others, E2open Intermediate LLC, E2open LLC, as borrower and Goldman Sachs Bank USA, as administrative agent and collateral agent;

 

D&O Insurance” has the meaning given in Clause 14.1;

 

5

 

 

D&O Insurance Costs” means the costs and expenses (including the total premium) incurred by the Group in implementing the D&O Insurance pursuant to and in accordance with the terms of Clause 14.1 (the total amount of which, without changing the definition thereof, is set out in the Consideration Allocation Schedule);

 

Data Room” means the virtual data room, hosted by Datasite under the name “Project Eagle” in connection with the Transaction as at 23:59 on 25 May 2021, and in respect of paragraph (k) of Schedule 3 only, as at 23:59 on 26 May;

 

Debt Financing Agreements” has the meaning given in paragraph 2.1 of Schedule 4;

 

Debt Security” means each of the security agreements, mortgages, collateral assignments, pledge agreements or other similar agreements delivered to the security agent under the Existing Facilities and each of the other agreements, instruments or documents that creates or purports to create a lien in favour of the security agent (for the benefit of the secured parties) and/or the secured parties under the Existing Facilities;

 

Deed of Release” means one or more deeds of release in customary form (and any equivalent release document(s), notice(s) or form(s) required in applicable jurisdictions in customary form) pursuant to which all of the Debt Security shall be released on the Completion Date, subject to receipt by the relevant recipient(s) of the Bank Pay-Off Amount;

 

Director Expenses” has the meaning given in Clause 4.8(b);

 

Disclosed” has the meaning given in the Management Warranty Deed;

 

Disclosed Exit Bonuses” means those Exit Bonuses, details and amounts of which are set out in the Consideration Allocation Schedule;

 

Disclosed Transaction Costs” means those Transaction Costs, details and amounts of which are set out in the Consideration Allocation Schedule;

 

Dispute” has the meaning given in Clause 29.3;

 

Encumbrance” means any interest or equity of any person (including any right to acquire, option or right of pre-emption), any mortgage, charge, debenture, pledge, lien, assignment, hypothecation, security interest (including any created by Law), title retention or other security agreement or arrangement, and any agreement, arrangement or obligation to grant or create any of the foregoing;

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder, all as the same shall be in effect at the time (or any successor statute and related rules and regulations);

 

Exchange Rate” means, with respect to a particular currency for a particular day, the closing mid-point spot rate of exchange for that currency into sterling on such date as published in the London edition of the Financial Times first published thereafter or, where no such rate is published in respect of that currency for such date, at the rate quoted by HSBC Bank plc as at the close of business in London as at such date;

 

6

 

 

Existing Facilities” means:

 

(a) the senior and super senior facilities agreement dated 11 August 2017 and entered into between, amongst others, BluJay Solutions Group Holdings Limited (as Parent) and TPG Specialty Lending Europe 1 Advisors, Ltd. (as the Agent and Security Agent), as amended, supplemented, novated and/or restated from time to time (the “SFA”); and

 

(b) any Finance Documents (as defined in the SFA), including associated hedging agreements or ancillary agreements in respect of the above;

 

Exit Bonuses” means the gross amount of any bonuses, incentives or commission to be paid or agreed to be paid or incurred or owing to any current or former employee or director (including a non-executive director) of any Group Company by any Group Company in connection with, or as a result of, the Transaction, together with any employer’s social security contributions, payroll, employment and similar Taxes thereon or in connection therewith for which a Group Company is or would be liable;

 

FP Sellers” means Francisco Partners Parallel Fund III (Cayman), L.P. and Francisco Partners III (Cayman), L.P.;

 

Fund” means any person, trust, or fund holding shares for investment purposes;

 

GAAP” means U.S. generally accepted accounting principles, in effect from time to time;

 

GAAS” means U.S. generally accepted auditing standards, in effect from time to time;

 

Good Reason” means, in respect of any person who is employed or engaged by a Group Company or a member of the Purchaser Group (the “Employing Company”) (a) such person’s (i) resignation as a result of his or her serious physical disability, permanent ill health or permanent mental incapacity as certified by an independent medical practitioner of good standing, (ii) constructive dismissal from their Employing Company, or (iii) retirement from their Employing Company after the applicable statutory retirement age for such person concerned, or (b) if the board of directors of a Group Company or a member of the Purchaser Group, in its sole discretion, determines by valid action that such person is deemed to have resigned from the Employing Company for “Good Reason” for the purposes of this Deed, or (c) a materially detrimental change to such person’s position, duties, base salary or annual bonus opportunity that is not cured by the Group Company or member of the Purchaser Group within thirty (30) days of written notice regarding such change for such person;

 

Group” means the Company and all of the subsidiary undertakings of the Company;

 

Group Company” means any member of the Group and “Group Companies” means all of them;

 

HSR Act” has the meaning given in Clause 5.1(a);

 

IFRS” means International Financial Reporting Standards as issued by the International Accounting Standards Board;

 

Institutional Directors” means Deep Shah, Lizhi Tan, Martin Fichtner and Quentin Lathuille;

 

Institutional Sellers” has the meaning given in Recital (1);

 

7

 

 

Intellectual Property Rights” means all intellectual property rights worldwide, including rights in patents, utility models, trade marks, service marks, logos, getup, trade names, internet domain names, copyright (including rights in computer software), design rights, moral rights and contractual waivers of moral rights, database rights and rights in data, confidential information and knowledge (including know how, inventions, secret formulae and processes, market information, and lists of customers and suppliers), and rights protecting goodwill and reputation, in all cases whether registered or unregistered; all other forms of protection having a similar nature or effect anywhere in the world to any of the foregoing and applications for or registrations (or rights to apply for registration) of any of the foregoing rights;

 

Investment Agreement” means the investment agreement dated 22 September 2017 between the Institutional Sellers, the Non-Institutional Sellers and the Company, as amended from time to time prior to the date hereof;

 

Irrecoverable VAT” means any output VAT paid which is not recoverable as input tax by a person or the representative member of any VAT group of which it forms part;

 

Known Leakage” means any Leakage which is, at least six (6) Business Days prior to Completion, agreed in writing between the Institutional Sellers and the Purchaser to be reflected in the calculation of the Ordinary Share Consideration payable at Completion;

 

Law” or “Laws” means all applicable:

 

(a) legislation, statutes, subordinate legislation, directives, regulations, instruments, by-laws or constitutional documents, and other legislative measures or decisions having the force of law, treaties, conventions and other agreements between states or between states and the European Union or the United States, as appropriate, or other supranational bodies, rules of common law, customary law and equity, any applicable direction, statement of practice, policy, rule or order that is set out by an Authority that is binding on a party, and all civil or other codes and all other laws of, or having effect in, any jurisdiction from time to time; and

 

(b) binding judgments, orders, decrees, awards, rulings or decisions from any court, tribunal or arbitrator, whether temporary, preliminary or permanent;

 

Leakage” has the meaning given in Clause 4.7;

 

Leakage Claim” has the meaning given in Clause 4.2;

 

Leakage Determination Date” has the meaning given in Clause 4.6;

 

Leakage Payment Amount” has the meaning given in Clause 4.2;

 

LLC Agreement” means the limited liability company agreement of E2open Holdings, LLC, a wholly owned subsidiary of the Purchaser, dated as of 4 February 2021, as the same may be amended from time to time;

 

Lock-Up Agreement” means a lock-up agreement in the Agreed Form;

 

Locked Box Accounts” means the unaudited management accounts of the Company for the period ended on the Locked Box Date, in the Agreed Form;

 

Locked Box Date” means 31 December 2020;

 

8

 

 

Longstop Date” means:

 

(a) 5.00 p.m. EST on the date that is six (6) months from the date hereof; or

 

(b) unless otherwise agreed in writing between the Institutional Sellers and the Purchaser, if either:

 

(i) the Antitrust Condition in Clause 5.1(a) shall not have been satisfied or waived; or

 

(ii) the Condition set forth in Clause 5.1(f) shall not have been satisfied or waived (but only as a result of a binding judgment, order, decree, award, ruling or decision from any court, tribunal or commission under the Antitrust Laws),

 

in each case, as at 5.00 p.m. EST on the date that is six (6) months from the date hereof and provided, except for the NSI Condition, all other Conditions to Completion shall have been satisfied or waived (or, in the case of Conditions that by their nature are to be satisfied at the Completion, shall be capable of being satisfied on such date), then the Longstop Date shall be extended to 5.00 p.m. EST on the date that is nine (9) months from the date hereof; or

 

(c) such later time and date as may be agreed between the Institutional Sellers and the Purchaser, or otherwise extended pursuant to Clause 5.4(d);

 

Losses” means all costs, losses, liabilities, damages, claims, demands, proceedings, expenses, penalties and properly incurred legal and other professional fees;

 

Management Borrowers” means Andrew Kirkwood and Michael Hunt;

 

Management Loan Repayment Amount” has the meaning given in Clause 3.5;

 

Management Loans” means (a) the promissory note dated 28 June 2019 between Andrew Kirkwood (as borrower) and the Company (as lender) for a principal amount of GBP 151,172.21 (plus all accrued interest), a copy of which is contained in Document 1.7.2 of the Data Room; and (b) the promissory note dated 26 April 2019 between Michael Hunt (as borrower) and the Company (as lender) for a principal amount of GBP 61,530.16 (plus all accrued interest), a copy of which is contained in Document 1.7.1 of the Data Room;

 

Management Sellers” has the meaning given in Recital (2);

 

Management Warranty Deed” means the management warranty deed entered into on the date of this Deed between Andrew Kirkwood, Michael Hunt, Joy Burkholder Meier and the Purchaser;

 

Master Consulting Services Agreement” means the master consulting services agreement between Francisco Partners Consulting LLC and the Company dated 3 May 2017;

 

Material Completion Obligation” means:

 

(a) in respect of the Sellers, those obligations set out in paragraphs 1(a), 1(b)(i), 1(b)(iii), 1(b)(iv), 1(c)(i)(B), 1(c)(i)(C) and 1(c)(ii)(A) of Schedule 2; and

 

(b) in respect of the Purchaser, those obligations set out in paragraphs 2(a), 2(b), 2(c)(i)(A), 2(c)(i)(D) and 2(c)(ii) (provided that, in respect of paragraph 2(c)(ii) of Schedule 2, the Sellers have provided all information reasonably requested by the transfer agent in order to issue the Consideration Shares) of Schedule 2;

 

9

 

 

Non-Institutional Sellers” means the Management Sellers and the Non-Management Sellers;

 

Non-Institutional Sellers’ Representative” has the meaning given in Clause 15.1;

 

Non-Management Sellers” has the meaning given in Recital (3);

 

NSI Act” means the United Kingdom’s National Security and Investment Act 2021;

 

NSI Condition” has the meaning given in Clause 5.1(c);

 

NYSE” means the New York Stock Exchange;

 

Ordinary Share Cash Consideration” has the meaning given in Clause 3.3(b);

 

Ordinary Share Consideration” has the meaning given in Clause 3.1;

 

Ordinary Shares” means the A Ordinary Shares, B Ordinary Shares and C Ordinary Shares;

 

Pay-Off Letter” means the payoff letter to be provided by a lender (or agent on behalf of a lender) under the Existing Facilities, setting out the amount (including all ancillary amounts) required to be paid by a particular date under the relevant Existing Facilities to the relevant finance parties in order to discharge and repay that Existing Facilities in full on that date, in customary form reasonably agreed by the Purchaser and the Institutional Sellers;

 

Paying Agent Account” means the paying agent account, details of which are set out in the Consideration Allocation Schedule;

 

Permitted Leakage” has the meaning given in Clause 4.8;

 

PIPE Financing” has the meaning given in Recital (C);

 

PIPE Financing Amount” has the meaning given in Recital (C);

 

PIPE Investors” has the meaning given in Recital (C);

 

PIPE Shares” has the meaning given in Recital (C);

 

Plan” means any benefit or compensation plan, including any share option, share purchase, restricted share, restricted share unit, share appreciation, phantom equity or other equity or equity based incentives, severance, separation pay, bonus, commissions, retention, stay bonuses, change in control or other transactions program, policy, agreement, contract or arrangement maintained, sponsored, contributed or required to be contributed to by any Group Company or with respect to which any Group Company has any current or contingent liability or obligation, excluding any schemes or arrangements mandated by a government entity outside of the United States;

 

Preference Share Consideration” means the aggregate amount payable pursuant to the Articles to redeem and repay the amounts as credited as paid up on the Preference Shares together with all accrued dividends in respect of the Preference Shares up to and including the Completion Date (converted from GBP to USD at the Exchange Rate one (1) Business Day prior to the delivery of the Consideration Allocation Schedule pursuant to Clause 6.1);

 

10

 

 

Preference Shares” means the 38,355,558 A preference shares of GBP 1.00 each in the capital of the Company;

 

Preferred Stock” means the preferred stock, par value USD 0.0001 per share, of the Purchaser;

 

President” has the meaning given to it in the definition of CFIUS Clearance;

 

Proxy Statement” has the meaning given in Clause 7.11;

 

Purchaser” has the meaning given in Recital (4);

 

Purchaser Board” has the meaning given in paragraph 4.1 of Schedule 4;

 

Purchaser Board Recommendation” has the meaning given in paragraph 4.1(b) of Schedule 4;

 

Purchaser Claim” has the meaning given in Clause 11.9;

 

Purchaser Financial Statements” has the meaning given in paragraph 5.4 of Schedule 4;

 

Purchaser Financing Agreements” has the meaning given in paragraph 2.1 of Schedule 4;

 

Purchaser Group” means the Purchaser and any subsidiary undertaking of the Purchaser, including, for the avoidance of doubt, the Group Companies from Completion;

 

Purchaser Qualified Plan” has the meaning given in Clause 7.2;

 

Purchaser SEC Documents” has the meaning given in paragraph 5.1 of Schedule 4;

 

Purchaser Stock” has the meaning given in paragraph 3.1 of Schedule 4;

 

Purchaser Stockholder Meeting” has the meaning given in Clause 7.15;

 

Regulatory Conditions” has the meaning given in Clause 5.1(c);

 

Relief” means any loss, allowance, credit, deduction, exemption or set off in respect of any Tax, or any repayment or refund of or saving of Tax;

 

Representatives” means, in relation to any Seller and its Affiliates, their respective directors, officers, employees, agents, consultants and professional advisers and, in relation to the Purchaser, any member of the Purchaser Group and their respective directors, officers, employees, agents, consultants and professional advisers;

 

Required Financial Statements” has the meaning given in Clause 7.3;

 

Requisite Stockholder Approval” means (a) the affirmative vote of a majority of the votes cast by the stockholders present in person or represented by proxy at a meeting of the Purchaser’s stockholders and entitled to vote thereon in favour of issuing the Consideration Shares and the PIPE Shares and (b) to the extent the Purchaser reasonably determines such amendment is required in order to implement the transactions contemplated by this Deed, the affirmative vote of a majority of the shares outstanding and entitled to vote thereon in favour of the Amended Certificate of Incorporation;

 

11

 

 

Restricted Business” means the provision of logistics and global trade management software and services related to such software applications;

 

Restricted Management Sellers” means each of Andrew Kirkwood, Joy Meier, Timothy Hinson, Christopher Timmer, Sian Hopwood, Scott Brown, Johnny Thogersen, Douglas Surrett, Sharon Plested, Patrick Maley, Michael Hunt, David Landau and Samuel Addeo;

 

Restricted Management Seller” shall be construed accordingly;

 

Restricted Period” has the meaning given in Clause 12.2;

 

Sarbanes-Oxley Act” means the Sarbanes-Oxley Act of 2002, as amended;

 

Scheduled Completion Date” has the meaning given in Clause 8.4;

 

SEC” means the Securities and Exchange Commission, or any other federal agency then administering the Securities Act or the Exchange Act;

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder, all as the same shall be in effect at the time (or any successor statute and related rules and regulations);

 

Seller’s Nominee” has the meaning given in paragraph 2(c)(ii) of Schedule 2;

 

Seller Warranties” means the warranties given by the Sellers as set out in Clause 10;

 

Sellers” has the meaning given in Recital (3) and “Seller” shall be construed accordingly;

 

Senior Employee” means each of Andrew Kirkwood (Chief Executive Officer of the Group), Michael Hunt (Chief Financial Officer of the Group) and any other employee, director or independent service provider or consultant of the Group whose gross base salary or compensation exceeds $200,000 (or local equivalent) per year;

 

Shares” means the Ordinary Shares and the Preference Shares;

 

Signing Form 8-K” has the meaning given in Clause 13.5;

 

Signing Press Release” has the meaning given in Clause 13.5;

 

Stockholder Approval Condition” has the meaning given in Clause 5.1(d);

 

Stockholder Conditions” means the Stockholder Approval Condition and the Stockholder Listing Condition;

 

Stockholder Listing Condition” has the meaning given in Clause 5.1(e);

 

Subscription Agreement” has the meaning given in Recital (C);

 

Support Agreements” has the meaning given in Recital (D);

 

Surviving Provisions” means Clauses 1, 5.12, 5.13, 8.5(d), 13, 15, 18, 20 to 29.1 (inclusive);

 

12

 

 

Tax” means:

 

(a) all forms of tax, levy, impost, contribution, duty, liability and charge in the nature of taxation (including payment under the Corporation Tax (Instalment Payments) Regulations 1998) and all related withholdings or deductions of any nature (including, for the avoidance of doubt, PAYE and National Insurance contribution liabilities in the United Kingdom and corresponding obligations elsewhere); and

 

(b) all related fines, penalties, charges and interest,

 

in each case, imposed, collected or assessed by, or payable to, a Tax Authority whether directly or primarily chargeable against, recoverable from or attributable to any of the Group Companies or another person (including as a transferee or successor, by contract, or otherwise by operation of Law) and regardless of whether any Group Company has, or may have, any right of reimbursement against any other person (and “Taxes” shall be construed accordingly);

 

Tax Authority” means a taxing or other governmental (local or central), state or municipal authority (whether within or outside the United Kingdom) competent to impose a liability for or to collect Tax;

 

Tax Deed” means the deed relating to tax entered into on the date of this Deed between Andrew Kirkwood, Michael Hunt, Joy Burkholder Meier and the Purchaser;

 

Temasek Seller” means Anderson Investments Pte. Ltd.;

 

Trading Day” means a day on which the New York Stock Exchange is open for business (excluding any day during which trading of the Class A Common Stock has been suspended for more than ninety (90) minutes);

 

Transaction” means the transactions contemplated by this Deed and/or the other Transaction Documents or any part thereof;

 

Transaction Costs” means any professional fees, expenses or other disbursements paid or agreed to be paid or incurred or owing in connection with the Transaction by any Group Company or the potential initial public offering of shares of the Company (or one of its parent undertakings or subsidiary undertakings), in each case excluding VAT payable thereon other than Irrecoverable VAT;

 

Transaction Documents” means this Deed, the Subscription Agreements, the Support Agreement, the Management Warranty Deed, the Amended Investor Rights Agreement, the Tax Deed, the Lock-Up Agreements, any document in the Agreed Form and any other document to be delivered on Completion (as set out in Schedule 2);

 

Transfer Taxes” means all transfer, real estate transfer, stamp duty, stamp duty reserve, documentary, notarial, registration and other similar Taxes;

 

VAT” means: (a) any value added tax imposed by the Value Added Tax Act 1994; (b) any tax imposed in compliance with the Council Directive of 28 November 2006 on the common system of value added tax (EC Directive 2996/112); and (c) or any other similar tax, whether chargeable in the United Kingdom or in a member state of the European Union in substitution for, or levied in addition to, such tax referred to in paragraphs (a) or (b) above, or imposed elsewhere;

 

13

 

 

VWAP” means, for any Trading Day, the volume-weighted average price per share of the Class A Common Stock as reported by Bloomberg L.P. in respect of the period from 9:30 am to 4:00 pm, New York City time on such Trading Day;

 

W&I Insurer” means Ambridge Europe Limited; and

 

Working Hours” means 9:30 am to 5:30 pm on a Business Day.

 

1.2 In this Deed, unless the context otherwise requires:

 

(a) references to an “undertaking” and “group undertaking” shall be construed in accordance with section 1161 of the United Kingdom Companies Act 2006 and references to “subsidiary undertaking” and “parent undertaking” shall be construed in accordance with section 1162 of the United Kingdom Companies Act 2006, save that an undertaking shall be treated as an undertaking whether or not formed or incorporated in the United Kingdom and for the purposes of the membership requirement in sections 1162(2)(b) and (d) and section 1162(3)(a) as a member of another undertaking even if its shares in that other undertaking are registered in the name of: (i) its nominee; or (ii) another person (or its nominee) by way of security or in connection with the taking of security;

 

(b) every reference to a particular Law shall be construed also as a reference to all other Laws made under the Law referred to and to all such Laws as amended, re-enacted, consolidated or replaced or as their application or interpretation is affected by other Laws from time to time and whether before or after Completion provided that, as between the parties, no such amendment or modification made after the date of this Deed shall apply for the purposes of this Deed to the extent that it would impose any new or extended obligation, liability or restriction on, or otherwise adversely affect the rights of, any party;

 

(c) references to Clauses and Schedules are references to clauses of and schedules to this Deed, references to paragraphs are references to paragraphs of the Schedule in which the reference appears and references to this Deed include the Schedules;

 

(d) references to the singular shall include the plural and vice versa and references to one gender include any other gender;

 

(e) references to a “party” means a party to this Deed (or with respect to the Company, the applicable clauses hereof) and includes its successors in title, personal representatives and permitted assigns;

 

(f) references to a “person” includes any individual, partnership, body corporate, corporation sole or aggregate, state or agency of a state, and any unincorporated association or organisation, in each case whether or not having separate legal personality;

 

(g) references to a “company” includes any company, corporation or other body corporate wherever and however incorporated or established;

 

(h) references to “sterling”, “pounds sterling”, “GBP” or “£” are references to the lawful currency from time to time of the United Kingdom;

 

14

 

 

(i) references to “dollars”, “USD”, “US$” or “$” are references to the lawful currency from time to time of the United States of America;

 

(j) for the purposes of applying a reference to a monetary sum expressed in sterling, an amount in a different currency shall be deemed to be an amount in sterling translated at the Exchange Rate at the relevant date;

 

(k) references to times of the day are to London time unless otherwise stated;

 

(l) references to writing shall include any modes of reproducing words in a legible and non-transitory form;

 

(m) references to any English legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court official or any other legal concept or thing shall in respect of any jurisdiction other than England be deemed to include what most nearly approximates in that jurisdiction to the English legal term;

 

(n) words introduced by the word “other” shall not be given a restrictive meaning because they are preceded by words referring to a particular class of acts, matters or things;

 

(o) general words shall not be given a restrictive meaning because they are followed by words which are particular examples of the acts, matters or things covered by the general words and the words “includes” and “including” shall be construed without limitation; and

 

(p) a procuring obligation:

 

(i) subject to Clause 1.2(p)(ii) below, where used in the context of a Seller, means that such Seller undertakes to exercise its voting rights and use such powers as are available to it from time to time in its capacity as a shareholder of the Company and/or as appointor of any directors of any Group Company that are appointed by such Seller and/or its Affiliates from time to time (subject to such directors’ fiduciary obligations), to ensure compliance with that obligation; and

 

(ii) where used in the context of a Management Seller in respect of Schedule 3 only, means that such Management Seller undertakes to take such action as is available to him or her within the scope of his or her authority as an employee, officer or manager of any Group Company and, to the extent relevant and he or she is lawfully able to do so (including without acting or voting in a manner inconsistent with his or her fiduciary duties), a director or officer of any Group Company, to procure (to the foregoing extent) the relevant matter.

 

1.3 The headings and sub-headings in this Deed are inserted for convenience only and shall not affect the construction of this Deed.

 

1.4 Each of the Schedules to this Deed shall form part of this Deed.

 

1.5 References to this Deed include this Deed as amended or varied in accordance with its terms.

 

1.6 All warranties, indemnities, covenants, agreements and obligations given or entered into by more than one Seller under this Deed are given or entered into severally and not jointly nor jointly and severally and accordingly the liability of each Seller in respect of any breach of any such obligation, undertaking or liability shall extend only to any loss or damage arising from its own breach.

 

15

 

 

2. SALE OF shares

 

2.1 On the terms set out in this Deed, each Seller shall sell with full title guarantee and free from all Encumbrances and the Purchaser shall purchase (or procure that a Purchaser Nominee purchases) the legal and beneficial title to the Shares set forth against that Seller’s name in column 2 of Schedule 1 with effect from Completion, together with all rights attaching to such Shares as at Completion (including all dividends, yields and distributions declared, paid or made in respect of such Shares after the Completion Date).

 

2.2 Each of the Sellers irrevocably waives any and all rights and restrictions in respect of the Shares that may have been conferred on it under the Articles, the Investment Agreement or otherwise, including any right of pre-emption, redemption, first refusal or other restriction on transfer in respect of the Shares.

 

3. CONSIDERATION

 

3.1 The aggregate purchase price for the sale of all of the Ordinary Shares under this Deed (the “Ordinary Share Consideration”) shall be the sum of:

 

(a) USD 1,187,621,793; plus

 

(b) an amount of additional consideration calculated on the basis of USD 63,000 multiplied by the number of days elapsed from (and including) the Locked Box Date up to (and excluding) the Completion Date (the “Additional Consideration”); plus

 

(c) the Management Loan Repayment Amount; minus

 

(d) the Preference Share Consideration; minus

 

(e) the Known Leakage (if any); minus

 

(f) an amount equal to the Disclosed Transaction Costs; minus

 

(g) an amount equal to the Disclosed Exit Bonuses; minus

 

(h) an amount equal to the D&O Insurance Costs; minus

 

(i) an amount equal to the Director Expenses; minus

 

(j) an amount equal to the Consulting Payments.

 

3.2 The aggregate purchase price for the sale of all of the Preference Shares under this Deed shall be the Preference Share Consideration.

 

3.3 At Completion, the Consideration shall be satisfied as follows:

 

(a) subject to Clause 7.8, the issuance of 72,383,299 shares of Class A Common Stock in book-entry form by the Purchaser (or its transfer agent acting on its behalf) to the Sellers (or to a Seller’s Nominee) as set out in the Consideration Allocation Schedule and in accordance with Schedule 2 hereof, in each case, free from Encumbrances (other than as set forth herein, restrictions on the transfer of Class A Common Stock as set forth in the Amended Investor Rights Agreement or under any relevant requirements of, NYSE, the Securities Act or the Exchange Act), the aggregate value of which, for the purposes of this Deed, is agreed to be USD 730,854,170 (the “Consideration Shares” and the aggregate value of such Consideration Shares, the “Consideration Share Value”);

 

16

 

 

(b) the payment in cash by the Purchaser to the Paying Agent Account of the Preference Share Consideration; and

 

(c) the payment in cash by the Purchaser to the Paying Agent Account of an aggregate amount equal to the sum of the following (the “Ordinary Share Cash Consideration”):

 

(i) the Ordinary Share Consideration; minus

 

(ii) the Consideration Share Value,

 

and such issuance and payment shall be an absolute discharge to the Purchaser who shall not be concerned with the subsequent application of the amount of Preference Share Consideration and Ordinary Share Cash Consideration so paid or the allocation of the Consideration Shares so issued.

 

3.4 At Completion, the Purchaser shall procure payment by or on behalf of the relevant Group Company of the Bank Pay-Off Amount in accordance with the Pay-Off Letter to the providers of finance under the Existing Facilities.

 

3.5 Each Management Borrower acknowledges and agrees that: (a) the outstanding sums owed by him at Completion under his Management Loan shall be repayable at Completion in accordance with its terms (as amended from time to time) and that such amounts shall be converted from GBP into USD at the Exchange Rate on the Business Day prior to the delivery of the Consideration Allocation Schedule pursuant to Clause 6.1 (in respect of each Management Borrower, such amount being the “Management Loan Repayment Amount” and aggregate amount being the Management Loan Repayment Amounts); and (b) his Management Loan Repayment Amount shall be deducted from that part of the Ordinary Share Cash Consideration paid to him for his Shares in full and final settlement of his Management Loan. Immediately following Completion and subject to the Paying Agent receiving the Ordinary Share Cash Consideration pursuant to Clause 3.3(c), each Management Borrower directs the Paying Agent to deduct from the payment of that Management Borrower’s portion of the Ordinary Share Cash Consideration received by the Paying Agent pursuant to Clause 3.3(c) and to transfer (as agent for and on behalf of that Management Borrower) to the Company’s Bank Account, an amount equal to the Management Loan Repayment Amount of such Management Borrower on account of the obligation of such Management Borrower to repay such amount under its Management Loan.

 

3.6 The Company irrevocably agrees that all rights of any kind (past, present or future), obligations and liabilities of each Management Borrower and all claims under, pursuant to or arising (directly or indirectly) out of the repayment of the Management Loans in USD pursuant to Clause 3.5, shall be released with effect from Completion whether arising before or on the Completion Date upon such repayment in accordance with Clause 3.5.

 

17

 

 

3.7 As soon as practicable following Completion, the Purchaser shall procure, to the extent not paid prior to the Completion Date, the payment by the relevant Group Company to each relevant payee of the Disclosed Transaction Costs plus any VAT chargeable thereon to the extent not already included within Disclosed Transaction Costs (such VAT (or amount in respect of VAT) to be paid to the relevant payee if the payee is the person required to account to the relevant Tax Authority for the VAT or otherwise such VAT to be paid direct to the relevant Tax Authority in the event that the reverse charge applies).

 

3.8 The Purchaser shall procure the payment by the relevant Group Company of an amount equal to the Disclosed Exit Bonuses, after deduction of any payroll and social security contributions (including any PAYE and employee National Insurance Contributions in the United Kingdom) thereon, and any applicable employer’s social security contributions (in each case, which shall be paid to the relevant Tax Authority) as set out in the Consideration Allocation Schedule to the persons entitled to such amounts through Group payroll by (i) no later than the first regularly scheduled payroll following Completion; or (i) if the first regularly scheduled payroll following Completion occurs within ten (10) Business Days of Completion, by no later than the second regularly scheduled payroll following Completion, and, in each case, in accordance with the existing payroll practices of the relevant Group Company following Completion (and procure that the relevant Group Company pays any employer National Insurance Contributions, payroll, employment and similar Taxes to the relevant Tax Authority in accordance with applicable Law).

 

3.9 Where any payment is made by a Seller in satisfaction of a liability arising under this Deed it shall, to the extent possible, be treated as a reduction of that part of the Consideration paid to such Seller in respect of its Shares.

 

3.10 Each Seller irrevocably agrees that the Consideration will be allocated in accordance with article 62.3 of the Articles and shall be apportioned among the Sellers in accordance with the Consideration Allocation Schedule but the Purchaser shall not be concerned with, or have any liability whatsoever with respect to, such apportionment or for any failure by any person to apportion such sum among the Sellers in accordance herewith.

 

4. LEAKAGE

 

4.1 Each Seller severally:

 

(a) warrants to the Purchaser (in respect of itself and its Affiliates only) that, during the period from (and including) the Locked Box Date up to (and including) the date of this Deed, neither that Seller nor any of its Affiliates has received or benefited from any Leakage from any Group Company; and

 

(b) irrevocably undertakes to the Purchaser that there shall be no Leakage to, or for the benefit of, such Seller nor any of its Affiliates from any Group Company from the date of this Deed up to (and including) the Completion Date.

 

18

 

 

 

4.2 Subject to Completion occurring, in the event of a breach of Clause 4.1 by any Seller (or its Affiliates), each Seller severally (but not jointly nor jointly or severally) undertakes to pay to the Purchaser, within ten (10) Business Days from receipt of written demand for payment by the Purchaser, on a dollar for dollar basis, an amount in cash equal to the aggregate amount of such Leakage received by such Seller or any of its Affiliates or from which such Seller or its Affiliates has benefitted (save for any Known Leakage allocated to such Seller, as set out in the Consideration Allocation Schedule, and deducted from the Ordinary Share Consideration at Completion) (the “Leakage Payment Amount”), provided that any claim to be made by the Purchaser pursuant to this Clause 4.2 (a “Leakage Claim”), must be made in writing to the relevant Seller(s) within six (6) months following the Completion Date and the Sellers shall cease to be under any liability to the Purchaser or any other person in respect of all and any such Leakage Claims not notified to the relevant Sellers within such time period. Any such notice in writing shall set out, where calculable and on a without prejudice basis, the Purchaser’s calculation of the Leakage Payment Amount and such other information as is relevant to the claim at the time and in the possession or under the control of the Purchaser, provided always that failure to provide such details shall not invalidate such notice or prejudice the Purchaser’s right to claim under this Clause 4, except only to the extent that the liability of a Seller is increased as a result of such failure.

 

4.3 The aggregate liability of a Seller pursuant to this Clause 4 shall in no event exceed the aggregate amount of the Leakage received, or deemed to be received pursuant to Clause 4.5, by that Seller or any of its Affiliates (or from which that Seller and any of its Affiliates has benefited or deemed to have benefitted pursuant to Clause 4.5).

 

4.4 For the avoidance of doubt, the Purchaser acknowledges and agrees that the only remedy available to it for breach of the provisions of Clause 4.1 is contained in Clause 4.2. The liability of the Sellers, for any Leakage Claim notified under Clause 4.2, shall (if it has not been previously satisfied, settled or withdrawn), cease six (6) months after the date on which such Leakage Claim was notified in writing to the relevant Seller(s) unless court proceedings have been started in respect of the subject matter of the claim by such time and the proceedings have not been withdrawn or terminated and for the purposes of this Clause 4.4, court proceedings shall not be deemed to have been started unless a statement of claim is both issued and validly served on the relevant Seller(s).

 

4.5 In respect of any Leakage pursuant to Clauses 4.7(h), 4.7(j) or 4.7(k), each Seller shall be deemed, for the purposes of this Clause 4, to have received or benefitted from its proportion of such Leakage based on the proportions set out in column 3 of Schedule 1.

 

4.6 If any Leakage Payment Amount is notified by the Purchaser to the relevant Seller(s) and either: (a) agreed; (b) not disputed by the relevant Seller(s) within ten (10) Business Days from receipt of written demand for payment by the Purchaser; or (c) disputed by the relevant Seller(s) and subsequently determined by a court of competent jurisdiction (following a maximum of one appeal) (“Finally Determined”) under Clause 4.4, and payment of such Leakage Payment Amount has not made by the relevant Seller within twenty-five (25) Business Days of such agreement or determination (the “Leakage Determination Date”), unless otherwise agreed with that Seller, the Purchaser shall within twenty (20) Business Days cancel such number of Consideration Shares as are held by such Seller as equals:

 

 

where

 

xmeans the number of Consideration Shares to be cancelled;

 

a” means an amount equal to the Leakage Payment Amount as agreed or Finally Determined in respect of the relevant Seller; and

 

19 

 

 

b” means the VWAP for the five (5) Trading Day period ending one (1) Trading Day prior to the Leakage Determination Date.

 

The relevant Seller(s) shall cooperate reasonably with the Purchaser and the transfer agent of the Purchaser (in each case, acting reasonably) to the extent necessary to effect the cancelation of any such Consideration Shares.

 

4.7 Leakage” means the following (with the exception of Permitted Leakage):

 

(a) the declaration, making or payment of any dividend or any distribution of capital, income or profit (whether in cash or kind) or bonus share issue by a Group Company to or for the benefit of any Seller or any of its Affiliates;

 

(b) any payments made, accrued or assumed (or future benefits granted) (whether in cash or in kind) by any Group Company to or for the benefit of any Seller or any of its Affiliates in respect of any share or loan capital (including any interest, coupon or fixed entitlement thereon) or other class or type of securities of any Group Company held by any Seller or any of its Affiliates being issued, redeemed, purchased or repaid, or any other return of capital by any Group Company (which, for the avoidance of doubt, includes the payment or prepayment of any amount of principal or interest on any such share or loan capital or other securities);

 

(c) the making of any payment by a Group Company, or the sale, purchase, transfer, surrender or disposal by a Group Company of any asset or right, to or for the benefit of, or from any Seller or any of its Affiliates;

 

(d) the entry into by any Group Company of any guarantee, security, surety or indemnity of any kind relating to the obligation of any Seller or any of its Affiliates or the assumption, incurrence, indemnification, the increase or discharge by any Group Company of any liability of any Seller or any of its Affiliates;

 

(e) the creation of any Encumbrance over any of the assets or securities of any Group Company in favour, or for the benefit, of any Seller or any of its Affiliates;

 

(f) the forgiveness, release, deferral, discount or waiver (whether in whole or in part) of any amount, right, benefit, obligation, debt or claim owed, in favour of or due to any Group Company by any Seller or any of its Affiliates;

 

(g) any emoluments (including bonuses), consultant, advisory, management, shareholder, directors’ payments or fees (including any monitoring fees and any Institutional Directors’ bonus or other compensation) paid by any Group Company to or for the benefit of any Seller or any of its Affiliates;

 

(h) the payment or incurrence by a Group Company of any Exit Bonuses or Transaction Costs;

 

(i) any agreement to do or give effect any of the things in Clauses 4.7(a) to 4.7(h) above which takes effect on the Locked Box Date or any date thereafter;

 

(j) the payment of any fees or costs to or on behalf of any Seller or any of its Affiliates which are or were incurred by any Group Company as a result of the matters set out in sub-paragraphs 4.7(a) to 4.7(i) (inclusive) above; and

 

20 

 

 

(k) without double counting, in respect of any matter referred to in Clauses 4.7(a) to 4.7(j) any Tax accrued or becoming payable (or any Tax which would have accrued or become payable but for the use of a Relief) by a Group Company excluding any VAT (other than any Irrecoverable VAT).

 

4.8 Permitted Leakage” means any of the following made by any Group Company:

 

(a) any payment in respect of salaries, pension contributions, performance or other bonuses or other reimbursements, benefits or expenses due to any Management Sellers or any of their respective Affiliates in the ordinary course of business in accordance with past practice by virtue of their employment and not arising in connection with the sale of Shares, together with any employer social security contributions and other equivalent Taxes thereon (which for the avoidance of doubt does not include any Exit Bonus, other than any Disclosed Exit Bonus, or any other bonus in an aggregate amount in excess of the Broader Staff Bonus);

 

(b) any payments made in respect of directors’ out-of-pocket expenses to any Institutional Director and in the total amount set out in the Consideration Allocation Schedule together with any employer social security contributions and other equivalent Taxes thereon (the “Director Expenses”);

 

(c) any consultant, advisory, management, shareholder, directors’ payments or fees (including any monitoring fees and any Institutional Directors’ bonus or other compensation) paid by any Group Company to or for the benefit of any Seller or any of its Affiliates in accordance with, and as required by the terms of, the Master Consulting Services Agreement or in connection with the termination of the Master Consulting Services Agreement and in the total amount as set out in the Consideration Allocation Schedule, together with (x) in the case of payments or fees to a consultant, adviser or shareholder any VAT thereon, or (y) in the case of payments to a director any employer social security contributions and other equivalent Taxes thereon (the “Consulting Payments”);

 

(d) any payment made by or on behalf of any Group Company to the extent that specific provision, reserve or allowance has been specifically and identifiably made for it in the Locked Box Accounts;

 

(e) the provision of ordinary course services to any portfolio company of any Institutional Seller or any of its Affiliates on arm’s length terms and in the ordinary course of business, provided that such arrangements have been Disclosed prior to (i) the date hereof in respect of such arrangements entered into prior to the date hereof, or (ii) Completion, in respect of such arrangements entered into on or following the date hereof;

 

(f) any payment expressly and specifically required by the terms of any Transaction Document;

 

(g) any accrual of dividends in respect of the Preference Shares to the extent included in the calculation of the Preference Share Consideration;

 

(h) anything undertaken at the written request, or with the prior written consent, of any member of the Purchaser Group expressly acknowledged to constitute Permitted Leakage;

 

21 

 

 

(i) any Disclosed Transaction Costs;

 

(j) any liability assumed by a Group Company (other than a liability to pay Transaction Costs) pursuant to an engagement letter with a professional advisor in connection with the Transaction or the procedure related to the potential initial public offering of shares of the Company (or one of its parent undertakings or subsidiary undertakings), in each case as Disclosed in the Data Room, and provided that if any such liability results in an actual payment of fees, costs, disbursements or expenses to such professional provider, such payment shall not be deemed to be Permitted Leakage unless such payment is a Disclosed Transaction Cost;

 

(k) any forgiveness, release, or waiver of any amount, right, benefit, obligation, debt or claim owed or due to the Company by the Management Borrowers as a result of the outstanding sums owed at Completion under the Management Loans being converted from GBP to USD and paid to the Company in USD pursuant to Clause 3.5; and

 

(l) any Disclosed Exit Bonuses; and

 

(m) the D&O Insurance Costs.

 

5. CONDITIONs

 

5.1 Completion shall be subject to:

 

(a) all waiting periods applicable to the consummation of the transactions contemplated by this Deed (including for the avoidance of doubt the receipt by the Institutional Sellers of Consideration Shares) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”) shall have expired or been terminated, and there shall not be in effect any voluntary agreement between Purchaser, on the one hand, and the Federal Trade Commission or the Department of Justice, on the other hand, pursuant to which parties have agreed not to consummate the Transaction for any period of time (the “Antitrust Condition”);

 

(b) written confirmation from the New Zealand Overseas Investment Office or the relevant New Zealand Government Minister that a direction order has been issued allowing the Transaction, pursuant to the Overseas Investment Act 2005 (New Zealand) to the extent required by Law;

 

(c) if the NSI Act commences prior to Completion and the Transaction (or any part of it) becomes subject to a requirement thereunder to notify the UK Secretary of State for Business, Energy and Industrial Strategy (“BEIS”) and obtain the approval of BEIS prior to Completion, written confirmation from BEIS approving the Transaction pursuant to the NSI Act (the “NSI Condition” and together with the confirmation referred to in Clause 5.1(b), the “Regulatory Conditions”);

 

(d) the Requisite Stockholder Approval having been obtained (the “Stockholder Approval Condition”);

 

(e) the shares of Class A Common Stock to be issued as Consideration Shares having been approved for listing on the NYSE, subject to official notice of issuance (the “Stockholder Listing Condition”); and

 

22 

 

 

(f) there being no Law of any Authority enjoining or preventing the sale and purchase of the Shares under this Deed or the transactions contemplated hereby,

 

(together, the “Conditions”).

 

5.2 The Conditions (other than the Stockholder Listing Condition) are not capable of being waived. The Institutional Sellers may, to such extent as they think fit and are legally entitled to do so, jointly waive the Stockholder Listing Condition, in whole or in part, by written notice to the Purchaser.

 

5.3 Each party shall be responsible for its own costs arising out of or in connection with obtaining the CFIUS Clearance in connection with the Transaction, provided that the Temasek Seller shall be responsible for the payment of any filing fees required, and the fees of its counsel, in connection with obtaining the CFIUS Clearance in connection with the Transaction.

 

5.4 Subject to Clauses 5.6 and 5.9, the:

 

(a) Purchaser the Institutional Sellers and the Management Sellers shall each use all reasonable endeavours to ensure the satisfaction of the Antitrust Condition and the Regulatory Conditions and that the CFIUS Clearance is obtained, including but not limited to working together in good faith to make and send all filings and notifications to CFIUS in relation to the CFIUS Clearance as promptly as practicable after the date hereof and responding promptly to any follow-up queries or requests from CFIUS (provided for the avoidance of doubt that obtaining CFIUS Clearance shall not be deemed to be a Condition, and the decision as to whether to file a notice or a declaration with respect to obtaining the CFIUS Clearance shall be in the sole discretion of the Temasek Seller; provided, that, to the extent the Temasek Seller elects not to, or does not, file the CFIUS Clearance, the Purchaser shall have no obligations with respect to the CFIUS Clearance); and

 

(b) Purchaser shall use all reasonable endeavours and take all steps necessary to ensure the satisfaction of the Stockholder Conditions and the Institutional Sellers and the Management Sellers shall reasonably cooperate with the Purchaser in connection therewith, in each case in accordance with the provisions set forth in this Deed,

 

in each case, as soon as practicable and, in any event, no later than:

 

(c) the Longstop Date; or

 

(d) such later time and date as may be agreed in writing by the Institutional Sellers and the Purchaser and, provided that, if the NSI Act comes into force following the date that is three (3) months from the date of this Deed and prior to Completion:

 

(i) the Purchaser and the Institutional Sellers shall reasonably consult to determine any extension to the Longstop Date for the purpose of obtaining the NSI Condition; and

 

(ii) if the Purchaser and the Institutional Sellers fail to reach agreement pursuant to Clause 5.4(d)(i), either the Purchaser or the Institutional Sellers may, by written notice to such other party, extend the Longstop Date to the date that is nine (9) months from the date hereof (and as so extended in accordance with this Clause 5.4(d) shall be the Longstop Date for purposes of this Deed).

 

23 

 

 

5.5 Without prejudice to the generality of the Purchaser’s obligations under Clause 5.4 and subject to Clauses 5.6 and 5.9, the Purchaser shall, and shall procure that each of its Affiliates shall, co-operate fully in and take all reasonable actions necessary to procure the satisfaction of the Antitrust Condition and the Regulatory Conditions as soon as practicable and in any event by the Longstop Date, including:

 

(a) if a suit or other action is threatened or instituted by any Authority or other entity challenging the validity or legality, or seeking to restrain the consummation of the Transaction, use all reasonable actions to avoid, resist, resolve or, if necessary, defend such suit or action and use all reasonable actions to avoid or eliminate each and every impediment under any antitrust, competition or trade regulation law that may be asserted by any Authority with respect to the Transaction (unless such suit or action relates to receipt by the Institutional Sellers of Consideration Shares);

 

(b) submitting, or cause to be submitted, an appropriate Notification and Report Form pursuant to the HSR Act within ten (10) Business days of the date of this Deed, and promptly submit any other notification required for the Transaction pursuant to any applicable Antitrust Law;

 

(c) making and sending all filings and notifications to any relevant Authority in relation to the Regulatory Conditions as soon as reasonably practicable after the date of this Deed;

 

(d) other than notifications required to fulfil the Antitrust Condition or the Regulatory Condition, not submitting any notification with any Authority in relation to the Transaction, or in relation to any acquisition of, or definitive written agreement to acquire, any business, person or assets which competes with, supplies or is a customer of the Group, if such notification would be reasonably expected to preclude or materially delay the satisfaction of the Antitrust Condition or the Regulatory Conditions, without obtaining the prior written consent of the Institutional Sellers to the making of it and its form and content (such consent not to be unreasonably withheld, delayed or conditioned);

 

(e) promptly (and in any case within one (1) Business Day) notify the Institutional Sellers of any material communication (whether written or oral) from any relevant Authority in relation to the Antitrust Condition and the Regulatory Conditions, keeping the Institutional Sellers regularly and reasonably informed of the progress of any notification or filing and providing such assistance as may reasonably be required in relation thereto;

 

(f) making an appropriate response to any request for information from any relevant Authority in relation to the Antitrust Condition and the Regulatory Conditions promptly and in any event in accordance with any relevant time limit;

 

(g) consulting with, and taking into account the reasonable views of the Institutional Sellers as to the mode, content and timing of all material communications (whether made orally or in writing) with any relevant Authority in relation to the Antitrust Condition and the Regulatory Conditions, giving the Institutional Sellers and their Representatives a reasonable opportunity to comment on drafts of such communications and to provide the Institutional Sellers the opportunity to participate in substantive telephone calls and meetings with any such Authority (save to the extent that such Authority expressly requests that an Institutional Seller should not participate in such meetings or telephone calls); and

 

24 

 

 

(h) providing the Institutional Sellers with copies of all material communications from any relevant Authority in connection with the Antitrust Condition and the Regulatory Conditions, without delay, to the extent only that to do so is reasonably practicable provided, however, that the Purchaser may redact any information it reasonably deems to be commercially sensitive and designate applicable materials as for review by the each Institutional Seller’s outside counsel on a confidential basis only.

 

5.6 Notwithstanding any other provision in this Deed, the Purchaser and its Affiliates are not required to offer, accept or agree, nor shall any Seller or any Group Company, offer, accept or agree, unless previously agreed in writing by the Purchaser, to any Commitment to any Authority, including any divestitures, licenses of assets, supply or exchange agreements or hold separate agreements, or other actions in relation to the Antitrust Laws, the Overseas Investment Act 2005 (New Zealand), the CFIUS Clearance or the NSI Act, including any amendment, variation or modification of the terms of any Transaction Document. Further, Purchaser may not make a Commitment to an Authority responsible for administering the Antitrust Law if such Commitment would result in a material adverse effect on the Group, the Purchaser and their respective subsidiaries, taken as a whole, without the written agreement of the Institutional Sellers (which agreement shall not be unreasonably withheld, delayed or conditioned).

 

5.7 Without prejudice to the generality of the Institutional Sellers and Management Sellers’ obligations under Clause 5.4 and subject to Clauses 5.6 and 5.9, the Institutional Sellers and Management Sellers shall, and shall procure that, prior to Completion, the Group Companies shall co-operate fully in and take all reasonable actions necessary to procure the satisfaction of the Antitrust Condition and the Regulatory Conditions as soon as practicable and in any event by the Longstop Date, including:

 

(a) if a suit or other action is threatened or instituted by any Authority or other entity challenging the validity or legality, or seeking to restrain the consummation of the Transaction, and such suit or action relates to receipt by the Institutional Sellers of the Consideration Shares, use all reasonable actions to avoid, resist, resolve or, if necessary, defend such suit or action and use all reasonable actions to avoid or eliminate each and every impediment under any antitrust, competition or trade regulation law that may be asserted by any Authority with respect to receipt by the Institutional Sellers of the Consideration Shares;

 

(b) submitting, or cause to be submitted, all appropriate Notification and Report Forms pursuant to the HSR Act within ten (10) Business days of the date of this Deed, and promptly submit any other notification required for the Transaction pursuant to any applicable Antitrust Law;

 

(c) promptly (and in any case within one (1) Business Day) notify the Purchaser of any material communication (whether written or oral) from any relevant Authority in relation to the Antitrust Condition;

 

(d) making an appropriate response to any request for information from any relevant Authority in relation to the Antitrust Condition promptly and in any event in accordance with any relevant time limit;

 

25 

 

 

(e) subject to the first sentence of Clause 5.10, consulting with, and taking into account the reasonable views of the Purchaser as to the mode, content and timing of all material communications (whether made orally or in writing) with any relevant Authority in relation to the Antitrust Condition, giving the Purchaser and its Representatives a reasonable opportunity to comment on drafts of such communications and to provide the Purchaser the opportunity to participate in substantive telephone calls and meetings with any such Authority (save to the extent that such Authority expressly requests that the Purchaser should not participate in such meetings or telephone calls); and

 

(f) providing the Purchaser with copies of all material communications from any relevant Authority in connection with the Antitrust Condition, without delay, to the extent only that to do so is reasonably practicable; provided, however, that the Institutional Sellers may redact any information they reasonably deem to be commercially sensitive and designate applicable materials as for review by the Purchaser’s outside counsel on a confidential basis only.

 

5.8 Without prejudice to Clause 5.4 and subject to Clause 5.9, each Institutional Seller, Management Seller, the Company and the Purchaser shall, and shall ensure that each of their respective Affiliates shall, provide the such other party and any Authority in relation to the Antitrust Condition and the Regulatory Conditions, with any information and documents reasonably required for the purpose of making any filings, notifications or communications to any such Authority that are required to satisfy the Antitrust Condition and the Regulatory Conditions.

 

5.9 Nothing in this Clause 5 shall require a party to disclose commercially sensitive or legally privileged information regarding itself, its Affiliates or any of the foregoing’s Representatives to another party, except to the extent necessary in order to ensure that the Antitrust Condition and the Regulatory Conditions are satisfied, in which case such disclosure shall be on a confidential external counsel-to-counsel basis only.

 

5.10 Notwithstanding anything to the contrary set forth herein, the Purchaser shall control the strategy with respect to the satisfaction of the Antitrust Conditions, provided that the Purchaser shall reasonably consult with the Institutional Sellers and take into account and in good faith the Institutional Sellers’ reasonable comments with respect thereto. The Institutional Sellers shall promptly notify the Purchaser, and the Purchaser shall promptly notify the Institutional Sellers, upon such parties becoming aware that any Condition has been satisfied.

 

5.11 If at any time either a Seller, the Company or the Purchaser becomes aware of any event or circumstance that would be reasonably likely to prevent any Condition being satisfied, it shall, in the case of a Seller or the Company, promptly notify the Purchaser and, in the case of the Purchaser, promptly notify the Institutional Sellers.

 

Termination and Effect of Termination

 

5.12 (a) If the Conditions are not satisfied by the Longstop Date, the Purchaser or, acting jointly, the Institutional Sellers may, in their sole discretion, terminate this Deed with immediate effect except that the Surviving Provisions and any rights or liabilities that have accrued prior to that time shall continue in full force and effect, subject to Clause 5.13. (b) Prior to the Longstop Date, if the matters set forth in the Requisite Stockholder Approval have been submitted to the Purchaser’s stockholders for approval at the Purchaser Stockholder Meeting (as it may be adjourned or postponed) at which a vote was held to obtain the Requisite Stockholder Approval and the Requisite Stockholder Approval shall not have been obtained at such meeting (including any adjournment or postponement thereof), then the Purchaser or, acting jointly, the Institutional Sellers may, in their sole discretion, terminate this Deed with immediate effect except that the Surviving Provisions shall continue in full force and effect, subject to Clause 5.13.

 

26 

 

 

5.13 If this Deed is terminated:

 

(a) pursuant to Clause 5.12(a) as a result of the Antitrust Condition not being satisfied (and at the time of such termination, (x) all other Conditions (other than the Stockholder Conditions) are satisfied or would have been satisfied as of the LongStop Date but for the willful and material breach of the Purchaser of its obligations under this Deed with respect to such Condition and (y) the Stockholder Approval Condition has either (A) been satisfied or (B) not been satisfied where the Purchaser Stockholder Meeting has not been held and the Purchaser’s breach of Clause 7.15 was the principal cause of the failure of the Purchaser Stockholder Meeting to be held),, except where (i) the Institutional Sellers do not agree to a Commitment, which the Purchaser in good faith has irrevocably committed to make to any relevant Authority (which commitment would be made subject to the receipt of consent of the Institutional Sellers under Clause 5.6 to the extent required) in order to satisfy such Antitrust Condition and such refusal to agree was the principal cause of such Antitrust Condition not being satisfied, (ii) the Antitrust Condition not being satisfied relates to a HSR filing for the receipt by the Institutional Sellers of Consideration Shares, or (iii) the Institutional Sellers breach this Deed and such breach was the principal cause of the Antitrust Condition not being satisfied, the Purchaser shall pay to the Sellers a fee equal to an amount of USD 60,000,000 (sixty million) (inclusive of any VAT thereon); or

 

(b) pursuant to Clause 5.12(b) as a result of the Requisite Stockholder Approval not being obtained at the Purchaser Stockholder Meeting (or at any postponement or adjournment thereof) where a vote with respect to the Requisite Stockholder Approval was taken (and at the time of such termination, all other Conditions (other than the Stockholder Listing Condition) are satisfied or are then capable of being satisfied), except where the Institutional Sellers are in breach of this Deed at or prior to the time of the Purchaser Stockholder Meeting at which a vote with respect to the Requisite Stockholder Approval was taken and such breach was the principal cause of the Requisite Stockholder Approval not being obtained, the Purchaser shall pay to the Sellers a fee equal to an amount of USD 15,000,000 (fifteen million) (inclusive of any VAT thereon),

 

27 

 

 

(each a “Break Fee”), in each case, payable to the Paying Agent Account (or such other account the Institutional Sellers notify the Purchaser in writing) not later than ten (10) Business Days following written demand for payment from the Institutional Sellers following such termination of this Deed in circumstances in which a Break Fee is payable in accordance with Clauses 5.13(a) or 5.13(b). The provisions set out in this Clause 5.13 shall be the sole and exclusive remedy of the Company, the Sellers and their respective Affiliates, successors or assigns against the Purchaser and its Affiliates in the circumstances where a Break Fee is payable (whether framed in tort, contract or otherwise). Upon payment of the Break Fee, when and if payable hereunder, the Purchaser and its Affiliates (including any of their respective shareholders or members) shall have no further liability to the Company or the Sellers or their respective Affiliates, successors or assigns (including any of their respective shareholders or members) arising out of or otherwise relating to this Deed or the transactions contemplated hereby or the termination hereof, including any breach of this Deed, whether wilful, intentional or otherwise and none of the Company, the Sellers or their respective Affiliates (including any of their respective shareholders or members), successors or assigns shall be entitled to bring or maintain any other claim, action or proceeding against the Purchaser or any of its Affiliates (including any of their respective shareholders or members) or seek to obtain any recovery, judgment or damages of any kind against the Purchaser or any of its Affiliates (including any of their respective shareholders or members) arising out of or otherwise relating to this Deed or the transactions contemplated hereby or the termination hereof, including any breach of this Deed, whether wilful, intentional or otherwise. In no event shall more than one Break Fee be paid or payable, and in no event shall a Break Fee be paid or payable on more than one occasion. In no event will the Company and the Sellers be entitled to both the payment of the Break Fee hereunder and the right to specifically enforce the terms of this Deed or any equitable remedy hereunder. The parties acknowledge and agree that if any obligation to pay any Break Fee shall arise in accordance with this Clause 5.13, such obligation shall not imply that the Purchaser has committed any breach of its obligations under this Deed. The parties acknowledge and agree that the provisions set out in this Clause 5.13 are no more extensive than is reasonably necessary to protect the legitimate interests of the Sellers and the Group, and the agreements set forth in this Clause 5.13 are an integral part of this Deed and without these agreements the parties would not enter into this Deed.

 

6. notifications to determine payments on completion

 

6.1 Not less than five (5) Business Days prior to the Scheduled Completion Date or such other time as the Purchaser and the Institutional Sellers may agree in writing, the Institutional Sellers shall provide the Purchaser with a schedule (the “Consideration Allocation Schedule”) setting out:

 

(a) the amount of the Ordinary Share Consideration and allocation between the various Sellers;

 

(b) the amount of the Preference Share Consideration and allocation between the various Sellers;

 

(c) the amount of the Ordinary Share Cash Consideration and allocation between the various Sellers;

 

(d) the allocation of the Consideration Shares between those Sellers (or a Seller’s Nominee) who qualify as accredited investors (as such term is defined in Rule 501(A) of the United States Securities Act of 1933 as in effect on the date of this Deed);

 

(e) the amount of the Management Loan Repayment Amount in respect of each Management Borrower;

 

(f) the amount of the Bank Pay-Off Amount (together with currency, payee and account details);

 

(g) the amount of the Disclosed Transaction Costs (together with currency, payee and account details);

 

(h) the amount of the Disclosed Exit Bonuses (together with currency, payee and account details);

 

(i) the amount of the Additional Consideration and the allocation between the various Sellers;

 

28 

 

 

(j) the amount of the D&O Insurance Costs;

 

(k) the amount of the Director Expenses;

 

(l) the amount of the Consulting Payments;

 

(m) the amount of any Known Leakage (for the avoidance of doubt, comprising those items agreed in writing between the Purchaser and the Institutional Sellers at least six (6) Business Days prior to the Scheduled Completion Date to constitute Known Leakage) and the allocation between the various Sellers;

 

(n) details of the Paying Agent Account and the Company’s Bank Account (including sort code, account number and IBAN); and

 

(o) the Consideration.

 

Release of Debt Security

 

6.2 The Purchaser shall provide such information and assistance as the Sellers may reasonably request in connection with the release of all Debt Security granted or entered into by any Group Company under the Existing Facilities.

 

6.3 No later than ten (10) Business Days prior to the Scheduled Completion Date, the Institutional Sellers or their Representatives shall deliver to the Purchaser the draft form of the Pay-Off Letter and Deed of Release to be delivered in executed form at Completion (in a form acceptable to the agents and lenders under the Existing Facilities), in each case in customary form reasonably acceptable to the Purchaser and the Institutional Sellers.

 

6.4 As soon as reasonably practicable following receipt of the Deed of Release and Pay-Off Letter, the Purchaser agree to use all commercially reasonable efforts to discuss the final wording of the applicable Deeds of Release and Pay-Off Letters with the Institutional Sellers or their Representatives, and the Institutional Sellers or their Representatives shall give reasonable consideration to any reasonable comments which the Purchaser may have on such draft(s) and which have been notified in writing to the Institutional Sellers or their Representatives, provided that the Sellers shall not be obliged to consider any such comments received later than five (5) Business Days prior to the Scheduled Completion Date.

 

7. PRE-COMPLETION OBLIGATIONS

 

Sellers’ pre-completion obligations

 

7.1 Except as otherwise specifically stated in this Deed or with the prior written consent of the Purchaser, during the period from the date of this Deed to Completion:

 

(a) each Management Seller shall procure that each Group Company carries on its business in all material respects in accordance with applicable Law and in the ordinary and usual course in accordance with past practice; and

 

(b) each Seller shall procure that no Group Company shall undertake any of the matters set out in Part 1 of Schedule 3 of this Deed.

 

29 

 

 

7.2 Prior to Completion, the applicable Group Company shall, at least one (1) Business Day prior to the Scheduled Completion Date, adopt written resolutions (or take other reasonably necessary and appropriate action) (i) to terminate each Plan that is intended to be qualified under Section 401(a) of the Code (“Company Qualified Plan”), (ii) to cease contributions to such Company Qualified Plan, and (iii) to fully vest all participants under such Company Qualified Plan, such termination, cessation, and vesting to be effective no later than the Business Day preceding the Scheduled Completion Date. The Group Companies shall provide Purchaser with an advance copy of such proposed resolutions (and any related documents) and a reasonable opportunity to comment thereon prior to adoption or execution. The Purchaser or any of its applicable Affiliates shall cause a tax-qualified defined contribution plan that includes a cash or deferred arrangement within the meaning of Section 401(k) of the Code established or maintained by Purchaser or any such Affiliate (the “Purchaser Qualified Plan”) to accept eligible rollover distributions (as defined in Section 402(c)(4) of the Code) from employees participating in the Company Qualified Plan with respect to such employee’s account balances in the form of cash (but including notes, in the case of loans to the extent allowable under the Purchaser Qualified Plan), if elected by such employees in accordance with applicable law and the applicable Company Qualified Plan.

 

Required Financial Statements; Proxy Statement; Cooperation

 

7.3 As soon as reasonably practicable following the date of this Deed, the Company shall provide to the Purchaser (and shall use reasonable endeavours to so deliver no later than 30 June 2021) (a) consolidated balance sheets of the Group Companies as of 31 March 2021 and 31 March 2020 and the related consolidated statements of income, equity and cash flows of the Group Companies for the years then ended, in each case audited in accordance with US GAAS and prepared in a manner consistent with IFRS and (b) an unaudited consolidated balance sheet of the Group Companies as of 31 March 2019 and 31 March 2020 and the related unaudited consolidated statements of income, equity and cash flows of the Group Companies for the year then ended, in each case, prepared in a manner consistent with IFRS (collectively, the “Required Financial Statements”), for inclusion in the Proxy Statement. For the avoidance of doubt, failure to deliver the Required Financial Statements described in clause (a) of the definition thereof by 30 June 2021 shall not result in a breach by the Company of this Deed, provided that the Company is using reasonable endeavours to provide as soon as reasonably practicable following the date of this Deed such Required Financial Statements. The Company shall reasonably cooperate, and shall direct its independent auditors to reasonably cooperate, with the Purchaser in connection with the preparation of any pro forma financial statements that are derived in part from the Required Financial Statements or other financial statements of the Company or any Group Company (including with respect to the three (3) month period ended 31 March 2021) and shall provide the Purchaser with a reasonable opportunity to consult with the Company and its representatives, including its independent auditors, from time to time prior to Completion, with respect to the progress of the preparation of such Required Financial Statements or pro forma financial statements.

 

7.4 Prior to the Completion, the Company shall, and shall cause the Group Companies and their respective representatives to, use its reasonable endeavours to provide to the Purchaser such data, information and documents relating to the Sellers or Group Companies as may be reasonably requested by the Purchaser for purposes of the preparation of the Proxy Statement (or any supplement or amendment thereto). Prior to the Completion, each Seller shall use its reasonable endeavours to provide to the Purchaser such data and information relating to such Seller as may be reasonably requested by the Purchaser to the extent the provision of such information is reasonably necessary or advisable for the preparation of the Proxy Statement (or any supplement or amendment thereto).

 

7.5 If, at any time prior to the receipt of the Requisite Stockholder Approval, any information relating to the Sellers, the Group Companies or any of their respective Affiliates, should be discovered by the Sellers or the Group Companies which should be set forth in an amendment of, or a supplement to, the Proxy Statement, so that any of such documents would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Sellers and/or the Company, as appropriate, shall, as soon as reasonably practicable, notify the Purchaser, and provide the Purchaser with any such requisite updates to the information provided pursuant to Clause 7.4 relating to the Sellers and/or the Company, as appropriate, such that the Purchaser may file with the SEC, any appropriate amendment of, or supplement to, the Proxy Statement describing such information and, to the extent required by applicable Law, disseminate such amendment or supplement to the stockholders of the Purchaser; provided that no Seller shall have any obligation pursuant to this Clause 7.5 other than in respect of information relating to such Seller provided by such Seller pursuant to Clause 7.4.

 

30 

 

 

7.6 Each of the Sellers and the Company undertakes that none of the information supplied or to be supplied by such Seller or the Company, respectively, for inclusion or incorporation by reference in the Proxy Statement will, at the date it is first filed with the SEC or mailed or otherwise made available to the stockholders of the Purchaser or at the time of the Purchaser Stockholder Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.

 

Purchaser’s pre-completion obligations

 

7.7 Except as otherwise specifically stated in this Deed or with the prior written consent of the Institutional Sellers, during the period from the date of this Deed to Completion, the Purchaser shall procure that each member of the Purchaser Group carries on its business in all material respects in accordance with applicable Law and in the ordinary and usual course in accordance with past practice and shall procure that no member of the Purchaser Group shall undertake any of the matters set out in Part 2 of Schedule 3 of this Deed.

 

7.8 Except as otherwise specifically stated in this Deed, during the period from the date of this Deed to Completion, if the Purchaser splits, combines, reclassifies, subdivides or recapitalizes its share capital, the number of Consideration Shares to be issued pursuant to this Deed shall be equitably adjusted, without duplication, to proportionately reflect such split, combination, reclassification, subdivision or recapitalization to put the Sellers receiving Consideration Shares in the same position as they would have been in had such split, combination, reclassification, subdivision or recapitalization not occurred.

 

7.9 Clauses 7.1 and 7.7 shall not operate so as to restrict or prevent:

 

(a) any matter reasonably undertaken by any Group Company or the Purchaser Group in an emergency or disaster situation with the intention of minimising any adverse effect of such situation, provided always that the Purchaser or the Institutional Sellers (as applicable) shall be notified in writing of any such actions as soon as reasonably practicable;

 

(b) any matter reasonably undertaken by any Group Company or the Purchaser Group that is necessary to comply with any applicable directions or orders of an Authority in relation to the COVID-19 pandemic, provided the Management Sellers and the Purchaser shall take reasonable steps to mitigate any material adverse effects of any such actions on the business of the Group Company and Purchaser Group respectively and notify the other parties of such required measures as soon as practicable;

 

31 

 

 

(c) the completion or performance of any obligations undertaken pursuant to any contract or arrangement entered into by any member of the Group or the Purchaser Group prior to the date of this Deed that has been (i) Disclosed to the Purchaser by any Seller; or (ii) fairly disclosed (in such a manner and with sufficient detail to enable a seller to make a reasonably informed assessment of the nature and, scope and consequence to the Purchaser Group of the fact, matter disclosed or circumstance concerned) by the Purchaser to the Institutional Sellers, in each case prior to the date of this Deed;

 

(d) the payment of the Broader Staff Bonus and the employer’s social security contributions thereon; or

 

(e) entry into any contract or arrangement for the payment by a Group Company of any Disclosed Exit Bonuses;

 

(f) the completion or performance of any actions expressly required by (and, where specified, in accordance with) the Transaction Documents.

 

7.10 Nothing in this Deed, including this Clause 7, is intended to allow the Purchaser or any member of the Purchaser Group the ability, directly or indirectly, to control the Group or direct its operations in any circumstances prior to Completion.

 

Proxy Statement

 

7.11 As soon as reasonably practicable following the date of this Deed, the Purchaser shall prepare (with the Sellers and the Company’s reasonable cooperation with respect to information required or reasonably advisable to be provided by them for inclusion in) a proxy statement to be sent to the stockholders of the Purchaser relating to the Purchaser Stockholder Meeting (together with any amendments or supplements thereto, the “Proxy Statement”) and file (promptly following, and using reasonable endeavours to do so within three (3) Business Days following, such time as the Company provides the Required Financial Statements) the Proxy Statement with the SEC and (once the SEC has confirmed it has no further comments thereon or has declined to review the Proxy Statement) send such Proxy Statement to the stockholders of the Purchaser relating to the Purchaser Stockholder Meeting, in each case, in compliance with applicable Law, including the Exchange Act and the Securities Act. The Purchaser agrees that the Proxy Statement will comply in all material respects as to form and substance with applicable Law, including the requirements of the Exchange Act.

 

7.12 The Purchaser shall promptly notify Sellers upon the receipt of any comments from the SEC or any request from the SEC for amendments or supplements to the Proxy Statement and shall provide the Institutional Sellers with copies of all correspondence between it and its representatives, on the one hand, and the SEC, on the other hand, with respect to the Proxy Statement, in each case to the extent permitted in accordance with applicable Law. The Purchaser shall use all reasonable endeavours to respond as soon as reasonably practicable to any comments from the SEC with respect to the Proxy Statement and the Sellers and the Company shall reasonably cooperate in connection with the foregoing. Notwithstanding the foregoing, prior to filing the Proxy Statement (or any amendment or supplement thereto) to the SEC or responding to any comments of the SEC with respect thereto, the Purchaser shall: (a) provide the Institutional Sellers with a reasonable opportunity to review and comment on such document or response (including the proposed final version of such document or response); and (b) consider in good faith all comments reasonably proposed by the Institutional Sellers. Subject to Clause 5.6 and the provisions of this Clause 7, the Purchaser shall also take any other action reasonably determined to be required to be taken under the Securities Act, the Exchange Act or the listing rules and regulations of NYSE in connection with the transactions contemplated by this Deed and the issuance of the Consideration Shares, subject to the limitations of this Deed and the requirements set forth herein.

 

32 

 

 

7.13 The Purchaser undertakes that none of the information supplied or to be supplied by the Purchaser for inclusion or incorporation by reference in the Proxy Statement will, at the date it is first filed with the SEC or mailed or otherwise made available to the stockholders of the Purchaser or at the time of the Purchaser Stockholder Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.

 

7.14 If, at any time prior to the receipt of the Requisite Stockholder Approval, any information relating to the Purchaser or any of its Affiliates, should be discovered by the Purchaser which should be set forth in an amendment of, or a supplement to, the Proxy Statement, so that any of such documents would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Purchaser shall promptly notify the Institutional Sellers, and the Purchaser shall promptly file with the SEC, any appropriate amendment of, or supplement to, the Proxy Statement describing such information and, to the extent required by applicable Law, disseminate such amendment or supplement to the stockholders of the Purchaser.

 

Purchaser Stockholder Meeting

 

7.15 The Purchaser shall, as soon as practicable after the SEC has confirmed that it has no further comments on the Proxy Statement or has declined to review the Proxy Statement, establish a record date for, duly call, give notice of, convene and hold a special meeting of the stockholders of the Purchaser (together with any adjournment or postponement thereof, the “Purchaser Stockholder Meeting”) for the purpose of seeking the Requisite Stockholder Approval (which meeting shall be held not more than thirty (30) days after the date on which the Purchaser mails the Proxy Statement to its stockholders), and shall submit such proposals to such holders entitled to vote at the Purchaser Stockholder Meeting and, subject to Clause 7.18, shall not submit any other proposal that is not related to the transactions contemplated by this Deed to such holders in connection with the Purchaser Stockholder Meeting without the prior written consent of the Institutional Sellers (not to be unreasonably withheld, conditioned or delayed). The record date for the Purchaser Stockholder Meeting shall be determined with prior consultation with the Institutional Sellers. Notwithstanding anything to the contrary contained in this Deed, the Purchaser shall not adjourn or postpone the Purchaser Stockholder Meeting without the Institutional Sellers’ prior written consent (not to be unreasonably withheld, conditioned or delayed); provided that without the Institutional Sellers’ prior written consent, the Purchaser may (and in the case of Clause 7.15(b), at the reasonable request of the Institutional Sellers (acting jointly), shall) adjourn or postpone the Purchaser Stockholder Meeting:

 

(a) to the extent necessary to ensure that any supplement or amendment to the Proxy Statement is provided to the stockholders of the Purchaser within a reasonable amount of time in advance of the Purchaser Stockholder Meeting; and

 

33 

 

 

(b) for no longer than thirty (30) days in the aggregate (including through one or more successive postponements or adjournments), if there are not sufficient affirmative votes in person or by proxy at such meeting to constitute a quorum at the Purchaser Stockholder Meeting or to obtain the Requisite Stockholder Approval, whether or not a quorum would be present, in order to allow reasonable additional time for solicitation of proxies for purposes of obtaining a quorum or the Requisite Stockholder Approval.

 

7.16 The Purchaser agrees that, subject to Clause 7.18, the Purchaser Board: (a) shall recommend that the stockholders of the Purchaser entitled to vote thereon vote in favour of the authorisation and approval of all of the matters subject to the Requisite Stockholder Approval; (b) shall include the Purchaser Board Recommendation in the Proxy Statement; and (c) shall not withhold, withdraw, qualify or modify, or publicly announce its intent to withhold, withdraw, qualify or modify, in a manner adverse to the Sellers, the Purchaser Board Recommendation (set forth in this sub-paragraph (c) of this Clause 7.16, a “Purchaser Board Adverse Recommendation Change”). Nothing in this Clause 7.16 shall prohibit the Purchaser from disclosing to its stockholders (i) any fact or circumstance that is required to be disclosed under applicable Law, or the failure of which to disclose would be inconsistent with the fiduciary duties of the Purchaser Board under applicable Law or (ii) any fact or circumstance that the Purchaser determines, in good faith and after consultation with its outside legal counsel, is material to the stockholders of the Purchaser in making their decision in how to vote on the matters subject to the Requisite Stockholder Approval, or from otherwise complying with Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act; provided that to the extent that the Purchaser reasonably determines that such disclosure could have substantially the same effect as a withdrawal, qualification or modification of the Purchaser Board Recommendation in a manner adverse to the Sellers, the Purchaser shall publicly reaffirm the Purchaser Board Recommendation concurrently with making such disclosure unless the Purchaser Board has determined, in good faith after consultation with its outside legal counsel, that such reaffirmation would be a breach of its fiduciary duties under applicable Law. The Purchaser shall take all reasonable lawful action to solicit from its stockholders proxies in favour of the proposals to approve all of the matters subject to the Requisite Stockholder Approval and shall take all other action reasonably necessary or advisable to secure the vote or consent of the Purchaser’s stockholders that are required by the rules of the NYSE and Delaware General Corporation Law, as amended.

 

7.17 From and after the date of this Deed until the Completion (or if earlier, termination of this Deed), the Purchaser shall, and shall cause its subsidiaries to, use all reasonable endeavours to (subject to the receipt of any Required Financial Statements required to be set forth therein): (a) timely file or furnish all forms, documents and reports reasonably determined to be required to be filed or furnished by it with the SEC; (b) resolve any outstanding or unresolved comments in any comment letters from the staff of the SEC received by the Purchaser relating to any of its forms, documents or reports filed or furnished with the SEC, or any determination letter received from the NYSE in a manner as reasonably determined by the Purchaser in good faith; and (c) take all reasonable (as determined by the Purchaser in good faith) actions necessary to comply in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the applicable rules and regulations promulgated thereunder to the extent applicable to the Purchaser, and the applicable listing and corporate governance rules and regulations of the NYSE.

 

7.18 Notwithstanding anything to the contrary contained in this Deed, and subject to compliance with Clause 7.15, at any time prior to the receipt of the Requisite Stockholder Approval, the Purchaser Board may make a Purchaser Board Adverse Recommendation Change if, but only if, the Purchaser Board reasonably determines in good faith, based on the advice of its outside legal counsel, that the failure to make a Purchaser Board Adverse Recommendation Change would result in a breach of its fiduciary duties under applicable Law (which for purposes of this Clause 7.18 shall be the law of the State of Delaware).

 

34 

 

 

7.19 The Purchaser’s obligation to call, give notice of and hold the Purchaser Stockholder Meeting and a vote for the Requisite Stockholder Approval in accordance with Clause 7.15 shall not be limited or otherwise affected by any Purchaser Board Adverse Recommendation Change.

 

NYSE Listing

 

7.20 The Purchaser shall, prior to Completion, prepare and file with the NYSE a supplemental listing application covering the Consideration Shares and shall use all reasonable endeavours to cause the Consideration Shares to be approved for listing on the NYSE, subject to official notice of issuance, prior to or as of Completion. The Sellers and the Company will cooperate with the Purchaser as reasonably requested by the Purchaser to, as soon as reasonably practicable, furnish to the Purchaser such information concerning the Sellers and the Company, respectively, that may be required or reasonably advisable in connection with any action contemplated by this Clause 7.20.

 

Pre-Completion Access

 

7.21 From the date of this Deed until the Completion Date, (a) in respect of Clauses 7.21(a) and 7.21(b), each of the Sellers shall; and (b) in respect of Clause 7.21(c), each of the Management Sellers shall, in each case, use its reasonable endeavours to procure that each of the Group Companies (and senior management and boards of directors thereof) will, at the sole expense of the Purchaser and during normal Working Hours and subject to appropriate confidentiality undertakings, provide the Purchaser and its Representatives with:

 

(a) such information regarding the business and affairs, and access to the books and records of, the Group Companies as the Purchaser may reasonably require from time to time (but excluding anything which is subject to legal privilege);

 

(b) reasonable access to the directors, officers and senior management of the Group (who shall be instructed to give all such reasonable information and assistance as the Purchaser may reasonably request); and

 

(c) cooperation in connection with the arrangement of the debt financing and/or PIPE Financing required in connection with the acquisition of the Shares (the “Financing”), including cooperation with customary marketing, rating and syndication efforts and structuring and preparation of a collateral package,

 

in each case, to the extent reasonably required by the Purchaser for it to either: (i) comply with its express obligations under the Transaction Documents, (ii) utilise for post-Completion integration purposes (including for the completion of technical operational diligence), (iii) implement and arrange the Financing; and/or (iv) implement any management incentive scheme of the Group or plan for the issue of the Consideration Shares at Completion, and subject to reasonable advance notice being given in writing to the Institutional Sellers. Any access or cooperation granted pursuant to this Clause 7.21 shall only be permitted provided that such access or cooperation does not:

 

35 

 

 

(d) interfere unreasonably with, or affect adversely, the operations or business of any of the Group Companies;

 

(e) require any of the Group Companies or their respective officers, directors, shareholders and employees to take any action that would, or that would reasonably be expected to, conflict with or violate any Group Company’s constitutional documents or any Laws applicable to it (including but not limited to antitrust and competition laws); or

 

(f) require any of the Group Companies to take any action or enter into any arrangement that would be effective prior to the Completion Date.

 

Section 280G

 

7.22 To the extent necessary to avoid the application of Section 280G of the Internal Revenue Code of 1986, as amended, and the Treasury Regulations promulgated thereunder (collectively, the “Code”), the Sellers shall request that each individual (each, a “Disqualified Individual”) to whom any payment or benefit is required or proposed to be made in connection with the transactions contemplated by this Deed that could constitute “parachute payments” under Section 280G(b)(2) of the Code (“Section 280G Payments”) execute a written agreement waiving such Disqualified Individual’s right to receive some or all of such payment or benefit (the “Waived Benefits”), to the extent necessary so that all remaining payments and benefits applicable to such Disqualified Individual shall not be deemed a parachute payment, and accepting in substitution for the Waived Benefits the right to receive the Waived Benefits only if approved by the applicable equityholders entitled to vote on such matter in a manner that complies with Section 280G(b)(5)(B) of the Code. Prior to the Completion, the Sellers shall submit the Waived Benefits of each Disqualified Individual who has executed a waiver in accordance with this Clause 7.21 for approval of the applicable equityholders entitled to vote on such matter and such Disqualified Individual’s right to receive the Waived Benefits shall be conditioned upon receipt of the requisite approval by the applicable equityholders entitled to vote on such matter in a manner that is intended to comply with Section 280G(b)(5)(B) of the Code. The Sellers shall provide the Purchaser and its counsel with a copy of the waiver agreement, disclosure statement and underlying calculations contemplated by this Clause 7.21 within a reasonable time prior to delivery to each Disqualified Individual and the applicable equityholders entitled to vote on such matter of such waiver agreement and disclosure statement, respectively, and the Sellers shall consider in good faith any changes reasonably requested by the Purchaser or its counsel. The Purchaser shall provide to the Sellers, no less than fifteen (15) days prior to Completion, information regarding any arrangements that may provide for Section 280G Payments and are entered into at the direction of the Purchaser or between the Purchaser or any of its Affiliates and a Disqualified Individual, and the Sellers and the Purchaser shall cooperate in good faith with respect to calculating the value of such arrangements.

 

Disclosure

 

7.23 On the date falling two (2) Business Days prior to the Completion Date, each of the Sellers who are also Warrantors (pursuant to and as defined in the Management Warranty Deed) shall deliver to the Purchaser a duly executed copy of the Completion Disclosure Letter (as defined in the Management Warranty Deed).

 

36 

 

 

8. COMPLETION

 

8.1 Completion shall take place by conference call and exchange of signature pages by email or other electronic transmission at 9:00 a.m. Eastern Time (or at any other place and time as agreed in writing by the Institutional Sellers and the Purchaser) on the fifth (5th) Business Day following notification of the satisfaction or waiver of the final outstanding Condition or on such other date as agreed in writing by the Institutional Sellers and the Purchaser.

 

8.2 At Completion:

 

(a) each Institutional Seller shall severally do or procure the carrying out of all those things listed in paragraphs 1(a) to 1(c) of Schedule 2;

 

(b) each Management Seller shall severally do or procure the carrying out of all those things listed in paragraphs 1(a) and 1(c) of Schedule 2;

 

(c) each Non-Institutional Seller shall severally do or procure the carrying out of all those things listed in paragraph 1(a) of Schedule 2; and

 

(d) the Purchaser shall do or procure the carrying out of all those things listed in paragraph 2 of Schedule 2.

 

8.3 All documents and items delivered and payments made in connection with Completion shall be held by the recipient to the order of the person delivering them until such time as Completion takes place.

 

8.4 The date on which Completion is required to take place in accordance with Clause 8.1 is referred to in this Deed as the “Scheduled Completion Date” and such expression shall include any later date set for Completion in accordance with Clause 8.5(a).

 

8.5 Without prejudice to any other remedies or accrued rights which the Sellers (or any of them) may have against the Purchaser or the Purchaser may have against the Sellers (or any of them), if the Purchaser has not complied with its Material Completion Obligations at Completion or if the Sellers have not complied with their Material Completion Obligations at Completion (a “Completion Default”), the Institutional Sellers, in the case of a Completion Default by the Purchaser, or the Purchaser, in the case of a Completion Default by any Seller, shall be entitled, at their discretion:

 

(a) to defer Completion to any subsequent Business Day falling not more than twenty (20) Business Days after the Scheduled Completion Date or any later date set for Completion in accordance with this Clause, provided that such deferral may not be past the Longstop Date. In such event the provisions of this Clause 8 shall apply to Completion so deferred;

 

(b) to waive the requirement to fulfil those obligations in whole or in part and following such waiver to complete the sale and purchase of the Shares;

 

(c) so far as practicable, to complete the sale and purchase of the Shares in accordance with Clause 8.1 and Schedule 2; or

 

(d) provided Completion has been deferred at least once by the party seeking to terminate in accordance with Clause 8.5(a) and the parties have used reasonable endeavours to effect Completion, to terminate this Deed by notice in writing to the party responsible for the Completion Default, following which this Deed shall cease to have effect immediately except that the Surviving Provisions and any rights or liabilities that have accrued prior to that time shall continue in full force and effect.

 

37 

 

 

8.6 Subject to Clause 5.9 and the other provisions of this Deed, if CFIUS Clearance is not obtained on or prior to Completion, the Purchaser the Institutional Sellers and the Management Sellers shall continue to work together in good faith to make and send all filings and notifications to CFIUS in relation to the CFIUS Clearance as promptly as practicable and respond promptly to any follow-up queries or requests from CFIUS in accordance with this Deed.

 

8.7 Neither the Sellers nor the Purchaser shall be obliged to complete the sale and purchase of any of the Shares unless the sale and purchase of all of the Shares is completed simultaneously.

 

9. POST-COMPLETION OBLIGATIONS

 

9.1 The Purchaser shall, and shall procure that each Group Company shall, at the sole expense of the requesting party, for a period of seven (7) years from Completion, or such longer period as prescribed by applicable Law, give reasonable access to books, records and documents which solely relate to the Group (such obligation only to apply insofar as such books, records and documents relate to the period prior to Completion) available for inspection to any Seller and its Representatives (but excluding anything which is subject to legal privilege), in each case, as any Seller reasonably requires for its Tax, regulatory and/or accounting purposes only to the extent to comply with any applicable Law or requirement of any Authority or accounting body and access or copies shall be provided only to the extent required for these purposes.

 

9.2 Following Completion, the Purchaser shall be responsible for preparing all Tax returns in relation to the Group Companies and dealing with all other matters relating to such Tax returns, including the conduct of all related negotiations and correspondence with the Tax Authorities.

 

9.3 Within thirty (30) days following Completion, the Purchaser undertakes to file any necessary notice with the Director of Investments of Innovation, Science and Economic Development Canada of the Transaction pursuant to Section 12 of the Investment Canada Act.

 

9.4 In the event that any Consideration Shares held by any Seller that has delivered a Lock-Up Agreement prior to or upon the Completion are not subject to registration in connection with the consummation of the transactions contemplated by this Agreement pursuant to the Amended Investor Rights Agreement, the Purchaser shall cause all such Consideration Shares to be included in the New Shelf (as defined in the Amended Investor Rights Agreement) in accordance with Section 4.1(a) of the Amended Investor Rights Agreement.

 

10. WARRANTIES, UNDERTAKINGS and limitations OF THE SELLERs

 

10.1 Subject to Clauses 10.2 to 10.6:

 

(a) each Seller severally (and in respect of itself only) warrants to the Purchaser in respect of itself only, that as at the date of this Deed and as at the Completion Date:

 

(i) in respect of each Seller that is not an individual, it is validly incorporated, in existence and duly registered under the laws of its country of incorporation;

 

(ii) it has the requisite power and authority to enter into and perform this Deed and the other Transaction Documents in accordance with their terms;

 

38 

 

 

 

(iii) this Deed and the other Transaction Documents constitute (or shall constitute when executed) valid, legal and binding obligations on it in accordance with their respective terms, assuming due authorization, execution and delivery by the other parties hereto (except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity);

 

(iv) the execution and delivery of this Deed by it and the other Transaction Documents and the performance of and compliance with their terms and provisions will not conflict with or result in a breach of, or constitute a default under, its constitutional documents (to the extent applicable), any agreement, arrangement or instrument to which it is a party or by which it is bound, any order, judgment or decree of any court or Authority to which it is a party or by which it is bound, or, subject to the satisfaction of the Conditions, any Law or order that applies to or binds it or any of its property;

 

(v) no consent, action, approval or authorisation of, and no registration, declaration, notification or filing with or to, any Authority (other than as required pursuant to the Conditions or as otherwise expressly set out in this Deed) is required to be obtained, or made, by it to authorise the execution or performance by it of this Deed and each of the Transaction Documents to which it is party;

 

(vi) it is the sole legal and beneficial owner of the Shares set out against its name in column 2 of Schedule 1 and is entitled and has the power and authority to transfer the full ownership of such Shares on the terms set out in this Deed and there is no Encumbrance affecting any of such Shares nor any agreement or arrangement to create any such Encumbrance; and

 

(b) each Institutional Seller severally (and in respect of itself only) warrants to the Purchaser in respect of itself only, that as at the date of this Deed and as at the Completion Date, there are no agreements or arrangements between it or its respective Affiliates, on the one hand, and any Group Company, on the other hand, other than the Investment Agreement and, in respect of the FP Sellers only, the Master Consulting Services Agreement.

 

10.2 The aggregate liability of each Seller for all Claims which may be brought against that Seller to the extent permitted by the terms of this Deed, shall be limited to the aggregate amount of the Consideration payable to that Seller in accordance with this Deed.

 

10.3 The Company shall have no liability to the Purchaser or its Affiliates, successors or assigns (including any of its shareholders or members) arising out of or otherwise relating to this Deed or the transactions contemplated hereby or the termination hereof, including any breach of this Deed, except for breaches of Clauses 3.6, 5.6, 5.8, 5.11, 5.13, 7.3, 7.4, 7.5, 7.6, 7.11, 7.12, 7.20, 13 and 27.4 by any Company.

 

10.4 Specific written notice of any Claim shall be given by the Purchaser to the Institutional Sellers on or before (i) the third anniversary of the Completion Date in respect of any breaches of Clause 13 relating to any information relating to the Purchaser Group, any of the Group Companies and/or the Business and (ii) the second anniversary of the Completion Date in respect of all other Claims, and the Sellers shall cease to be under any liability to the Purchaser or otherwise in respect of all and any Claim(s) not so notified to the Institutional Sellers within such applicable period. Such written notice shall include such detail (including the amount claimed) as is reasonably available to the Purchaser at the time of the relevant facts and circumstances giving rise to the Claim, provided that the Purchaser’s failure to provide such detail shall not prejudice the Purchaser’s recovery in respect of such Claim, except to the extent that the liability of the Sellers (or costs of the Sellers in defending such Claim) is increased as a result of such failure.

 

39

 

 

10.5 Any Claim notified pursuant to Clause 10.4 shall (if it has not been previously satisfied, settled or withdrawn) be deemed to be irrevocably withdrawn six (6) months after the relevant notice has been given by the Purchaser, unless at such time legal proceedings in respect of the relevant Claim have been commenced by being both issued and validly served on the Seller(s).

 

10.6 The provisions of Clauses 10.2 and 10.4 shall not apply in respect of a Claim against a Seller if it is (or the delay in the discovery of which is) the consequence of fraud by that Seller.

 

10.7 Nothing in the Transaction Documents shall, or shall be deemed to, relieve or abrogate the Purchaser of any common law or other duty to mitigate any loss or damage.

 

10.8 Each Seller undertakes to the Purchaser that (save in the case of fraud or fraudulent misrepresentation) it:

 

(a) has no rights against (and irrevocably waives any rights (whether past, present or future, whether known or unknown) it may have against); and

 

(b) shall not make any claim against (and irrevocably waives any claim (whether past, present or future, whether known or unknown) it may have against),

 

any Group Company or any of their directors, officers, employees, agents, advisers or other representatives, any direct or indirect shareholder of the Purchaser, any provider of investment advice or finance to the Purchaser, any person otherwise connected with the Purchaser or their current or former Representatives, in connection with (i) the transactions contemplated by the Transaction Documents and/or (ii) pursuant to the Investment Agreement, in each case, except as may be expressly agreed between a Seller and the Purchaser.

 

11. WARRANTIES, LIMITATIONS and undertakings OF THE PURCHASER

 

11.1 Except as set forth in Schedule 5, the Purchaser warrants to each Seller as at the date of this Deed and as at the Completion Date each of the matters set out in Schedule 4.

 

11.2 The Purchaser shall not modify or waive, or provide consent to modify or waive (including consent to termination, to the extent required), any provision of any Subscription Agreement or any remedy under any Subscription Agreement, in each case, without the prior written consent of the Institutional Sellers; provided, that any modification or waiver that is solely ministerial in nature and does not affect any economic or any other material term (including any conditions to closing) of a Subscription Agreement shall not require the prior written consent of the Institutional Sellers. If the Purchaser is required to consummate Completion hereunder, the Purchaser shall use all reasonable endeavours to take, or cause to be taken, all reasonable actions and do, or cause to be done, all things reasonably necessary, proper or advisable to consummate the transactions contemplated by the Subscription Agreements on the terms and subject to the conditions described therein, including maintaining in effect the Subscription Agreements and to:

 

40

 

 

(a) satisfy on a timely basis all conditions and covenants applicable to the Purchaser in the Subscription Agreements and otherwise comply with its obligations thereunder;

 

(b) if all conditions under the Subscription Agreements (other than those conditions that by their nature are to be satisfied at Completion, but which conditions are then capable of being satisfied) have been satisfied, consummate the transactions contemplated by the Subscription Agreements at or prior to Completion;

 

(c) deliver notices to counterparties to the Subscription Agreements as required by and in the manner set forth in the Subscription Agreements in order to cause timely funding in advance of Completion; and

 

(d) without limiting the Sellers’ rights to enforce the Subscription Agreements, enforce the Purchaser’s rights under the Subscription Agreements, subject to all provisions thereof, if all conditions in the Subscription Agreements (other than those conditions that by their nature are to be satisfied at Completion, but which conditions are then capable of being satisfied) have been satisfied, to cause the applicable PIPE Investors to fund the amounts set forth in the Subscription Agreements in accordance with their terms.

 

11.3 The Purchaser shall ensure that there shall be no amendment, modification, termination, replacement, restatement, cancellation or other change made to any Debt Financing Agreement that would adversely affect the ability of the Purchaser to satisfy its obligations under the Transaction Documents (and any change which causes the conditionality of any such Debt Financing Agreement to become more onerous shall be regarded as adversely affecting the ability of the Purchaser to satisfy its obligations under the Transaction Documents) and the Purchaser shall not do any act or take any step or omit to do any act or take any step that would in any way:

 

(a) reduce the aggregate amount of the finance committed and available to be drawn by the Purchaser thereunder in a way which would adversely affect the ability of the Purchaser to satisfy its obligations under the Transaction Documents;

 

(b) reduce the period of time for which funds are available to be drawn by the Purchaser in a way which would adversely affect the ability of the Purchaser to satisfy its obligations under the Transaction Documents; or

 

(c) otherwise adversely affect the ability of the Purchaser to draw funds thereunder on the Completion Date sufficient to enable the Purchaser to meet its obligations under the Transaction Documents and all fees (including any VAT properly chargeable thereon) and expenses required to be paid in connection with such financing.

 

11.4 The Purchaser further undertakes to the Sellers that it shall take all action necessary to draw such amounts as it requires under the Debt Financing Agreements on the Completion Date sufficient for the Purchaser to meet its obligations under the Transaction Documents and all fees (including any VAT properly chargeable thereon) and expenses required to be paid in connection with such financing.

 

11.5 To the extent that such funds referred to in Clause 11.4 are not capable of being drawn as a result of a failure of the relevant counterparty to perform its obligations under the Debt Financing Agreements, the Purchaser undertakes to take all such actions (or procure that such action is taken) as is necessary to enforce its or any other member of the Purchaser Group’s rights against such counterparty under the relevant agreements.

 

41

 

 

11.6 The Purchaser undertakes to the Sellers that (save in the case of fraud or fraudulent misrepresentation) it:

 

(a) has no rights against (and irrevocably waives any rights (whether past, present or future, whether known or unknown) it may have against); and

 

(b) shall not make any claim against (and irrevocably waives any claim (whether past, present or future, whether known or unknown) it may have against),

 

any Group Company, any director of a Group Company, any Affiliate of the Sellers, any provider of investment or finance to the Sellers, any person otherwise connected with the Sellers or each of the forgoing’s respective current or former Representatives (each of which shall be entitled to enforce this Clause 11.6) under the Contracts (Rights of Third Parties) Act 1999) in connection with the transactions contemplated by the Transaction Documents. Notwithstanding the foregoing, the Purchaser shall not be deemed to have released or waived any claim or defence which Purchaser determines after the Completion Date is necessary to defend against any action brought by any director, officer, employee, contractor, or agent prior to the Completion Date.

 

11.7 The Purchaser shall, and shall procure that each Group Company shall, from and following Completion, waive, release and discharge each Institutional Director from any and all liabilities or obligations to a Group Company and shall, and shall procure that each Group Company shall, waive any and all claims (in the absence of fraud) the Purchaser or the relevant Group Company has or may have against an Institutional Director in connection with his appointment as a director of, or employment with, or conduct in relation to, any Group Company on or prior to the Completion.

 

11.8 Notwithstanding anything to the contrary set forth herein, none of the warranties (including the warranties set forth in Clause 11.1 and on Schedule 4 (other than those warranties set forth in paragraph 1, paragraph 3 and paragraph 4 of Schedule 4, subject to Clause 11.9)) and, subject to the following sentence, undertakings of the Purchaser (other than Part 2 of Schedule 3, subject to Clause 11.9) in this Deed whose performance is contemplated prior to Completion shall survive the Completion, and the Purchaser shall have no liability to any party with respect to such warranties and undertakings following the Completion. This Clause 11.8 shall not limit any undertaking of the Purchaser which by its terms contemplates performance following the Completion.

 

11.9 Specific written notice of any claim for any breach of the warranties set forth in paragraph 1, paragraph 3 or paragraph 4 of Schedule 4 and undertakings set forth in Part 2 of Schedule 3 (“Purchaser Claim”) shall be given by the Institutional Sellers to the Purchaser on or before the date falling six months following the Completion Date, and the Purchaser shall cease to be under any liability to any Sellers or otherwise in respect of all and any Purchaser Claim(s) not so notified to the Purchaser within such applicable period. Such written notice shall include such detail (including the amount claimed) as is reasonably available to the Institutional Sellers at the time of the relevant facts and circumstances giving rise to the Purchaser Claim, provided that the Institutional Sellers’ failure to provide such detail shall not prejudice a Seller’s recovery in respect of such Purchaser Claim, except to the extent that the liability of the Purchaser (or costs of the Purchaser in defending such Purchaser Claim) is increased as a result of such failure.

 

11.10 The aggregate liability of the Purchaser for all claims which may be brought by the Sellers against the Purchaser for any breach of the warranties set forth in Clause 11.1 and Schedule 4 or undertakings set forth in Part 2 of Schedule 3, in each case to the extent permitted by the terms of this Deed, shall be limited to the aggregate amount of the Consideration payable in accordance with this Deed.

 

42

 

 

12. RESTRICTIve covenants

 

12.1 Each Seller undertakes that it shall not, and shall procure that its Affiliates shall not, directly or indirectly, at any time during the period of one (1) year following the Completion Date (other than with the prior written consent of the Purchaser), offer employment to, enter into a contract for the service of, or attempt to entice away or encourage to terminate such person’s relationship with any Group Company, any Senior Employee, provided that nothing in this Clause 12.1 shall prohibit:

 

(a) a Seller or any of its Affiliates from employing or engaging any person who responds to a bona fide recruitment advertisement (not specifically directed at any particular Senior Employee) provided that such response was not solicited or induced, directly or indirectly, by that Seller or any of its Affiliates; or

 

(b) an Institutional Seller or any of its Affiliates from employing or engaging any person:

 

(i) whose employment or engagement with the Purchaser Group or a Group Company has been terminated by the relevant Group Company other than as a result of a breach of this Clause 12 by that Seller or its Affiliates; or

 

(ii) who has resigned from their employment or engagement with the Purchaser Group or a Group Company for Good Reason,

 

in each case, on and from the time of such termination or resignation respectively; or

 

(c) a Management Seller or any of its Affiliates from employing or engaging any person:

 

(i) whose employment or engagement with the Purchaser Group or a Group Company has been terminated by the relevant Group Company other than as a result of a breach of this Clause 12 by that Seller or its Affiliates; or

 

(ii) who has resigned from their employment or engagement with the Purchaser Group or a Group Company for Good Reason,

 

in each case, on and from the date that is six (6) months following such termination or resignation respectively.

 

12.2 Each Restricted Management Seller severally undertakes to the Purchaser that he or she will not at any time during the period of twelve (12) months following the Completion Date (the “Restricted Period”) (other than with the prior written consent of the Purchaser):

 

(a) directly or indirectly within any jurisdiction in which the business of any Group Company is carried on at Completion, be engaged, concerned, connected with or otherwise interested in any Restricted Business which is carried on in direct or indirect competition with the Business. Notwithstanding this Clause 12.2(a), any Restricted Management Seller shall be permitted to, be the holder or beneficial owner by way of a bona fide investment, of any class of securities listed, or dealt in, on a recognised investment exchange (including within the meaning of Part XVIII of the Financial Services and Markets Act 2000), provided that he or she neither holds nor is beneficially interested in more than a total of three per cent (3%) of any single class of such listed securities;

 

43

 

 

(b) solicit or entice away or deal with, any person who is at the Completion Date or, at any time during the period of twelve (12) months prior to the Completion Date, was a customer of any Group Company in each case so as to compete with, or harm the goodwill of, any Group Company; and

 

(c) solicit or entice away from any Group Company any person who is at the Completion Date or, at any time during the period of twelve (12) months prior to the Completion Date, a supplier who had supplied goods and/or services to any Group Company, if that solicitation or enticement causes or would cause that supplier to cease supplying, or to materially reduce its supply of, those goods or services to any Group Company,

 

in each case, provided that if (x) such Restricted Management Seller’s employment or engagement with the Purchaser Group or a Group Company has been terminated other than as a result of a breach of this Clause 12.2 by the Restricted Management Seller; or (y) such Restricted Management Seller has resigned from their employment or engagement with the Purchaser Group or a Group Company for Good Reason, the then remaining term of the Restricted Period at the time of such termination or resignation shall be reduced by fifty per cent (50%).

 

12.3 Each of the restrictions contains in this Clause 12 shall be construed as a separate provision of this Deed. If any restriction is unenforceable but would be valid if reduced in scope or duration or any part of it were deleted, the parties agree that the restriction shall apply with the minimum modifications as may be necessary to make it valid and enforceable. Each Seller acknowledges and agrees (after receiving legal advice) that each restriction is considered to be fair and reasonable and is not greater than is reasonably necessary to protect the interests of the Purchaser, each Group Company and their respective Affiliates.

 

13. CONFIDENTIALITY AND ANNOUNCEMENTS

 

13.1 Subject to Clause 13.6, each party:

 

(a) shall treat as strictly confidential:

 

(i) the provisions of this Deed and the other Transaction Documents (including the identities of the parties to such agreements), their subject matter and any documents referred to therein and the process of their negotiation;

 

(ii) in the case of the Sellers, any information received or held by each Seller or any of their respective Representatives which relates to the Purchaser Group or, following Completion, any of the Group Companies (including all confidential information or trade secrets in their possession concerning the business, affairs, customers, clients or suppliers of any of the Group Companies); and

 

(iii) in the case of the Purchaser, any information directly or indirectly received or held by the Purchaser or any of its Representatives which relates to any Seller or any of their respective Affiliates or, prior to Completion, to any of the Group Companies (including all confidential information or trade secrets in their possession concerning the business, affairs, customers, clients or suppliers of any of the Group Companies),

 

(together, the “Confidential Information”); and

 

44

 

 

(b) shall not, except with the prior written consent of the party to whom the Confidential Information concerns (which shall not be unreasonably withheld or delayed), make use of (save for the purposes of performing its obligations under this Deed) or disclose to any person (other than its Representatives and providers of finance in accordance with Clause 13.2 and in the case of the Institutional Sellers and the Purchaser, to the persons described in Clause 13.3) any Confidential Information.

 

13.2 Each party undertakes that it shall only disclose Confidential Information to its Representatives and providers of finance for the purposes of the Transaction where it is reasonably required for the purposes of performing its obligations under this Deed or the other Transaction Documents and only where such recipients are informed of the confidential nature of the Confidential Information and the provisions of this Clause 13 and agree to comply with this Clause 13 as if they were a party to it.

 

13.3 Clauses 13.1 and 13.2 shall in no way prevent or restrict the Institutional Sellers or the Purchaser or any of their respective Representatives from disclosing Confidential Information to:

 

(a) such party’s Representatives;

 

(b) any general partner, limited partner, trustee, nominee or manager of, or adviser to, such party or of or to any of its Affiliates, or any investor or potential investor in any of them;

 

(c) any company or fund (including any unit trust, investment trust, limited partnership or general partnership) which is advised by, or the assets of which are managed by (whether solely or jointly with others) such party or in respect of which such party is a general partner, or which is advised or managed by such party’s general partner, trustee, nominee, manager or adviser, or any potential investors in any such company or fund or any potential such company or fund;

 

(d) any co-investment scheme of such party or any person holding shares under such scheme or entitled to the benefit of shares under such scheme;

 

(e) the Non-Institutional Sellers and each of their respective Affiliates;

 

(f) in the case of the Sellers and the Group, any existing provider of finance to any of the foregoing, any trustee or nominee on their behalf, any rating agency or the directors, officers, employees, agents, consultants, advisers, auditors or bankers of any actual provider of finance to the foregoing, in each case, provided that such disclosure is on a strictly confidential and need to know basis only in connection with the repayment of the amounts under the Existing Facilities and release of Encumbrances in relation to the Existing Facilities (including in respect of the Bank Pay-Off Amount, the Debt Security, the Pay-Off Letter and the Deed of Release) and provided that such recipients are informed of the confidential nature of the Confidential Information and agree to comply with reasonable confidentiality undertakings; and/or

 

45

 

 

(g) in the case of the Purchaser, any actual or potential provider of finance to any of the foregoing, any trustee or nominee on their behalf, any rating agency or the directors, officers, employees, agents, consultants, advisers, auditors or bankers of any actual or potential provider of finance to the foregoing, in each case, provided that such disclosure is on a strictly confidential and need to know basis and provided that such recipients are informed of the confidential nature of the Confidential Information and agree to comply with reasonable confidentiality undertakings.

 

13.4 Subject to Clauses 13.5 and 13.6, no party shall make any announcement (including any communication to the public, to any customers, suppliers or employees of any of the Group Companies) concerning the subject matter of this Deed without the prior written consent of the Institutional Sellers and the Non-Institutional Sellers’ Representative (in the case of the Purchaser) and the Purchaser (in the case of the Sellers) (which shall not be unreasonably withheld or delayed).

 

13.5 Notwithstanding anything to the contrary set forth herein, as promptly as practicable following the date of this Deed, the Purchaser shall prepare and file a Current Report on Form 8-K pursuant to the Securities Exchange Act to report the execution of this Deed and the Subscription Agreements, and make public all material non-public information provided to potential PIPE Investors prior to the date of this Deed (the “Signing Form 8-K”), and the Purchaser and the Institutional Sellers shall issue a mutually agreeable press release announcing the execution of this Deed (the “Signing Press Release”). Prior to filing with the SEC, the Purchaser will make available to the Institutional Sellers a draft of the Signing Form 8-K and will provide the Institutional Sellers with a reasonable opportunity to comment on such drafts and shall consider such comments in good faith.

 

13.6 Clauses 13.1 and 13.4 shall not apply if and to the extent that:

 

(a) such disclosure or announcement is required by Law or by the rules of any stock exchange or any or any supervisory, regulatory, governmental or other Authority (including, for the avoidance of doubt, any Tax Authority) having applicable jurisdiction, provided that before the Purchaser files any document with the SEC, the Purchaser shall provide to the Institutional Sellers, copies of all such documents proposed to be filed sufficiently in advance of filing to provide the Institutional Sellers a reasonable opportunity to review such documents and comment thereon;

 

(b) such disclosure is to a Tax Authority in connection with the Tax affairs of the disclosing party (or Affiliate thereof);

 

(c) such disclosure or announcement is required in order to facilitate any assignment or proposed assignment of the whole or any part of the rights or benefits under this Deed which is permitted by Clause 22;

 

(d) the Confidential Information concerned has come into the public domain other than through its fault (or that of its Representatives) or the fault of any person to whom such Confidential Information has been disclosed in accordance with this Clause 13.6; or

 

(e) disclosure is made by the Purchaser to the W&I Insurer, provided such information is disclosed on a confidential basis.

 

13.7 The provisions of this Clause 13 shall survive termination of this Deed or Completion, as the case may be, and shall continue for a period of five (5) years from the date of this Deed.

 

46

 

 

14. d&o insurance

 

14.1 Prior to the Completion Date, the Institutional Sellers, at the cost of the Sellers, shall procure that the Company arrange for (and Purchaser shall procure that such is maintained until the sixth anniversary of the Completion Date) irrevocable run-off directors’ and officers’ insurance (“D&O Insurance”) in respect of those directors of any Group Company who resign from any board of a Group Company at or prior to Completion.

 

14.2 Any director covered by the D&O Insurance may enforce his or her rights under this Clause 14 under the Contracts (Rights of Third Parties) Act 1999.

 

15. NON-INSTITUTIONAL sellerS’ REPRESENTATIVE

 

15.1 Subject to Clause 15.3, each Non-Institutional Seller hereby irrevocably appoints each FP Seller to act as its representative and represent each Non-Institutional Seller for the purposes contemplated by this Deed (the “Non-Institutional Sellers’ Representative”).

 

15.2 Each Non-Institutional Seller hereby irrevocably agrees that it shall be bound by any steps or actions taken or any agreement entered into by the Non-Institutional Sellers’ Representative acting in accordance with this Deed. The Purchaser and the Institutional Sellers shall be entitled to rely on the authority of the Non-Institutional Sellers’ Representative to act on behalf of each Non-Institutional Seller without further enquiry.

 

15.3 If for any reason each of the FP Sellers shall not be able to act as the Non-Institutional Sellers’ Representative and the Non-Institutional Sellers nominate in writing another person to fill the role of Non-Institutional Sellers’ Representative by a decision taken by Non-Institutional Sellers representing a majority of the aggregate number of Shares held by the Non-Institutional Sellers, such other person so notified in writing to the Purchaser and the Institutional Sellers shall be the Non-Institutional Sellers’ Representative in substitution for the FP Sellers from time to time.

 

15.4 Each Non-Institutional Seller irrevocably and unconditionally undertakes severally to indemnify and hold the Non-Institutional Sellers’ Representative harmless against all Losses arising from the exercise or the purported exercise in good faith of any of the rights or duties of the Non-Institutional Sellers’ Representative contemplated by this Deed.

 

15.5 Each Non-Institutional Sellers agrees that any information relating to any other Seller’s holding of securities in the Group and amounts payable to any other Seller under the Transaction Documents (including the information in Schedule 1 and the Consideration Allocation Schedule) is confidential, and that they shall only be entitled to receive and/or have access to such information to the extent that that information relates to that Non-Institutional Seller.

 

16. POWER OF ATTORNEY

 

16.1 From Completion and for so long after Completion as each Seller remains the registered holder of the Shares set forth against its name in column 2 of Schedule 1, each Seller shall appoint the Purchaser to be its lawful attorney with authority in its name and on its behalf to exercise any or all of the voting and other rights, powers and privileges attaching to such Shares in such manner and on such terms as the Purchaser in its absolute and unfettered discretion sees fit.

 

16.2 The power of attorney given in Clause 16.1 shall be irrevocable, save with the written consent of the Purchaser, and is given by way of security to secure the proprietary interest of the Purchaser in the relevant Shares as the Purchaser of the relevant Shares, but shall expire on the date on which the Purchaser is entered in the register of members of the Company as holder of the relevant Shares.

 

47

 

 

16.3 For so long as the power of attorney given in Clause 16.1 remains in force, each Seller undertakes:

 

(a) not to exercise or allow or appoint any person to exercise any rights which attach to the relevant Shares or are exercisable in its capacity as registered holder of the relevant Shares without the Purchaser’s prior written consent;

 

(b) to hold on bare trust for the Purchaser and to promptly account to the Purchaser for any and all dividends, interest and/or other distributions received by such Seller in respect of the relevant Shares and to, as soon as reasonably practicable after receipt, notify the Purchaser as attorney of anything received by such Seller in its capacity as registered holder of the relevant Shares;

 

(c) to act promptly in accordance with the Purchaser’s instructions in relation to any rights exercisable or anything received by it in its capacity as registered holder of the relevant Shares and if so directed by the Purchaser, to promptly exercise any or all such rights in accordance with the direction of the Purchaser;

 

(d) to cause to deliver to the Purchaser’s registered office any notice, letter, communication or other correspondence of any nature whatsoever relating to the relevant Shares, including any notice of general meeting or written resolution of the Company, as soon as reasonably practicable; and

 

(e) to ratify, authorise and confirm whatever the Purchaser may do or cause to be done, and all documents considered, approved, signed, executed, completed, delivered and otherwise perfected by the Purchaser, as attorney in its name or on its behalf in exercising the powers contained in this Clause 16.1.

 

16.4 Nothing in this Clause 16.1 shall require any Seller to take any action (or require it to omit to take any action) that would breach any applicable Law.

 

17. FURTHER ASSURANCE

 

Each party shall (and shall procure that each of its Affiliates shall) execute and deliver or procure, so far as they are reasonably able, the execution and delivery of, all such documents, and do all such things, as the other parties may reasonably require at the cost of such other party for the purpose of giving full effect to the provisions of this Deed.

 

18. ENTIRE AGREEMENT AND REMEDIES

 

18.1 This Deed and the other Transaction Documents together set out the entire agreement between the parties relating to the subject matter of this Deed and matters described in the other Transaction Documents and, save to the extent expressly set out in this Deed or any other Transaction Document, supersede and extinguish any prior drafts, agreements, undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing, relating thereto.

 

48

 

 

18.2 The Purchaser acknowledges and agrees that in entering into this Deed and the Transaction Documents, it has not relied and is not relying on, and shall have no claim or remedy in respect of, any statement, representation, warranty, undertaking, assurance, promise, understanding or other provision made by or on behalf of the Sellers, any of their Representatives or any other person (whether party to this Deed or not), whether written or oral, express or implied, which is not expressly set out in this Deed, any other Transaction Document or related agreements.

 

18.3 The Purchaser acknowledges and agrees that neither it nor any of its Representatives has any rights against (and waives any rights it may have against), and shall not make any claim or bring any action against (and waives any claim it may have against), any Representative of any of the Sellers in relation to the Transaction and the Sellers and the Company acknowledge and agree that neither such Seller nor the Company nor any of their respective Representatives has any rights against (and waives any rights it may have against), and shall not make any claim or bring any action against (and waives any claim it may have against), any Representative of the Purchaser in relation to the Transaction.

 

18.4 Save as expressly set out in this Deed, and subject to the limitations set forth in this Deed, the only right or remedy of the Purchaser, the Sellers or the Company in relation to any statement, representation, warranty, undertaking, assurance, promise, understanding or other provision set out in this Deed or any other Transaction Document shall be for breach of this Deed or the relevant Transaction Document to the exclusion of all other rights and remedies (including those in tort or arising under statute) and, in respect of any breach of this Deed or any Transaction Document, the only remedy shall be a claim for damages in respect of such breach. The Purchaser, the Sellers and the Company acknowledge and agree that damages may not be an adequate remedy for any breach of this Deed or the relevant Transaction Document and that the remedies of injunction, specific performance and other equitable remedies may be appropriate for any such threatened or actual breach.

 

18.5 Save as expressly set out in this Deed, no party shall not be entitled to rescind or terminate this Deed in any circumstances whatsoever at any time, whether before or after Completion, and each party waives any rights of rescission or termination it may have.

 

18.6 Each Seller irrevocably agrees that the Investment Agreement will terminate with effect from Completion and all rights of any kind (past, present or future), obligations and liabilities of each Seller and the Company and all claims under, pursuant to or arising (directly or indirectly) out of the Investment Agreement shall be released with effect from Completion whether arising before or on the Completion Date.

 

18.7 If there is any conflict between the terms of this Deed and any other agreement, this Deed shall prevail (as between the parties to this Deed and as between the Sellers and their respective Affiliates (on the one hand) and any members of the Purchaser Group (on the other hand)) unless:

 

(a) such other agreement (including the Amended Investor Rights Agreement) expressly states that it overrides this Deed in the relevant respect; and

 

(b) the Sellers, the Purchaser and the Company are either also parties to that other agreement or otherwise expressly agree in writing that such other agreement shall override this Deed in that respect.

 

18.8 This Clause 18 shall not exclude any liability for or remedy in respect of fraud or fraudulent misrepresentation.

 

49

 

 

19. POST-COMPLETION EFFECT OF AGREEMENT

 

Notwithstanding Completion, each provision of this Deed and any other Transaction Document not performed at or before Completion but which remains capable of performance will remain in full force and effect and, except as otherwise expressly provided and subject to Law, without limit in time.

 

20. WAIVER AND VARIATION

 

20.1 A failure or delay by a party to exercise any right or remedy provided under this Deed or by Law, whether by conduct or otherwise, shall not constitute a waiver of that or any other right or remedy, nor shall it preclude or restrict any further exercise of that or any other right or remedy. No single or partial exercise of any right or remedy provided under this Deed or by Law, whether by conduct or otherwise, shall preclude or restrict the further exercise of that or any other right or remedy.

 

20.2 A waiver of any right or remedy under this Deed shall only be effective if given in writing and shall not be deemed a waiver of any subsequent breach or default. A party that waives a right or remedy provided under this Deed or by Law in relation to another party does not affect its rights in relation to any other party.

 

20.3 No variation or amendment of this Deed shall be valid unless it is in writing and duly executed by or on behalf of the Purchaser, the Institutional Sellers and the Non-Institutional Sellers’ Representative. Unless expressly agreed, no variation or amendment shall constitute a general waiver of any provision of this Deed, nor shall it affect any rights or obligations under or pursuant to this Deed which have already accrued up to the date of variation or amendment and the rights and obligations under or pursuant to this Deed shall remain in full force and effect except and only to the extent that they are varied or amended.

 

21. INVALIDITY

 

Where any provision of this Deed is or becomes illegal, invalid or unenforceable in any respect under the Laws of any jurisdiction then such provision shall be deemed to be severed from this Deed and, if possible, replaced with a lawful provision which, as closely as possible, gives effect to the intention of the parties under this Deed and, where permissible, that shall not affect or impair the legality, validity or enforceability in that, or any other, jurisdiction of any other provision of this Deed.

 

22. ASSIGNMENT AND SUCCESSORS

 

22.1 Except as provided in this Clause 22 or as the Institutional Sellers, the Non-Institutional Sellers’ Representative and the Purchaser specifically agree in writing, no person shall assign, transfer, charge or otherwise deal with all or any of its rights under this Deed nor grant, declare, create or dispose of any right or interest in it.

 

22.2 Subject to Clauses 22.3 and 23, the Purchaser may assign the benefit of this Deed and/or of any other Transaction Document to which it is a party, in whole or in part, to, and it may be enforced by:

 

(a) any member of the Purchaser Group, provided that the Purchaser shall procure that such assignee or transferee reassigns its rights or obligations under this Deed to another member of the Purchaser Group if such assignee or transferee ceases to be a member of the Purchaser Group; or

 

50

 

 

(b) any bank or financial lender or creditor or any member of their groups (including any trustee or nominee on their behalf or funds) lending money or making other banking facilities available to the Purchaser for the acquisition of the Shares or by way of security.

 

Any such person to whom an assignment is made under this Clause 22.2 may itself make an assignment as if it were the Purchaser under this Clause 22.2.

 

22.3 Any assignment made pursuant to this Clause 22 and Clause 23.3 shall be on the basis that:

 

(a) the Sellers may discharge their obligations under this Deed to the assignor until they receive notice of the assignment;

 

(b) the liability of the Sellers to any assignee shall not be greater than its liability to the Purchaser;

 

(c) the assignment shall not result in any other Taxes, costs or expenses for which any of the Sellers or their direct or indirect owners would be responsible; and

 

(d) the Purchaser will remain liable for any obligations under this Deed to the extent the Purchaser Nominee does not satisfy such obligations.

 

23. purchaser nominee

 

23.1 This Deed shall be binding on and continue for the benefit of the successors and assignees of each party.

 

23.2 The Purchaser shall be entitled to nominate any of its Affiliates (a “Purchaser Nominee”) to acquire the Company on its behalf, provided that the Purchaser provides the Institutional Sellers a written notice of such nomination or nominations at least ten (10) Business Days prior to Completion (the “Purchaser Nomination Notice”), provided that (a) the Purchaser will remain liable for all obligations of the Purchaser and Purchaser Nominee under this Deed, (b) the liability of a Seller to any Purchaser Nominee shall not be greater than its liability to the Purchaser. Any such Purchaser Nomination Notice shall specify in reasonable detail the identity and corporate details of the relevant Purchaser Nominee, and (c) the nomination shall not result in any other Taxes, costs or expenses for which any of the Sellers or their direct or indirect owners would be responsible.

 

23.3 If the Purchaser delivers to the Seller a Purchaser Nomination Notice pursuant to Clause 23.2, it shall also be entitled to assign to the Purchaser Nominee all of its rights and benefits in respect of the acquisition of the Shares pursuant to Clauses 22.2(a) and 22.3.

 

24. PAYMENTS, SET OFF AND DEFAULT INTEREST

 

24.1 Any payment to be made pursuant to this Deed by the Purchaser to the Sellers shall be made to the Paying Agent Account by way of electronic transfer in immediately available funds on or before the due date for payment. Receipt of such sum in such account on or before the due date for payment shall be a good discharge by the payor of its obligation to make such payment and the payor shall not be concerned with, or have any liability whatsoever with respect to, such apportionment or application of such amounts.

 

51

 

 

24.2 All payments under this Deed shall be made free from any set-off, counterclaim or other deduction or withholding of any nature whatsoever, except for deductions or withholdings required to be made by Law. If any deductions or withholdings are required by Law to be made from any such payments, the amount of any such payment (excluding for these purposes any payment in respect of the Consideration, Exit Bonuses and any Break Fees) shall be increased by such amount as will, after the deduction or withholding has been made, leave the recipient of the payment with the same amount as it would have been entitled to receive in the absence of any such requirement to make a deduction or withholding. The parties agree that, as at the date of this Deed, no deductions or withholdings are required by Law to be made from any payment in respect of the Consideration.

 

24.3 If, following the payment of an additional amount under Clause 24.2 above, the recipient subsequently obtains a saving, reduction, credit or payment in respect of the deduction or withholding giving rise to such additional amount, the recipient shall pay to the payer a sum equal to the amount of such saving, reduction, credit or payment (in each case to the extent of the additional amount) such payment to be made within seven (7) days of the receipt of the saving, reduction, credit or payment as the case may be.

 

24.4 Where a party defaults in the payment of any sum payable by virtue of this Deed or any other Transaction Documents the liability such party shall be increased to include an amount equal to interest on such sum from the date when payment is due to the date of actual payment (both before and after judgment) at that annual rate which is 2% per annum above the base lending rate of HSBC Bank plc from time to time in effect during such period. Such interest shall accrue from day to day and be compounded quarterly and shall be payable without prejudice to any other remedy available to the Sellers in respect of such default.

 

25. NOTICES

 

25.1 Any notice or other communication given under this Deed or in connection with the matters contemplated herein shall, except where otherwise specifically provided, be in writing in the English language, addressed as provided in Clause 25.2 and served:

 

(a) by courier, in which case it shall be deemed to have been given two (2) Business Days after its delivery to a representative of the courier; or

 

(b) by e-mail, in which case it shall be deemed to have been given when despatched subject to no automated response or bounce-back being received, provided that any notice despatched outside Working Hours shall be deemed given at the start of the next period of Working Hours.

 

25.2 Notices under this Deed shall be sent for the attention of the person and to the address, or e-mail address, subject to Clause 25.3, as set out below:

 

For the FP Seller:  
   
Name: Francisco Partners III (Cayman), L.P. and Francisco Partners Parallel Fund III (Cayman), L.P.
   
For the attention of: Deep Shah
   
Address: 207 Sloane Street, 2nd Floor, London, SW1X 9QX, United Kingdom

 

52

 

 

E-mail address: Shah@franciscopartners.com
   
with copies to (such copies not in themselves constituting valid service of such notice):
   
Name: Latham & Watkins (London) LLP
   
For the attention of: Kem Ihenacho and Cory Tull
   
Address: 99 Bishopsgate, London EC2M 3XF
   
E-mail address: Kem.Ihenacho@lw.com and Cory.Tull@lw.com
   
   
For the Temasek Seller:  
   
Name: Anderson Investments Pte. Ltd.
   
For the attention of: Fock Wai Hoong and Martin Fichtner
   
Address: c/o Temasek Capital Management Pte Ltd
  60B Orchard Road, #06-18 Tower 2
  The Atrium@Orchard
   
E-mail address: waihoong@temasek.com.sg and
  martinfichtner@temasek.com.sg
   
with copies to (such copies not in themselves constituting valid service of such notice):
   
Name: Debevoise & Plimpton LLP
   
For the attention of: Kevin M. Schmidt
   
Address: 919 Third Avenue, New York, NY 10011
   
E-mail address: kmschmidt@debevoise.com
   
   
For the Non-Management Sellers and the Management Sellers:
   
Name: Francisco Partners III (Cayman), L.P. and Francisco Partners Parallel Fund III (Cayman), L.P.
   
For the attention of: Deep Shah
   
Address: 207 Sloane Street, 2nd Floor, London, SW1X 9QX, United Kingdom
   
E-mail address: Shah@franciscopartners.com
   
with copies to (such copies not in themselves constituting valid service of such notice):
   
Name: Latham & Watkins (London) LLP

 

53

 

 

For the attention of: Kem Ihenacho and Cory Tull
   
Address: 99 Bishopsgate, London EC2M 3XF
   
E-mail address: Kem.Ihenacho@lw.com and Cory.Tull@lw.com
   
For the Purchaser:  
   
Name: E2open Parent Holdings, Inc.
   
For the attention of: Michael Farlekas and Laura Fese
   
Address: c/o E2open, LLC, 9600 Great Hills Trail, Suite 300E, Austin, Texas 78759
   
E-mail address: Michael.Farlekas@e2open.com and
  Laura.Fese@e2open.com
   
with a copy to (such copy in itself not constituting valid service of such notice):
   
Name: Kirkland & Ellis (International) LLP
   
For the attention of: David Holdsworth, Rachel Greenhalgh and Lauren M.Colasacco, P.C.
   
Address: 30 St Mary Axe, London, EC3A 8AF
   
E-mail address: david.holdsworth@kirkland.com;
  rachel.greenhalgh@kirkland.com; and
  lauren.colasacco@kirkland.com
   
For the Company:  
   
Name: BluJay Topco Limited
   
For the attention of: Andrew Kirkwood and Joy Burkholder Meier
   
Address: Blue Tower 14th Floor, MediaCityUK, Salford Quays, United Kingdom, M50 2ST
   
E-mail address: andrew.kirkwood@blujaysolutions.com; and joy.meier@blujaysolutions.com
   
with a copy to, prior to Completion (such copy in itself not constituting valid service of such notice):
   
Name: Latham & Watkins (London) LLP
   
For the attention of: Kem Ihenacho and Cory Tull
   
Address: 99 Bishopsgate, London EC2M 3XF

 

54

 

 

E-mail address: Kem.Ihenacho@lw.com and Cory.Tull@lw.com
   
with a copy to, following Completion (such copy in itself not constituting valid service of such notice):
   
Name: Kirkland & Ellis (International) LLP
   
For the attention of: David Holdsworth, Rachel Greenhalgh and Lauren M.Colasacco, P.C.
   
Address: 30 St Mary Axe, London, EC3A 8AF
   
E-mail address: david.holdsworth@kirkland.com;
  rachel.greenhalgh@kirkland.com; and
  lauren.colasacco@kirkland.com

 

25.3 Any party to this Deed may notify the other parties of any change to its address or other details specified in Clause 25.2 provided that such notification shall only be effective on the date specified in such notice or five (5) Business Days after the notice is given, whichever is later.

 

25.4 Any notice to be given to or by any or all of the Non-Institutional Sellers under this Deed shall be deemed to have been properly given if it is given to or by Non-Institutional Sellers’ Representative in accordance with the terms of this Deed.

 

26. COSTS

 

26.1 Except as otherwise provided in this Deed, no party will be responsible for another party’s costs arising out of or in connection with the preparation, negotiation and implementation of this Deed and all other Transaction Documents and, for the avoidance of doubt, the Sellers will be responsible for any and all costs in respect of the establishment, maintenance and operation of the Paying Agent Account.

 

26.2 The Purchaser shall bear the cost of all Transfer Taxes imposed in connection with this Deed or any of the Transaction Documents or any transaction contemplated thereby or hereby (including as a result of the agreement to transfer or the transfer of Shares). The Purchaser shall be responsible for arranging the payment of all such Transfer Taxes, including fulfilling any administrative or reporting obligation imposed by the jurisdiction in question in connection with such payment.

 

27. RIGHTS OF THIRD PARTIES

 

27.1 The specified third party beneficiaries of the undertakings referred to in Clauses 3.4, 3.8, 10.8, 14.2, 18.3 and 18.6 shall, in each case, have the right to enforce the relevant terms by reason of the Contracts (Rights of Third Parties) Act 1999.

 

27.2 Any member of the Purchaser Group and any Group Company may rely on and enforce the terms of Clause 12 and any Seller, Group Company and member of the Purchaser Group may rely and enforce the terms of Clause 13, in each case, by reason of the Contracts (Rights of Third Parties) Act 1999.

 

55

 

 

27.3 Except as provided for in Clause 27.1 and 27.2, a person who is not a party to this Deed shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.

 

27.4 Each party represents to the other that any rights they each may have to terminate, rescind or agree any amendment, variation, waiver or settlement under this Deed are not subject to the consent of any person that is not a party to this Deed.

 

28. COUNTERPARTS

 

This Deed may be executed in any number of counterparts. Each counterpart shall constitute an original of this Deed but all the counterparts together shall constitute but one and the same instrument.

 

29. GOVERNING LAW AND JURISDICTION

 

29.1 This Deed and any non-contractual rights or obligations arising out of or in connection with it shall be governed by and construed in accordance with the laws of England and Wales; provided that, for the avoidance of doubt, any determination of fiduciary duties, including in connection with Purchaser’s reasonable and/or good faith determinations in connection therewith pursuant to Clauses 7.16 and 7.18, shall be governed by Delaware law.

 

29.2 The parties irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction to settle any Disputes, and waive any objection to proceedings before such courts on the grounds of venue or on the grounds that such proceedings have been brought in an inappropriate forum.

 

29.3 For the purposes of this Clause, “Dispute” means any dispute, controversy, claim or difference of whatever nature arising out of, relating to, or having any connection with this Deed, including a dispute regarding the existence, formation, validity, interpretation, performance or termination of this Deed or the consequences of its nullity and also including any dispute relating to any non-contractual rights or obligations arising out of, relating to, or having any connection with this Deed.

 

29.4 Notwithstanding anything to the contrary set forth herein, including this Clause 29, the governing law, jurisdiction and dispute provisions of the Amended Investor Rights Agreement, the Support Agreements, the Subscription Agreements, the Debt Financing Agreements and the Lock-Up Agreements shall govern with respect to the matters set forth in such agreements.

 

30. PROCESS AGENT

 

30.1 Without prejudice to any other permitted mode of service, the parties agree that service of any claim form, notice or other document for the purpose of or in connection with any action or proceeding in England or Wales arising out of or in any way relating to this Deed or any other Transaction Document governed by the laws of England or Wales shall be duly served upon:

 

(a) the Purchaser if it is delivered personally or sent by recorded or special delivery mail to E2open Ltd, 1020 Eskdale Road, Winnersh Triangle, Reading, RG41 5TS marked for the attention of the directors; and

 

(b) each of the FP Sellers if it is delivered personally or sent by recorded or special delivery mail to Francisco Partners Operations LLP of 207 Sloane Street, London SW1X 9QX marked for the attention of the designated members,

 

56

 

 

or, in each case, such other person and address in England or Wales as such party shall notify the Institutional Sellers and the Non-Institutional Sellers’ Representative in writing from time to time, whether or not such claim form, notice or other document is forwarded to the relevant party or received by such party.

 

[Rest of the page left intentionally blank]

 

57

 

 

Schedule 1: THE SELLERS

 

[Attached]

 

58

 

 

 

Schedule 2: COMPLETION OBLIGATIONS

 

1.            Sellers’ OBLIGATIONS

 

At Completion:

 

(a) each Seller shall severally deliver to, or procure the delivery to, the Purchaser of:

 

(i) solely to the extent a document required to be delivered pursuant to this paragraph 2 is executed via power of attorney, a copy of any such executed power of attorney in the Agreed Form under which any document to be delivered to the Purchaser by such Seller under this Schedule 2 has been executed;

 

(ii) a stock transfer form in respect of the Shares set forth against its name in column 2 of Schedule 1 into the name of the Purchaser, duly executed by the registered holder(s) thereof; and

 

(iii) share certificates in respect of all such Shares, or a deed of indemnity, in the Agreed Form, for any lost share certificates.

 

(b) each Institutional Seller shall severally deliver to, or procure the delivery to, the Purchaser of:

 

(i) the Amended Investor Rights Agreement, duly executed by or on behalf of each Institutional Seller;

 

(ii) a copy of such Institutional Seller’s corporate authorisations approving the Transaction and the execution by each such Institutional Seller of the Transaction Documents to which it is a party;

 

(iii) the written resignations as a director of the Company, in the Agreed Form, of each Institutional Director as a director of the Company; and

 

(iv) a fully executed deed of termination in respect of the Master Consulting Services Agreement, in the Agreed Form;

 

(c) each Institutional Seller and Management Seller shall severally:

 

(i) deliver to, or procure the delivery to, the Purchaser of:

 

(A) the written resignations of any other director of a Group Company, in the Agreed Form, the identity of whom the Purchaser has notified the Institutional Sellers not less than five (5) Business Days prior to the Scheduled Completion Date;

 

(B) the duly executed Deed of Release;

 

(C) the duly executed Pay-Off Letter;

 

(D) the certificate of incorporation, any certificate(s) of incorporation on change of name, the common seal and the statutory books and registers (which will be written up to but not including Completion) of the Company as are kept by the Company or required to be kept by Law, which shall be deemed delivered to the Purchaser if they are in the possession or control of a Group Company; and

 

59 

 

 

(E) the authentication codes issued by the Registrar of Companies for each Group Company incorporated in England that has joined the Protected Online Filing Scheme;

 

(ii) procure that through written consents or resolutions of the board of directors or duly convened board meetings of the relevant Group Company:

 

(A) in the case of the Company, the transfers of the Shares (subject only to due stamping) are approved for registration of the Purchaser (or a relevant Purchaser Nominee) as the holder of the Shares in the register of members of the Company;

 

(B) the resignations of the Institutional Directors in accordance with paragraph 1(c)(i)(A) from the board of each relevant Group Company are accepted with effect from Completion;

 

(C) such persons as are nominated by the Purchaser as directors and secretary of the Company are appointed with effect as at Completion, the identity of whom the Purchaser has notified the Institutional Sellers not less than five (5) Business Days prior to the Scheduled Completion Date;

 

(D) all existing authorities to bankers in respect of operation of the bank accounts of the Group are revoked and authority granted in favour of such persons as the Purchaser may direct to operate such accounts, the identity of whom the Purchaser has notified the Institutional Sellers not less than five (5) Business Days prior to the Scheduled Completion Date; and

 

(iii) deliver to, or procure the delivery to, the Purchaser of copies of such resolutions set out in paragraph 1(c)(ii) above.

 

2.            PURCHASER’S OBLIGATIONS

 

At Completion the Purchaser shall:

 

(a) comply with its obligations set out in Clauses 3.2 to 3.4 (inclusive);

 

(b) subject to receipt of the Requisite Stockholder Approval file the Amended Certificate of Incorporation with the Delaware Secretary of State;

 

(c) deliver to, or procure the delivery to:

 

(i) the Institutional Sellers:

 

(A) solely to the extent a document required to be delivered pursuant to this paragraph 2 is executed via power of attorney, a copy of any such executed power of attorney in the Agreed Form under which any document to be delivered to the Sellers by the Purchaser under this Schedule 2 has been executed;

 

60 

 

 

(B) copies of all resolutions adopted by the board of directors of the Purchaser authorising the execution, delivery and performance of this Deed and the other and the consummation of the transactions contemplated hereby;

 

(C) the execution by the Purchaser of the Transaction Documents to which it is a party; and

 

(D) the Amended Investor Rights Agreement, duly executed by the Purchaser;

 

(ii) each Seller or to such of its Affiliates who, in each case, qualify as accredited investors (as such term is defined in Rule 501(A) of the United States Securities Act of 1933 as in effect on the date of this Deed) and as are notified by a Seller to the Purchaser in writing at the latest five (5) Business Days prior to Completion (each such a person a “Seller’s Nominee”), evidence from the Purchaser’s transfer agent of the issue by the Purchaser to each Seller and/or each such Seller Nominee of book-entry shares representing the number of whole shares representing such Seller’s respective proportion of the Consideration Shares. The Consideration Shares shall bear the following legend:

 

THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL, IS AVAILABLE; and

 

(d) procure that the board of directors of the Purchaser shall be composed as set forth in the Amended Investor Right Agreements, to serve in accordance with the Constitutional Documents of the Purchaser; provided, that such persons nominated to be by the Institutional Sellers in accordance with the Amended Investor Rights Agreement shall be identified as promptly as practicable following the date of this Deed (but in no event later than the date on which the Proxy Statement is filed with the SEC).

 

61 

 

 

Schedule 3: PRE-COMPLETION OBLIGATIONS

 

Part 1 – Sellers

 

Each Seller shall, from the date of this Deed until Completion, severally procure that none of the Group Companies:

 

(a) creates, allocates, allots, issues, redeems, reduces or repurchases any share capital, loan capital or securities of any kind (including, for the avoidance of doubt, any right or option to acquire or to be issued any such share capital, loan capital or securities) except to or in favour of another Group Company;

 

(b) amend the terms of, or the rights and/or obligations attaching to, the Shares;

 

(c) acquires any of the issued equity instruments, debt instruments or other securities of any company or other person;

 

(d) establishes a direct or indirect subsidiary undertaking or branch in any jurisdiction, other than a special purpose vehicle incorporated solely for the purposes of acquiring or disposing of any shares, assets, business, undertakings or any other interest in an asset to the extent to Purchaser has consented to such acquisition or disposition to the extent required by this Deed and, for the avoidance of doubt, undertakes no other activities or operations other than acting as a holding company;

 

(e) makes any significant change in the nature or organisation of the business of the Group as a whole, including by voluntarily discontinuing or ceasing to operate all or a material part of the business of the Group as a whole;

 

(f) initiates, or consents to, any kind of insolvency process or any arrangement with its creditors, or does any of the foregoing with respect to any other Group Company;

 

(g) acquires or disposes of, or agree to acquire or dispose of, any shares, assets, business, undertakings or any other interest in an asset, for a value in excess of USD 15,000,000 (inclusive of VAT) (whether individually or when aggregated with all other such amounts between the date of this Deed and Completion), other than the acquisition of the common stock of Raven Logistics, Inc., by BluJay Solutions Inc., pursuant to a stock purchase agreement between BluJay Solutions Inc., and Duane Kuzak dated 4 May 2021 (the “Raven SPA”), provided, that the Company and the Sellers shall provide the Purchaser with an opportunity to review and comment on any amendment to the Raven SPA, and shall consider the Purchaser’s comments in good faith, and the purchase price for such acquisition shall not exceed the amount set forth in such document as of the date hereof without the Purchaser’s consent;

 

(h) enters into, or amends, any contract, understanding or arrangement with a Seller or its Affiliates;

 

(i) declares, makes or pays a dividend or other distribution (whether in cash, stock or in kind) or from any of its reserves or makes any reduction of its paid-up share capital;

 

(j) creates any Encumbrance over its shares, assets or undertaking (other than Encumbrances which arise by operation of Law or in the ordinary and usual course of business);

 

62 

 

 

(k) (i) assigns, transfers, licenses or otherwise disposes of any Intellectual Property Rights owned by any Group Company, (ii) lets lapse, abandons, or allows to expire any Intellectual Property Rights owned by any Group Company but excluding any such Intellectual Property Rights which have not been regularly used in the Business in the twelve (12) months prior to the date hereof (for the avoidance of doubt, such exclusion to apply to the Intellectual Property Rights in documents 9.1.4, 9.1.5 and 9.1.6 of the Data Room); or (iii) discloses any know-how, confidential information or trade secrets forming part of the Intellectual Property Rights owned by such Group Company save for in the ordinary course and subject to appropriate confidentiality obligations;

 

(l) makes any material alteration to its constitutional documents;

 

(m) institutes or settles any litigation, arbitration, mediation, or other legal proceedings which are reasonably likely to result in a payment or liability by any Group Company (whether conditional or otherwise) in excess of USD 5,000,000 (except in respect of debt collection in the ordinary course of business);

 

(n) establishes or modifies (other than as required by Law) any profit sharing, bonus, retention, incentive, severance scheme or pension or retirement scheme, other than employee commission plans to provide for quota retirement and pay-out of commission based on bookings for software as a service (SaaS), logistics as a service (LaaS) and license and maintenance in relation thereto, as substantially set forth in document 14.15 of the Data Room;

 

(o) adopts, enters into, amends or terminates (other than as required by Law) any Plan (or any plan or arrangement that would have constituted a Plan had it been in effect on the Completion Date), except in connection with the acquisition of the common stock of Raven Logistics, Inc., by BluJay Solutions Inc. pursuant to the Raven SPA;

 

(p) terminates, or amends the terms (other than as required by Law) of, the employment of any Senior Employee, save for in the event of gross misconduct justifying summary dismissal, other than an increase in the salary of certain employees of BluJay Solutions (India) Private Ltd, provided that the aggregate amount of such increases shall not exceed 10% of the aggregate amount of the salaries of all employees of BluJay Solutions (India) Private Ltd in each case allocated in a manner consistent with past practice;

 

(q) engages or appoints any Senior Employee (other than to fill a vacancy);

 

(r) incurs any additional borrowings (other than by an existing bank overdraft or similar facility within limits subsisting at the date of this Deed), or enters into any guarantee or indemnity or other arrangement to secure another person’s (other than another Group Company’s) obligations, in excess of USD 1,000,000, other than in the ordinary and usual course of business, or makes any loan in excess of USD 1,000,000, in each case whether individually, or when aggregated with all other such amounts loaned or borrowed (as applicable) by any Group Company between the date of this Deed and Completion, other than in the ordinary and usual course of business;

 

(s) amend the terms of the Existing Facilities other than in the ordinary and usual course of business;

 

(t) make any material change to the terms of, or voluntarily terminate, any agreement or arrangement in respect of which the Group’s aggregate revenue or cost in the twelve (12) months immediately preceding the date of this Deed exceeded USD 1,000,000 (exclusive of VAT), other than in the ordinary course and usual course of business;

 

(u) changes its accounting reference date, or changes any material basis, accounting method, accounting period, policy, or practice relating to Tax or make or change any material election relating to Tax (unless required by applicable Laws);

 

63 

 

 

(v) removes its auditors or appoint new auditors, other than to comply with applicable Laws;

 

(w) changes its residence for Tax purposes or establishes a permanent establishment or other taxable presence in any jurisdiction other than the jurisdiction of residence for tax purposes of the relevant Group Company;

 

(x) file, amend or revoke any return, election, declaration, report, claim for refund, information return or statement or other document filed with an Authority with respect to Taxes in a manner that is materially inconsistent with past practice, settle any material tax claim or claimed deficiency, or enter into any Tax indemnity agreement or similar arrangement with a related party, on a non-arm’s length basis or with a Tax Authority;

 

(y) settles, compromises, agrees or materially negotiates any material audit, enquiry, assessment, dispute or litigation relating to Tax with any Tax Authority, enters into any material closing agreement or similar agreement with any Tax Authority, or consents to any material extension or waiver of the limitation period relating to Tax or engages in any voluntary discussions with any Tax Authority in relation to any material Tax liability or potential material Tax liability; or

 

(z) agrees or commits, conditionally or otherwise and whether or not in writing, to do any of the foregoing.

 

64 

 

 

Part 2 – Purchaser

 

The Purchaser shall, from the date of this Deed until Completion, procure that no member of the Purchaser Group will:

 

(a) amend, modify or otherwise change its organisational documents in a manner that would reasonably be expected to prevent, impede or materially delay the transactions contemplated by this Deed or otherwise in a manner materially adverse to the Sellers;

 

(b) except as contemplated by this Deed or solely among any members of the Purchaser Group (including in respect of tax distributions paid in accordance with the LLC Agreement), but not by the Purchaser itself, authorise, set aside, make or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any share capital, or make any other actual, constructive or deemed distribution in respect of the share capital;

 

(c) other than in connection with the transactions contemplated by this Deed (including the Subscription Agreements), issue any equity interests or convertible or exchangeable securities, other than (A) the conversion or exercise of existing debentures and warrants or pursuant to the LLC Agreement or the Certificate of Incorporation of the Purchaser, (B) the issuance of shares of Purchaser Stock upon the exercise of any equity award that is outstanding as of the date of this Deed in accordance with its terms or is granted pursuant to Section (C) of this paragraph, (C) the issuance of options, shares of restricted stock or other equity awards to then current employees, directors or independent contractors or other service providers or (D) the issuance of shares of Class A Common Stock for an aggregate purchase price of no more than $200 million at a price per share no less than the lesser of (x) $10.00 and (y) 10% less than the then-current five-day VWAP so long as such issuance does not in and of itself require shareholder approval (beyond shareholder approval of the Amended Certificate of Incorporation);

 

(d) solely with respect to the Purchaser (and not, for the avoidance of doubt, any other member of the Purchaser Group) merge or consolidate with any person or voluntarily adopt a plan of complete or partial liquidation, dissolution, restructuring or other reorganization of the Purchaser;

 

(e) agrees or commits, conditionally or otherwise and whether or not in writing, to do any of the foregoing.

 

65 

 

 

Schedule 4: PURCHASER’S WARRANTIES

 

All warranties set out in this Schedule 4 shall be qualified (x) by information disclosed or reflected in the Purchaser SEC Documents publicly furnished or filed with the SEC as at two (2) Business Days prior to the date of this Deed (but excluding any risk factor disclosures contained under the headings “Risk Factors” or “Quantitative and Qualitative Disclosures about Market Risk,” or any disclosure of risks included in any “forward-looking statements” disclaimer or any other statements that are similarly cautionary, predictive or forward-looking in nature) and (y) as set forth on Schedule 5.

 

1.            capacity and authority

 

1.1 The Purchaser is a corporation duly formed, validly existing and in good standing under the laws of the State of Delaware.

 

1.2 The Purchaser has all requisite power and authority to enter into and perform this Deed and the other Transaction Documents in accordance with their terms, subject in all cases to the receipt of the Requisite Stockholder Approval.

 

1.3 This Deed and the other Transaction Documents constitute (or shall constitute when executed) valid, legal and binding obligations on the Purchaser in accordance with their terms, assuming due authorization, execution and delivery by the other parties hereto (except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity).

 

1.4 The execution and delivery of this Deed and the other Transaction Documents by the Purchaser and the performance of and compliance with their terms and provisions will not conflict with or result in a breach of, or constitute a default under, the constitutional documents of the Purchaser, any agreement, arrangement or instrument to which the Purchaser is a party or by which it is bound, any order, judgment or decree of any court or Authority to which it is a party or by which it is bound, or any Law or order that applies to or binds the Purchaser or any of its property, subject in all cases to the receipt of the Requisite Stockholder Approval.

 

1.5 No consent, action, approval or authorisation of, and no registration, declaration, notification or filing with or to, any Authority (other than as required pursuant to the Conditions or as otherwise expressly set out in this Deed) is required to be obtained, or made, by the Purchaser to authorise the execution or performance of this Deed and each of the Transaction Documents to which it is party by the Purchaser, subject to the filing of the Amended Certificate of Incorporation with the Delaware Secretary of State.

 

2.            purchaser financing agreements

 

2.1 The Institutional Sellers have been provided with correct and complete copies of (a) all Subscription Agreements and (b) (i) an executed debt commitment letter dated on or about the date of this Agreement signed by the relevant finance provider(s) only enclosing a form of amendment agreement to the Credit Agreement to enable the Purchaser to pay Consideration under this Agreement on the Completion Date, (ii) an executed fee letter and (iii) an executed conditions precedent satisfaction letter (subject, in the case of the related fee letter, to customary redactions with respect to confidential fee arrangements and “market flex” provisions) pursuant to which the Purchaser will have available funds, together with the PIPE Financing Amount, in order to meet its obligations under the Transaction Documents (such debt financing agreements, the “Debt Financing Agreements” and, together with the Subscription Agreements, the “Purchaser Financing Agreements”).

 

66 

 

 

2.2 Each Purchaser Financing Agreement is in full force and effect and has been duly executed by and is binding upon the Purchaser and its Affiliates and, to the Purchaser’s knowledge, all other parties thereto.

 

2.3 The Purchaser has or will have fully committed funds immediately available to it and such funds are sufficient to satisfy its obligations hereunder at Completion and, in the case of any related loan facilities, the Purchaser will be able to satisfy all conditions of drawdown thereunder at or prior to Completion.

 

3.            capitalisation of THE PURCHASER

 

3.1 The authorised capital stock of the Purchaser consists of (the “Purchaser Stock”):

 

(a) 1,000,000 shares of Preferred Stock, par value $0.0001 per share, of which no shares are issued and outstanding as of the date of this Deed;

 

(b) 2,500,000,000 shares of Class A Common Stock, of which 187,051,142 shares are issued and outstanding as of May 25, 2021;

 

(c) 13,000,000 shares of Class B Non-Voting Common Stock, par value $0.0001 per share, divided into 9,000,000 shares of Series B-1 Common Stock, par value $0.0001 per share, of which 8,120,367 shares are issued and outstanding as of May 25, 2021, and 4,000,000 shares of Series B-2 Common Stock, par value $0.0001 per share, of which 3,372,184 shares are issued and outstanding as of May 25, 2021; and

 

(d) 40,000,000 shares of Class V Common Stock, par value $0.0001 per share, of which 35,636,680 shares are issued and outstanding as of May 25, 2021.

 

3.2 All of the shares of the Purchaser Stock described in paragraph 3.1 of this Schedule 4 as issued and outstanding have been duly authorised and are validly issued, fully paid, non-assessable and free of pre-emptive right.

 

3.3 Other than the Purchaser Stock and incentive equity issued to directors, employees and other service providers, no other class of capital stock or series of any class of capital stock or (except as set forth in Schedule 5) securities convertible into capital stock of the Purchaser is authorised or outstanding.

 

3.4 Except as set forth in Schedule 5 or incentive equity issued to directors, employees and other service providers, as of the date of this Deed, no other shares of capital stock of the Purchaser, or any securities convertible into any capital stock of the Purchaser, were issued, reserved for issuance or outstanding, and the Purchaser does not have outstanding any options or other equity interests to purchase, any pre-emptive rights or other rights to subscribe for or to purchase, or any written contracts, leases, licenses, indentures, agreements, commitments or other legally binding arrangements to issue or sell, shares of its capital stock or any such options, equity interests, rights, convertible securities or warrants other than granted under the Purchaser’s equity plans.

 

3.5 As of the Completion, the Consideration Shares will be duly authorised, validly issued, fully paid and non-assessable and issued to the Sellers free from all Encumbrances other than pursuant to applicable Law, the legends described herein and the Amended Investor Rights Agreement and/or Lock-Up Agreements, as appropriate.

 

67 

 

 

4.            authority of THE PURCHASER board of directors

 

4.1 As of the date hereof, the Board of Directors of the Purchaser (the “Purchaser Board”) has:

 

(a) approved and declared advisable this Deed and the Transaction; and

 

(b) resolved to recommend, upon the terms and subject to the conditions of this Deed, that the holders of voting shares of Purchaser Stock vote to approve the issuance of the Consideration Shares and the PIPE Shares and, to the extent required, the Amended Certificate of Incorporation and directed that such matters be submitted for consideration by such holders at a meeting of the Purchaser’s stockholders (the “Purchaser Board Recommendation”).

 

4.2 The Requisite Stockholder Approval is the only vote of the holders of any shares of Purchaser Stock necessary to approve the transactions contemplated by this Deed.

 

5.            sec reports and financial statements

 

5.1 Other than as set forth on Schedule 5, the Purchaser has filed or furnished all forms, reports, schedules, statements and other documents (including any exhibits thereto) required to be filed or furnished by it with the SEC (all such documents and reports publicly filed or furnished by the Purchaser (including the Purchaser’s predecessor registrant, CC Neuberger Principal Holdings I) or any subsidiary of the Purchaser, the “Purchaser SEC Documents”).

 

5.2 As of their respective dates or, if amended, as of the date of the last such amendment, the Purchaser SEC Documents complied as to form in all material respects with the requirements of the Securities Act and the Exchange Act, as the case may be, and the applicable rules and regulations promulgated thereunder, each as in effect on the date so filed, and none of the Purchaser SEC Documents at the time they were filed or furnished contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

5.3 The certifications and statements required by (i) Rule 13a-14 under the Exchange Act and (ii) 18 U.S.C. §1350 (Section 906 of the Sarbanes-Oxley Act) relating to the Purchaser SEC Documents are accurate and complete as of the dates made and comply as to form and content with all applicable Laws.

 

5.4 The financial statements (including all related notes and schedules) included in the Purchaser SEC Documents (the “Purchaser Financial Statements”) at the time they were filed or furnished:

 

(a) fairly present in all material respects the consolidated financial position of the Purchaser and its consolidated subsidiaries, as at the respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for the respective periods then ended (except, in the case of unaudited statements, subject to normal year-end audit adjustments, the absence of notes and to any other adjustments described therein, including in any notes thereto or with respect to pro forma financial information, subject to the qualifications stated therein);

 

(b) were prepared in conformity with GAAP applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto and except, in the case of unaudited statements, subject to normal year-end audit adjustments, the absence of notes and to any other adjustments described therein, including in any notes thereto or with respect to pro forma financial information, subject to the qualifications stated therein); and

 

68 

 

 

(c) comply as to form in all material respects with the published rules and regulations of the SEC applicable thereto.

 

5.5 There are no outstanding or unresolved comments in any comment letters of the staff of the SEC received by the Purchaser relating to the Purchaser SEC Documents.

 

5.6 None of the Purchaser SEC Documents is, to the Purchaser’s knowledge, the subject of ongoing review by the SEC.

 

5.7 Neither the Purchaser nor any of its subsidiaries are a party to, nor do they have any commitment to become a party to: (a) any joint venture or off-balance sheet partnership; or (b) any similar contract, agreement, lease, license, commitment, understanding, franchise, warranty, guaranty, mortgage, note, bond or other instrument or consensual obligation that is legally binding (including any of the arrangements in sub-paragraph (b) of this paragraph relating to any transaction or relationship between or among the Purchaser or one of its subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or person, on the other hand) or any “off-balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K of the Exchange Act), where the result, purpose or effect of such arrangements in sub-paragraph (b) of this paragraph is to avoid disclosure of any material transaction involving, or material liabilities of, the Purchaser or any of its subsidiaries in the Purchaser Financial Statements or other the Purchaser SEC Documents.

 

6.            REGISTRATION

 

6.1 As of the date hereof, the issued and outstanding shares of Class A Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on the NYSE under the symbol “ETWO”.

 

6.2 The Purchaser is in compliance in all material respects with the current listing and governance rules and regulations of NYSE applicable to the Purchaser.

 

6.3 As of the date hereof, none of the Purchaser or any of its Affiliates has taken any action in an attempt to terminate the registration of the Class A Common Stock under the Exchange Act.

 

69 

 

 

Schedule 5: PURCHASER’S DISCLOSURES

 

[Attached]

 

70 

 

 

This Deed has been executed as a deed and is delivered and takes effect on the date stated at the beginning of it.

 

EXECUTED and delivered as a DEED by )  
     
Francisco Partners GP III Management (Cayman) Limited )  
     
acting in its capacity as general partner of )  
     
Francisco Partners GP III (Cayman) L.P., ) /s/ Deep Shah
     
acting in its capacity as general partner of ) Authorised Signatory
     
Francisco Partners III (Cayman), L.P. )  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered as a DEED by )  
     
Francisco Partners GP III Management (Cayman) Limited )  
     
acting in its capacity as general partner of )  
     
Francisco Partners GP III (Cayman) L.P., ) /s/ Deep Shah
     
acting in its capacity as general partner of ) Authorised Signatory
     
Francisco Partners Parallel Fund III (Cayman), L.P. )  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

 

EXECUTED and delivered as a DEED by )
   
ANDERSON INVESTMENTS PTE. LTD. )
   
acting by              Wai Hoong             ) /s/ Wai Hoong  
   
an authorised signatory ) Authorised Signatory

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )  
   
as a DEED by ANDREW KIRKWOOD )  
   
acting by their attorney, Francisco Partners III (Cayman), L.P. )  
   
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
   
in the presence of: ) Attorney

 

/s/ Quentin Lathuille   Signature of Witness
   
Quentin Lathuille   Name of Witness
   
Flat A, 26 Redcliffe Square   Address of Witness
   
LONDON SW10 9JY    
   
   
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )  
   
as a DEED by CHRISTOPHER TIMMER )  
   
acting by their attorney, Francisco Partners III (Cayman), L.P. )  
   
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
   
in the presence of: ) Attorney

 

/s/ Quentin Lathuille   Signature of Witness
   
Quentin Lathuille   Name of Witness
   
Flat A, 26 Redcliffe Square   Address of Witness
   
LONDON SW10 9JY    
   
   
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed] 

 

 

 

 

EXECUTED and delivered )  
   
as a DEED by SIAN HOPWOOD )  
   
acting by their attorney, Francisco Partners III (Cayman), L.P. )  
   
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
   
in the presence of: ) Attorney

 

/s/ Quentin Lathuille   Signature of Witness
   
Quentin Lathuille   Name of Witness
   
Flat A, 26 Redcliffe Square   Address of Witness
   
LONDON SW10 9JY    
   
   
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed] 

 

 

 

 

 

EXECUTED and delivered )  
   
as a DEED by JOHNNY THØGERSEN )  
   
acting by their attorney, Francisco Partners III (Cayman), L.P. )  
   
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
   
in the presence of: ) Attorney

 

/s/ Quentin Lathuille   Signature of Witness
   
Quentin Lathuille   Name of Witness
   
Flat A, 26 Redcliffe Square   Address of Witness
   
LONDON SW10 9JY    
   
   
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]  

 

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by JOY BURKHOLDER MEIER   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by SHARON PLESTED   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by RONALD SCOTT BROWN   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by DOUGLAS SURRETT   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by PATRICK ROHLINGER   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

 

         
EXECUTED and delivered   )    
       
as a DEED by TIMOTHY HINSON   )    
         
acting by their attorney, Francisco Partners III (Cayman), L.P.   )    
         
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah
         
in the presence of:   )   Attorney

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

EXECUTED and delivered   )    
       
as a DEED by WILLIAM MADDEN   )    
         
acting by their attorney, Francisco Partners III (Cayman), L.P.   )    
         
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah
         
in the presence of:   )   Attorney

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

EXECUTED and delivered   )    
       
as a DEED by TONYA MILLER   )    
         
acting by their attorney, Francisco Partners III (Cayman), L.P.   )    
         
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah
         
in the presence of:   )   Attorney

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

EXECUTED and delivered   )    
       
as a DEED by PATRICK MALEY   )    
         
acting by their attorney, Francisco Partners III (Cayman), L.P.   )    
         
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah
         
in the presence of:   )   Attorney

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

EXECUTED and delivered   )    
       
as a DEED by SCOTT CRAVEN   )    
         
acting by their attorney, Francisco Partners III (Cayman), L.P.   )    
         
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah
         
in the presence of:   )   Attorney

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )    
       
as a DEED by SIEGFRIED MÄNZEL )    
       
acting by their attorney, Francisco Partners III
(Cayman), L.P.
)    
       
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
       
in the presence of: ) Attorney  

 

 

/s/ Quentin Lathuille   Signature of Witness  
       
Quentin Lathuille   Name of Witness  
       
Flat A, 26 Redcliffe Square   Address of Witness  
       
LONDON SW10 9JY      
       
Investment Professional   Occupation of Witness  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )    
       
as a DEED by TIM CONROY )    
       
acting by their attorney, Francisco Partners III
(Cayman), L.P.
)    
       
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
       
in the presence of: ) Attorney  

 

 

/s/ Quentin Lathuille   Signature of Witness  
       
Quentin Lathuille   Name of Witness  
       
Flat A, 26 Redcliffe Square   Address of Witness  
       
LONDON SW10 9JY      
       
Investment Professional   Occupation of Witness  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )    
       
as a DEED by KATIE KINRAID )    
       
acting by their attorney, Francisco Partners III
(Cayman), L.P.
)    
       
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
       
in the presence of: ) Attorney  

 

 

/s/ Quentin Lathuille   Signature of Witness  
       
Quentin Lathuille   Name of Witness  
       
Flat A, 26 Redcliffe Square   Address of Witness  
       
LONDON SW10 9JY      
       
Investment Professional   Occupation of Witness  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered )    
       
as a DEED by DAN GRIMM )    
       
acting by their attorney, Francisco Partners III
(Cayman), L.P.
)    
       
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
       
in the presence of: ) Attorney  

 

 

/s/ Quentin Lathuille   Signature of Witness  
       
Quentin Lathuille   Name of Witness  
       
Flat A, 26 Redcliffe Square   Address of Witness  
       
LONDON SW10 9JY      
       
Investment Professional   Occupation of Witness  

 

[Signature Page – Share Purchase Deed]

 

 

 

EXECUTED and delivered )    
       
as a DEED by MICHAEL HUNT )    
       
acting by their attorney, Francisco Partners III
(Cayman), L.P.
)    
       
under a power of attorney dated 18 May 2021 ) /s/ Deep Shah  
       
in the presence of: ) Attorney  

 

 

/s/ Quentin Lathuille   Signature of Witness  
       
Quentin Lathuille   Name of Witness  
       
Flat A, 26 Redcliffe Square   Address of Witness  
       
LONDON SW10 9JY      
       
Investment Professional   Occupation of Witness  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by DAVID LANDAU   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by JOHANNES BOOS   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by SAMUEL ADDEO   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by DOUGLAS BRAUN   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by ROBERT FARRELL   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed

 

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by ANDREW HICKS   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by JONATHON HARSTON   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by MARTIN HISCOX   )      
           
acting by their attorney, Francisco Partners III
(Cayman), L.P.
  )      
           
under a power of attorney dated 18 May 2021   )   /s/ Deep Shah  
           
in the presence of:   )   Attorney  

 

/s/ Quentin Lathuille   Signature of Witness
     
Quentin Lathuille   Name of Witness
     
Flat A, 26 Redcliffe Square   Address of Witness
     
LONDON SW10 9JY    
     
     
     
Investment Professional   Occupation of Witness

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by   )      
           

E2OPEN PARENT HOLDINGS, INC.

  )   /s/ Michael Farlekas  
           
acting by Michael Farlekas,   )   Chief Executive Officer  
           
its Chief Executive Officer   )      

 

[Signature Page – Share Purchase Deed]

 

 

 

 

EXECUTED and delivered   )      
           
as a DEED by   )      
           
BLUJAY TOPCO LIMITED   )   /s/ Michael Hunt  
           
acting by Michael Hunt, a director   )   Director  
           
and Deep Shah, a director   )      
           
    )   /s/ Deep Shah  
           
    )   Director  

 

[Signature Page – Share Purchase Deed]

 

 

 

 

Exhibit 2.2

 

PRIVILEGED AND CONFIDENTIAL

 

27 May 2021

 

THE WARRANTORS

details of whom are set out in Schedule 1

 

and

 

E2open Parent Holdings, Inc.

 

 

 

MANAGEMENT WARRANTY DEED

 

related to

 

BLUJAY TOPCO LIMITED

 

 

 

 

99 Bishopsgate
London EC2M 3XF
United Kingdom
Tel: +44.20.7710.1000

www.lw.com

 

 

 

 

 

TABLE OF CONTENTS

 

Clause Page
     
1. DEFINITIONS AND INTERPRETATION  1
2. WARRANTIES 8
3. WARRANTOR REPRESENTATIVE 9
4. ENTIRE AGREEMENT, REMEDIES AND TERMINATION 9
5. WAIVER AND VARIATION 9
6. INVALIDITY 10
7. ASSIGNMENT AND SUCCESSORS 10
8. NOTICES 11
9. CONFIDENTIALITY 11
10. COSTS 12
11. RIGHTS OF THIRD PARTIES 12
12. COUNTERPARTS 12
13. GOVERNING LAW AND JURISDICTION 12
14. PROCESS AGENT 13

SCHEDULE 1 14
WARRANTORS  
SCHEDULE 2 15
WARRANTIES  
SCHEDULE 3 35
LIMITATIONS ON LIABILITY OF WARRANTORS  
SCHEDULE 4 38
PARTICULARS OF THE COMPANY AND THE SUBSIDIARIES  
SCHEDULE 5 39
PROPERTIES  

 

 

 

 

THIS DEED is made on 27 May 2021

 

BETWEEN

 

(1) THE WARRANTORS details of whom are set out in Schedule 1 (the “Warrantors”); and

 

(2) E2open Parent Holdings, Inc., a corporation incorporated in the State of Delaware, whose principal office is at 9600 Great Hills Trail, Suite 300E Austin, TX, United States of America (the “Purchaser”).

 

WHEREAS

 

(A) The Company is private limited company incorporated in England & Wales.

 

(B) The Warrantors and other shareholders in the Company and the Purchaser are to enter into a share purchase deed on the date of this Deed relating to the sale of the entire issued share capital of the Company (the “SPA”).

 

(C) The Warrantors have agreed to give certain warranties in respect of the Group on the terms and conditions set out in this Deed.

 

IT IS AGREED THAT

 

1. DEFINITIONS AND INTERPRETATION

 

1.1 In this Deed, unless the context otherwise requires:

 

Accounts” means the audited consolidated financial statements of the Company made up as at the relevant Accounts Date including the consolidated balance sheet, consolidated profit and loss accounts and cash flow statement, together with all notes, reports, statements and other documents required by applicable Law to be included in or attached to them;

 

Accounts Date” means each of 31 March 2020, 31 March 2019 and 31 March 2018;

 

Affiliate” has the meaning given in the SPA;

 

Affiliated Group” means any affiliated group as defined in Section 1504 of the Code that files or has filed a consolidated return for U.S. federal income tax purposes (or any consolidated, combined or unitary group under state, local or non-U.S. law);

 

Anti-Corruption Laws” means laws, regulations, or orders relating to anti-bribery or anti-corruption (governmental or commercial), including, without limitation, laws that prohibit the corrupt payment, offer, promise, or authorisation of the payment or transfer of anything of value (including gifts or entertainment), directly or indirectly, to any foreign government official, foreign government employee, person or commercial entity to obtain a business advantage, or the offer, promise, or gift of, or the request for, agreement to receive or receipt of a financial or other advantage to induce or reward the improper proper performance of a relevant function or activity; such as, without limitation, the U.S. Foreign Corrupt Practices Act of 1977, as amended from time to time, the UK Bribery Act of 2010 and all national and international laws enacted to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions;

 

Authority” has the meaning given in the SPA;

 

Business Day” has the meaning given in the SPA;

 

Business Intellectual Property” has the meaning given in paragraph 17.3 of Schedule 2;

 

1 

 

 

CARES Act” means (i) the Coronavirus Aid, Relief, and Economic Security Act Pub. L. 116-136, enacted March 27, 2020, and (ii) Division N – Additional Coronavirus Response and Relief of the Consolidated Appropriations Act, 2021 (H.R. 133), in each case, together with all rules and regulations and guidance issued by any Government Entity with respect thereto;

 

CBA” has the meaning given in Paragraph 20.10 of Schedule 2;

 

Claim” means any demand or claim made by the Purchaser against any of the Warrantors, whether in contract or otherwise, under or in relation to or for any breach of the Warranties;

 

Code” means the U.S. Internal Revenue Code of 1986, as amended;

 

Company” means BluJay Topco Limited, a private limited company incorporated in England and Wales with registered number 08044932 and having its registered office at Blue Tower 14th Floor, MediaCityUK, Salford Quays, United Kingdom, M50 2ST, further particulars of which are set out in Part 1 of Schedule 4;

 

Competition Law” means the national and directly effective legislation of any jurisdiction which governs the conduct of companies or individuals in relation to restrictive or other anti- competitive agreements or practices (including, but not limited to, cartels, pricing, resale pricing, market sharing, bid rigging, terms of trading, purchase or supply and joint ventures), dominant or monopoly market positions (whether held individually or collectively) and the control of acquisitions or mergers;

 

Completion” has the meaning given in the SPA;

 

Completion Date” has the meaning given in the SPA;

 

Completion Disclosure Letter” means the disclosure letter (together with any documents attached to it) to be provided by the Warrantors to the Purchaser disclosing information constituting exceptions to the Completion Warranties given pursuant to Clause 2, in relation to matters or circumstances arising after the date of this Deed of which the Warrantors first became aware after the date of this Deed;

 

Completion Warranties” has the meaning given to it in Clause 2.1(b);

 

Confidential Information” has the meaning given to it in Clause 9.1;

 

COVID-19” means the novel coronavirus, SARS-CoV-2 or COVID-19 (and all related strains and sequences), including any intensification, resurgence or any evolutions or mutations thereof, and/or related or associated epidemics, pandemics, disease outbreaks or public health emergencies;

 

Data Protection Laws” means all applicable laws, regulations, guidelines, codes of conduct and codes of practice which have the effect of creating legally binding obligations on the Group relating to data protection and information security including the Data Protection Act 2018, the General Data Protection Regulation (Regulation (EU) 2016/679) (“GDPR”), the GDPR as it forms part of the laws of England and Wales, Scotland and Northern Ireland by virtue of section 3 of the European Union (Withdrawal) Act 2018, the Data Protection, Privacy and Electronic Communications (Amendments etc) (EU Exit) Regulations 2019 and the Privacy and Electronic Communications (EC Directive) Regulations 2003 and any relevant analogous legislation or requirements in other jurisdictions, in each case as amended, consolidated, re-enacted or replaced from time to time;

 

Data Room” means the virtual data, hosted by Datasite under the name “Project Eagle” in connection with the Transaction as at 11.59pm on 25 May 2021;

 

2 

 

 

Disclosed” means fairly disclosed in such a manner and with sufficient detail to enable a purchaser to make a reasonably informed assessment of the nature, scope and consequence to the Group of the fact, matter or circumstance concerned;

 

Disclosure Letter” means the disclosure letter dated the date hereof, written and delivered by the Warrantors to the Purchaser immediately before the signing of this Deed;

 

Dispute” has the meaning given to it in Clause 13.3;

 

Domain Names” has the meaning given to it in paragraph 18.6 of Schedule 2;

 

Employees” means the individuals who are employed by any of the Group Companies from time to time;

 

Encumbrance” has the meaning given in the SPA;

 

ERISA” means the Employee Retirement Income Security Act of 1974, as amended;

 

Exchange Rate” has the meaning given in the SPA;

 

Existing Facilities Agreement” has the meaning given in the SPA;

 

Government Entity” means: (a) any national, federal, state, county, municipal, local, or foreign government or any entity exercising executive, legislative, judicial, regulatory, taxing, or administrative functions of or pertaining to government; (b) any public international organization; (c) any agency, division, bureau, arbitral body (public or private), department, or other political subdivision of any government, entity, or organization described in the foregoing clauses (a) or (b) of this definition; (d) any company, business, enterprise, or other entity owned, in whole or in part, or controlled by any government, entity, organization, or other person described in the foregoing clauses (a), (b), or (c) of this definition; or (d) any political party;

 

Group” has the meaning given in the SPA;

 

Group Company” has the meaning given in the SPA;

 

German Occupational Pension Benefits” means any pension benefits under German law (Leistungen der betrieblichen Altersversorgung)

 

Institutional Sellers” has the meaning given in the SPA;

 

Intellectual Property” means all intellectual property rights worldwide, including rights in patents, utility models, trade marks, service marks, logos, getup, trade names, internet domain names, copyright (including rights in computer software), design rights, moral rights and contractual waivers of moral rights, database rights and rights in data, confidential information and knowledge (including know how, inventions, secret formulae and processes, market information, and lists of customers and suppliers), and rights protecting goodwill and reputation, in all cases whether registered or unregistered; all other forms of protection having a similar nature or effect anywhere in the world to any of the foregoing and applications for or registrations (or rights to apply for registration) of any of the foregoing rights;

 

IP Agreements” has the meaning given in paragraph 17.7 of Schedule 2;

 

IRS” means the United States Internal Revenue Service;

 

IT Contracts” means all arrangements and agreements under which:

 

3 

 

 

(a) any third party provides any element of, or services relating to, IT Systems, including without limitation leasing, hire-purchase, software licences, support, maintenance, services, development and design agreements; and

 

(b) the Group provides any third party with any element of, or services relating to, IT Systems, including without limitation leasing, hire-purchase, software licences, support, maintenance services, development and design agreements;

 

IT Systems” means all computer hardware (including network and telecommunications equipment), databases and software (save for off-the-shelf commercial software) which are owned, used, leased or licensed by or to the Group and which are material to the Group;

 

Law” or “Laws” has the meaning given in the SPA;

 

Locked Box Accounts” has the meaning given in the SPA;

 

Locked Box Date” has the meaning given in the SPA;

 

Losses” has the meaning given in the SPA;

 

Material Contract” means the contracts with the top 25 customers of the Group and the top 20 suppliers of the Group contained in folder 14 (Clean Team Only) of the Data Room;

 

Material Owned Intellectual Property” has the meaning given in paragraph 17.2 of Schedule 2;

 

Non-Institutional Sellers” has the meaning given to that term in the SPA;

 

Pension Schemes” means the pension, benefit, death benefit, early retirement and similar schemes, plans, gratuities and / or arrangements provided or arranged as required by any applicable Law by a Group Company to its Employees, former employees, directors and former directors and / or in respect of any of their dependants, or under or with respect to which a Group Company has any liability or obligation;

 

Personal Data” has the meaning given by the GDPR, as amended, consolidated, re-enacted or replaced from time to time;

 

Plan” means any benefit or compensation plan, including any share option, share purchase, restricted share, restricted share unit, share appreciation, phantom equity or other equity or equity based incentives, employment, consulting, severance, separation pay, bonus, commissions, retention, stay bonuses, change in control or other transactions program, policy, agreement, contract or arrangement maintained, sponsored, contributed or required to be contributed to by any Group Company or with respect to which any Group Company has any current or contingent liability or obligation, and any contracts or arrangements between a Group Company and a current Employee, director, officer or other individual service provider, excluding any schemes or arrangements mandated by a Government Entity outside of the United States;

 

Proceedings” has the meaning given in paragraph 13.1 of Schedule 2;

 

Properties” means the land and premises particulars of which are set out in Schedule 5;

 

Proxy Statement” has the meaning given in the SPA;

 

Purchaser Group” has the meaning given in the SPA;

 

Purchaser Stockholder Meeting” has the meaning given in the SPA;

 

4 

 

 

Registered Intellectual Property” has the meaning given in paragraph 17.1 of Schedule 2;

 

Relief” has the meaning given in the SPA;

 

Representatives” has the meaning given in the SPA;

 

Required Financial Statements” has the meaning given in the SPA;

 

Sanctioned Personmeans any person or entity:

 

(a) designated on the restricted persons lists maintained by the Office of Foreign Assets Control of the US Department of the Treasury, the US Department of Commerce, the US Department of State and any other agency of the US government, including the Specially Designated Nationals and Blocked Persons or “Foreign Sanctions Evaders”;

 

(b) designated on the Consolidated United Nations Security Council Sanctions List, the Consolidated Canadian Autonomous Sanctions List, the Consolidated List of Persons, Groups and Entities Subject to EU Financial Sanctions maintained by the European Commission, the Consolidated List of Asset Freeze Targets maintained by Her Majesty’s Treasury, or any equivalent list maintained by the competent sanctions authority of any EU Member State;

 

(c) that is, or is part of, a government of a Sanctioned Territory;

 

(d) directly or indirectly 50% or more owned or controlled by any of the foregoing; or

 

(e) that is located, organised or residing in any Sanctioned Territory;

 

Sanctioned Territorymeans any country or other territory subject to a comprehensive export, import, financial or investment embargo under any Sanctions Law, which currently includes (inter alia) Cuba, Iran, North Korea, Syria and the Ukrainian territory of Crimea and Sevastopol (and which may in the future change);

 

Sanctions Laws” means any applicable Laws relating to export/import control and economic or financial sanctions of the United States of America, Canada, the United Nations Security Council, the United Kingdom and the European Union (or any member state thereof);

 

Sellers” has the meaning given in the SPA;

 

Senior Employee” means any current or former Employee, director or other individual independent service provider or contractor of the Group whose gross base salary or compensation exceeds $200,000 (or local equivalent) per year;

 

Shares” has the meaning given in the SPA;

 

Signing Press Release” has the meaning given in the SPA;

 

Signing Warranties” has the meaning given to it in Clause 2.1(a);

 

SPA” has the meaning given to the term in Recital (B);

 

Subsidiaries” means the companies whose details are set out in Part 2 of Schedule 4;

 

Tax”, “Taxes” and “Taxation” each have the meaning given in the SPA;

 

Tax Authority” has the meaning given in the SPA;

 

5 

 

 

Tax Claim” means a claim in respect of the breach of any of the Tax Warranties;

 

Tax Warranties” means the Warranties in paragraph 23 and, to the extent they relate to Tax, paragraphs 2.2(c)(iii), 5.1, 5.2 and 22.2 of Schedule 2;

 

Transaction” means the transactions contemplated by this Deed and/or the other Transaction Documents or any part thereof;

 

Transaction Documents” has the meaning given in the SPA;

 

Treasury Regulations” means the United States Treasury Regulations promulgated under the Code, and any reference to any particular Treasury Regulation section shall be interpreted to include any final or temporary revision of or successor to that section regardless of how numbered or classified;

 

VAT” has the meaning given in the SPA;

 

WARN Act” means the Worker Adjustment and Retraining Notification Act of 1988, as amended;

 

W&I Insurance” has the meaning given in paragraph 9(a) of Schedule 3;

 

W&I Insurer” has the meaning given in the SPA;

 

Warranties” means the warranties given by the Warrantors as set out in Clause 2 and Schedule 2;

 

Warrantor Representative” has the meaning given in Clause 3.1; and

 

Working Hours” has the meaning given in the SPA.

 

1.2 In this Deed, unless the context otherwise requires:

 

(a) references to an “undertaking” and “group undertaking” shall be construed in accordance with section 1161 of the United Kingdom Companies Act 2006 and references to “subsidiary undertaking” and “parent undertaking” shall be construed in accordance with section 1162 of the United Kingdom Companies Act 2006, save that an undertaking shall be treated as an undertaking whether or not formed or incorporated in the United Kingdom and for the purposes of the membership requirement in sections 1162(2)(b) and (d) and section 1162(3)(a) as a member of another undertaking even if its shares in that other undertaking are registered in the name of (i) its nominee or (ii) another person (or its nominee) by way of security or in connection with the taking of security;

 

(b) every reference to a particular Law shall be construed also as a reference to all other Laws made under the Law referred to and to all such Laws as amended, re-enacted, consolidated or replaced or as their application or interpretation is affected by other Laws from time to time and whether before or after Completion provided that, as between the parties, no such amendment or modification made after the date of this Deed shall apply for the purposes of this Deed to the extent that it would impose any new or extended obligation, liability or restriction on, or otherwise adversely affect the rights of, any party;

 

(c) references to Clauses and Schedules are references to clauses of and schedules to this Deed, references to paragraphs are references to paragraphs of the Schedule in which the reference appears and references to this Deed include the Schedules;

 

6 

 

 

(d) references to the singular shall include the plural and vice versa and references to one gender include any other gender;

 

(e) references to a “party” means a party to this Deed and includes its successors in title, personal representatives and permitted assigns;

 

(f) references to a “person” includes any individual, partnership, body corporate, corporation sole or aggregate, state or agency of a state, and any unincorporated association or organisation, in each case whether or not having separate legal personality;

 

(g) references to a “company” includes any company, corporation or other body corporate wherever and however incorporated or established;

 

(h) references to “sterling”, “pounds sterling”, “GBP” or “£” are references to the lawful currency from time to time of the United Kingdom;

 

(i) references to “dollars”, “USD”, “US$” or “$” are references to the lawful currency from time to time of the United States of America;

 

(j) references to “euro”, “EUR” or “€” are references to the lawful currency from time to time of the European Union;

 

(k) references to any other currency in Schedule 4 are references to the lawful currency of the jurisdiction in which the relevant Group Company is incorporated;

 

(l) for the purposes of applying a reference to a monetary sum expressed in sterling, an amount in a different currency shall be deemed to be an amount in sterling translated at the Exchange Rate at the relevant date;

 

(m) where it is necessary to determine whether a monetary limit or threshold set out in paragraph 1 of Schedule 3 has been reached or exceeded (as the case may be) and the value of the relevant Claim is expressed in a currency other than dollars, the value of each such claim shall be translated into dollars at the Exchange Rate applicable to that amount of such non-dollar currency on the date of receipt by the Warrantor of written notification from the Purchaser in accordance with paragraph 2 of Schedule 3, or if such day is not a Business Day, on the Business Day immediately preceding such day;

 

(n) references to times of the day are to London time unless otherwise stated;

 

(o) references to writing shall include any modes of reproducing words in a legible and non-transitory form;

 

(p) references to any English legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court official or any other legal concept or thing shall in respect of any jurisdiction other than England be deemed to include what most nearly approximates in that jurisdiction to the English legal term;

 

(q) words introduced by the word “other” shall not be given a restrictive meaning because they are preceded by words referring to a particular class of acts, matters or things;

 

(r) general words shall not be given a restrictive meaning because they are followed by words which are particular examples of the acts, matters or things covered by the general words and the words “includes” and “including” shall be construed without limitation; and

 

7 

 

 

(s) “material” or “materially” shall be construed as a reference to materiality in the context of the Group (taken as a whole).

 

1.3 The headings and sub-headings in this Deed are inserted for convenience only and shall not affect the construction of this Deed.

 

1.4 Each of the Schedules to this Deed shall form part of this Deed.

 

1.5 References to this Deed include this Deed as amended or varied in accordance with its terms.

 

1.6 All warranties, indemnities, covenants, agreements and obligations given or entered into by more than one Warrantor under this Deed are given or entered into severally and not jointly or jointly and severally and accordingly the liability of each Warrantor in respect of any breach of any such obligation, undertaking or liability shall extend only to any loss or damage arising from its own breach.

 

2. WARRANTIES

 

2.1 Each Warrantor severally (and not jointly or jointly and severally) warrants to the Purchaser in the terms set out in Schedule 2 that:

 

(a) each of the Warranties other than the Warranties set out in paragraphs 5.4 and 24 of Schedule 2 is true and accurate at the date of this Deed (the “Signing Warranties”); and

 

(b) each of the Warranties will be true and accurate as at the Completion Date by reference to the facts and circumstances then existing (on the basis that any reference (express or implied) in the Warranties to the “date of this Deed” shall be construed as a reference to the “Completion Date” for the purposes of this Clause 2.1(b)) (the “Completion Warranties”).

 

2.2 Each Warrantor acknowledges that the Purchaser is entering into the SPA on the basis of, and in express reliance on, the Warranties.

 

2.3 The Warranties, other than the Warranties given in paragraphs 1 and 4 of Schedule 2 of this Deed, are given subject to matters Disclosed in this Deed, the Disclosure Letter, the Completion Disclosure Letter, the Data Room and any other Transaction Document.

 

2.4 Notwithstanding any other provision of this Deed, the provisions of Schedule 3 shall operate to limit and exclude the liability of the Warrantors in respect of the Warranties.

 

2.5 Where any payment is made by a Warrantor in satisfaction of a liability arising under this Deed it shall, to the extent possible, be treated as a reduction of that part of the Consideration (as defined in the SPA) paid to such Warrantor pursuant to the SPA in respect of its Shares.

 

2.6 Each Warrantor undertakes to the Purchaser that as of the date of this Deed (save in the case of fraud or fraudulent misrepresentation) it:

 

(a) has no rights against (and waives any rights it may have against); and

 

(b) shall not make any claim against (and waives any claim it may have against),

 

any Group Company or any of their directors, officers, employees, agents, advisers or other representatives, any direct or indirect shareholder of the Purchaser, any provider of investment advice or finance to the Purchaser, any person otherwise connected with the Purchaser or their current or former Representatives, in connection with any claim by the Purchaser under this Deed (except as may be expressly agreed between a Warrantor and any particular person).

 

8 

 

 

2.7 Each Warrantor undertakes to deliver to the Purchaser a duly executed copy of the Completion Disclosure Letter on the date falling two (2) Business Days prior to the Completion Date, provided that a draft of such Completion Disclosure Letter will be provided by the Warrantors to the Purchaser at least five (5) Business Days prior to the Completion Date to allow the Purchaser and its Representatives reasonable opportunity to review and raise any reasonable queries and/or comments as to the matters set out therein (and the Warrantors shall take into account such reasonable queries and/or comments).

 

3. Warrantor representative

 

3.1 Subject to Clause 3.3 each Warrantor hereby irrevocably appoints Andrew Kirkwood to act as their representative and represent each Warrantor for the purposes contemplated by this Deed (the “Warrantor Representative”).

 

3.2 Each Warrantor hereby irrevocably agrees that it shall be bound by any steps or actions taken or any agreement entered into by the Warrantor Representative acting in accordance with this Deed. The Purchaser shall be entitled to rely on the authority of the Warrantor Representative to act on behalf of each Warrantor without further enquiry.

 

3.3 If for any reason Andrew Kirkwood shall not be able to act as the Warrantor Representative and the Warrantors nominate in writing another person to fill the role of Warrantor Representative, such other person so notified in writing to the Purchaser shall be the Warrantor Representative in substitution for Andrew Kirkwood from time to time.

 

3.4 Each Warrantor irrevocably and unconditionally undertakes severally to indemnify and hold the Warrantor Representative harmless against all Losses arising from the exercise or the purported exercise in good faith of any of the rights or duties of each of the Warrantor Representative contemplated by this Deed.

 

4. ENTIRE AGREEMENT, REMEDIES and Termination

 

4.1 This Deed and the other Transaction Documents together set out the entire agreement between the parties relating to the subject matter of this Agreement and matters described in the other Transaction Documents and, save to the extent expressly set out in this Deed or any other Transaction Document, supersede and extinguish prior drafts, agreements, undertakings, representations, warranties, promises, assurances and arrangements of any nature whatsoever, whether or not in writing, relating thereto.

 

4.2 Save as expressly set out in this Deed, no party shall be entitled to rescind or terminate this Deed in any circumstances whatsoever at any time, whether before or after Completion, and each party waives any rights of rescission or termination it may have. Notwithstanding this Clause 4.2, if Completion does not occur and the SPA is terminated or rescinded for any reason, this Deed shall automatically terminate without any liability being incurred by the Warrantors or the Purchaser (save in respect of any antecedent breach of this Deed).

 

4.3 The rights, powers, privileges and remedies provided in this Deed are cumulative and not exclusive of any rights, powers, privileges or remedies provided by Law.

 

5. WAIVER And Variation

 

5.1 A failure or delay by a party to exercise any right or remedy provided under this Deed or by Law, whether by conduct or otherwise, shall not constitute a waiver of that or any other right or remedy, nor shall it preclude or restrict any further exercise of that or any other right or remedy. No single or partial exercise of any right or remedy provided under this Deed or by Law, whether by conduct or otherwise, shall preclude or restrict the further exercise of that or any other right or remedy.

 

9 

 

 

5.2 A waiver of any right or remedy under this Deed shall only be effective if given in writing and shall not be deemed a waiver of any subsequent breach or default. A party that waives a right or remedy provided under this Deed or by Law in relation to another party does not affect its rights in relation to any other party.

 

5.3 No variation or amendment of this Deed shall be valid unless it is in writing and duly executed by or on behalf of the Purchaser and the Warrantors Representative. Unless expressly agreed, no variation or amendment shall constitute a general waiver of any provision of this Deed, nor shall it affect any rights or obligations under or pursuant to this Deed which have already accrued up to the date of variation or amendment and the rights and obligations under or pursuant to this Deed shall remain in full force and effect except and only to the extent that they are varied or amended.

 

6. INVALIDITY

 

Where any provision of this Deed is or becomes illegal, invalid or unenforceable in any respect under the Laws of any jurisdiction then such provision shall be deemed to be severed from this Deed and, if possible, replaced with a lawful provision which, as closely as possible, gives effect to the intention of the parties under this Deed and, where permissible, that shall not affect or impair the legality, validity or enforceability in that, or any other, jurisdiction of any other provision of this Deed.

 

7. ASSIGNMENT and Successors

 

7.1 Except as provided in this Clause 7 or as the Purchaser and the Warrantor Representative specifically agree in writing, no person shall assign, transfer, charge or otherwise deal with all or any of its rights under this Deed nor grant, declare, create or dispose of any right or interest in it.

 

7.2 Subject to Clause 7.3, the Purchaser may assign the benefit of this Deed and/or of any other Transaction Document to which it is a party, in whole or in part, to, and it may be enforced by:

 

(a) any member of the Purchaser Group, provided that the Purchaser shall procure that such assignee or transferee reassigns its rights or obligations under this Deed to another member of the Purchaser Group if such assignee or transferee ceases to be a member of the Purchaser Group; or

 

(b) any bank or financial lender or creditor or any member of their groups (including any trustee or nominee on their behalf or funds) to the Purchaser, by way of security.

 

Any such person to whom an assignment is made under this Clause 7.2 may itself make an assignment as if it were the Purchaser under this Clause 7.2.

 

7.3 Any assignment made pursuant to this Clause 7 shall be on the basis that:

 

(a) each Warrantor may discharge its obligations under this Deed to the assignor until it receives notice of the assignment;

 

(b) the liability of each Warrantor to any assignee shall not be greater than its liability to the Purchaser;

 

(c) the assignment shall not result in any other Taxes, costs or expenses for which any of the Warrantors would be responsible; and

 

(d) the Purchaser will remain liable for any obligations under this Deed.

 

10 

 

 

7.4 This Deed shall be binding on and continue for the benefit of the successors and assignees of each party.

 

8. NOTICES

 

Any notice or other communication given under this Deed or in connection with the matters contemplated herein shall, except where otherwise specifically provided, be in writing in the English language, addressed and served in accordance with the notice provisions set out in clause 25 of the SPA.

 

9. CONFIDENTIALITY

 

9.1 Except as expressly provided in this Deed or with the prior written approval of each of the Warrantors and the Purchaser, each Warrantor undertakes to the Purchaser, and the Purchaser undertakes to each Warrantor, to keep confidential at all times after the date of this Deed, and not directly or indirectly to reveal, disclose or use for their or its own or any other purposes, any confidential information received or obtained as a result of entering into or performing, or supplied by or on behalf of a party in the negotiations leading to, this Deed and which relates to or comprises:

 

(a) the provisions and subject matter of and negotiations relating to this Deed and the other Transaction Documents;

 

(b) in the case of the Warrantors, any confidential information received or held by the relevant Warrantor relating to the Purchaser Group, or, following Completion, any Group Company (including all confidential information or trade secrets in their possession concerning the business, affairs, customers, clients or suppliers of any of the Group Companies); or

 

(c) in the case of the Purchaser, any confidential information received or held by the Purchaser (or any of its Representatives) relating to the Warrantors (or any of them), or, prior to Completion, any Group Company (including all confidential information or trade secrets in their possession concerning the business, affairs, customers, clients or suppliers of any of the Group Companies),

 

(collectively, the “Confidential Information”) and Confidential Information shall include written information and information transferred or obtained orally, visually, electronically or by any other means.

 

9.2 Clause 9.1 shall not prevent disclosure of Confidential Information by a party to the extent such party can demonstrate that:

 

(a) disclosure is required by Law or by any stock exchange or any regulatory, governmental or other Authority (including any Tax Authority) having applicable jurisdiction;

 

(b) disclosure is required for the purpose of any arbitral or judicial proceedings arising out of this Deed or any other Transaction Document;

 

(c) disclosure is of Confidential Information which was lawfully in the possession of that party (as evidenced by written records) without any obligation of secrecy before being received or held or which has previously become publicly available other than through that party’s fault;

 

(d) disclosure is made on a confidential basis to the prospective providers of warranty and indemnity insurance to the Purchaser or any of its direct of indirect shareholders;

 

11 

 

 

(e) disclosure is reasonably required for the efficient management of the Tax affairs of the relevant party or any of its Affiliates;

 

(f) disclosure is made to the Institutional Sellers or any of its Affiliates provided that such information is disclosed on a confidential basis;

 

(g) disclosure is made by the Purchaser to a member of the Purchaser Group (but excluding any investee or portfolio company of the Purchaser or any of its Affiliates), or to any of their directors, officers, advisers or agents provided such information is disclosed on a confidential basis; or

 

(h) in the case of the Purchaser, if disclosure was permitted pursuant to Clause 13.3 of the SPA.

 

10. COSTS

 

Except as otherwise provided in this Deed or any other Transaction Document, no party shall be responsible for another party’s costs arising out of or in connection with the preparation, negotiation and implementation of this Deed and all other Transaction Documents.

 

11. RIGHTS OF THIRD PARTIES

 

11.1 The specified third party beneficiaries of the undertakings referred to in Clause 2.6 shall, in each case, have the right to enforce the relevant terms by reason of the Contracts (Rights of Third Parties) Act 1999.

 

11.2 Except as provided for in Clause 11.1, a person who is not a party to this Deed shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.

 

11.3 Each party represents to the other that any rights they each may have to terminate, rescind or agree any amendment, variation, waiver or settlement under this Deed are not subject to the consent of any person that is not a party to this Deed.

 

12. COUNTERPARTS

 

This Deed may be executed in any number of counterparts. Each counterpart shall constitute an original of this Deed but all the counterparts together shall constitute but one and the same instrument.

 

13. GOVERNING LAW AND JURISDICTION

 

13.1 This Deed and any non-contractual rights or obligations arising out of or in connection with it shall be governed by and construed in accordance with the laws of England and Wales.

 

13.2 The parties irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction to settle any Disputes, and waive any objection to proceedings before such courts on the grounds of venue or on the grounds that such proceedings have been brought in an inappropriate forum.

 

13.3 For the purposes of this Clause, “Dispute” means any dispute, controversy, claim or difference of whatever nature arising out of, relating to, or having any connection with this Deed, including a dispute regarding the existence, formation, validity, interpretation, performance or termination of this Deed or the consequences of its nullity and also including any dispute relating to any non-contractual rights or obligations arising out of, relating to, or having any connection with this Deed.

 

12 

 

 

14. PROCESS AGENT

 

Without prejudice to any other permitted mode of service, the parties agree that service of any claim form, notice or other document for the purpose of or in connection with any action or proceeding in England or Wales arising out of or in any way relating to this Deed or any other Transaction Document governed by the laws of England or Wales shall be duly served upon the Purchaser if it is delivered personally or sent by recorded or special delivery mail to E2Open Ltd, 1020 Eskdale Road, Winnersh Triangle, Reading, RG41 5TS marked for the attention of the directors or such other person and address in England or Wales as such party shall notify all the other parties in writing from time to time, whether or not such claim form, notice or other document is forwarded to the relevant party or received by such party.

 

13 

 

 

Schedule 1

 

WARRANTORS

 

 

(1)

Name

(2)

NOTICE DETAILS

1. Andrew Kirkwood [Redacted]
2. Michael Hunt [Redacted]
3. Joy Burkholder Meier [Redacted]

 

14 

 

 

Schedule 2

 

WARRANTIES

 

1. CAPACITY AND AUTHORITY

 

1.1 The relevant Warrantor has the requisite power and authority to enter into and perform this Deed and the other Transaction Documents (if and to the extent applicable), and this Deed and such Transaction Documents constitute lawful, valid and binding obligations on such Warrantor in accordance with their respective terms.

 

1.2 The execution and delivery of this Deed and the other Transaction Documents (if and to the extent applicable) by the relevant Warrantor and the performance of and compliance with their respective terms and provisions will not:

 

(a) conflict with or result in a breach of any agreement or instrument to which such Warrantor is a party or by which he is bound, or any law that applies to or binds such Warrantor or any of their property; or

 

(b) result in a breach of, or default under, any order, judgment, decree or other decision or ruling of any court or Government Entity in any jurisdiction.

 

2. SHARE Capital and the group

 

2.1 The Share Capital

 

(a) There is no Encumbrance, and there is no agreement, arrangement or obligation to create or give an Encumbrance, in relation to any share or loan capital (whether issued or unissued) of any member of the Group.

 

(b) The Shares comprise the whole of the issued and allotted share capital of the Company, have been validly issued and allotted and are each fully paid or credited as fully paid and have not been repaid in whole or in part.

 

(c) The Company or a Subsidiary is the sole legal and beneficial owner of the whole allotted and issued share capital of each of the Subsidiaries and all such shares have been validly issued and allotted, are fully paid up and free from Encumbrances, and there are no agreements or commitments to create any Encumbrances over such shares.

 

(d) No person has any right (whether exercisable now or at a future date and whether contingent or otherwise) to require any Group Company:

 

(i) to allot, or grant rights to subscribe for, share or loan capital or any other security giving rise to a right over, or an interest in, the capital of any Group Company; or

 

(ii) to convert any existing securities into or otherwise acquire, or to issue securities, shares, debentures or other securities that have rights to convert into, shares or other securities in any Group Company, including pursuant to an option or warrant.

 

2.2 The Group

 

(a) The information in respect of each Group Company set out in Schedule 4 is true and accurate in all respects, and the issued share capital as listed for each Group Company in Schedule 4 constitutes the entire issued share capital of that Subsidiary.

 

15 

 

 

(b) Each Group Company is validly established, in existence and duly registered under the laws of the country in which it is incorporated and has all necessary corporate powers and authority to carry on its business as presently conducted.

 

(c) None of the Group Companies:

 

(i) holds or beneficially owns, or has agreed to acquire, any interest of any nature in any shares, debentures or other securities of any company other than the Subsidiaries;

 

(ii) is or has agreed to become a member of any limited partnership, partnership or other unincorporated association, joint venture or consortium (other than recognised trade associations);

 

(iii) have any branch, agency or permanent establishment outside the country of its incorporation; or

 

(iv) has allotted or issued any securities that are convertible into shares.

 

(d) The statutory books of each Group Company (i) are in its possession and control, (ii) are up-to-date, (iii) are maintained in accordance with applicable law and have been filed correctly and in a timely manner with the registrar of companies or other applicable authority in the relevant jurisdiction, (iv) contain, in all material respects, an accurate record of the matters which should be dealt with in them, and (v) no written notice (which is still current) that any of them is incorrect or should be rectified has been received in the two years ending on the date of this Deed or which is still pending.

 

(e) All matters which are required under applicable law to be registered, filed and/or reported to public registers (including commercial, trade or UBO-registers), have been duly reported and filed to such registers and, if required, registered therein.

 

3. CONSTITUTIONAL AND CORPORATE DOCUMENTS

 

3.1 The copies of the current articles of association or incorporation or other constitutional and corporate documents of each Group Company have been provided in the Data Room and are complete and accurate in all material respects. Other than those documents and the investment agreement dated 22 September 2017 between the FP Investors, the Temasek Investors, the Managers (each as defined therein) and the Company in relation to the Company, which shall terminate with immediate effect upon Completion in accordance with its terms with no liability or expense of any Group Company, there are no agreements which regulate the corporate relationships of any Group Company or which oblige any Group Company to subject itself to the management of, or transfer its profit to, a third party.

 

3.2 No Group Company has acquired or disposed of any company, entity or other undertaking in the last three years.

 

4. Insolvency

 

4.1 No receiver or administrative receiver, insolvency administrator or manager or receiver and manager or trustee or similar person has been appointed over the whole or any part of the assets or undertaking of any Group Company. No administrator has been appointed in respect of any Group Company, nor has any administration order been made or have any insolvency proceedings or comparable proceedings been commenced in each case, in respect of any Group Company and no petition or application for such an order or proceeding or any notice of appointment of, or of any intention to appoint, an administrator or such proceeding has been threatened, presented, made, served or filed.

 

16 

 

 

4.2 No voluntary arrangement, compromise, composition, scheme of arrangement, standstill agreement, deferral, proceedings or steps leading to any form of bankruptcy, moratorium, stay or limitation of creditors’ rights, interim or provisional supervision by a court or court appointee, or any distress, execution, commercial rent arrears recovery or other process levied or exercised, or any event similar to any such events ,rescheduling or other readjustment or reorganisation or other arrangement between any Group Company and its creditors (or any class of them) has been proposed or approved by any Group Company other than in the ordinary course of trading.

 

4.3 No petition has been threatened or presented against any Group Company by any third party and no order has been made, no resolution has been passed and no meeting has been convened for the purpose of winding up or striking off any Group Company or for the appointment of a provisional liquidator or special manager to any Group Company.

 

4.4 No Group Company has stopped paying its debts as and when they fall due nor is it insolvent or unable to pay its debts.

 

4.5 No step has been taken with a view to the dissolution or striking-off the register of any Group Company.

 

4.6 No event or circumstance has occurred or exists in respect of any Group Company analogous to those described in paragraphs 4.1 to 4.5 above.

 

5. ACCOUNTS

 

5.1 The Accounts:

 

(a) have been prepared in accordance with applicable Law and IFRS as at the relevant Accounts Date; and

 

(b) show a true and fair view of the:

 

(i) assets and liabilities, the state of affairs and the financial position as at the relevant Accounts Date; and

 

(ii) profit or loss and cash flows for the financial year ended on the relevant Accounts Date,

 

of the Group taken as a whole.

 

5.2 The unaudited consolidated financial statements of the Company for the period beginning 1 January 2021 and ending 31 March 2021, including the consolidated balance sheet, consolidated profit and loss accounts and cash flow statement (the “Management Accounts”), have been prepared with due care and good faith, in accordance with the same accounting policies, principles, practices, categorisations and monthly reporting procedures as applied in the Locked Box Accounts. The Management Accounts represent a reasonably accurate view, which is not materially misstated, of the results of the Group in the relevant period and of the financial position of the Group at the relevant date.

 

5.3 The Locked Box Accounts:

 

(a) have been properly prepared in accordance with applicable Law and IFRS and with due care and attention on the same basis and using the same accounting policies, principles and estimation techniques employed in preparing the Accounts; and

 

(b) having regard to the purpose for which they were prepared, are not misleading and show a true and fair view of the:

 

17 

 

 

(i) assets and liabilities, the state of affairs and the financial position as at the Locked Box Date; and

 

(ii) profits or losses for the period to which it relates,

 

of the Group taken as a whole.

 

5.4 The Required Financial Statements, when delivered, are prepared in accordance with applicable Law and IFRS applied on a consistent basis as at the relevant date of such Required Financial Statements and show a true and fair view of the assets and liabilities, state of affairs and the financial position as at the relevant date of such Required Financial Statements of the Group taken as a whole.

 

5.5 Each Group Company’s accounting records are in its possession or under its control. The books of account and other financial records of each Group Company have been kept accurately in all material respects in the ordinary course of business, the transactions entered therein represent bona fide transactions, and the revenues, expenses, assets and liabilities of the Group Companies have been properly recorded therein in all material respects. Each Group Company has devised and maintains a system of internal accounting policies and controls sufficient to provide reasonable assurances that (i) transactions are executed in all material respects in accordance with management’s authorization; (ii) the transactions are recorded as necessary to permit the preparation of financial statements in conformity with IFRS and to maintain accountability for assets; and (iii) the amount recorded for assets on the books and records of each Group Company is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any difference (collectively, “Internal Controls”). The Company has not identified and has not received written notice from an independent auditor of (i) any significant deficiency or material weakness in the system of Internal Controls utilized by the Group Companies; (ii) any fraud that involves the Group Companies’ management or other employees who have a role in the preparation of financial statements or the Internal Controls utilized by the Group Companies; or (iii) any claim or allegation regarding any of the foregoing. There are no significant deficiencies or material weaknesses in the design or operation of the Internal Controls over financial reporting that would reasonably be expected to materially and adversely affect the Group Companies’ ability to record, process, summarize and report financial information.

 

5.6 No Group Company has any liabilities that are required to be disclosed on a balance sheet in accordance with IFRS, except (i) liabilities specifically reflected and adequately reserved against in the Accounts or specifically identified in the notes thereto; (ii) liabilities which have arisen after the Locked Box Date in the ordinary course of business consistent with past practice (none of which results from, arises out of or was caused by any breach of contract, infringement or violation of Law); or (iii) liabilities arising under the SPA or the performance by the Company of its obligations thereunder.

 

5.7 No Group Company maintains any “off-balance sheet arrangement” within the meaning of Item 303 of Regulation S-K of the Securities Exchange Act.

 

5.8 Provided at folder 2.2 of the Data Room are true and complete copies of the Accounts, the Management Accounts and the Locked Box Accounts.

 

6. Period SINCE THE Locked Box DATE

 

6.1 Since the Locked Box Date:

 

(a) no Group Company has declared, authorised, paid or made a dividend or other distribution (other than to another Group Company);

 

18 

 

 

(b) no resolution of the members or any class of members of any Group Company has been passed;

 

(c) no Group Company has changed its accounting reference date or has materially changed any of its accounting policies or practices (including reserving for its liabilities);

 

(d) no Group Company has acquired or disposed of (i) any asset with a book value in excess of USD 500,000 or (ii) assets with an aggregate book value in excess of USD 500,000;

 

(e) the Group Companies have operated the business of the Group in all material respects in the ordinary course of business consistent with past practice;

 

(f) there has been no material adverse change in the turnover or financial position of the Group taken as a whole and the Group’s business has not been materially effected by the loss of any important customer or important source of supply. For these purposes an important customer or source of supply in relation to the Group means one of which in either of the two financial periods immediately preceding the period for which the Locked Box Accounts were prepared accounts for 5 per cent or more of (in the case of a customer) the turnover of the Group or (in the case of a source of supply) of the goods, services or equipment supplied to the Group;

 

(g) no share or loan capital or any security giving rise to a right over its capital has been allotted, issued, repurchased, repaid (or become liable to be repaid) or redeemed or agreed to be allotted, issued, repurchased, repaid (or become liable to be repaid) or redeemed by any Group Company;

 

(h) no Group Company has acquired or disposed of a business as a going concern;

 

(i) other than in the ordinary course of business or as contemplated by any lease agreement or contract to which any of the Group Companies is a party and which has been Disclosed, or as is contained in the Group’s annual budget, the Group Companies have not incurred or agreed to incur capital expenditure in excess of USD 100,000 in aggregate;

 

(j) other than in the ordinary course of business, no Group Company has: (i) lent or agreed to lend any sum in the nature of borrowings; or (ii) incurred or agreed to incur any additional material borrowings or any other material indebtedness;

 

(k) no Group Company has (i) negotiated, modified, extended, or entered into any CBA or (ii) recognised or certified any labor union, labor organization, works council, or group of Employees as the bargaining representative for any Employees;

 

(l) no Group Company has implemented or announced any employee layoffs, plant closings, reductions in force, furloughs, temporary layoffs, salary or wage reductions, work schedule changes or any other such actions that could implicate the WARN Act;

 

(m) no Group Company has (i) adopted, entered into, amended or terminated any Pension Scheme or Plan (or any plan or arrangement that would have constituted a Plan had it been in effect on the Completion Date), (ii) increased the base salary, wages, benefits, bonuses or other compensation payable or to become payable to any of its Senior Employees, (iii) taken any action to accelerate the vesting, payment or funding of any material compensation or benefits under any Pension Scheme or Plan, (iv) granted any bonus, severance or termination pay, benefit or grant any equity or equity-based awards to any Employee or other individual independent service provider or contractor of the Group Company, (v) hired or terminated (other than for cause) any Senior Employee or (vi) offered or promised, or taken any action of the foregoing;

 

19 

 

 

(n) no Group Company has (i) assigned, transferred, licensed, let lapse, abandoned, allowed to expire or otherwise disposed of any Material Owned Intellectual Property, or (ii) disclosed any know-how, confidential information or trade secrets forming part of the Material Owned Intellectual Property save for in the ordinary course and under a duty of confidentiality; and

 

(o) there has been no material amendment to any of the Group's standard terms and conditions applicable to the customers and suppliers.

 

7. FINANCE

 

7.1 The Data Room contains details of all overdrafts, loans or other financial facilities as well as any hedging contracts and derivative instruments of the Group currently outstanding or available to any Group Company (excluding any such overdrafts, loans or other financial facilities or instruments under which any amounts are owing from one Group Company to another) (the “Finance Documents”).

 

7.2 No indebtedness of any Group Company is due and payable save in the ordinary course of business and no Encumbrance over any of the assets of the Group Companies is now enforceable, whether by virtue of the stated maturity date of the indebtedness having been reached or otherwise.

 

7.3 No Group Company has received notice (which is current and still outstanding) from any counterparty under the Finance Documents:

 

(a) that it is in material default under the terms of any of the Finance Documents (including the Existing Facilities Agreement), in each case which default remains outstanding at the date of this Deed;

 

(b) to repay (either in whole or part) any amount owing under any of the Finance Documents in advance of their stated maturity;

 

(c) to crystallise any Encumbrance over any of the assets of any Group Company; or

 

(d) for payment of any penalty, prepayment fee, break fee, premium, interest or other amount.

 

7.4 Other than the Existing Facilities Agreements and any guarantees and/or Encumbrances entered into in connection with the Existing Facilities Agreement, no Group Company has given or entered into any guarantee, mortgage, charge, pledge, lien, assignment or other security agreement or arrangement or is responsible for the indebtedness or for the default in the performance of any obligation, of any person other than another Group Company, other than those entered into in the ordinary course of business.

 

7.5 No Group Company is owed any individual debt in excess of USD 100,000 other than trade debts incurred in the ordinary course of business or owing between members of the Group.

 

7.6 No Group Company has factored, discounted or securitised any of its receivables, nor has it engaged in any financing of a type which would not be required to be shown or reflected in the Locked Box Accounts.

 

7.7 All charges in favour of any Group Company which require registration have been duly registered and are valid and enforceable.

 

7.8 None of the Group Companies has entered into any cash pooling agreements or similar arrangements with or participated in any cash pooling or similar system and is not required to enter into any such agreements or participate in any such system.

 

20 

 

 

7.9 The amounts borrowed or guaranteed by the Group Companies, either individually or in aggregate, do not exceed any limitation on its borrowings or guarantees imposed by any of its financial facilities or contained in its constitutional documents, any debt programme or in any agreement or instrument binding upon any Group Company.

 

8. REAL ESTATE

 

8.1 The details in relation to the Properties are true, accurate and not misleading.

 

8.2 The Properties are the only premises owned, leased or occupied by any Group Company. No Group Company is party to any agreement to acquire or dispose of any freehold or leasehold property in respect of which the acquisition or disposal has not yet completed.

 

8.3 In relation to each Property:

 

(a) a Group Company is solely legally and beneficially entitled to such Property; and

 

(b) none are subject to any subleases or licences to occupy to a third party.

 

8.4 No Group Company has received any written notice from a relevant Authority of any proceeding in compulsory purchase pending or threatened against the Properties and no Property is subject to an order, resolution or proposal for compulsory acquisition.

 

8.5 Complete copies of each of the leases, subleases, licences or other agreements pursuant to which the Group Companies hold and/or occupy the Properties (the “Leases”) are contained in the Data Room.

 

8.6 No Group Company has received written notification of a breach of any of the Leases where such breach is outstanding.

 

8.7 No Group Company has any continuing liabilities (whether actual or contingent) in relation to formerly owned or occupied land and buildings.

 

8.8 No Group Company (nor any third-party for whom such liabilities (whether actual or contingent) have been assumed by any Group Company) has handled, stored, released, disposed or arranged for the disposal of, exposed any person to, or owned, leased or operated any real property contaminated by, any hazardous substance, material or waste, in each case so as to give rise to any material liability (whether actual or contingent) for any Group Company.

 

8.9 Each of the Properties is in a good state of repair and condition and fit for the use to which it is currently being put by the Group.

 

8.10 There is no option, pre-emption or right to acquire any Property and no Group Company has any option, pre-emption or right to acquire any land or buildings other than the Properties.

 

8.11 In relation to each of the Leases:

 

(a) there are no material subsisting breaches nor any material non-observance of any covenant, condition or agreement contained in the Lease on the part of either the relevant landlord or the Group Company;

 

(b) no rent review is outstanding or in progress;

 

(c) there are no existing or anticipated dilapidation costs other than as provided for in the Accounts, the Management Accounts or the Locked Box Accounts;

 

21 

 

 

(d) no notice of termination has been served on or by any Group Company; and

 

(e) the relevant Lease is in full force, and no notice to determine such Lease has been served by a Group Company.

 

8.12 There exists no dispute between any Group Company and the owner or occupier of any other premises adjacent to or neighbouring the Properties and there are no circumstances that may give rise to, any such dispute after the date of this Deed.

 

9. Assets

 

9.1 All material assets included in the Locked Box Accounts or acquired by any of the Group Companies or which have otherwise arisen since the Locked Box Date, other than any assets disposed of or realised in the ordinary and usual course of trading, are:

 

(a) legally and beneficially owned by the Group free from Encumbrances (save for those Encumbrances arising by operation of law in the ordinary course of business); and

 

(b) where capable of possession, in the possession or under the control of the relevant Group Company (save where held by a third party in the ordinary course of business).

 

9.2 The property, rights and assets owned, leased or otherwise used by, the Group Companies comprise all the property, rights and assets necessary for the carrying on of the business of the Group substantially in the manner in which, and to the extent to, it has been conducted in the 12 month period prior to the date of this Deed.

 

10. INSURANCE

 

Copies of all of the material policies of insurance maintained by or covering each of the Group Companies are included in the Data Room and are true and accurate. All such material policies are currently in full force and effect and nothing has been done or omitted to be done by any Group Company which would make any such material policy of insurance void or voidable. All sums falling due in respect of premiums on such material policies of insurance have been paid. There is no outstanding claim by any Group Company under any such material policies, there have been no such claims in excess of USD 100,000 in the previous two years and there are no circumstances likely to give rise to such a claim.

 

11. CONTRACTS

 

11.1 A complete and accurate copy of each Material Contract is contained in the Data Room.

 

11.2 Each of the Material Contracts is in full force and effect and binding on the parties to it. No notice of termination of any Material Contract has been received or served by a Group Company and there are no grounds for termination, rescission, avoidance or repudiation in the terms of any such Material Contract that will be triggered by the Transaction.

 

11.3 No Group Company is in material breach or default under any Material Contract and no other party to such an agreement or arrangement is in material breach or material default thereunder. There are no circumstances likely to give rise to any such breach or default.

 

11.4 No Group Company is a party to or subject to any material contract, transaction, arrangement, understanding or obligation (other than in relation to any Property or contract of employment) which:

 

(a) is not materially in the ordinary and usual course of business; or

 

(b) is not wholly on an arm’s length basis; or

 

22 

 

 

(c) materially restricts its ability to operate in any jurisdiction in which it operates as at the date of this Deed.

 

11.5 There are no existing contracts or arrangements between, on the one hand, any Group Company and, on the other hand, any Warrantor, any person who is or was a shareholder in a Group Company, or any person connected with any of them other than on normal commercial terms in the ordinary course of business.

 

11.6 No Group Company is party to any contract, arrangement or understanding with any current or former Employee, director or individual independent service provider of any Group Company, or any person connected with any of such persons, or in which any such person is interested (whether directly or indirectly), other than on normal commercial terms in the ordinary course of business.

 

11.7 No Group Company has in the last 12 months, sent or received either a written notice of a dispute, or any allegation of any breach or default in respect of a Material Contract.

 

11.8 No Group Company is or has been engaged in any agreement, arrangement, practice or conduct which amounts to an infringement of the Competition Law of any jurisdiction in which any Group Company conducts business.

 

11.9 There are no powers of attorney in force that have been given by any member of the Group to any person to enter into any contract or commitment on its behalf (other than to its directors, officers and Employees to enter into routine trading contracts in the ordinary course of their duties).

 

12. COMPLIANCE WITH LAWS

 

12.1 Each Group Company has at all times conducted its business in all material respects in accordance with all applicable Laws.

 

12.2 All material licences, permits, registrations and authorisations (public and private) have been obtained by the Group to enable the Group Companies to carry on their businesses and occupy their Properties, in the jurisdictions, and in the manner in which such businesses are currently carried on, and all such material licences, registrations and authorisations are valid and subsisting.

 

12.3 No Group Company is affected by any existing or pending judgments or rulings and no Group Company has given any undertakings arising from legal proceedings to an Authority or other third party.

 

12.4 No Group Company, nor any director, officer, or employee, nor agent or other person acting on behalf or for the benefit of any Group Company (in each case, whilst acting in such capacity) has, during the period of five years prior to the date of this Deed committed any breach of any Anti-Corruption Law.

 

12.5 No Group Company has conducted or initiated any internal investigation or would have had good cause for conducting or made a voluntary, directed or involuntary disclosure to any Government Entity or similar agency with respect to any alleged or suspected act or omission arising under or relating to any noncompliance with or offence under any Anti-Corruption Law.

 

13. Litigation

 

13.1 No Group Company is, or in the three year period prior to the date of this Deed, has been, engaged or involved in, or otherwise subject to any of the following matters (such matters being referred to as “Proceedings”):

 

23 

 

 

(a) any litigation or administrative, mediation, arbitration, actions, hearings, suits or other proceedings, or any claims, actions or hearings before any Authority in each case of a value exceeding USD 500,000 (except for debt collection in the normal course of business); or

 

(b) any dispute with, or any investigation, inquiry or enforcement proceedings by, any Authority (including pursuant to any Anti-Corruption Law) in any jurisdiction which, in each case, is material,

 

and no such Proceedings have been threatened or are pending and there are no circumstances likely to give rise to any such Proceedings.

 

13.2 No Group Company:

 

(a) is affected by any existing or pending judgment, order, decree, determination, award, ruling, injunction, writ, award or decision from any court, tribunal or arbitrator; or

 

(b) has given any undertaking to any court, tribunal, arbitrator, or any governmental, regulatory or similar body or any other third party arising out of, or in connection with, any Proceedings which remains in force.

 

13.3 There is no action, suit, investigation or other proceeding pending or threatened against or affecting: (i)  any Seller; or (ii) any Group Company, in each case before any court, arbitrator, governmental body, agency or official that in any manner challenges or seeks to prevent, enjoin, alter or materially delay the execution or consummation of the SPA, this Deed or the Transaction, and there are no circumstances likely to give rise to any of the foregoing.

 

14. Sanctions

 

14.1 No Group Company nor any of their respective directors, officers or employees (in that capacity):

 

(a) is a Sanctioned Person;

 

(b) has at any time during the five years prior to the date of this Deed engaged in any transaction or dealing, or provided funds or anything of value, to a Sanctioned Person or Sanctioned Territory; or

 

(c) has in the last five years breached any Sanctions Laws.

 

14.2 No Group Company has in the five years prior to the date of this Deed received any correspondence from any Authority in relation to a potential, alleged or actual breach by any Group Company of any Sanctions Laws, and no allegation has been made in the two years prior to the date of this Deed with respect to any potential or actual breach by any Group Company of any Sanctions Laws.

 

15. GUARANTEES And indemnities

 

No Group Company is a party to a guarantee, indemnity or other agreement to secure or incur a financial or other obligation with respect to the obligations of a third party (other than another Group Company).

 

16. EFFECT OF SALE ON SHARES

 

16.1 The acquisition of the Shares by the Purchaser will not:

 

(a) give rise to, or cause to become exercisable, any right of pre-emption over the Shares;

 

24 

 

 

(b) result in a breach of contract, order, judgment, injunction, undertaking, decree or other like imposition;

 

(c) result in the creation, imposition, crystallisation or enforcement of any Encumbrance on any of the assets of any Group Company;

 

(d) result in any director, officer or Senior Employee leaving any of the Group Companies;

 

(e) result in the loss or impairment of or any default under any Material Contract, Lease, IP Agreement, IT Contract, licence, authorisation or consent required by any of the Group Companies for the purposes of its business;

 

(f) result in any present or future indebtedness of any of the Group Companies becoming due and payable, or capable of being declared due and payable, prior to its stated maturity date or in any financial facility of any of the Group Companies being withdrawn; or

 

(g) entitle any person to acquire or affect the entitlement of any person to acquire shares in the Company.

 

17. INTELLECTUAL PROPERTY

 

17.1 Materially complete and accurate particulars are set out in Data Room folder 9 of all registrable Intellectual Property owned (or applied for) by the Group Companies (the “Registered Intellectual Property”).

 

17.2 Materially complete and accurate particulars are set out in Data Room folder 9 of all unregistrable Intellectual Property, including Intellectual Property in software, owned by the Group Companies (together with the Registered Intellectual Property, the “Material Owned Intellectual Property”).

 

17.3 The Group Companies either legally and beneficially own, or have legal, valid and enforceable licences to use, all the Intellectual Property required to carry on the Group’s business in the same manner as it is currently carried on (the “Business Intellectual Property”) and the Business Intellectual Property:

 

(a) is not subject to any Encumbrance or any licence or authority in favour of another; and

 

(b) will not be lost or liable to termination as a result of the Transaction or the execution or performance of any of the Transaction Documents.

 

17.4 The Material Owned Intellectual Property:

 

(a) is wholly owned (legally and beneficially) by the Group Companies, free from Encumbrances;

 

(b) has not been licensed to any third party other than as Disclosed in the Data Room and the Disclosure Letter;

 

(c) is not the subject of any failed application for registration;

 

(d) is not subject to any agreement that restricts its use, disclosure, licensing or transfer by the Group Companies; and

 

(e) is fully enforceable against third parties and is not the subject of any on-going enforceability, revocation or invalidity challenge.

 

25 

 

 

17.5 Each current and former officer, employee, contractor or consultant employed or engaged (as relevant) by a Group Company to develop Intellectual Property has entered into a written agreement with a Group Company under which such person: (i) irrevocably assigns to such Group Company all Intellectual Property created during their employment with or engagement with such Group Company automatically upon creation of such Intellectual Property; and (ii) irrevocably waives all moral rights relating to such Intellectual Property. Each such person has not made any claims under ‘droit moral rights’ and all Material Owned Intellectual Property is free and clear of any claims or rights by former and current personnel. Compensation claims against the Group Companies and/or the Sellers in connection with inventions by personnel have not been raised at any point in time either by personnel or inventors of any Material Owned Intellectual Property and there is no basis for any such claims.

 

17.6 In respect of the Registered Intellectual Property:

 

(a) all application and renewal fees due prior to the date of this Deed have been paid;

 

(b) in the case of registrations, the registrations are not subject to removal, amendment, challenge or surrender; and

 

(c) in the case of applications, there are no oppositions nor anything else that would prevent the applications from being granted.

 

17.7 In respect of each of the material agreements relating to licensing of any Intellectual Property by any Group Company or otherwise affecting any Group Company’s ability to use, enforce or disclose any Intellectual Property (the “IP Agreements”):

 

(a) complete copies of all IP Agreements are set out in Data Room folder 9.3;

 

(b) each IP Agreement is in full force and effect and binding on the parties to it;

 

(c) the terms of each IP Agreement have been complied with by the parties in all material respects, no notice of termination of any IP Agreements has been received or served by a Group Company and nor will any such IP Agreement be liable to be terminated as a result of the Transaction; and

 

(d) no Group Company has sent or received a written notice of termination, breach or dispute in the last 12 months in respect of an IP Agreement.

 

17.8 The activities, products or services of the Group Companies do not and have not infringed, misused or misappropriated the Intellectual Property of any third party during the last three years. No Material Owned Intellectual Property is being or has been infringed, misused or misappropriated by a third party during the last three years.

 

17.9 No Group Company has disclosed, nor is aware of the disclosure by any person of, any trade secrets, confidential information or know-how (including source code) forming part of the Material Owned Intellectual Property, except in the ordinary course of business and: (i) in the case of source code, under a binding agreement with a reputable source code escrow agent on that agent’s standard terms and conditions; or (ii) in relation to any other such disclosure, under a written agreement on the basis that such disclosure is to be treated as confidential in nature. The release of any such source code has not been triggered and: (i) there are currently no circumstances that exist that are likely to trigger the release of such source code; and (ii) the release of such source code will not be triggered as a result of the Transaction.

 

18. INFORMATION TECHNOLOGY

 

18.1 Folder 8 of the Data Room includes complete and current details of the IT Systems and the IT Contracts.

 

26 

 

 

18.2 All IT Systems are either (a) legally and beneficially owned by the Group free from any Encumbrance; or (b) supplied by third party suppliers on legally enforceable, binding, valid and written arm’s length commercial terms, and comprise all IT Systems that are required to operate the business of each Group Company as presently conducted, and such IT Systems will be owned or available for use by each Group Company on the same terms, at and immediately after Completion as such IT Systems were owned or used immediately before Completion.

 

18.3 The IT Systems have not been materially defective or materially failed to function during the twenty four (24) months immediately preceding the date of this Deed nor have there been any logical or physical intrusions to the IT Systems or losses of data which have had (or are having) a material adverse effect on the business of the Group.

 

18.4 The Group Companies have not used any Open Source Software. No software products owned by the Group Companies use, are modified on the basis of, combined with and/or distributed together with, in whole or in part, any Open Source Software in such a way as to render such software products itself, in whole or in part, open source or capable of being used, modified or distributed only under the applicable licence of the Open Source Software (i.e. result in a so-called copy-left effect). Free and Open Source Software (jointly the “Open Source Software”) means any software licensed or distributed as open source software or under similar licensing or distribution models, in particular such requiring that such software derived from or distributed with such software be disclosed or distributed in source code form, in particular (but without limitation) such licensed under GNU’s General Public License (“GPL”) or its Affero GPL, Mozilla License, Common Public License, Apache License, BSD License, Artistic License, or Sun Community Source License.

 

18.5 In respect of each IT Contract: (i) it is in full force and effect and has not been terminated; (ii) none of the provisions has been or is subject of any dispute or controversy between the parties; (iii) the obligations of each party under it have been fully complied with in full and on time and (iv) the Group Companies have not otherwise given cause for premature termination of such IT Contract.

 

18.6 The Group Companies have not: (i) incorporated open source code into any software; or (ii) used open source code in the development of, any software, in respect of each of the foregoing, the use of which is based on a licence which includes “copyleft” terms or which otherwise restricts the Group’s ability freely to license or distribute its software on terms of its choosing.

 

18.7 All the domain names used in or in connection with the business of the Group as presently carried on are listed in the Disclosure Letter (the “Domain Names”). A Group Company is the registrant of each of the Domain Names and no Domain Name is alleged by any third party to be an abusive registration.

 

18.8 The Group Companies are in possession of all passwords and other information to allow the Group to administer the Domain Names and any social media accounts which use the Group’s trade marks.

 

19. DATA PROTECTION

 

19.1 The Group has in the last 36 months materially complied, and materially complies, with the Data Protection Laws.

 

19.2 No Group Company has received any notice or threat of investigation in the last 36 months from any Authority or any other person alleging non-compliance with Data Protection Laws.

 

19.3 No Group Company has received any complaint (which is current and still outstanding at the date of this Deed) from any individual about its use of their Personal Data.

 

27 

 

 

19.4 No Group Company transfers Personal Data from within the EU to any entity outside of the EU, other than in compliance with the Data Protection Laws.

 

19.5 No Group Company receives (other than from its customers in the ordinary course of providing its services) or provides data sets of Personal Data to or from any third party.

 

19.6 There has been no breach of the Group’s IT Systems that has resulted in a loss of material amounts of Personal Data or any special categories of Personal Data.

 

19.7 The Group has not suffered any cyber attacks in the last two years.

 

20. EMPLOYEES

 

20.1 The Data Room contains copies of:

 

(a) the contracts of employment of the Warrantors;

 

(b) any contracts for services with (i) directors and (ii) contractors and consultants whose annual remuneration is in excess of USD 250,000 per annum;

 

(c) the standard terms and conditions, staff handbooks and employment policies which apply to each Group Company’s Employees;

 

(d) contracts of employment providing for severance in excess of the amount prescribed by Law;

 

(e) contracts or arrangements providing for any retention, stay-around, change in control bonus or transaction bonus; and

 

(f) the terms of all Pension Schemes, each Plan (and all material documents pursuant to which each Plan is established, funded, operated or administered), share incentive schemes, share option schemes or profit sharing, commission, bonus or other incentive schemes applicable to any of the Employees.

 

20.2 In the last twelve (12) months, no Group Company has given notice of termination to, or received notice of resignation from, any Senior Employee.

 

20.3 No offer of employment has been made by a Group Company to an individual who would be entitled to a fixed salary (which, for the avoidance of doubt excludes bonus, commission and any other elements of remuneration outside of salary) of greater than USD 200,000 if such offer were accepted, which has not yet been accepted or which has been accepted but where the employment has not yet started.

 

20.4 There have been no transfers under the Transfer of Undertakings (Protection of Employment) Regulations 2006, as amended (“TUPE”) (or similar local legislation applicable to a Group Company), in the past three years.

 

20.5 No Group Company has any current disciplinary proceedings or appeals in respect of any Senior Employee.

 

20.6 No Group Company has any obligation to make a payment on redundancy in excess of the amount prescribed by Law, or as provided for by a current social plan agreement or an agreement with an individual Employee and no Group Company operates any discretionary practice of making excess payments.

 

28 

 

 

20.7 No Group Company owes any sum to an Employee other than remuneration for the current pay period, accrued holiday pay for the current holiday year, accrued bonuses or commission payments for the current bonus or commission period and expenses claims.

 

20.8 No Group Company has been involved in any actual or threatened material industrial dispute or strike action and there has been no actual or threatened unfair employment practice charges, labor organizing activities, material employment grievances or arbitrations, lockouts, work stoppages, slowdowns, picketing or handbilling against or affecting any Group Company.

 

20.9 No Group Company is involved in any existing material claim against any Group Company from any Employee or former Employee.

 

20.10 The Data Room contains copies of all works council agreements applying in any Group Company and all collective bargaining agreements or other contracts with any labor union or labor organization affecting any group of Employees (each a “CBA”). In particular, (i) no Group Company is party to a current reconciliation of interest agreement or social plan, (ii) there are no representation or certification proceedings presently pending or threatened to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority and (iii) no labor union, works council, other labor organization, or group of Employees has made a demand for recognition or certification.

 

20.11 Each of the Group Companies has in relation to each of its Employees, its former employees, relevant trade unions, works councils or other bodies representing one or more of the Employees at all times complied with all applicable Laws respecting labor, employment and employment practices in all material respects, including, without limitation, all Laws respecting terms and conditions of employment, health and safety, wages and hours (including the classification of independent contractors and exempt and non-exempt employees), immigration (including the completion of Forms I-9 for all employees and the proper confirmation of employee visas), employment harassment, discrimination or retaliation, whistleblowing, disability rights or benefits, equal opportunity, plant closures and layoffs (including the WARN Act), employee trainings and notices, workers' compensation, labor relations, employee leave issues, COVID-19, affirmative action, unemployment insurance, CBAs (including any pre-signing legal or contractual requirement to provide notice to, or to enter into any consultation procedure with, any labor union, labor organization or works council, which is representing any Employee, in connection with the Transaction), reorganization plans (sociaal plan) or other rules on the co-determination of Employees or their representatives or any employment agreement.

 

20.12 No employee has been, as a result of COVID-19, placed on furlough, made redundant, had his or her salary, wages or working hours reduced, or been terminated, and no such actions are currently planned or announced, including as a result of COVID-19 or any Law, directive, guideline or recommendation by any governmental entity in connection with or in response to COVID-19. No Group Company has otherwise experienced any material employment-related liability with respect to COVID-19 and no current or former Employee has filed or threatened any Proceedings against any Group Company related to COVID-19.

 

20.13 All Group Companies have registered their Employees with the social security authorities. All contributions relating to social security and wage tax have been duly paid.

 

20.14 Neither the execution and delivery of the SPA nor the consummation of the Transaction, directly or indirectly, could: (i) result in any payment (whether in cash or in kind) becoming due to any current or former Employee, director, individual independent contractor, or consultant, who is an individual providing services to the Group Company; (ii) increase any compensation or benefits otherwise payable (including pursuant to the Pension Schemes and Plans); (iii) result in the acceleration of the time of payment or vesting or funding or increase the amount or value of any such compensation or compensation benefits; or (iv) give rise to the payment of any amount that would not be deductible by Group Company by reason of Section 280G of the Code or any amount that could, individually or in combination with any other such payment, constitute an “excess parachute payment”, as defined in Section 280G(b)(1) of the Code.

 

29 

 

 

 

20.15 Each Group Company has promptly, thoroughly and impartially investigated all sexual harassment, or other discrimination, retaliation or policy violation allegations of which any of them is aware. With respect to each such allegation with potential merit, each Group Company has taken prompt corrective action that is reasonably calculated to prevent further improper action. No Group Company reasonably expects any material liabilities with respect to any such allegations and is not aware of any allegations relating to officers, directors, employees, contractors, or agents of any Group Company, that, if known to the public, would bring any Group Company into material disrepute.

 

21. pensionS

 

21.1 With the exception of the Pension Schemes and the Plans set out in the Data Room, no Group Company:

 

(a) has any obligations in respect of any retirement benefits (including any pre-pension, early retirement, continuance of payment of pension contributions in case of sickness or disability, or similar benefits payable on or following retirement, termination of employment, disability or death, (jointly and separately the “Retirement Benefits”)) for or in respect of any present or former employee or managing director of any of the Group Companies, and/or their spouses or dependants; or

 

(b) operates, sponsors, is bound by or has or could reasonably be expected to have any liability or legal obligation towards any pension, benefit, gratuity or compensation arrangement that provides benefits which are calculated on a defined benefit basis and nor has any Group Company operated, sponsored, been bound by any liability or subject to any legal obligation whether contingent or otherwise towards any such arrangement.

 

21.2 The Group Companies are not, nor are any of the current or former employees, engaged in any dispute in relation to the Pension Schemes and/or predecessors thereof, and no such dispute has been threatened in writing. No Group Company has received notice in writing of any pending or threatened investigations or audits which have been or may be carried out in respect of any of the Group Companies, or any of their respective officers in relation to the Pension Schemes.

 

21.3 The Pension Schemes are funded through a pension fund or third party insurance in accordance with the applicable pension agreements and Laws. All financial obligations due in respect of the pension obligations (including past service liabilities) have been fully satisfied within the appropriate time period allowed.

 

21.4 The Group Companies are not required to participate in or to contribute to any industry pension fund (bedrijfstakpensioenfonds), nor have they, or the Sellers, received any request or notification requiring it to participate in or contribute to such industry pension fund and there are no claims or actions of any kind that are pending, threatened or expected against any Group Company in that respect.

 

21.5 Each current and former participant has validly participated and participates in the Pension Schemes and/or predecessors thereof, on terms fully consistent with the Pension Schemes and/or predecessors thereof, as applicable at such point in time.

 

21.6 Except regarding requests for individual transfers of pension benefits (individuele waardeoverdrachten) of employees that left the Group Companies or are hired by the Group Companies that are not already pending, the Group Companies are not subject to any obligation whatsoever regarding special additional contributions regarding Retirement Benefits, including payment obligations in respect of additional purchases of pension benefits (inkoop), back-service, coming-service, voluntary continuation after dismissal of participation, individual or collective transfers of pension benefits (waardeoverdrachten), annual funding of indexations (toeslagbetalingen) and/or the provision of additional funds in respect of any shortfalls in the capital or funding of any pension schemes and/or pension providers, to be made in addition to the regular, periodical contributions to the Pension Schemes.

 

30 

 

 

21.7 No Group Company is obliged to provide German Occupational Pension Benefits either directly or via an external pension provider to one of its (i) current or former Employees, (ii) current or former Senior Employees, (iii) current or former managing directors or to any of their surviving dependents.

 

22. u.s. employee benefits

 

22.1 A complete and correct list of each material Plan has been provided in folder 13.10.3 of the Data Room.

 

22.2 Each Plan has been established, maintained, funded, operated and administered in compliance in all material respects with its terms and applicable laws, including ERISA and the Code. Each Plan that is intended to be qualified under Section 401(a) of the Code has received a current favourable determination or opinion letter from the IRS and nothing has occurred that could be reasonably expected to adversely affect such Plan’s qualification. All contributions (including employee deferrals), premiums, distributions, and other payments required by and due under the terms of each Plan have been timely paid or made in accordance with the terms of such Plan and in compliance in all material respects with applicable law. With respect to each Plan, there has been no non-exempt prohibited transaction (as defined in Section 406 of ERISA or Section 4975 of the Code) and no breach of fiduciary duty (as determined under ERISA). No Plan is and no Group Company has any current or contingent liability or obligation under or with respect to any: (i) “defined benefit plan” (as defined in Section 3(35) of ERISA) or plan that is or was subject to Section 412 of the Code or Title IV of ERISA, including as a consequence of at any time being considered a single employer under Section 414 of the Code with any other person; (ii)  “multiemployer plan” (as defined in Section 3(37) of ERISA); (iii)  multiple employer plan within the meaning of Section 413(c) of the Code; or (iv) multiple employer welfare arrangement (as defined in Section 3(40) of ERISA). No Group Company has any obligation to provide post-termination or retiree welfare benefits to any person except as required by Section 4980B of the Code for which the covered individual pays the full cost of coverage for themselves and their qualified beneficiaries. No Group Company has incurred (whether or not assessed), or is reasonably expected to incur or to be subject to, any tax or other penalty with respect to the reporting requirements under Sections 6055 and 6056 of the Code, as applicable, or under Section 4980B, 4980D or 4980H of the Code nor do any circumstances exist that would reasonably be expected to result in any such tax or penalty.

 

23. TAX

 

23.1 Each Group Company has:

 

(a) submitted all Tax returns, notices and other information, which are or have been required by law to be filed with or provided to any Tax Authority by the requisite dates (taking into account any applicable extension or grace period) and all such Tax returns were true, correct, complete and made on a proper basis when made and remain true, correct and complete in all material respects, and none of them is or as far as the Warrantors are aware is likely to be the subject of any dispute with or investigation or enquiry by any Tax Authority;

 

(b) within any applicable time limits (taking into account any applicable extension or grace periods that have been granted), discharged its liability to make any payment of Tax which has fallen due (whether or not shown on any Tax return) and is not, under any liability to pay any material penalty, fine, surcharge or interest in respect of Taxation; and

 

(c) made all deductions and withholdings on account of Tax required to be made by law in respect of any payment made or benefit or consideration provided, and has to the extent required by law properly accounted to the applicable Tax Authority for all such deductions and withholdings.

 

31 

 

 

23.2 Each Group Company has maintained, and has in its possession or under its control, all material records and documentation that it is required to maintain in relation to Taxation as required by all relevant legal requirements.

 

23.3 No Group Company has been subject to any investigation or audit by any Tax Authority or incurred any material penalties in relation to Tax, and no Tax Authority has indicated in writing that it intends to make such an investigation or audit. No Group Company is involved in a dispute in relation to Tax.

 

23.4 The Locked Box Accounts make full and proper provision for all Taxation and deferred Tax liabilities and in particular for all Taxation in respect of all taxable profits earned, accrued or received (including to the extent deemed to be earned, accrued or received) or in respect of any event or circumstance occurring or deemed to occur in either case on or before the Locked Box Date.

 

23.5 All transactions entered into by each Group Company have been entered into on terms which were at arm's length.

 

23.6 Since the Locked Box Date, no Group Company has been involved in any transaction which has given rise to a liability to Tax on a Group Company (or would have given or might give rise to such a liability but for the availability of any Relief) other than Tax for which it is liable in the ordinary course of business.

 

23.7 No Group Company has entered into any transaction or series of transactions the main purpose of which was the avoidance of Tax, or has otherwise engaged in or been a party to any “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4 (or any similar or analogous provision of U.S. state, local or non-U.S. law)..

 

23.8 Each Group Company is and has at all times been resident for Tax purposes only in the jurisdiction in which it was incorporated and no Tax Authority has asserted to any Group Company that such Group Company is subject to Tax in any other jurisdiction.

 

23.9 None of the Group Companies are subject to any contractual or statutory liability to indemnify, pay or reimburse any person (including a Tax Authority) in respect of any liability relating to Taxation which is the primary liability of any other person. None of the Group Companies is liable for the Taxes of another person under Treasury Regulation Section 1.1502-6 (or comparable provisions of U.S. state, local or non-U.S. law), by contract, as a transferee or successor, by operation of Law or otherwise.

 

23.10 The sale of the Group Companies or any of them will not (including but not limited to the entry into, becoming unconditional or Completion of the SPA) give rise to any deemed disposal or realisation by any Group Company of any asset or liability for any Taxation purpose or any de-grouping charge in respect of Taxation, any clawback, withdrawal or disallowance of any relief or allowance previously given in respect of Taxation.

 

23.11 All documents which are required to evidence title of any Group Company or to any asset held by them and which are liable to stamp duty or transfer or registration Taxation (or any similar Taxation) ("Transfer Tax") or are required to be stamped either with a particular stamp denoting that no Transfer Tax is chargeable or that the document has been produced to the appropriate authority, have been properly and duly stamped and the appropriate Transfer Tax has been paid (together with any related interest and penalties). The share registers of each Group Company have been kept in their respective jurisdictions of incorporation (and nowhere else) at all times and no other registers of shares in a Group Company have been maintained or kept.

 

32 

 

 

23.12 There are no Encumbrances for Taxes on any of the assets of a Group Company other than Encumbrances for Taxes not yet due and payable.

 

23.13 No Group Company has waived (or been requested to waive) any statute of limitations with respect to any Taxes, consented to extend the time in which any Tax may be assessed or collected by any taxing authority, or agreed to any extension of time for filing any Tax return, in each case, which is still in effect.

 

23.14 No deficiency or proposed adjustment which has not been paid or resolved for any Tax has been asserted or assessed by any Tax Authority against a Group Company.

 

23.15 No Group Company has ever (i) been a member of an Affiliated Group or filed or been included in a combined, consolidated or unitary income Tax return, other than an Affiliated Group with the Company as the parent entity or (ii) distributed stock of another person, or had its stock distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Sections 355 (or so much of Section 356 as relates to Section 355) or 361 of the Code.

 

23.16 No Group Company will be required to include any material item or amount of income in, or exclude any material item or amount of deduction from, taxable income for any taxable period (or portion thereof) ending after the Completion Date as a result of any (i) change in or use of an improper method of accounting for a taxable period (or portion thereof) ending on or prior to the Completion Date, (ii) “closing agreement,” as described in Section 7121 of the Code (or any similar provision of U.S. state, local or non-U.S. income Tax law), (iii) prepaid income or deferred revenue received prior to the Completion, (iv) instalment sale or open transaction disposition made prior to the Completion, or (v) intercompany transaction or excess loss account described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision of state, local, or non U.S. income Tax Law).

 

23.17 No Group Company will be required to make any payment after the Completion Date as a result of an election under Section 965 of the Code.

 

23.18 The Company is, and at all times since its formation has been, properly treated as a corporation for U.S. federal and all applicable U.S. state and local income Tax purposes.

 

23.19 No Group Company is a “United States real property holding corporation” within the meaning of Section 897 of the Code.

 

23.20 No Group Company has either (i) elected to defer the payment of any “applicable employment taxes” (as defined in Section 2302(d)(1) of the CARES Act) pursuant to Section 2302 of the CARES Act, (ii) deferred any payment of Taxes (including withholding Taxes) pursuant to IRS Notice 2020-65 or any related or similar order or declaration from any Government Entity (including the Presidential Memorandum, dated August 8, 2020, issued by the President of the United States) nor (iii) claimed any “employee retention credit” pursuant to Section 2301 of the CARES Act.

 

23.21 Each Group Company has withheld from their respective employees, independent contractors, creditors, equityholders and other applicable third parties and timely remitted to the appropriate Government Entity all material amounts with respect to Taxes that were required to be so withheld and remitted under applicable Tax Laws, are in material compliance with all Tax withholding and remitting provisions of applicable Tax Laws, and have each complied in all material respects with all Tax information reporting provisions of all applicable Tax Laws. Each Group Company has properly classified for Tax purposes, in all material respects, all employees, leased employees, individual consultants and independent contractors.

 

33 

 

 

23.22 Each Group Company is registered for the purposes of sales Tax, use Tax, value-added Tax or any similar Tax in all jurisdictions where it is required by law to be so registered, and has complied in all material respects with all legal requirements relating to such Taxes (including by receiving and retaining any appropriate Tax exemption certificates and other applicable documentation).

 

23.23 Each Group Company has (i) timely paid to the appropriate Government Entity all material amounts required to be paid under applicable escheat and unclaimed property Laws and (ii) complied in all material respects with applicable escheat and unclaimed property Laws.

 

23.24 No Group Company has any obligation to “gross-up” or otherwise indemnify any current or former Employee, individual independent contractor, or consultant, who is an individual providing services to the Group Company for the imposition of the excise tax under Section 4999 of the Code or under Section 409A of the Code.

 

24. INFORMATION SUPPLIED

 

24.1 The information supplied by the Group Companies for inclusion or incorporation by reference in the Proxy Statement or any announcement or public statement regarding the transactions contemplated hereby (including the Signing Press Release and any other press release) did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, and in light of the circumstances in which they were made, was not misleading, at (a) the time such information is filed, submitted or made publicly available (provided, if such information is revised by any subsequently filed amendment or supplement to the Proxy Statement this clause (a) shall refer to the time of such subsequent amendment or supplement); (b) the time the Proxy Statement is first mailed to the Purchaser’s stockholders or made available to the Purchaser’s stockholders or (c) the time of the Purchaser Stockholder Meeting, except that no warranty is made with respect to statements made or incorporated by reference therein based on information supplied by the Purchaser or its Affiliates for inclusion therein (subject, in each case, to the qualifications and limitations set forth in the materials provided by the Group Companies or that are included in such filings and/or mailings).

 

34 

 

 

Schedule 3

 

LIMITATIONS ON LIABILITY OF WARRANTORS

 

1. FINANCIAL LIMITS ON CLAIMS

 

1.1 Notwithstanding anything to the contrary set out in this Deed or any other Transaction Document, the aggregate liability of each Warrantor in respect of any and all Claims (including any costs, expenses and other liabilities (and any irrecoverable VAT thereon) payable by such Warrantor in connection with such Claims) shall not exceed USD 1.

 

1.2 No Warrantor shall be liable in respect of any single Claim (and such Claim shall be disregarded for all purposes) unless the amount of the liability pursuant to that Claim (other than a Tax Claim or a Claim pursuant to paragraph 1 or 4 of Schedule 2) (ignoring any liability for costs and expenses in connection with such Claim) would (but for this paragraph 1.2) exceed USD 100,000.

 

1.3 The Warrantors shall not be liable in respect of any Claim unless Completion has occurred under the SPA.

 

2. TIME LIMITS ON CLAIMS

 

2.1 No Warrantor shall be liable in respect of any Claim unless the Purchaser has given notice in writing of such Claim to the relevant Warrantor against whom the Claim is brought:

 

(a) in the case of a Tax Claim, within the period of seven years beginning with the Completion Date; and

 

(b) in the case of a Claim (other than a Tax Claim), within the period of twelve (12) months beginning with the Completion Date.

 

2.2 The Purchaser shall give notice in writing of any Claim to the Warrantors as soon as reasonably practicable and, in any event, within thirty (30) Business Days of the Purchaser becoming aware of the facts, matters or circumstances giving rise to such Claim. Such notice shall include such detail as is reasonably available to the Purchaser at the time of the relevant facts and circumstances giving rise to the Claim, provided that the Purchaser’s failure to provide such detail shall not prejudice the Purchaser’s recovery in respect of such Claim (save if and to the extent the alleged Losses arise or are increased as a direct result of such failure).

 

2.3 To the extent the fact, matter, event or circumstance giving rise to a Claim is capable of remedy, the Warrantors shall not be liable for such Claim if and to the extent that it is remedied to the reasonable satisfaction of the Purchaser within twenty (20) Business Days of the date of the notice referred to in paragraph 2.1.

 

2.4 The Warrantors shall not be liable in respect of any Claim (other than a Tax Claim) and any liability of the Warrantors in respect of such Claim shall absolutely determine and cease, to the extent the Claim is not previously satisfied, withdrawn or settled, unless legal proceedings in respect of such Claim have been issued and served within six (6) months after the date of the notice referred to in paragraph 2.1 is given or, in the case of a contingent liability, six (6) months after such liability becomes an actual liability.

 

2.5 For the avoidance of doubt, the Purchaser may give notice of any single Claim in accordance with this paragraph 2, whether or not the amount set out in paragraph 1.2 or paragraph Error! Reference source not found. of this Schedule 3 has been exceeded at the time the notice is given.

 

35 

 

 

3. AWARENESS OF THE WARRANTORS

 

Each Warranty is qualified by reference to (and is only given to the extent of) the knowledge of the relevant Warrantor, being limited to the actual knowledge of the relevant Warrantor, in the case of the Signing Warranties, as at the date of this Deed, and in the case of the Completion Warranties, as at immediately prior to the Completion Date, having made due and careful enquiry of each other Warrantor and each of Sam Addeo (Chief Technology Officer), David Landau (Chief Product Officer), Tonya Miller (Group Financial Controller), Patrick Sarsfield (Head of Tax & Treasury), Chris Timmer (Chief Revenue Officer) and Scott Brown (EVP Cloud & Support Services). No Warrantor shall be deemed to have any implied, constructive or imputed knowledge or awareness regarding the subject matter of any Warranty.

 

4. DISCLOSURE

 

The Warrantors shall have no liability for a Claim:

 

(a) in the case of the Signing Warranties only, to the extent that the facts and circumstances giving rise to the Claim have been Disclosed in this Deed, the Disclosure Letter or the Data Room; and

 

(b) in the case of the Completion Warranties, to the extent that the facts and circumstances giving rise to the Claim have been Disclosed in the Completion Disclosure Letter.

 

5. KNOWLEDGE OF PURCHASER

 

The Warrantors shall not be liable in respect of any Claim if and to the extent that the Purchaser is actually aware (excluding, for the avoidance of doubt, implied, imputed or constructive knowledge) of any fact, matter, event or circumstance which is the subject matter of the Claim. For the purposes of this Deed, the awareness of the Purchaser shall mean the actual knowledge of Michael Farlekas, Laura L. Fese and Jarett Janik as of this date of this Deed.

 

6. CONTINGENT LIABILITIES

 

The Warrantors shall not be liable in respect of any contingent liability in relation to any Claim unless and until such contingent liability becomes an actual liability and is due and payable and, for the avoidance of doubt, provided always that such Claim is notified within the timescales set out in paragraph 2 of this Schedule 3. The fact that the liability may not have become an actual liability within the time limits provided in paragraph 2 shall not exonerate a Warrantor in respect of any Claim properly notified within such time limits.

 

7. ACCOUNTS

 

The Warrantors shall not be liable in respect of any Claim if and to the extent that (and for the avoidance of doubt only to the extent of such allowance, provision or reserve) allowance, provision or reserve in respect of the fact, matter, event or circumstance giving rise to such Claim has been specifically, identifiably and expressly made in the Locked Box Accounts.

 

8. Losses

 

No Warrantor shall be liable for, and the Purchaser shall not be entitled to claim for, any loss of profit, loss of business, loss of goodwill or any indirect or consequential losses under this Deed or any other Transaction Document, whether actual or prospective, or for any punitive damages.

 

9. INSURANCE

 

Notwithstanding any provisions to the contrary in this Deed:

 

(a) the parties acknowledge that the Purchaser is intending to obtain a policy of insurance for the benefit of it and/or the Purchaser Group (including, after Completion, the Group Companies) to cover Losses arising in respect of breaches of and claims under the Warranties (the “W&I Insurance”);

 

36 

 

 

(b) the Purchaser acknowledges and agrees that it will not be entitled to make, will not make, and irrevocably waives any right it may have to make any Claim against any of the Warrantors except to the extent that the Claim arises from the fraud of such Warrantor;

 

(c) the Purchaser agrees and undertakes that the W&I Insurance shall contain: (i) an express waiver in favour of the Warrantors from the W&I Insurer waiving all its rights to take subrogated action or to exercise rights assigned to it against the Warrantors in relation to any Claim, other than in the event of fraud by such Warrantor, and then only to the extent that the claim arises as a result of fraud; and (ii) express provisions to allow for such waiver to be enforceable by the Warrantors under the Contracts (Rights of Third Parties) Act 1999;

 

(d) the Purchaser:

 

(i) shall not agree to any amendment, variation or waiver of the waiver referred to in paragraph 9(c) without the prior written consent of the Warrantors’ Representative;

 

(ii) shall not novate, or otherwise assign, its respective rights with respect to the waiver referred to in paragraph 9(c) or knowingly do anything which causes the waiver referred to in paragraph 9(c) not to have full force and effect in accordance with its terms; and

 

(iii) shall, without limitation to any rights of the Warrantors to separately enforce such terms, use all reasonable endeavours to enforce any term in the W&I Insurance under which the W&I Insurer waives its rights to take subrogated action against any of the Warrantors upon the terms set out in the W&I Insurance; and

 

(e) the Purchaser acknowledges and agrees that no Warrantor shall be liable to pay any excess or any of the costs relating to the W&I Insurance.

 

10. NO DUPLICATION OF RECOVERY

 

The Purchaser shall not be entitled to recover damages or obtain payment, reimbursement, restitution or indemnity more than once in respect of the same Loss, regardless of whether more than one Claim arises in respect of it.

 

11. VOLUNTARY ACTS/FUTURE CHANGES

 

11.1 The Warrantors shall not be liable in respect of any Claim if and to the extent that the Claim would not have arisen but for, or is increased as a result of:

 

(a) any voluntary act or omission of any Group Company prior to Completion taken at the express written request of or with the express prior written consent of the Purchaser; or

 

(b) any voluntary change in the accounting bases, policies, practices or methods applied in preparing any accounts of any Group Company following Completion.

 

12. DUTY TO MITIGATE

 

The Purchaser shall procure that all reasonable steps and proceedings are taken by each member of the Purchaser Group and each of their directors and officers in order to mitigate any Claim. Nothing in the Transaction Documents shall or shall be deemed to relieve the Purchaser of any common law or other duty to mitigate any loss or damage.

 

13. FRAUD And Wilful Misconduct

 

Nothing in this Schedule 3 shall have the effect of excluding, limiting or restricting any liability of any of the Warrantors in respect of a claim under or in connection with this Deed (including any Claim) arising as a result of any fraud or wilful misconduct by any such Warrantor.

 

37 

 

 

 

Schedule 4

 

[Attached]

 

38 

 

 

Schedule 5

 

[Attached]

 

39 

 

 

This Deed has been executed as a deed and is delivered and takes effect on the date stated at the beginning of it.

 

EXECUTED and delivered )  
     
as a DEED by )  
     
Andrew Kirkwood )      /s/ Andrew Kirkwood
     
in the presence of: )  

 

     
/s/ Elaine Kirkwood        Signature of Witness
     
Elaine Kirkwood        Name of Witness
     
111 Pinehill Road        Address of Witness
     
Crowthoren, RG45 7JP, UK    
     
Home Worker        Occupation of Witness

 

     
EXECUTED and delivered )  
     
as a DEED by Andrew Kirkwood )  
     
as attorney for Michael Hunt pursuant to a )  
     
power of attorney dated 19 May 2021 )      /s/ Andrew Kirkwood
     
in the presence of: )  

 

     
/s/ Elaine Kirkwood        Signature of Witness
     
Elaine Kirkwood        Name of Witness
     
111 Pinehill Road        Address of Witness
     
Crowthoren, RG45 7JP, UK    
     
     
     
Home Worker        Occupation of Witness

 

[Project Eagle – Signature Page to Management Warranty Deed]

 

 

 

 

EXECUTED and delivered      )  
     
as a DEED by Andrew Kirkwood      )  
     
as attorney for Joy Burkholder Meier pursuant to      )  
     
a power of attorney dated 18 May 2021      )      /s/ Andrew Kirkwood
     
in the presence of:      )  
     

 

/s/ Elaine Kirkwood        Signature of Witness
     
Elaine Kirkwood      Name of Witness
     
111 Pinehill Road      Address of Witness
     
Crowthoren, RG45 7JP, UK    
     
     
     
Home Worker      Occupation of Witness

 

[Project Eagle – Signature Page to Management Warranty Deed]

 

 

 

 

EXECUTED and delivered      )  
     
as a DEED by      )  
     
E2OPEN PARENT HOLDINGS, INC.      )      /s/ Michael Farlekas
     
acting by Michael Farlekas,      )      Chief Executive Officer
     
its Chief Executive Officer      )  

 

[Project Eagle – Signature Page to Management Warranty Deed]

 

 

 

Exhibit 2.3

 

Date: 27 May 2021

 

TAX DEED
 
relating to
 

BLUJAY TOPCO LIMITED

 

made between
 
THE COVENANTORS
 
and
 
THE PURCHASER

 

 

 

Table of Contents

 

Page

 

1 Definitions and interpretation 2

 

2 Covenants 4

 

3 Limitations 5

 

4 Financial and time limits 6

 

5 Notification of claims 6

 

6 Payment 6

 

Schedule 1 7

 

 

 

THIS DEED is made on 27 May 2021

 

PARTIES

 

(1) THE PERSONS, whose details are set out in column (1) of Schedule 1 (each a “Covenantor” and together, the “Covenantors”); and

 

(2) E2open Parent Holdings, Inc., a corporation incorporated in the State of Delaware, whose principal office is at 9600 Great Hills Trail, Suite 300E Austin, TX, United States of America (the “Purchaser”).

 

INTRODUCTION

 

This Deed has been executed pursuant to the provisions of an agreement for the sale and purchase of the entire issued share capital of BluJay Topco Limited (the “Company”), dated [●] 2021 between inter alia the Covenantors and the Purchaser (the “SPA”), and constitutes the Tax Deed as defined in the SPA.

 

IT IS AGREED as follows:

 

1 Definitions and interpretation

 

1.1 Words and expressions which are defined in the SPA but which are not defined in this Deed shall (to the extent the context permits) have the meanings set out in the SPA (including any schedule thereto).

 

1.2 In this Deed (unless the context otherwise requires) the following words and expressions shall have the meanings set out below:

 

Accounts Relief” means a Relief which has been treated as an asset in the Locked Box Accounts (including in calculating and so reducing or eliminating any provision for deferred tax in the Locked Box Accounts);

 

Event” means any transaction, circumstance, state of affairs, act, event, arrangement, provision, omission or other event of whatever nature;

 

Purchaser’s Relief” means: (i) any Relief arising at any time attributable to any member of the Purchaser’s Tax Group (other than a Group Company); and (ii) any Relief that arises after the Locked Box Date;

 

Purchaser’s Tax Group” means the Purchaser and any person within the same group of companies as the Purchaser for any relevant Tax purposes, including without limitation a Group Company after the Completion Date;

 

Taxation Authority Claim” means (i) any assessment, notice, letter, determination, demand or other document issued or action taken by or on behalf of any Tax Authority, from which it appears that a Group Company may have a Tax Liability which is relevant for the purposes of this Deed; and (ii) any self-assessment made by the a Group Company from which it appears that a Group Company may have a Tax Liability which is relevant for the purposes of this Deed;

 

2

 

 

Tax Liability” means:

 

(a) a liability or increased liability to make an actual payment of or in respect of Tax; and also

 

(b) the loss, non-availability or reduction in the amount of any Accounts Relief, in which case the amount of such Tax Liability shall, for the purposes of this Deed be:

 

(i) in the case of a right to a repayment of Tax, the amount of the repayment (together with any interest or repayment supplement in respect thereof) which would have been obtained but for such loss, non-availability or reduction; and

 

(ii) in the case of an Accounts Relief other than a right to repayment of Tax, the amount of Tax which could have been saved (assuming sufficient income, profits and gains or Tax Liabilities against which to set the Accounts Relief and assuming the rates of Tax current as at the date when the Accounts Relief is lost, reduced or found to be unavailable) but for such loss, non-availability or reduction of the Accounts Relief;

 

(c) the use or setting off of any Purchaser's Relief in circumstances where, but for such use or setting off, a Group Company would have had a liability to make an actual payment of (or in respect of) Tax in respect of which the Purchaser would have been able to make a claim against the Covenantors under this Deed, in which case the amount of such Tax Liability shall be the amount of (or in respect of) Tax saved as a result of such use or setting off; and

 

1.3 references to:

 

(a) profits” include income, profits or gains of any description or from any source;

 

(b) profits “earned, accrued, received or otherwise recognized” include profits deemed to have been or treated as earned, accrued, received or otherwise recognised for Taxation purposes;

 

(c) profits as being earned, accrued or received on or before a particular date or in respect of particular period shall include income, profits or gains which, for the purposes of any Tax, are deemed to have been or are treated as having been earned, accrued or received on or before that date;

 

(d) any Event occurring includes an Event which is deemed for the purposes of any Tax to occur; and

 

(e) any Event occurring on or before a particular date includes any Event which is deemed to have or is treated as having occurred on or before that date; and

 

1.4 unless otherwise stated:

 

(a) references to "period" are to a period of time and not to an accounting period, unless the phrase "accounting period" is used;

 

3

 

 

(b) for the purposes of determining the time at which any of the matters mentioned below occurred (that is, whether the same occurred on, before or after Completion, or in respect of a period before or after Completion) it shall be assumed that an accounting period (and a period of account) of the relevant Group Company ended on Completion (and/or, where relevant, that any other period by reference to which Tax falls to be charged or assessed ended on Completion). The matters are:

 

(i) any profits being earned, accrued, received or otherwise recognized;

 

(ii) any Relief arising; and

 

(iii) any Event occurring.

 

2 Covenants

 

2.1 Subject to the provisions of Clause 3 of this Deed, the Covenantors hereby severally covenant to pay to the Purchaser (to be treated so far as possible as a repayment of the Consideration) on demand an amount equal to:

 

(a) any Tax Liability of a Group Company which arises:

 

(i) as a consequence of or by reference to any Event which occurred on or before Completion; or

 

(ii) in respect of or by reference to any income, profits or gains which were earned, accrued, received or otherwise recognized on or before Completion or in respect of any period ending on or before Completion; and

 

(b) any Tax Liability of a Group Company arising at any time:

 

(i) in respect of Tax which is chargeable directly or primarily against any person (not being a Group Company or any member of the Purchaser's Tax Group) which, at any time prior to Completion was treated for the purposes of any Tax as a member of the same group of companies as a Group Company or as otherwise associated or connected with a Group Company; or

 

(ii) in respect of VAT which would not have arisen but for a Group Company’s membership of any VAT group of which it was a member at any time prior to Completion; and

 

(c) any Tax Liability falling within paragraphs (b) or (c) of the definition of Tax Liability which arises at any time; and

 

(d) all costs and expenses reasonably and properly incurred by a Group Company or any other member of the Purchaser’s Group in connection with any Tax Liability mentioned in this Clause 2 or with any Taxation Authority Claim therefor or in connection with successfully taking or defending any action under this Deed.

 

4

 

 

3 Limitations

 

3.1 The Covenantors shall not be liable under Clause 2 of this Deed in respect of any Tax Liability if and only to the extent that:

 

(a) specific express provision or reserve in respect of that Tax Liability was made in the Locked Box Accounts or such Tax Liability was otherwise taken into account in the preparation of the Locked Box Accounts (not including any provision, reserve or allowance made in respect of deferred tax);

 

(b) that Tax Liability has been settled or discharged on or before the Locked Box Date and such settlement or discharge has been taken into account in the Locked Box Accounts;

 

(c) that Tax Liability arises as a result of any change, made after Completion, in:

 

(i) law (including any increase in rates of Tax, other than any increase in the rate of any interest, fine or penalty relating to Tax);

 

(ii) the published practice of, or any published extra statutory concession of, any Tax Authority; or

 

(iii) generally accepted accountancy practice or principles;

 

(d) that Tax Liability would not have arisen but for a voluntary act or transaction carried out, made or effected by a Group Company after Completion of which the Purchaser was aware would give rise to the Tax Liability not including any act, omission or transaction carried out, made or effected:

 

(A) pursuant to a legally binding obligation or commitment of a Group Company entered into on or before Completion;

 

(B) in the ordinary course of the business or trade of a Group Company; or

 

(C) at the written request, or with the written consent, of any Covenantors;

 

(e) that Tax Liability arises as a result of the Purchaser or a Group Company making any change, after Completion, in its accounting policies or practice, except where the change is made by a Group Company and was necessary in order to comply with any law or generally accepted accounting practice;

 

(f) that Tax Liability has been made good without cost to any Group Company or any other member of the Purchaser's Tax Group; or

 

(g) any Relief, other than a Purchaser's Relief, is actually available to a Group Company (at no additional cost) to reduce or eliminate that Tax Liability.

 

5

 

 

4 Financial and time limits

 

4.1 Notwithstanding any other provision of this Deed, the liability of the Covenantors under this Deed shall be limited to £1.

 

4.2 The Covenantors shall not be liable in respect of a claim under Clause 2 of this Deed unless written notice of such claim is given by the Purchaser to the Covenantors within six months of the date of Completion.

 

5 Notification of claims

 

The Purchaser shall, as soon as reasonably practicable, notify the Covenantors if it becomes aware of any Taxation Authority Claim from which it appears that the Covenantors may have a liability under Clause 2 of this Deed in excess of £1 (taking into account the limitation set out in Clause 4.1 of this Deed).

 

6 Payment

 

6.1 Payment by the Covenantors in respect of any liability under this Deed must be made in cleared and immediately available funds on demand.

 

6.2 All sums payable by the Covenantors to the Purchaser pursuant to Clause 2 of this Schedule shall be paid free and clear of all deductions, withholdings, set-offs or counterclaims whatsoever save only as required by law, in which event the Covenantors shall pay such additional amount as shall be required to ensure that the net amount received by the Purchaser will equal the full amount which would have been received had no such deduction, withholding, set-off or counterclaim been made.

 

6.3 Where any payment is made from the Covenantors to the Purchaser pursuant to Clause 2 of this Deed and that sum is subject to a charge to Tax in the hands of the Purchaser (or would be in the absence of any Reliefs) then, in addition to the sum payable, the Covenantors shall pay such additional sum as will ensure that after payment of such Tax (including any Tax which would have been charged in the absence of any Reliefs) the Purchaser shall be left with a sum equal to the sum that it would have received in the absence of such a charge to Tax.

 

7 Miscellaneous

 

The provisions of clauses 20 (Waiver and Variations), 21 (Invalidity), 25 (Notices), 27 (Rights of Third Parties), 28 (Counterparts) and 29 (Governing Law and Jurisdiction) of the SPA shall apply to this deed as if the same were incorporated herein with all appropriate consequential amendments being made.

 

6

 

 

Schedule 1

 

covenantors

 

 

 

Name

1. Andrew Kirkwood
2. Michael Hunt
3. Joy Meier

 

7

 

 

This Deed has been executed as a deed and is delivered and takes effect on the date stated at the beginning of it.

 

EXECUTED and delivered )    
       
as a DEED by )    
       
ANDREW KIRKWOOD )             /s/ Andrew Kirkwood
       
in the presence of: )    

 

    /s/ Elaine Kirkwood   Signature of Witness
     
    Elaine Kirkwood   Name of Witness
     
   111 Pinehill Road   Address of Witness
     
   Crowthoren, RG45 7JP, UK    
     
     
     
    Home Worker   Occupation of Witness

 

EXECUTED and delivered )    
       
as a DEED by MICHAEL HUNT )    
       
acting by their attorney,           Andrew Kirkwood )  
       
under a power of attorney dated 18 May 2021 )             /s/ Andrew Kirkwood
       
in the presence of: )   Attorney

 

    /s/ Elaine Kirkwood   Signature of Witness
     
    Elaine Kirkwood   Name of Witness
     
   111 Pinehill Road   Address of Witness
     
   Crowthoren, RG45 7JP, UK    
     
     
     
    Home Worker   Occupation of Witness

 

[Project Eagle - Signature Page to Tax Deed]

 

 

 

EXECUTED and delivered )    
       
as a DEED by A Joy Burkholder Meier )    
       
acting by their attorney,           Andrew Kirkwood )  
       
under a power of attorney dated 18 May 2021 )             /s/ Andrew Kirkwood
       
in the presence of: )   Attorney

 

    /s/ Elaine Kirkwood   Signature of Witness
     
    Elaine Kirkwood   Name of Witness
     
   111 Pinehill Road   Address of Witness
     
   Crowthoren, RG45 7JP, UK    
     
     
     
    Home Worker   Occupation of Witness

 

[Project Eagle - Signature Page to Tax Deed]

 

 

 

EXECUTED and delivered )    
       
as a DEED by )    
       
E2open Parent Holdings, Inc. )  
       
acting by Laura L. Fese, )             /s/ Laura L. Fese
       
Executive Vice President and General Counsel )    

 

[Project Eagle - Signature Page to Tax Deed]

 

 

Exhibit 10.1

 

Execution Version

 

SUPPORT AGREEMENT

 

This SUPPORT AGREEMENT (this “Agreement”), is made as of May 27, 2021, by and between BluJay Topco Limited, a private limited company incorporated in England and Wales (the “Company”), E2open Parent Holdings, Inc., a Delaware corporation (“Purchaser”), and the person set forth on Schedule A hereto (the “Stockholder”).

 

WHEREAS, as of the date hereof, the Stockholder is the holder of the number of shares of Class A common stock and/or Class V common stock, in each case, par value $0.0001 per share (“Purchaser Shares”), of Purchaser set forth opposite the Stockholder’s name on Schedule A (all Purchaser Shares owned by the Stockholder, or hereafter issued to or otherwise acquired, whether beneficially or of record, or owned by the Stockholder prior to the termination of this Agreement, as well as shares set forth on Schedule A, being referred to herein as the “Subject Shares”);

 

WHEREAS, Purchaser, the Company, and the shareholders of the Company (the “Sellers”) propose to enter into a Share Purchase Deed, dated as of the date hereof (the “Purchase Agreement”), which provides, among other things, for the purchase by Purchaser or its direct or indirect subsidiary from the Sellers of 100% of the issued and outstanding shares of the Company, upon the terms and subject to the conditions set forth in the Purchase Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement); and

 

WHEREAS, as a condition to their willingness to enter into the Purchase Agreement, the Company and the Sellers have required that the Stockholder, and as an inducement and in consideration therefor, the Stockholder (in the Stockholder’s capacity as a holder of the Subject Shares) has agreed to, enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 

Article I
VOTING AGREEMENT; GRANT OF PROXY

 

The Stockholder hereby covenants and agrees that:

 

1.1            Voting of Subject Shares. Stockholder irrevocably and unconditionally agrees, from and after the date hereof, at every meeting of the holders of Purchaser Shares (the “Purchaser Stockholders”), however called, and at every adjournment or postponement thereof (or pursuant to a written consent if the Purchaser Stockholders act by written consent in lieu of a meeting), the Stockholder shall, or shall cause the holder of record on any applicable record date to, be present (in person or by proxy) and to vote the Subject Shares (a) in favor of the transactions contemplated by the Purchase Agreement, including issuing the Consideration Shares and the PIPE Shares and amending the Certificate of Incorporation of Purchaser to increase the authorized number of shares of Class A Common Stock (in order to facilitate the issuance of the Consideration Shares and the PIPE Shares), (b) in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters of this Section 1.1 are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of any such matters on the date on which the meeting is held, and (c) against approval of (i) any proposal made in opposition to the Purchase Agreement or the consummation of the Transaction, (ii) any action or agreement that would to the knowledge of such Stockholder result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Purchase Agreement, or of such Stockholder contained in this Agreement, and (iii) any other action that would reasonably be expected to materially impede, materially interfere with, materially delay, materially postpone or materially and adversely affect or prevent the transactions contemplated by the Purchase Agreement or this Agreement.

 

 

1.2            No Inconsistent Arrangements. Prior to termination of this Agreement, the Stockholder shall not, directly or indirectly, (a) create any Encumbrance other than restrictions imposed (i) by Law, (ii) pursuant to this Agreement, (iii) pursuant to the governance documents of Purchaser or that certain Amended and Restated Limited Liability Company Agreement of E2open Holdings, LLC, dated as of February 4, 2021, as amended from time to time, or (iv) pursuant to that certain Investors Rights Agreement, dated as of February 4, 2021, by and among Purchaser and certain of its stockholders (as amended from time to time, the “Investor Rights Agreement”), on any Subject Shares, (b) transfer, sell, assign, gift or otherwise dispose of (collectively, “Transfer”), or enter into any contract with respect to any Transfer of, the Subject Shares or any interest therein, (c) grant or permit the grant of any proxy, power of attorney or other authorization in or with respect to the Subject Shares, (d) deposit or permit the deposit of the Subject Shares into a voting trust or, except pursuant to the Investor Rights Agreement, enter into a voting agreement or arrangement with respect to the Subject Shares, or (e) take any action that, to the knowledge of the Stockholder, would have the effect of preventing the Stockholder from performing the Stockholder’s obligations hereunder; provided that this clause (e) shall not prevent any director or officer of Purchaser, in such capacity, from taking such actions as may be permitted under Section 7.17 of the Purchase Agreement. Any action taken in violation of the foregoing sentence shall be null and void ab initio. Notwithstanding the foregoing, (i) the Stockholder may (A) make Transfers of the Subject Shares to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder, (B) make Transfers of the Subject Shares to stockholders, direct or indirect affiliates (within the meaning set forth in Rule 405 under the Securities Act), current or former partners (general or limited), members or managers of the Stockholder, as applicable, (C) exercise a warrant (including a net or cashless exercise of such warrant) to purchase Purchaser Shares (which Purchaser Shares shall be “Subject Shares” subject to the obligations of this Agreement), or (D) make Transfers not involving a change in beneficial ownership; provided, that, with respect to clauses (A), (B) and (D) above, the transferee agrees in writing to be bound by the terms and conditions of this Agreement (and provides to the Purchaser the irrevocable proxy with respect to the Transferred Subject Shares on the terms set forth in Section 1.4) and either the Stockholder or the transferee provides the Company with a copy of such agreement (and irrevocable proxy) promptly upon consummation of any such Transfer (it being understood and agreed that any purported Transfer described in clauses (A), (B) or (D) that fails to satisfy the requirements of this proviso shall be null and void ab initio); and (E) pledge or otherwise encumber the Subject Shares in connection with third party credit facilities in existence on the date of this Agreement; provided that such pledge or encumbrance does not impact the validity, enforceability or exercisability of the proxy given in Section 1.4). It is hereby clarified that if any involuntary Transfer of any of the Subject Shares shall occur (such as in the case of appointment of a receiver to the Stockholder’s assets as part of bankruptcy proceedings), the transferee (which term, as used herein, shall include the initial transferee and any and all subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the termination of this Agreement. For purposes of this Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.

 

2

 

1.3            Documentation and Information. The Stockholder shall permit and hereby authorizes Purchaser to publish and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company and Purchaser reasonably determine to be necessary in connection with the Transaction, the Stockholder’s identity and ownership of the Subject Shares and the nature of the Stockholder’s commitments and obligations under this Agreement.

 

1.4            Irrevocable Proxy. The Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that the Stockholder has heretofore granted with respect to the Subject Shares. The Stockholder hereby irrevocably appoints Purchaser as attorney-in-fact and proxy for and on behalf of the Stockholder, for and in the name, place and stead of the Stockholder, to: (a) attend any and all meetings of the Purchaser Stockholders held for matters addressed in Section 1.1, (b) vote, express consent or dissent or issue instructions to the record holder to vote the Subject Shares solely in accordance with the provisions of Section 1.1 at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1 and (c) grant or withhold, or issue instructions to the record holder to grant or withhold, solely consistent with the provisions of Section 1.1, all written consents with respect to the Subject Shares at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1. Purchaser agrees not to exercise the proxy granted herein for any purpose other than the purposes described in this Section 1.4. The foregoing proxy shall be deemed to be a proxy coupled with an interest, is irrevocable (and as such shall survive and not be affected by the death, incapacity, mental illness or insanity of the Stockholder, as applicable) until the termination of this Agreement and shall not be terminated by operation of law or upon the occurrence of any other event other than the termination of this Agreement pursuant to Section 3.2. The Stockholder authorizes such attorney and proxy to substitute any other person to act hereunder, to revoke any substitution and to file this proxy and any substitution or revocation with the Secretary of Purchaser. The Stockholder hereby affirms that the proxy set forth in this Section 1.4 is given to Purchaser in connection with and granted in consideration of and as an inducement to the Company and Purchaser to enter into the Purchase Agreement and that such proxy is given solely to secure the obligations of the Stockholder under Section 1.1. The proxy set forth in this Section 1.4 is executed and intended to be irrevocable, subject, however, to its automatic termination upon the termination of this Agreement pursuant to Section 3.2. With respect to any Subject Shares that are owned beneficially by the Stockholder but are not held of record by the Stockholder, the Stockholder shall take all action necessary to cause the record holder of such Subject Shares to grant the irrevocable proxy and take all other actions provided for in this Section 1.4 with respect to such Subject Shares.

 

3

 

1.5            Enforcement of Irrevocable Proxy. Purchaser hereby covenants to the Company that Purchaser shall exercise the proxy granted by the Stockholder in Section 1.4 (and any irrevocable proxy granted by a Transferee as contemplated in Section 1.2) to the extent necessary to cause the Subject Shares to be counted for purposes of determining of a quorum for the matters addressed in Section 1.1, and to vote the Subject Shares, express consent or dissent or issue instructions to the record holder to vote the Subject Shares in accordance with the provisions of Section 1.1.

 

1.6            Waivers. Stockholder hereby irrevocably and unconditionally agrees that the Stockholder will not bring, commence, institute, maintain, prosecute or voluntarily aid or participate in any action, claim, suit or cause of action, in law or in equity, in any court or before any Authority, which (i) challenges the validity of or seeks to enjoin the operation of any provision of this Agreement or (ii) alleges that the execution and delivery of this Agreement by the Stockholder, or the approval of the Purchase Agreement by the Purchaser Board, breaches any fiduciary duty of the Purchaser Board or any member thereof; provided, that the Stockholder may defend against, contest or settle any such action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder’s capacity as a director, officer or securityholder of Purchaser.

 

1.7            No Ownership Interest. Nothing contained in this Agreement will be deemed to vest in Purchaser any direct or indirect ownership or incidents of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares will remain and belong to the Stockholder, and Purchaser will have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein with respect to the Subject Shares and except as otherwise expressly provided in the Purchase Agreement.

 

Article II
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER

 

The Stockholder represents and warrants to the Company and Purchaser that:

 

2.1            Organization; Authorization; Binding Agreement. The Stockholder, if not a natural person, is duly incorporated or organized, as applicable, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization. The Stockholder has full legal capacity and power, right and authority to execute and deliver this Agreement and to perform the Stockholder’s obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder, and constitutes a legal, valid and binding obligation of the Stockholder enforceable against the Stockholder in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity.

 

2.2            Ownership of Subject Shares; Total Shares. The Stockholder is the record or beneficial owner of the Subject Shares and has good and marketable title to the Subject Shares free and clear of any Encumbrances (including any restriction on the right to vote or otherwise transfer the Subject Shares), except (a) as provided hereunder, (b) pursuant to any applicable restrictions on Transfer under the Securities Act, (c) subject to any risk of forfeiture with respect to any Purchaser Shares granted to the Stockholder under an employee benefit plan of Purchaser, (d) as provided in the governing documents of Purchaser and (e) as provided in the Investor Rights Agreement. The Subject Shares listed on Schedule A opposite the Stockholder’s name constitute all of the Purchaser Shares owned by the Stockholder as of the date hereof. Except pursuant to Purchaser’s governing documents, no person has any contractual or other right or obligation to purchase or otherwise acquire any of the Subject Shares. For purposes of this Agreement “Beneficial Ownership” shall be interpreted as defined in Rule 13d-3 under the Exchange Act; provided that for purposes of determining Beneficial Ownership, a person shall be deemed to be the Beneficial Owner of any securities that may be acquired by such person pursuant to any contract or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of 60 days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing).

 

4

 

2.3            Voting Power. Subject in each case to the provisions of the Investor Rights Agreement, the Stockholder has full voting power with respect to the Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case, with respect to all of the Subject Shares. None of the Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Subject Shares, except as provided hereunder or in the Investor Rights Agreement.

 

2.4            Reliance. The Stockholder has had the opportunity to review the Purchase Agreement and this Agreement with counsel of the Stockholder’s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Transaction. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Purchaser, the Company or any of their respective agents or representatives. The Stockholder understands that such Stockholder (and not Purchaser, the Company or their respective Affiliates) shall be responsible for such Stockholder’s tax liability that may arise as a result of the Transaction (if any). The Stockholder understands and acknowledges that the Company, the Sellers and Purchaser are entering into the Purchase Agreement in reliance upon the Stockholder’s execution, delivery and performance of this Agreement.

 

2.5            Absence of Litigation. With respect to the Stockholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of the Stockholder, threatened in writing against, the Stockholder or any of the Stockholder’s properties or assets (including the Subject Shares) that could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

2.6            Non-Contravention. The execution and delivery of this Agreement by the Stockholder and the performance of the transactions contemplated by this Agreement by the Stockholder does not and will not violate, conflict with, or result in a breach of: (a) the organizational documents of such Stockholder, (b) any applicable Law or any injunction, judgment, order, decree, ruling, charge, or other restriction of any Authority to which the Stockholder is subject, or (c) any contract to which the Stockholder is a party or is bound or to which the Subject Shares are subject, such that it could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

5

 

Article III
MISCELLANEOUS

 

3.1            Notices. All notices, requests and other communications to either party hereunder shall be in writing (including electronic mail) and shall be given, (a) if to Purchaser or the Company, in accordance with the provisions of the Purchase Agreement and (b) if to the Stockholder, to the Stockholder’s address or electronic mail address set forth on a signature page hereto, or to such other address or electronic mail address as the Stockholder may hereafter specify in writing to Purchaser.

 

3.2            Termination. This Agreement shall terminate automatically (except in the case of (b) or (c), in which case, the Stockholder may elect in its sole discretion to terminate upon written notice to the Purchaser and the Company) and become void and of no further force and effect, without any notice or other action by any person, upon the earlier of (a) the valid termination of the Purchase Agreement in accordance with its terms, (b) the date that is twenty (20) days after the Longstop Date, (c) following (i)  any amendment or other modification of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that changes to a non-de minimis degree the form of or amount of consideration payable or otherwise impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder or the Purchaser in any material respect, or (ii) any waiver of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder in any material respect and (d) the Completion. Upon termination of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, that nothing set forth in this Section 3.2 shall relieve any party from liability for any willful and material breach of this Agreement prior to termination hereof, with any such liability not to exceed an amount equal to USD 15,000,000 plus reasonable out of pocket fees and expenses incurred by the Purchaser in connection with the negotiation of the Transaction and/or enforcement of this Agreement (including reasonable attorneys’ fees) (the “Cap”). An amount not to exceed the Cap shall only be payable to Purchaser by the Stockholder if the Break Fee is actually paid or payable by Purchaser to the Company pursuant to the Purchase Agreement. Under no circumstances shall the Stockholder be liable for damages of any kind in any amount due and owing to the Company. In the event the Completion shall have occurred pursuant to the Purchase Agreement, no party shall have any liability or other obligation under this Agreement whatsoever, including with respect to any willful and material breach occurring prior to Completion. The provisions of this Article III shall survive any termination of this Agreement.

 

3.3            Confidentiality. Except to the extent required by applicable Law, the Stockholder shall hold any non-public information regarding this Agreement, the Purchase Agreement and the Transaction in strict confidence and shall not divulge any such information to any third person until Purchaser has publicly disclosed its entry into the Purchase Agreement and this Agreement; provided, however, that the Stockholder may disclose such information (a) to its attorneys, accountants, consultants and other representatives (provided such representatives are subject to confidentiality obligations at least as restrictive as those contained herein), and (b) to any Affiliate, partner, member, stockholder, parent or subsidiary of Stockholder, provided in each case that the Stockholder informs the person receiving the information that such information is confidential and such person agrees in writing to abide by the terms of this Section 3.3. Neither the Stockholder nor any of its Affiliates (other than Purchaser, whose actions shall be governed by the Purchase Agreement), shall issue or cause the publication of any press release or other public announcement with respect to this Agreement, the Transaction, the Purchase Agreement or the other transactions contemplated hereby or thereby without the prior written consent of the Company and Purchaser, except as may be required by applicable Law in which circumstance such announcing party shall make reasonable efforts to consult with the Company and Purchaser to the extent practicable.

 

6

 

3.4            Amendments and Waivers. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

3.5            Binding Effect; Benefit; Assignment. The provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and their respective successors and assigns. Neither party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party hereto.

 

3.6            Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the parties hereto arising out of or relating to this Agreement, each party hereto: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware (the “Delaware Courts”); (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 3.6; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any party hereto; (e) agrees that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with Section 3.1 of this Agreement; and (f) irrevocably and unconditionally waives the right to trial by jury.

 

3.7            Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all parties by facsimile or electronic transmission in .PDF format shall be sufficient to bind the parties to the terms and conditions of this Agreement.

 

7

 

3.8            Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof; provided, for the avoidance of doubt, the foregoing shall in no way invalidate any right or obligation of any party pursuant to the Investor Rights Agreement.

 

3.9            Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the parties hereto agree that the court making such determination will have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision.

 

3.10            Specific Performance. Subject to the limitations set forth in Section 3.2, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any Delaware Court, this being in addition (subject to Section 3.2) to any other remedy to which they are entitled at law or in equity, and each of the parties hereto waives any bond, surety or other security that might be required of any other party with respect thereto.

 

3.11            Construction.

 

(a)            For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.

 

(b)            The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.

 

8

 

(c)            As used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

(d)            Except as otherwise indicated, all references in this Agreement to “Sections,” “Articles,” and “Schedules” are intended to refer to Sections or Articles of this Agreement and Schedules to this Agreement, respectively.

 

(e)            The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

3.12            Further Assurances. Each of the parties hereto will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary under applicable Law to perform their respective obligations as expressly set forth under this Agreement.

 

3.13            Capacity as Stockholder. The Stockholder signs this Agreement solely in the Stockholder’s capacity as a holder of Purchaser Shares, and not in the Stockholder’s capacity as a director, officer or employee of Purchaser or any of its Subsidiaries or in the Stockholder’s capacity as a trustee or fiduciary of any employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director or officer of Purchaser in the exercise of his or her fiduciary duties as a director or officer of Purchaser or in his or her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of Purchaser or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director, officer, trustee or fiduciary.

 

3.14            Conversion or Exercise. Nothing contained in this Agreement shall require the Stockholder (or shall entitle any proxy of the Stockholder) to (a) convert, exercise or exchange any option, warrants or convertible securities in order to obtain any underlying Subject Shares or (b) vote, or execute any consent with respect to, any Subject Shares underlying such options, warrants or convertible securities that have not yet been issued as of the applicable record date for that vote or consent.

 

3.15            No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless and until (a) the Purchaser Board has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of Purchaser’s organizational documents, the Transaction, (b) the Purchase Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto.

 

3.16            Additional Shares. The Stockholder agrees that any additional securities of the Purchaser acquired by the Stockholder after the date of this Agreement and prior to the termination of this Agreement (including through the exercise of any stock options, warrants or otherwise) shall automatically be subject to the terms of this Agreement as though owned by the Stockholder on the date hereof and shall constitute Subject Shares.

 

(SIGNATURE PAGE FOLLOWS)

 

9

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  BLUJAY TOPCO LIMITED
   
     
  By: /s/ Andrew Kirkwood
    Name:  Andrew Kirkwood
    Title: Director

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  E2OPEN PARENT HOLDINGS, INC.
   
     
  By: /s/ Laura L. Fese
    Name: Laura L. Fese
    Title: Executive Vice President and General Counsel

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  NEUBERGER BERMAN OPPORTUNISTIC CAPITAL SOLUTIONS MASTER FUND LP
     
  By: Neuberger Berman Investment Advisers LLC
  Its: Investment Manager

 

 

  By: /s/ Charles Kantor

  Name: Charles Kantor
  Title: Managing Director

 

  NBOKS CO-INVEST FUND I LP
     
  By: Neuberger Berman Investment Advisers LLC
  Its: Investment Manager

 

 

  By: /s/ Charles Kantor
  Name: Charles Kantor
  Title: Managing Director

 

[Signature Page to Support Agreement]

 

 

Schedule A

 

Name of Stockholder   No. Shares
of Class A
Common
Stock
    No. Shares
of Class V
Common
Stock
    No. Shares
of Series B-1
Common
Stock
    No. Shares
of Series B-2
Common
Stock
    Shares of Class
A Common
Stock Subject to
Warrants
    Shares of Class A
Common Stock Issuable
upon Exchange of
Common Units
 
NBOKS Co-Invest Fund I LP   870,000                      
Neuberger Berman Opportunistic Capital Solutions Master Fund LP   20,530,000                       5,000,000      

 

 

 

Exhibit 10.2

 

Execution Version

 

SUPPORT AGREEMENT Exhibit 10.2

 

This SUPPORT AGREEMENT (this “Agreement”), is made as of May 27, 2021, by and between BluJay Topco Limited, a private limited company incorporated in England and Wales (the “Company”), E2open Parent Holdings, Inc., a Delaware corporation (“Purchaser”), and the person set forth on Schedule A hereto (the “Stockholder”).

 

WHEREAS, as of the date hereof, the Stockholder is the holder of the number of shares of Class A common stock and/or Class V common stock, in each case, par value $0.0001 per share (“Purchaser Shares”), of Purchaser set forth opposite the Stockholder’s name on Schedule A (all Purchaser Shares owned by the Stockholder, or hereafter issued to or otherwise acquired, whether beneficially or of record, or owned by the Stockholder prior to the termination of this Agreement, as well as shares set forth on Schedule A, being referred to herein as the “Subject Shares”);

 

WHEREAS, Purchaser, the Company, and the shareholders of the Company (the “Sellers”) propose to enter into a Share Purchase Deed, dated as of the date hereof (the “Purchase Agreement”), which provides, among other things, for the purchase by Purchaser or its direct or indirect subsidiary from the Sellers of 100% of the issued and outstanding shares of the Company, upon the terms and subject to the conditions set forth in the Purchase Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement); and

 

WHEREAS, as a condition to their willingness to enter into the Purchase Agreement, the Company and the Sellers have required that the Stockholder, and as an inducement and in consideration therefor, the Stockholder (in the Stockholder’s capacity as a holder of the Subject Shares) has agreed to, enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 

Article I
VOTING AGREEMENT; GRANT OF PROXY

 

The Stockholder hereby covenants and agrees that:

 

1.1            Voting of Subject Shares. Stockholder irrevocably and unconditionally agrees, from and after the date hereof, at every meeting of the holders of Purchaser Shares (the “Purchaser Stockholders”), however called, and at every adjournment or postponement thereof (or pursuant to a written consent if the Purchaser Stockholders act by written consent in lieu of a meeting), the Stockholder shall, or shall cause the holder of record on any applicable record date to, be present (in person or by proxy) and to vote the Subject Shares (a) in favor of the transactions contemplated by the Purchase Agreement, including issuing the Consideration Shares and the PIPE Shares and amending the Certificate of Incorporation of Purchaser to increase the authorized number of shares of Class A Common Stock (in order to facilitate the issuance of the Consideration Shares and the PIPE Shares), (b) in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters of this Section 1.1 are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of any such matters on the date on which the meeting is held, and (c) against approval of (i) any proposal made in opposition to the Purchase Agreement or the consummation of the Transaction, (ii) any action or agreement that would to the knowledge of such Stockholder result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Purchase Agreement, or of such Stockholder contained in this Agreement, and (iii) any other action that would reasonably be expected to materially impede, materially interfere with, materially delay, materially postpone or materially and adversely affect or prevent the transactions contemplated by the Purchase Agreement or this Agreement.

 

 

 

1.2            No Inconsistent Arrangements. Prior to termination of this Agreement, the Stockholder shall not, directly or indirectly, (a) create any Encumbrance other than restrictions imposed (i) by Law, (ii) pursuant to this Agreement, (iii) pursuant to the governance documents of Purchaser or that certain Amended and Restated Limited Liability Company Agreement of E2open Holdings, LLC, dated as of February 4, 2021, as amended from time to time, or (iv) pursuant to that certain Investors Rights Agreement, dated as of February 4, 2021, by and among Purchaser and certain of its stockholders (as amended from time to time, the “Investor Rights Agreement”), on any Subject Shares, (b) transfer, sell, assign, gift or otherwise dispose of (collectively, “Transfer”), or enter into any contract with respect to any Transfer of, the Subject Shares or any interest therein, (c) grant or permit the grant of any proxy, power of attorney or other authorization in or with respect to the Subject Shares, (d) deposit or permit the deposit of the Subject Shares into a voting trust or, except pursuant to the Investor Rights Agreement, enter into a voting agreement or arrangement with respect to the Subject Shares, or (e) take any action that, to the knowledge of the Stockholder, would have the effect of preventing the Stockholder from performing the Stockholder’s obligations hereunder; provided that this clause (e) shall not prevent any director or officer of Purchaser, in such capacity, from taking such actions as may be permitted under Section 7.17 of the Purchase Agreement. Any action taken in violation of the foregoing sentence shall be null and void ab initio. Notwithstanding the foregoing, (i) the Stockholder may (A) make Transfers of the Subject Shares to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder, (B) make Transfers of the Subject Shares to stockholders, direct or indirect affiliates (within the meaning set forth in Rule 405 under the Securities Act), current or former partners (general or limited), members or managers of the Stockholder, as applicable, (C) exercise a warrant (including a net or cashless exercise of such warrant) to purchase Purchaser Shares (which Purchaser Shares shall be “Subject Shares” subject to the obligations of this Agreement), or (D) make Transfers not involving a change in beneficial ownership; provided, that, with respect to clauses (A), (B) and (D) above, the transferee agrees in writing to be bound by the terms and conditions of this Agreement (and provides to the Purchaser the irrevocable proxy with respect to the Transferred Subject Shares on the terms set forth in Section 1.4) and either the Stockholder or the transferee provides the Company with a copy of such agreement (and irrevocable proxy) promptly upon consummation of any such Transfer (it being understood and agreed that any purported Transfer described in clauses (A), (B) or (D) that fails to satisfy the requirements of this proviso shall be null and void ab initio); and (E) pledge or otherwise encumber the Subject Shares in connection with third party credit facilities in existence on the date of this Agreement; provided that such pledge or encumbrance does not impact the validity, enforceability or exercisability of the proxy given in Section 1.4). It is hereby clarified that if any involuntary Transfer of any of the Subject Shares shall occur (such as in the case of appointment of a receiver to the Stockholder’s assets as part of bankruptcy proceedings), the transferee (which term, as used herein, shall include the initial transferee and any and all subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the termination of this Agreement. For purposes of this Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.

 

2

 

 

1.3            Documentation and Information. The Stockholder shall permit and hereby authorizes Purchaser to publish and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company and Purchaser reasonably determine to be necessary in connection with the Transaction, the Stockholder’s identity and ownership of the Subject Shares and the nature of the Stockholder’s commitments and obligations under this Agreement.

 

1.4            Irrevocable Proxy. The Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that the Stockholder has heretofore granted with respect to the Subject Shares. The Stockholder hereby irrevocably appoints Purchaser as attorney-in-fact and proxy for and on behalf of the Stockholder, for and in the name, place and stead of the Stockholder, to: (a) attend any and all meetings of the Purchaser Stockholders held for matters addressed in Section 1.1, (b) vote, express consent or dissent or issue instructions to the record holder to vote the Subject Shares solely in accordance with the provisions of Section 1.1 at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1 and (c) grant or withhold, or issue instructions to the record holder to grant or withhold, solely consistent with the provisions of Section 1.1, all written consents with respect to the Subject Shares at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1. Purchaser agrees not to exercise the proxy granted herein for any purpose other than the purposes described in this Section 1.4. The foregoing proxy shall be deemed to be a proxy coupled with an interest, is irrevocable (and as such shall survive and not be affected by the death, incapacity, mental illness or insanity of the Stockholder, as applicable) until the termination of this Agreement and shall not be terminated by operation of law or upon the occurrence of any other event other than the termination of this Agreement pursuant to Section 3.2. The Stockholder authorizes such attorney and proxy to substitute any other person to act hereunder, to revoke any substitution and to file this proxy and any substitution or revocation with the Secretary of Purchaser. The Stockholder hereby affirms that the proxy set forth in this Section 1.4 is given to Purchaser in connection with and granted in consideration of and as an inducement to the Company and Purchaser to enter into the Purchase Agreement and that such proxy is given solely to secure the obligations of the Stockholder under Section 1.1. The proxy set forth in this Section 1.4 is executed and intended to be irrevocable, subject, however, to its automatic termination upon the termination of this Agreement pursuant to Section 3.2. With respect to any Subject Shares that are owned beneficially by the Stockholder but are not held of record by the Stockholder, the Stockholder shall take all action necessary to cause the record holder of such Subject Shares to grant the irrevocable proxy and take all other actions provided for in this Section 1.4 with respect to such Subject Shares.

 

3

 

 

1.5            Enforcement of Irrevocable Proxy. Purchaser hereby covenants to the Company that Purchaser shall exercise the proxy granted by the Stockholder in Section 1.4 (and any irrevocable proxy granted by a Transferee as contemplated in Section 1.2) to the extent necessary to cause the Subject Shares to be counted for purposes of determining of a quorum for the matters addressed in Section 1.1, and to vote the Subject Shares, express consent or dissent or issue instructions to the record holder to vote the Subject Shares in accordance with the provisions of Section 1.1.

 

1.6            Waivers. Stockholder hereby irrevocably and unconditionally agrees that the Stockholder will not bring, commence, institute, maintain, prosecute or voluntarily aid or participate in any action, claim, suit or cause of action, in law or in equity, in any court or before any Authority, which (i) challenges the validity of or seeks to enjoin the operation of any provision of this Agreement or (ii) alleges that the execution and delivery of this Agreement by the Stockholder, or the approval of the Purchase Agreement by the Purchaser Board, breaches any fiduciary duty of the Purchaser Board or any member thereof; provided, that the Stockholder may defend against, contest or settle any such action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder’s capacity as a director, officer or securityholder of Purchaser.

 

1.7            No Ownership Interest. Nothing contained in this Agreement will be deemed to vest in Purchaser any direct or indirect ownership or incidents of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares will remain and belong to the Stockholder, and Purchaser will have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein with respect to the Subject Shares and except as otherwise expressly provided in the Purchase Agreement.

 

Article II
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER

 

The Stockholder represents and warrants to the Company and Purchaser that:

 

2.1            Organization; Authorization; Binding Agreement. The Stockholder, if not a natural person, is duly incorporated or organized, as applicable, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization. The Stockholder has full legal capacity and power, right and authority to execute and deliver this Agreement and to perform the Stockholder’s obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder, and constitutes a legal, valid and binding obligation of the Stockholder enforceable against the Stockholder in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity.

 

2.2            Ownership of Subject Shares; Total Shares. The Stockholder is the record or beneficial owner of the Subject Shares and has good and marketable title to the Subject Shares free and clear of any Encumbrances (including any restriction on the right to vote or otherwise transfer the Subject Shares), except (a) as provided hereunder, (b) pursuant to any applicable restrictions on Transfer under the Securities Act, (c) subject to any risk of forfeiture with respect to any Purchaser Shares granted to the Stockholder under an employee benefit plan of Purchaser, (d) as provided in the governing documents of Purchaser and (e) as provided in the Investor Rights Agreement. The Subject Shares listed on Schedule A opposite the Stockholder’s name constitute all of the Purchaser Shares owned by the Stockholder as of the date hereof. Except pursuant to Purchaser’s governing documents, no person has any contractual or other right or obligation to purchase or otherwise acquire any of the Subject Shares. For purposes of this Agreement “Beneficial Ownership” shall be interpreted as defined in Rule 13d-3 under the Exchange Act; provided that for purposes of determining Beneficial Ownership, a person shall be deemed to be the Beneficial Owner of any securities that may be acquired by such person pursuant to any contract or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of 60 days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing).

 

4

 

 

2.3            Voting Power. Subject in each case to the provisions of the Investor Rights Agreement, the Stockholder has full voting power with respect to the Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case, with respect to all of the Subject Shares. None of the Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Subject Shares, except as provided hereunder or in the Investor Rights Agreement.

 

2.4            Reliance. The Stockholder has had the opportunity to review the Purchase Agreement and this Agreement with counsel of the Stockholder’s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Transaction. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Purchaser, the Company or any of their respective agents or representatives. The Stockholder understands that such Stockholder (and not Purchaser, the Company or their respective Affiliates) shall be responsible for such Stockholder’s tax liability that may arise as a result of the Transaction (if any). The Stockholder understands and acknowledges that the Company, the Sellers and Purchaser are entering into the Purchase Agreement in reliance upon the Stockholder’s execution, delivery and performance of this Agreement.

 

2.5            Absence of Litigation. With respect to the Stockholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of the Stockholder, threatened in writing against, the Stockholder or any of the Stockholder’s properties or assets (including the Subject Shares) that could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

2.6            Non-Contravention. The execution and delivery of this Agreement by the Stockholder and the performance of the transactions contemplated by this Agreement by the Stockholder does not and will not violate, conflict with, or result in a breach of: (a) the organizational documents of such Stockholder, (b) any applicable Law or any injunction, judgment, order, decree, ruling, charge, or other restriction of any Authority to which the Stockholder is subject, or (c) any contract to which the Stockholder is a party or is bound or to which the Subject Shares are subject, such that it could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

5

 

 

Article III
MISCELLANEOUS

 

3.1            Notices. All notices, requests and other communications to either party hereunder shall be in writing (including electronic mail) and shall be given, (a) if to Purchaser or the Company, in accordance with the provisions of the Purchase Agreement and (b) if to the Stockholder, to the Stockholder’s address or electronic mail address set forth on a signature page hereto, or to such other address or electronic mail address as the Stockholder may hereafter specify in writing to Purchaser.

 

3.2            Termination. This Agreement shall terminate automatically (except in the case of (b) or (c), in which case, the Stockholder may elect in its sole discretion to terminate upon written notice to the Purchaser and the Company) and become void and of no further force and effect, without any notice or other action by any person, upon the earlier of (a) the valid termination of the Purchase Agreement in accordance with its terms, (b) the date that is twenty (20) days after the Longstop Date, (c) following (i)  any amendment or other modification of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that changes to a non-de minimis degree the form of or amount of consideration payable or otherwise impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder or the Purchaser in any material respect, or (ii) any waiver of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder in any material respect and (d) the Completion. Upon termination of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, that nothing set forth in this Section 3.2 shall relieve any party from liability for any willful and material breach of this Agreement prior to termination hereof, with any such liability not to exceed an amount equal to USD 15,000,000 plus reasonable out of pocket fees and expenses incurred by the Purchaser in connection with the negotiation of the Transaction and/or enforcement of this Agreement (including reasonable attorneys’ fees) (the “Cap”). An amount not to exceed the Cap shall only be payable to Purchaser by the Stockholder if the Break Fee is actually paid or payable by Purchaser to the Company pursuant to the Purchase Agreement. Under no circumstances shall the Stockholder be liable for damages of any kind in any amount due and owing to the Company. In the event the Completion shall have occurred pursuant to the Purchase Agreement, no party shall have any liability or other obligation under this Agreement whatsoever, including with respect to any willful and material breach occurring prior to Completion. The provisions of this Article III shall survive any termination of this Agreement.

 

3.3            Confidentiality. Except to the extent required by applicable Law, the Stockholder shall hold any non-public information regarding this Agreement, the Purchase Agreement and the Transaction in strict confidence and shall not divulge any such information to any third person until Purchaser has publicly disclosed its entry into the Purchase Agreement and this Agreement; provided, however, that the Stockholder may disclose such information (a) to its attorneys, accountants, consultants and other representatives (provided such representatives are subject to confidentiality obligations at least as restrictive as those contained herein), and (b) to any Affiliate, partner, member, stockholder, parent or subsidiary of Stockholder, provided in each case that the Stockholder informs the person receiving the information that such information is confidential and such person agrees in writing to abide by the terms of this Section 3.3. Neither the Stockholder nor any of its Affiliates (other than Purchaser, whose actions shall be governed by the Purchase Agreement), shall issue or cause the publication of any press release or other public announcement with respect to this Agreement, the Transaction, the Purchase Agreement or the other transactions contemplated hereby or thereby without the prior written consent of the Company and Purchaser, except as may be required by applicable Law in which circumstance such announcing party shall make reasonable efforts to consult with the Company and Purchaser to the extent practicable.

 

6

 

 

3.4            Amendments and Waivers. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

3.5            Binding Effect; Benefit; Assignment. The provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and their respective successors and assigns. Neither party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party hereto.

 

3.6            Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the parties hereto arising out of or relating to this Agreement, each party hereto: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware (the “Delaware Courts”); (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 3.6; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any party hereto; (e) agrees that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with Section 3.1 of this Agreement; and (f) irrevocably and unconditionally waives the right to trial by jury.

 

3.7            Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all parties by facsimile or electronic transmission in .PDF format shall be sufficient to bind the parties to the terms and conditions of this Agreement.

 

7

 

 

3.8            Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof; provided, for the avoidance of doubt, the foregoing shall in no way invalidate any right or obligation of any party pursuant to the Investor Rights Agreement.

 

3.9            Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the parties hereto agree that the court making such determination will have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision.

 

3.10          Specific Performance. Subject to the limitations set forth in Section 3.2, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any Delaware Court, this being in addition (subject to Section 3.2) to any other remedy to which they are entitled at law or in equity, and each of the parties hereto waives any bond, surety or other security that might be required of any other party with respect thereto.

 

3.11          Construction.

 

(a)           For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.

 

(b)           The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.

 

8

 

 

(c)           As used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

(d)           Except as otherwise indicated, all references in this Agreement to “Sections,” “Articles,” and “Schedules” are intended to refer to Sections or Articles of this Agreement and Schedules to this Agreement, respectively.

 

(e)           The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

3.12          Further Assurances. Each of the parties hereto will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary under applicable Law to perform their respective obligations as expressly set forth under this Agreement.

 

3.13          Capacity as Stockholder. The Stockholder signs this Agreement solely in the Stockholder’s capacity as a holder of Purchaser Shares, and not in the Stockholder’s capacity as a director, officer or employee of Purchaser or any of its Subsidiaries or in the Stockholder’s capacity as a trustee or fiduciary of any employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director or officer of Purchaser in the exercise of his or her fiduciary duties as a director or officer of Purchaser or in his or her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of Purchaser or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director, officer, trustee or fiduciary.

 

3.14          Conversion or Exercise. Nothing contained in this Agreement shall require the Stockholder (or shall entitle any proxy of the Stockholder) to (a) convert, exercise or exchange any option, warrants or convertible securities in order to obtain any underlying Subject Shares or (b) vote, or execute any consent with respect to, any Subject Shares underlying such options, warrants or convertible securities that have not yet been issued as of the applicable record date for that vote or consent.

 

3.15          No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless and until (a) the Purchaser Board has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of Purchaser’s organizational documents, the Transaction, (b) the Purchase Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto.

 

3.16          Additional Shares. The Stockholder agrees that any additional securities of the Purchaser acquired by the Stockholder after the date of this Agreement and prior to the termination of this Agreement (including through the exercise of any stock options, warrants or otherwise) shall automatically be subject to the terms of this Agreement as though owned by the Stockholder on the date hereof and shall constitute Subject Shares.

 

(SIGNATURE PAGE FOLLOWS)

 

9

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  BLUJAY TOPCO LIMITED
   
   
  By: /s/ Andrew Kirkwood
    Name:    Andrew Kirkwood
    Title:      Director

 

[Signature Page to Support Agreement]

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  E2OPEN PARENT HOLDINGS, INC.
   
   
  By: /s/ Laura L. Fese
    Name:    Laura L. Fese
    Title:      Executive Vice President and General Counsel

 

[Signature Page to Support Agreement]

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  CC NB SPONSOR 1 HOLDINGS LLC
   
   
  By: /s/ Matthew B. Skurbe
    Name:    Matthew B. Skurbe
    Title:      Senior Managing Director

 

[Signature Page to Support Agreement]

 

 

 

Schedule A

 

Name of
Stockholder
  No. Shares of
Class A
Common Stock
    No. Shares of
Class V
Common Stock
    No. Shares of
Series B-1
Common Stock
    No. Shares of
Series B-2
Common
Stock
    Shares of
Class A
Common Stock
Subject to
Warrants
    Shares of Class A
Common Stock
Issuable upon
Exchange of
Common Units
 
CC NB Sponsor 1 Holdings LLC     950,000                                

 

Exhibit 10.3

 

Execution Version

 

SUPPORT AGREEMENT

  

This SUPPORT AGREEMENT (this “Agreement”), is made as of May 27, 2021, by and between BluJay Topco Limited, a private limited company incorporated in England and Wales (the “Company”), E2open Parent Holdings, Inc., a Delaware corporation (“Purchaser”), and the person set forth on Schedule A hereto (the “Stockholder”).

 

WHEREAS, as of the date hereof, the Stockholder is the holder of the number of shares of Class A common stock and/or Class V common stock, in each case, par value $0.0001 per share (“Purchaser Shares”), of Purchaser set forth opposite the Stockholder’s name on Schedule A (all Purchaser Shares owned by the Stockholder, or hereafter issued to or otherwise acquired, whether beneficially or of record, or owned by the Stockholder prior to the termination of this Agreement, as well as shares set forth on Schedule A, being referred to herein as the “Subject Shares”);

 

WHEREAS, Purchaser, the Company, and the shareholders of the Company (the “Sellers”) propose to enter into a Share Purchase Deed, dated as of the date hereof (the “Purchase Agreement”), which provides, among other things, for the purchase by Purchaser or its direct or indirect subsidiary from the Sellers of 100% of the issued and outstanding shares of the Company, upon the terms and subject to the conditions set forth in the Purchase Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement); and

 

WHEREAS, as a condition to their willingness to enter into the Purchase Agreement, the Company and the Sellers have required that the Stockholder, and as an inducement and in consideration therefor, the Stockholder (in the Stockholder’s capacity as a holder of the Subject Shares) has agreed to, enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 

Article I
VOTING AGREEMENT; GRANT OF PROXY

 

The Stockholder hereby covenants and agrees that:

 

1.1            Voting of Subject Shares. Stockholder irrevocably and unconditionally agrees, from and after the date hereof, at every meeting of the holders of Purchaser Shares (the “Purchaser Stockholders”), however called, and at every adjournment or postponement thereof (or pursuant to a written consent if the Purchaser Stockholders act by written consent in lieu of a meeting), the Stockholder shall, or shall cause the holder of record on any applicable record date to, be present (in person or by proxy) and to vote the Subject Shares (a) in favor of the transactions contemplated by the Purchase Agreement, including issuing the Consideration Shares and the PIPE Shares and amending the Certificate of Incorporation of Purchaser to increase the authorized number of shares of Class A Common Stock (in order to facilitate the issuance of the Consideration Shares and the PIPE Shares), (b) in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters of this Section 1.1 are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of any such matters on the date on which the meeting is held, and (c) against approval of (i) any proposal made in opposition to the Purchase Agreement or the consummation of the Transaction, (ii) any action or agreement that would to the knowledge of such Stockholder result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Purchase Agreement, or of such Stockholder contained in this Agreement, and (iii) any other action that would reasonably be expected to materially impede, materially interfere with, materially delay, materially postpone or materially and adversely affect or prevent the transactions contemplated by the Purchase Agreement or this Agreement.

 

 

 

 

1.2            No Inconsistent Arrangements. Prior to termination of this Agreement, the Stockholder shall not, directly or indirectly, (a) create any Encumbrance other than restrictions imposed (i) by Law, (ii) pursuant to this Agreement, (iii) pursuant to the governance documents of Purchaser or that certain Amended and Restated Limited Liability Company Agreement of E2open Holdings, LLC, dated as of February 4, 2021, as amended from time to time, or (iv) pursuant to that certain Investors Rights Agreement, dated as of February 4, 2021, by and among Purchaser and certain of its stockholders (as amended from time to time, the “Investor Rights Agreement”), on any Subject Shares, (b) transfer, sell, assign, gift or otherwise dispose of (collectively, “Transfer”), or enter into any contract with respect to any Transfer of, the Subject Shares or any interest therein, (c) grant or permit the grant of any proxy, power of attorney or other authorization in or with respect to the Subject Shares, (d) deposit or permit the deposit of the Subject Shares into a voting trust or, except pursuant to the Investor Rights Agreement, enter into a voting agreement or arrangement with respect to the Subject Shares, or (e) take any action that, to the knowledge of the Stockholder, would have the effect of preventing the Stockholder from performing the Stockholder’s obligations hereunder; provided that this clause (e) shall not prevent any director or officer of Purchaser, in such capacity, from taking such actions as may be permitted under Section 7.17 of the Purchase Agreement. Any action taken in violation of the foregoing sentence shall be null and void ab initio. Notwithstanding the foregoing, (i) the Stockholder may (A) make Transfers of the Subject Shares to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder, (B) make Transfers of the Subject Shares to stockholders, direct or indirect affiliates (within the meaning set forth in Rule 405 under the Securities Act), current or former partners (general or limited), members or managers of the Stockholder, as applicable, (C) exercise a warrant (including a net or cashless exercise of such warrant) to purchase Purchaser Shares (which Purchaser Shares shall be “Subject Shares” subject to the obligations of this Agreement), or (D) make Transfers not involving a change in beneficial ownership; provided, that, with respect to clauses (A), (B) and (D) above, the transferee agrees in writing to be bound by the terms and conditions of this Agreement (and provides to the Purchaser the irrevocable proxy with respect to the Transferred Subject Shares on the terms set forth in Section 1.4) and either the Stockholder or the transferee provides the Company with a copy of such agreement (and irrevocable proxy) promptly upon consummation of any such Transfer (it being understood and agreed that any purported Transfer described in clauses (A), (B) or (D) that fails to satisfy the requirements of this proviso shall be null and void ab initio); and (E) pledge or otherwise encumber the Subject Shares in connection with third party credit facilities in existence on the date of this Agreement; provided that such pledge or encumbrance does not impact the validity, enforceability or exercisability of the proxy given in Section 1.4). It is hereby clarified that if any involuntary Transfer of any of the Subject Shares shall occur (such as in the case of appointment of a receiver to the Stockholder’s assets as part of bankruptcy proceedings), the transferee (which term, as used herein, shall include the initial transferee and any and all subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the termination of this Agreement. For purposes of this Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.

 

  2  

 

 

1.3            Documentation and Information. The Stockholder shall permit and hereby authorizes Purchaser to publish and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company and Purchaser reasonably determine to be necessary in connection with the Transaction, the Stockholder’s identity and ownership of the Subject Shares and the nature of the Stockholder’s commitments and obligations under this Agreement.

 

1.4           Irrevocable Proxy. The Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that the Stockholder has heretofore granted with respect to the Subject Shares. The Stockholder hereby irrevocably appoints Purchaser as attorney-in-fact and proxy for and on behalf of the Stockholder, for and in the name, place and stead of the Stockholder, to: (a) attend any and all meetings of the Purchaser Stockholders held for matters addressed in Section 1.1, (b) vote, express consent or dissent or issue instructions to the record holder to vote the Subject Shares solely in accordance with the provisions of Section 1.1 at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1 and (c) grant or withhold, or issue instructions to the record holder to grant or withhold, solely consistent with the provisions of Section 1.1, all written consents with respect to the Subject Shares at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1. Purchaser agrees not to exercise the proxy granted herein for any purpose other than the purposes described in this Section 1.4. The foregoing proxy shall be deemed to be a proxy coupled with an interest, is irrevocable (and as such shall survive and not be affected by the death, incapacity, mental illness or insanity of the Stockholder, as applicable) until the termination of this Agreement and shall not be terminated by operation of law or upon the occurrence of any other event other than the termination of this Agreement pursuant to Section 3.2. The Stockholder authorizes such attorney and proxy to substitute any other person to act hereunder, to revoke any substitution and to file this proxy and any substitution or revocation with the Secretary of Purchaser. The Stockholder hereby affirms that the proxy set forth in this Section 1.4 is given to Purchaser in connection with and granted in consideration of and as an inducement to the Company and Purchaser to enter into the Purchase Agreement and that such proxy is given solely to secure the obligations of the Stockholder under Section 1.1. The proxy set forth in this Section 1.4 is executed and intended to be irrevocable, subject, however, to its automatic termination upon the termination of this Agreement pursuant to Section 3.2. With respect to any Subject Shares that are owned beneficially by the Stockholder but are not held of record by the Stockholder, the Stockholder shall take all action necessary to cause the record holder of such Subject Shares to grant the irrevocable proxy and take all other actions provided for in this Section 1.4 with respect to such Subject Shares.

 

  3  

 

 

1.5            Enforcement of Irrevocable Proxy. Purchaser hereby covenants to the Company that Purchaser shall exercise the proxy granted by the Stockholder in Section 1.4 (and any irrevocable proxy granted by a Transferee as contemplated in Section 1.2) to the extent necessary to cause the Subject Shares to be counted for purposes of determining of a quorum for the matters addressed in Section 1.1, and to vote the Subject Shares, express consent or dissent or issue instructions to the record holder to vote the Subject Shares in accordance with the provisions of Section 1.1.

  

1.6            Waivers. Stockholder hereby irrevocably and unconditionally agrees that the Stockholder will not bring, commence, institute, maintain, prosecute or voluntarily aid or participate in any action, claim, suit or cause of action, in law or in equity, in any court or before any Authority, which (i) challenges the validity of or seeks to enjoin the operation of any provision of this Agreement or (ii) alleges that the execution and delivery of this Agreement by the Stockholder, or the approval of the Purchase Agreement by the Purchaser Board, breaches any fiduciary duty of the Purchaser Board or any member thereof; provided, that the Stockholder may defend against, contest or settle any such action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder’s capacity as a director, officer or securityholder of Purchaser.

 

1.7            No Ownership Interest. Nothing contained in this Agreement will be deemed to vest in Purchaser any direct or indirect ownership or incidents of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares will remain and belong to the Stockholder, and Purchaser will have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein with respect to the Subject Shares and except as otherwise expressly provided in the Purchase Agreement.

 

Article II
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER

 

The Stockholder represents and warrants to the Company and Purchaser that:

 

2.1           Organization; Authorization; Binding Agreement. The Stockholder, if not a natural person, is duly incorporated or organized, as applicable, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization. The Stockholder has full legal capacity and power, right and authority to execute and deliver this Agreement and to perform the Stockholder’s obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder, and constitutes a legal, valid and binding obligation of the Stockholder enforceable against the Stockholder in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity.

 

2.2            Ownership of Subject Shares; Total Shares. The Stockholder is the record or beneficial owner of the Subject Shares and has good and marketable title to the Subject Shares free and clear of any Encumbrances (including any restriction on the right to vote or otherwise transfer the Subject Shares), except (a) as provided hereunder, (b) pursuant to any applicable restrictions on Transfer under the Securities Act, (c) subject to any risk of forfeiture with respect to any Purchaser Shares granted to the Stockholder under an employee benefit plan of Purchaser, (d) as provided in the governing documents of Purchaser and (e) as provided in the Investor Rights Agreement. The Subject Shares listed on Schedule A opposite the Stockholder’s name constitute all of the Purchaser Shares owned by the Stockholder as of the date hereof. Except pursuant to Purchaser’s governing documents, no person has any contractual or other right or obligation to purchase or otherwise acquire any of the Subject Shares. For purposes of this Agreement “Beneficial Ownership” shall be interpreted as defined in Rule 13d-3 under the Exchange Act; provided that for purposes of determining Beneficial Ownership, a person shall be deemed to be the Beneficial Owner of any securities that may be acquired by such person pursuant to any contract or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of 60 days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing).

 

  4  

 

 

2.3            Voting Power. Subject in each case to the provisions of the Investor Rights Agreement, the Stockholder has full voting power with respect to the Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case, with respect to all of the Subject Shares. None of the Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Subject Shares, except as provided hereunder or in the Investor Rights Agreement.

 

2.4         Reliance. The Stockholder has had the opportunity to review the Purchase Agreement and this Agreement with counsel of the Stockholder’s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Transaction. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Purchaser, the Company or any of their respective agents or representatives. The Stockholder understands that such Stockholder (and not Purchaser, the Company or their respective Affiliates) shall be responsible for such Stockholder’s tax liability that may arise as a result of the Transaction (if any). The Stockholder understands and acknowledges that the Company, the Sellers and Purchaser are entering into the Purchase Agreement in reliance upon the Stockholder’s execution, delivery and performance of this Agreement.

 

2.5            Absence of Litigation. With respect to the Stockholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of the Stockholder, threatened in writing against, the Stockholder or any of the Stockholder’s properties or assets (including the Subject Shares) that could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

2.6         Non-Contravention. The execution and delivery of this Agreement by the Stockholder and the performance of the transactions contemplated by this Agreement by the Stockholder does not and will not violate, conflict with, or result in a breach of: (a) the organizational documents of such Stockholder, (b) any applicable Law or any injunction, judgment, order, decree, ruling, charge, or other restriction of any Authority to which the Stockholder is subject, or (c) any contract to which the Stockholder is a party or is bound or to which the Subject Shares are subject, such that it could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

  5  

 

 

Article III
MISCELLANEOUS

 

3.1            Notices. All notices, requests and other communications to either party hereunder shall be in writing (including electronic mail) and shall be given, (a) if to Purchaser or the Company, in accordance with the provisions of the Purchase Agreement and (b) if to the Stockholder, to the Stockholder’s address or electronic mail address set forth on a signature page hereto, or to such other address or electronic mail address as the Stockholder may hereafter specify in writing to Purchaser.

 

3.2            Termination. This Agreement shall terminate automatically (except in the case of (b) or (c), in which case, the Stockholder may elect in its sole discretion to terminate upon written notice to the Purchaser and the Company) and become void and of no further force and effect, without any notice or other action by any person, upon the earlier of (a) the valid termination of the Purchase Agreement in accordance with its terms, (b) the date that is twenty (20) days after the Longstop Date, (c) following (i)  any amendment or other modification of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that changes to a non-de minimis degree the form of or amount of consideration payable or otherwise impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder or the Purchaser in any material respect, or (ii) any waiver of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder in any material respect and (d) the Completion. Upon termination of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, that nothing set forth in this Section 3.2 shall relieve any party from liability for any willful and material breach of this Agreement prior to termination hereof, with any such liability not to exceed an amount equal to USD 15,000,000 plus reasonable out of pocket fees and expenses incurred by the Purchaser in connection with the negotiation of the Transaction and/or enforcement of this Agreement (including reasonable attorneys’ fees) (the “Cap”). An amount not to exceed the Cap shall only be payable to Purchaser by the Stockholder if the Break Fee is actually paid or payable by Purchaser to the Company pursuant to the Purchase Agreement. Under no circumstances shall the Stockholder be liable for damages of any kind in any amount due and owing to the Company. In the event the Completion shall have occurred pursuant to the Purchase Agreement, no party shall have any liability or other obligation under this Agreement whatsoever, including with respect to any willful and material breach occurring prior to Completion. The provisions of this Article III shall survive any termination of this Agreement.

 

3.3            Confidentiality. Except to the extent required by applicable Law, the Stockholder shall hold any non-public information regarding this Agreement, the Purchase Agreement and the Transaction in strict confidence and shall not divulge any such information to any third person until Purchaser has publicly disclosed its entry into the Purchase Agreement and this Agreement; provided, however, that the Stockholder may disclose such information (a) to its attorneys, accountants, consultants and other representatives (provided such representatives are subject to confidentiality obligations at least as restrictive as those contained herein), and (b) to any Affiliate, partner, member, stockholder, parent or subsidiary of Stockholder, provided in each case that the Stockholder informs the person receiving the information that such information is confidential and such person agrees in writing to abide by the terms of this Section 3.3. Neither the Stockholder nor any of its Affiliates (other than Purchaser, whose actions shall be governed by the Purchase Agreement), shall issue or cause the publication of any press release or other public announcement with respect to this Agreement, the Transaction, the Purchase Agreement or the other transactions contemplated hereby or thereby without the prior written consent of the Company and Purchaser, except as may be required by applicable Law in which circumstance such announcing party shall make reasonable efforts to consult with the Company and Purchaser to the extent practicable.

 

  6  

 

 

3.4            Amendments and Waivers. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

3.5            Binding Effect; Benefit; Assignment. The provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and their respective successors and assigns. Neither party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party hereto.

 

3.6            Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the parties hereto arising out of or relating to this Agreement, each party hereto: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware (the “Delaware Courts”); (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 3.6; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any party hereto; (e) agrees that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with Section 3.1 of this Agreement; and (f) irrevocably and unconditionally waives the right to trial by jury.

 

3.7            Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all parties by facsimile or electronic transmission in .PDF format shall be sufficient to bind the parties to the terms and conditions of this Agreement.

 

  7  

 

 

3.8            Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof; provided, for the avoidance of doubt, the foregoing shall in no way invalidate any right or obligation of any party pursuant to the Investor Rights Agreement.

 

3.9            Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the parties hereto agree that the court making such determination will have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision.

 

3.10            Specific Performance. Subject to the limitations set forth in Section 3.2, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any Delaware Court, this being in addition (subject to Section 3.2) to any other remedy to which they are entitled at law or in equity, and each of the parties hereto waives any bond, surety or other security that might be required of any other party with respect thereto.

 

3.11            Construction.

 

(a)            For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.

 

(b)            The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.

 

  8  

 

 

(c)            As used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

 

(d)            Except as otherwise indicated, all references in this Agreement to “Sections,” “Articles,” and “Schedules” are intended to refer to Sections or Articles of this Agreement and Schedules to this Agreement, respectively.

 

(e)            The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

3.12            Further Assurances. Each of the parties hereto will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary under applicable Law to perform their respective obligations as expressly set forth under this Agreement.

 

3.13            Capacity as Stockholder. The Stockholder signs this Agreement solely in the Stockholder’s capacity as a holder of Purchaser Shares, and not in the Stockholder’s capacity as a director, officer or employee of Purchaser or any of its Subsidiaries or in the Stockholder’s capacity as a trustee or fiduciary of any employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director or officer of Purchaser in the exercise of his or her fiduciary duties as a director or officer of Purchaser or in his or her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of Purchaser or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director, officer, trustee or fiduciary.

 

3.14            Conversion or Exercise. Nothing contained in this Agreement shall require the Stockholder (or shall entitle any proxy of the Stockholder) to (a) convert, exercise or exchange any option, warrants or convertible securities in order to obtain any underlying Subject Shares or (b) vote, or execute any consent with respect to, any Subject Shares underlying such options, warrants or convertible securities that have not yet been issued as of the applicable record date for that vote or consent.

 

3.15         No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless and until (a) the Purchaser Board has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of Purchaser’s organizational documents, the Transaction, (b) the Purchase Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto.

 

  9  

 

 

3.16            Additional Shares. The Stockholder agrees that any additional securities of the Purchaser acquired by the Stockholder after the date of this Agreement and prior to the termination of this Agreement (including through the exercise of any stock options, warrants or otherwise) shall automatically be subject to the terms of this Agreement as though owned by the Stockholder on the date hereof and shall constitute Subject Shares.

 

(SIGNATURE PAGE FOLLOWS)

 

  10  

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  BLUJAY TOPCO LIMITED
   
   
  By: /s/ Andrew Kirkwood
  Name: Andrew Kirkwood
  Title: Director

 

[Signature Page to Support Agreement]

 

   

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

  

E2OPEN PARENT HOLDINGS, INC.
   
   
  By: /s/ Laura L. Fese
  Name: Laura L. Fese
  Title:  Executive Vice President and General Counsel

 

[Signature Page to Support Agreement]

 

   

 

  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

  

CC NEUBERGER PRINCIPAL HOLDINGS I SPONSOR HOLDINGS LLC
   
   
  By: /s/ Douglas Newton
  Name: Douglas Newton
  Title: Authorized Signatory

  

[Signature Page to Support Agreement]

 

   

 

   

Schedule A

  

Name of Stockholder   No. Shares
of Class A
Common
Stock
  No. Shares
of Class V
Common
Stock
  No. Shares
of Series B-1
Common
Stock
  No. Shares
of Series B-2
Common
Stock
  Shares of Class
A Common
Stock Subject to
Warrants
  Shares of Class A
Common Stock Issuable
upon Exchange of
Common Units
 
CC Neuberger Principal Holdings I Sponsor LLC   12,766,286       2,483,714       10,280,000      

  

   

 

Exhibit 10.4

 

Execution Version

 

SUPPORT AGREEMENT

 

This SUPPORT AGREEMENT (this “Agreement”), is made as of May 27, 2021, by and between BluJay Topco Limited, a private limited company incorporated in England and Wales (the “Company”), E2open Parent Holdings, Inc., a Delaware corporation (“Purchaser”), and the person set forth on Schedule A hereto (the “Stockholder”).

 

WHEREAS, as of the date hereof, the Stockholder is the holder of the number of shares of Class A common stock and/or Class V common stock, in each case, par value $0.0001 per share (“Purchaser Shares”), of Purchaser set forth opposite the Stockholder’s name on Schedule A (all Purchaser Shares owned by the Stockholder, or hereafter issued to or otherwise acquired, whether beneficially or of record, or owned by the Stockholder prior to the termination of this Agreement, as well as shares set forth on Schedule A, being referred to herein as the “Subject Shares”);

 

WHEREAS, Purchaser, the Company, and the shareholders of the Company (the “Sellers”) propose to enter into a Share Purchase Deed, dated as of the date hereof (the “Purchase Agreement”), which provides, among other things, for the purchase by Purchaser or its direct or indirect subsidiary from the Sellers of 100% of the issued and outstanding shares of the Company, upon the terms and subject to the conditions set forth in the Purchase Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement); and

 

WHEREAS, as a condition to their willingness to enter into the Purchase Agreement, the Company and the Sellers have required that the Stockholder, and as an inducement and in consideration therefor, the Stockholder (in the Stockholder’s capacity as a holder of the Subject Shares) has agreed to, enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 

Article I
VOTING AGREEMENT; GRANT OF PROXY

 

The Stockholder hereby covenants and agrees that:

 

1.1            Voting of Subject Shares. Stockholder irrevocably and unconditionally agrees, from and after the date hereof, at every meeting of the holders of Purchaser Shares (the “Purchaser Stockholders”), however called, and at every adjournment or postponement thereof (or pursuant to a written consent if the Purchaser Stockholders act by written consent in lieu of a meeting), the Stockholder shall, or shall cause the holder of record on any applicable record date to, be present (in person or by proxy) and to vote the Subject Shares (a) in favor of the transactions contemplated by the Purchase Agreement, including issuing the Consideration Shares and the PIPE Shares and amending the Certificate of Incorporation of Purchaser to increase the authorized number of shares of Class A Common Stock (in order to facilitate the issuance of the Consideration Shares and the PIPE Shares), (b) in favor of any proposal to adjourn or postpone to a later date any meeting of the stockholders of the Company at which any of the foregoing matters of this Section 1.1 are submitted for consideration and vote of the stockholders of the Company if there are not sufficient votes for approval of any such matters on the date on which the meeting is held, and (c) against approval of (i) any proposal made in opposition to the Purchase Agreement or the consummation of the Transaction, (ii) any action or agreement that would to the knowledge of such Stockholder result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Purchase Agreement, or of such Stockholder contained in this Agreement, and (iii) any other action that would reasonably be expected to materially impede, materially interfere with, materially delay, materially postpone or materially and adversely affect or prevent the transactions contemplated by the Purchase Agreement or this Agreement.

 

 

1.2            No Inconsistent Arrangements. Prior to termination of this Agreement, the Stockholder shall not, directly or indirectly, (a) create any Encumbrance other than restrictions imposed (i) by Law, (ii) pursuant to this Agreement, (iii) pursuant to the governance documents of Purchaser or that certain Amended and Restated Limited Liability Company Agreement of E2open Holdings, LLC, dated as of February 4, 2021, as amended from time to time, or (iv) pursuant to that certain Investors Rights Agreement, dated as of February 4, 2021, by and among Purchaser and certain of its stockholders (as amended from time to time, the “Investor Rights Agreement”), on any Subject Shares, (b) transfer, sell, assign, gift or otherwise dispose of (collectively, “Transfer”), or enter into any contract with respect to any Transfer of, the Subject Shares or any interest therein, (c) grant or permit the grant of any proxy, power of attorney or other authorization in or with respect to the Subject Shares, (d) deposit or permit the deposit of the Subject Shares into a voting trust or, except pursuant to the Investor Rights Agreement, enter into a voting agreement or arrangement with respect to the Subject Shares, or (e) take any action that, to the knowledge of the Stockholder, would have the effect of preventing the Stockholder from performing the Stockholder’s obligations hereunder; provided that this clause (e) shall not prevent any director or officer of Purchaser, in such capacity, from taking such actions as may be permitted under Section 7.17 of the Purchase Agreement. Any action taken in violation of the foregoing sentence shall be null and void ab initio. Notwithstanding the foregoing, (i) the Stockholder may (A) make Transfers of the Subject Shares to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder, (B) make Transfers of the Subject Shares to stockholders, direct or indirect affiliates (within the meaning set forth in Rule 405 under the Securities Act), current or former partners (general or limited), members or managers of the Stockholder, as applicable, (C) exercise a warrant (including a net or cashless exercise of such warrant) to purchase Purchaser Shares (which Purchaser Shares shall be “Subject Shares” subject to the obligations of this Agreement), or (D) make Transfers not involving a change in beneficial ownership; provided, that, with respect to clauses (A), (B) and (D) above, the transferee agrees in writing to be bound by the terms and conditions of this Agreement (and provides to the Purchaser the irrevocable proxy with respect to the Transferred Subject Shares on the terms set forth in Section 1.4) and either the Stockholder or the transferee provides the Company with a copy of such agreement (and irrevocable proxy) promptly upon consummation of any such Transfer (it being understood and agreed that any purported Transfer described in clauses (A), (B) or (D) that fails to satisfy the requirements of this proviso shall be null and void ab initio); and (E) pledge or otherwise encumber the Subject Shares in connection with third party credit facilities in existence on the date of this Agreement; provided that such pledge or encumbrance does not impact the validity, enforceability or exercisability of the proxy given in Section 1.4). It is hereby clarified that if any involuntary Transfer of any of the Subject Shares shall occur (such as in the case of appointment of a receiver to the Stockholder’s assets as part of bankruptcy proceedings), the transferee (which term, as used herein, shall include the initial transferee and any and all subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the termination of this Agreement. For purposes of this Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.

 

2

 

1.3            Documentation and Information. The Stockholder shall permit and hereby authorizes Purchaser to publish and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that the Company and Purchaser reasonably determine to be necessary in connection with the Transaction, the Stockholder’s identity and ownership of the Subject Shares and the nature of the Stockholder’s commitments and obligations under this Agreement.

 

1.4            Irrevocable Proxy. The Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that the Stockholder has heretofore granted with respect to the Subject Shares. The Stockholder hereby irrevocably appoints Purchaser as attorney-in-fact and proxy for and on behalf of the Stockholder, for and in the name, place and stead of the Stockholder, to: (a) attend any and all meetings of the Purchaser Stockholders held for matters addressed in Section 1.1, (b) vote, express consent or dissent or issue instructions to the record holder to vote the Subject Shares solely in accordance with the provisions of Section 1.1 at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1 and (c) grant or withhold, or issue instructions to the record holder to grant or withhold, solely consistent with the provisions of Section 1.1, all written consents with respect to the Subject Shares at any and all meetings of Purchaser Stockholders or in connection with any action sought to be taken by written consent of Purchaser Stockholders without a meeting solely in respect of matters addressed in Section 1.1. Purchaser agrees not to exercise the proxy granted herein for any purpose other than the purposes described in this Section 1.4. The foregoing proxy shall be deemed to be a proxy coupled with an interest, is irrevocable (and as such shall survive and not be affected by the death, incapacity, mental illness or insanity of the Stockholder, as applicable) until the termination of this Agreement and shall not be terminated by operation of law or upon the occurrence of any other event other than the termination of this Agreement pursuant to Section 3.2. The Stockholder authorizes such attorney and proxy to substitute any other person to act hereunder, to revoke any substitution and to file this proxy and any substitution or revocation with the Secretary of Purchaser. The Stockholder hereby affirms that the proxy set forth in this Section 1.4 is given to Purchaser in connection with and granted in consideration of and as an inducement to the Company and Purchaser to enter into the Purchase Agreement and that such proxy is given solely to secure the obligations of the Stockholder under Section 1.1. The proxy set forth in this Section 1.4 is executed and intended to be irrevocable, subject, however, to its automatic termination upon the termination of this Agreement pursuant to Section 3.2. With respect to any Subject Shares that are owned beneficially by the Stockholder but are not held of record by the Stockholder, the Stockholder shall take all action necessary to cause the record holder of such Subject Shares to grant the irrevocable proxy and take all other actions provided for in this Section 1.4 with respect to such Subject Shares.

 

1.5            Enforcement of Irrevocable Proxy. Purchaser hereby covenants to the Company that Purchaser shall exercise the proxy granted by the Stockholder in Section 1.4 (and any irrevocable proxy granted by a Transferee as contemplated in Section 1.2) to the extent necessary to cause the Subject Shares to be counted for purposes of determining of a quorum for the matters addressed in Section 1.1, and to vote the Subject Shares, express consent or dissent or issue instructions to the record holder to vote the Subject Shares in accordance with the provisions of Section 1.1.

 

3

 

1.6            Waivers. Stockholder hereby irrevocably and unconditionally agrees that the Stockholder will not bring, commence, institute, maintain, prosecute or voluntarily aid or participate in any action, claim, suit or cause of action, in law or in equity, in any court or before any Authority, which (i) challenges the validity of or seeks to enjoin the operation of any provision of this Agreement or (ii) alleges that the execution and delivery of this Agreement by the Stockholder, or the approval of the Purchase Agreement by the Purchaser Board, breaches any fiduciary duty of the Purchaser Board or any member thereof; provided, that the Stockholder may defend against, contest or settle any such action, claim, suit or cause of action brought against the Stockholder that relates solely to the Stockholder’s capacity as a director, officer or securityholder of Purchaser.

 

1.7            No Ownership Interest. Nothing contained in this Agreement will be deemed to vest in Purchaser any direct or indirect ownership or incidents of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares will remain and belong to the Stockholder, and Purchaser will have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein with respect to the Subject Shares and except as otherwise expressly provided in the Purchase Agreement.

 

Article II
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER

 

The Stockholder represents and warrants to the Company and Purchaser that:

 

2.1            Organization; Authorization; Binding Agreement. The Stockholder, if not a natural person, is duly incorporated or organized, as applicable, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization. The Stockholder has full legal capacity and power, right and authority to execute and deliver this Agreement and to perform the Stockholder’s obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by the Stockholder, and constitutes a legal, valid and binding obligation of the Stockholder enforceable against the Stockholder in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally or by general principles of equity.

 

2.2            Ownership of Subject Shares; Total Shares. The Stockholder is the record or beneficial owner of the Subject Shares and has good and marketable title to the Subject Shares free and clear of any Encumbrances (including any restriction on the right to vote or otherwise transfer the Subject Shares), except (a) as provided hereunder, (b) pursuant to any applicable restrictions on Transfer under the Securities Act, (c) subject to any risk of forfeiture with respect to any Purchaser Shares granted to the Stockholder under an employee benefit plan of Purchaser, (d) as provided in the governing documents of Purchaser and (e) as provided in the Investor Rights Agreement. The Subject Shares listed on Schedule A opposite the Stockholder’s name constitute all of the Purchaser Shares owned by the Stockholder as of the date hereof. Except pursuant to Purchaser’s governing documents, no person has any contractual or other right or obligation to purchase or otherwise acquire any of the Subject Shares. For purposes of this Agreement “Beneficial Ownership” shall be interpreted as defined in Rule 13d-3 under the Exchange Act; provided that for purposes of determining Beneficial Ownership, a person shall be deemed to be the Beneficial Owner of any securities that may be acquired by such person pursuant to any contract or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise (irrespective of whether the right to acquire such securities is exercisable immediately or only after the passage of time, including the passage of time in excess of 60 days, the satisfaction of any conditions, the occurrence of any event or any combination of the foregoing).

 

4

 

2.3            Voting Power. Subject in each case to the provisions of the Investor Rights Agreement, the Stockholder has full voting power with respect to the Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case, with respect to all of the Subject Shares. None of the Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of the Subject Shares, except as provided hereunder or in the Investor Rights Agreement.

 

2.4            Reliance. The Stockholder has had the opportunity to review the Purchase Agreement and this Agreement with counsel of the Stockholder’s own choosing. The Stockholder has had an opportunity to review with its own tax advisors the tax consequences of the Transaction. The Stockholder understands that it must rely solely on its advisors and not on any statements or representations made by Purchaser, the Company or any of their respective agents or representatives. The Stockholder understands that such Stockholder (and not Purchaser, the Company or their respective Affiliates) shall be responsible for such Stockholder’s tax liability that may arise as a result of the Transaction (if any). The Stockholder understands and acknowledges that the Company, the Sellers and Purchaser are entering into the Purchase Agreement in reliance upon the Stockholder’s execution, delivery and performance of this Agreement.

 

2.5            Absence of Litigation. With respect to the Stockholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of the Stockholder, threatened in writing against, the Stockholder or any of the Stockholder’s properties or assets (including the Subject Shares) that could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

2.6            Non-Contravention. The execution and delivery of this Agreement by the Stockholder and the performance of the transactions contemplated by this Agreement by the Stockholder does not and will not violate, conflict with, or result in a breach of: (a) the organizational documents of such Stockholder, (b) any applicable Law or any injunction, judgment, order, decree, ruling, charge, or other restriction of any Authority to which the Stockholder is subject, or (c) any contract to which the Stockholder is a party or is bound or to which the Subject Shares are subject, such that it could reasonably be expected to prevent, delay or impair the ability of the Stockholder to perform the Stockholder’s obligations hereunder or to consummate the transactions contemplated hereby.

 

5

 

Article III
MISCELLANEOUS

 

3.1            Notices. All notices, requests and other communications to either party hereunder shall be in writing (including electronic mail) and shall be given, (a) if to Purchaser or the Company, in accordance with the provisions of the Purchase Agreement and (b) if to the Stockholder, to the Stockholder’s address or electronic mail address set forth on a signature page hereto, or to such other address or electronic mail address as the Stockholder may hereafter specify in writing to Purchaser.

 

3.2            Termination. This Agreement shall terminate automatically (except in the case of (b) or (c), in which case, the Stockholder may elect in its sole discretion to terminate upon written notice to the Purchaser and the Company) and become void and of no further force and effect, without any notice or other action by any person, upon the earlier of (a) the valid termination of the Purchase Agreement in accordance with its terms, (b) the date that is twenty (20) days after the Longstop Date, (c) following (i)  any amendment or other modification of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that changes to a non-de minimis degree the form of or amount of consideration payable or otherwise impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder or the Purchaser in any material respect, or (ii) any waiver of any term or provision of the Purchase Agreement without the prior written consent of the Stockholder that impacts a material term of the Purchase Agreement in a manner that is adverse to the Stockholder in any material respect and (d) the Completion. Upon termination of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, that nothing set forth in this Section 3.2 shall relieve any party from liability for any willful and material breach of this Agreement prior to termination hereof, with any such liability not to exceed an amount equal to USD 15,000,000 plus reasonable out of pocket fees and expenses incurred by the Purchaser in connection with the negotiation of the Transaction and/or enforcement of this Agreement (including reasonable attorneys’ fees) (the “Cap”). An amount not to exceed the Cap shall only be payable to Purchaser by the Stockholder if the Break Fee is actually paid or payable by Purchaser to the Company pursuant to the Purchase Agreement. Under no circumstances shall the Stockholder be liable for damages of any kind in any amount due and owing to the Company. In the event the Completion shall have occurred pursuant to the Purchase Agreement, no party shall have any liability or other obligation under this Agreement whatsoever, including with respect to any willful and material breach occurring prior to Completion. The provisions of this Article III shall survive any termination of this Agreement.

 

3.3            Confidentiality. Except to the extent required by applicable Law, the Stockholder shall hold any non-public information regarding this Agreement, the Purchase Agreement and the Transaction in strict confidence and shall not divulge any such information to any third person until Purchaser has publicly disclosed its entry into the Purchase Agreement and this Agreement; provided, however, that the Stockholder may disclose such information (a) to its attorneys, accountants, consultants and other representatives (provided such representatives are subject to confidentiality obligations at least as restrictive as those contained herein), and (b) to any Affiliate, partner, member, stockholder, parent or subsidiary of Stockholder, provided in each case that the Stockholder informs the person receiving the information that such information is confidential and such person agrees in writing to abide by the terms of this Section 3.3. Neither the Stockholder nor any of its Affiliates (other than Purchaser, whose actions shall be governed by the Purchase Agreement), shall issue or cause the publication of any press release or other public announcement with respect to this Agreement, the Transaction, the Purchase Agreement or the other transactions contemplated hereby or thereby without the prior written consent of the Company and Purchaser, except as may be required by applicable Law in which circumstance such announcing party shall make reasonable efforts to consult with the Company and Purchaser to the extent practicable.

 

6

 

3.4            Amendments and Waivers. Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

3.5            Binding Effect; Benefit; Assignment. The provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and their respective successors and assigns. Neither party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party hereto.

 

3.6            Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the parties hereto arising out of or relating to this Agreement, each party hereto: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware (the “Delaware Courts”); (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 3.6; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any party hereto; (e) agrees that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with Section 3.1 of this Agreement; and (f) irrevocably and unconditionally waives the right to trial by jury.

 

3.7            Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all parties by facsimile or electronic transmission in .PDF format shall be sufficient to bind the parties to the terms and conditions of this Agreement.

 

7

 

3.8            Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof; provided, for the avoidance of doubt, the foregoing shall in no way invalidate any right or obligation of any party pursuant to the Investor Rights Agreement.

 

3.9            Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the parties hereto agree that the court making such determination will have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision.

 

3.10            Specific Performance. Subject to the limitations set forth in Section 3.2, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any Delaware Court, this being in addition (subject to Section 3.2) to any other remedy to which they are entitled at law or in equity, and each of the parties hereto waives any bond, surety or other security that might be required of any other party with respect thereto.

 

3.11            Construction.

 

(a)            For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.

 

(b)            The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.

 

8

 

(c)            As used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

(d)            Except as otherwise indicated, all references in this Agreement to “Sections,” “Articles,” and “Schedules” are intended to refer to Sections or Articles of this Agreement and Schedules to this Agreement, respectively.

 

(e)            The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

3.12            Further Assurances. Each of the parties hereto will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary under applicable Law to perform their respective obligations as expressly set forth under this Agreement.

 

3.13            Capacity as Stockholder. The Stockholder signs this Agreement solely in the Stockholder’s capacity as a holder of Purchaser Shares, and not in the Stockholder’s capacity as a director, officer or employee of Purchaser or any of its Subsidiaries or in the Stockholder’s capacity as a trustee or fiduciary of any employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director or officer of Purchaser in the exercise of his or her fiduciary duties as a director or officer of Purchaser or in his or her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of Purchaser or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity as such director, officer, trustee or fiduciary.

 

3.14            Conversion or Exercise. Nothing contained in this Agreement shall require the Stockholder (or shall entitle any proxy of the Stockholder) to (a) convert, exercise or exchange any option, warrants or convertible securities in order to obtain any underlying Subject Shares or (b) vote, or execute any consent with respect to, any Subject Shares underlying such options, warrants or convertible securities that have not yet been issued as of the applicable record date for that vote or consent.

 

3.15            No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless and until (a) the Purchaser Board has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of Purchaser’s organizational documents, the Transaction, (b) the Purchase Agreement is executed by all parties thereto, and (c) this Agreement is executed by all parties hereto.

 

3.16            Additional Shares. The Stockholder agrees that any additional securities of the Purchaser acquired by the Stockholder after the date of this Agreement and prior to the termination of this Agreement (including through the exercise of any stock options, warrants or otherwise) shall automatically be subject to the terms of this Agreement as though owned by the Stockholder on the date hereof and shall constitute Subject Shares.

 

(SIGNATURE PAGE FOLLOWS)

 

9

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  BLUJAY TOPCO LIMITED
   
     
  By: /s/ Andrew Kirkwood
    Name:  Andrew Kirkwood
    Title: Director

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  E2OPEN PARENT HOLDINGS, INC.
   
     
  By: /s/ Laura L. Fese
    Name: Laura L. Fese
    Title: Executive Vice President and General Counsel

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  STOCKHOLDER
     
  INSIGHT VENTURE PARTNERS GROWTH-BUYOUT COINVESTMENT FUND (CAYMAN), L.P.
     
  By: Insight Venture Associates Growth-Buyout Coinvestment, L.P.
  Its: General Partner
     
  By: Insight Venture Associates Growth-Buyout Coinvestment, Ltd.
  Its: General Partner
   
  (Print Name of Stockholder)

 

  /s/ Andrew Prodromos
  (Signature)

 

  Andre Prodromos, Authorized Signatory
  (Name and Title of Signatory, if Signing on Behalf of an Entity)

 

  Address for Notices:
   
  1114 Avenue of the Americas, 36th Floor
New York, NY 10036
Attention: Andrew Prodromos
   
  Email:        aprodromos@insightpartners.com        

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  STOCKHOLDER
     
  INSIGHT VENTURE PARTNERS (CAYMAN),  X L.P.
     
  By: Insight Venture Associates IX, L.P.
  Its: General Partner
     
  By: Insight Venture IX, Ltd.
  Its: General Partner
   
  (Print Name of Stockholder)

 

  /s/ Andrew Prodromos
  (Signature)

 

  Andre Prodromos, Authorized Signatory
  (Name and Title of Signatory, if Signing on Behalf of an Entity)

 

  Address for Notices:
   
  1114 Avenue of the Americas, 36th Floor
New York, NY 10036
Attention: Andrew Prodromos
   
  Email:        aprodromos@insightpartners.com        

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  STOCKHOLDER
     
  INSIGHT VENTURE PARTNERS (DELAWARE),  X L.P.
     
  By: Insight Venture Associates IX, L.P.
  Its: General Partner
     
  By: Insight Venture IX, Ltd.
  Its: General Partner
   
  (Print Name of Stockholder)

 

  /s/ Andrew Prodromos
  (Signature)

 

  Andre Prodromos, Authorized Signatory
  (Name and Title of Signatory, if Signing on Behalf of an Entity)

 

  Address for Notices:
   
  1114 Avenue of the Americas, 36th Floor
New York, NY 10036
Attention: Andrew Prodromos
   
  Email:        aprodromos@insightpartners.com        

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  STOCKHOLDER
              
  INSIGHT E2OPEN AGGREGATOR, LLC
             
  (Print Name of Stockholder)

 

  /s/ Andrew Prodromos
  (Signature)

 

  Andre Prodromos, Authorized Signatory
  (Name and Title of Signatory, if Signing on Behalf of an Entity)

 

  Address for Notices:
   
  1114 Avenue of the Americas, 36th Floor
New York, NY 10036
Attention: Andrew Prodromos
   
  Email:        aprodromos@insightpartners.com        

 

[Signature Page to Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

  STOCKHOLDER
     
  INSIGHT VENTURE PARTNERS GROWTH-BUYOUT COINVESTMENT FUND (DELAWARE), L.P.
     
  By: Insight Venture Associates Growth-Buyout Coinvestment, L.P.
  Its: General Partner
     
  By: Insight Venture Associates Growth-Buyout Coinvestment, Ltd.
  Its: General Partner
   
  (Print Name of Stockholder)

 

  /s/ Andrew Prodromos
  (Signature)

 

  Andre Prodromos, Authorized Signatory
  (Name and Title of Signatory, if Signing on Behalf of an Entity)

 

  Address for Notices:
   
  1114 Avenue of the Americas, 36th Floor
New York, NY 10036
Attention: Andrew Prodromos
   
  Email:        aprodromos@insightpartners.com        

 

[Signature Page to Support Agreement]

 

 

Schedule A

 

Name of Stockholder   No. Shares
of Class A
Common
Stock
    No. Shares
of Class V
Common
Stock
    No. Shares
of Series B-1
Common
Stock
    No. Shares
of Series B-2
Common
Stock
    Shares of Class
 A Common
Stock Subject to
Warrants
    Shares of Class A
Common Stock Issuable
upon Exchange of
Common Units
 
Insight Venture Partners Growth-Buyout Coinvestment Fund (Cayman), L.P.   4,681,293           526,768     316,060          
Insight Venture Partners Growth-Buyout Coinvestment Fund (Delaware), L.P.   4,304,465           484,365     290,619              
Insight Venture Partners (Cayman) IX, L.P.   7,524,415           846,693     508,016              
Insight Venture Partners (Delaware) IX, L.P.   1,604,446           180,542     108,325              
Insight E2open Aggregator, LLC         26,566,466                       31,349,451 1

 

 

1 Insight E2open Aggregator, LLC holds in aggregate 31,349,451 shares of Class A Common Stock issuable upon the exchange of Common Units. Specifically, Insight E2open Aggregator, LLC holds 26,566,466 Common Units of E2open Holdings, LLC (“E2open Holdings”), 2,989,422 Series 1 Restricted Common Units of E2open Holdings, and 1,793,653 Series 2 Restricted Common Units of E2open Holdings. The Common Units represent non-voting limited liability company interests in E2open Holdings subject to the terms of the Third Amended and Restated Limited Liability Company Agreement of E2open Holdings (the "LLC Agreement"). Beginning on August 4, 2021, the Common Units may be exchanged at the discretion of the holder once per calendar quarter (subject to certain limitations set forth in the LLC Agreement) for shares of Class A common stock of the Company on a one-for-one basis (or the cash value thereof, at the election of the Company). The Series 1 Restricted Common Units and Series 2 Restricted Common Units each represent unvested, non-voting restricted limited liability company interests in E2open Holdings subject to the terms of the LLC Agreement. Each Series 1 Restricted Common Unit will vest on the first day on which the 5-day volume weighted average price of the Class A common stock is equal to at least $13.50, or upon certain change in control events specified in the LLC Agreement. Upon vesting, each Series 1 Restricted Common Unit will convert automatically into one Common Unit of E2open Holdings. Each Series 2 Restricted Common Unit will vest on the first day on which the 20-day volume weighted average price of the Class A common stock is equal to at least $15.00, or upon certain change in control events specified in the LLC Agreement. Upon, vesting, each Series 2 Restricted Common Unit will convert automatically into one Common Unit of E2open Holdings.

 

 

Exhibit 10.5

 

SUBSCRIPTION AGREEMENT

 

E2open Parent Holdings, Inc.
9600 Great Hills Trail, Suite 300E 

Austin, TX 78759

 

Ladies and Gentlemen:

 

This Subscription Agreement (this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto, by and between E2open Parent Holdings, Inc., a Delaware corporation (“E2open Parent”), and the undersigned subscriber (the “Investor”), in connection with the Share Purchase Agreement related to BluJay Topco Limited, a company incorporated in England and Wales (the “Company”), dated as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, the “Share Purchase Agreement”), by and among E2open Parent and the Sellers (as defined in the Share Purchase Agreement), pursuant to which, among other things, E2open Parent will purchase the entire issued ordinary shares of the Company and acquire, or procure the redemption in full in cash of, the entire issued A preference shares in the capital of the Company (together with the accrued dividend on such shares up to the date of the completion of the transactions contemplated by the Share Purchase Agreement (the “Transaction”)), on the terms and subject to the conditions therein. In connection with the Transaction, E2open Parent is seeking commitments from interested investors to purchase shares of E2open Parent’s class A common stock, par value $0.0001 per share (the “Shares”), in a private placement for a purchase price of $      per share (the “Per Share Purchase Price”). On or about the date of this Subscription Agreement, E2open Parent is entering into subscription agreements (the “Other Subscription Agreements” and together with the Subscription Agreement, the “Subscription Agreements”) with certain other investors (the “Other Investors” and together with the Investor, the “Investors”), pursuant to which the Investors, severally and not jointly, have agreed to purchase on the closing date of the Transaction, inclusive of the Shares subscribed for by the Investor, an aggregate amount of up to 28,909,022 Shares, subject to Section 5(f) of this Subscription Agreement. The aggregate purchase price to be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein as the “Subscription Amount.”

 

In connection therewith, and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein, and intending to be legally bound hereby, each of the Investor and E2open Parent acknowledges and agrees as follows:

 

1.           Subscription. The Investor hereby irrevocably subscribes for and agrees to purchase from E2open Parent, and E2open Parent agrees to issue and sell to Investor, the number of Shares set forth on the signature page of this Subscription Agreement on the terms and subject to the conditions provided for herein. The Investor acknowledges and agrees that E2open Parent reserves the right to accept or reject the Investor’s subscription for the Shares for any reason or for no reason, in whole or in part, at any time prior to its acceptance, and the same shall be deemed to be accepted by E2open Parent only when this Subscription Agreement is signed by a duly authorized person by or on behalf of E2open Parent; E2open Parent may do so in counterpart form.

 

 

 

 

2.           Closing. The closing of the sale of the Shares contemplated hereby (the “Closing”) is contingent upon the substantially concurrent consummation of the Transaction. The Closing shall occur on the date of, and substantially concurrently with and conditioned upon the effectiveness of, the Transaction. Upon (a) satisfaction or waiver of the conditions set forth in Section 3 below and (b) delivery of written notice from (or on behalf of) E2open Parent to the Investor (the “Closing Notice”), that E2open Parent reasonably expects all conditions to the Completion (as defined in the Share Purchase Agreement) of the Transaction to be satisfied or waived on a date that is not less than five (5) business days from the date on which the Closing Notice is delivered to the Investor, the Investor shall deliver to E2open Parent, three (3) business days prior to the closing date specified in the Closing Notice (the “Closing Date”), the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account(s) specified by E2open Parent in the Closing Notice. On the Closing Date, E2open Parent shall issue a number of Shares to the Investor set forth on the signature page to this Subscription Agreement and subsequently cause such Shares to be registered in book entry form in the name of the Investor on E2open Parent’s share register; provided, however, that E2open Parent’s obligation to issue the Shares to the Investor is contingent upon E2open Parent having received the Subscription Amount in full accordance with this Section 2. If the Closing does not occur within two (2) business days following the Closing Date specified in the Closing Notice, E2open Parent shall promptly (but not later than one (1) business day thereafter) return the Subscription Amount in full to the Investor. For purposes of this Subscription Agreement, “business day” shall mean a day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to close.

 

3.           Closing Conditions.

 

a.           The obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject to the following conditions:

 

(i)            no applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby;

 

(ii)            all conditions precedent to the Completion of the Transaction under the Share Purchase Agreement shall have been satisfied or waived (as determined by the parties to the Share Purchase Agreement and other than those conditions under the Share Purchase Agreement which, by their nature, are to be fulfilled at the Completion of the Transaction, including to the extent that any such condition is dependent upon the consummation of the purchase and sale of the Shares pursuant to this Subscription Agreement or the Other Subscription Agreements) and the Completion of the Transaction shall occur, on the Closing Date, substantially concurrently with or on the same date as the Closing; and

 

2 

 

 

(iii)            no suspension of the qualification of the Shares for offering or sale or trading in any applicable jurisdiction, or initiation or threatening of any proceedings for any such purposes, shall have occurred.

 

b.           The obligation of E2open Parent to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to the condition that all representations and warranties of the Investor contained in this Subscription Agreement are true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing shall constitute a reaffirmation by the Investor of each of the representations and warranties of the Investor contained in this Subscription Agreement as of the Closing Date.

 

c.           The obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to the conditions that (i) all representations and warranties of E2open Parent contained in this Subscription Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing shall constitute a reaffirmation by E2open Parent of each of the representations and warranties of E2open Parent contained in this Subscription Agreement as of the Closing Date and (ii) all obligations, covenants and agreements of E2open Parent required to be performed by it at or prior to the Closing Date shall have been performed in all material respects; provided, that, the U.S. Securities and Exchange Commission’s (the “SEC”) issuance of the Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “Statement”), made on April 12, 2021, and any consequences thereof or actions taken by E2open Parent in response thereto, shall not cause either of the conditions in this clause (c) to be deemed to not have been satisfied so long as any such consequences or actions shall not have caused a material adverse effect on the business, financial condition or results of operations of E2open Parent and its subsidiaries, taken as a whole (a “Material Adverse Effect”). For the avoidance of doubt, any restatement of the financial statements of E2open and any amendments to previously filed reports required to be filed by E2open Parent with the SEC (the “SEC Reports”) or delays in filing SEC reports, in connection with the Statement or any subsequent related agreements or other guidance from the SEC with respect to the Statement, shall not be considered to result in a Material Adverse Effect.

 

4.           Further Assurances. The parties hereto shall execute and deliver such additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription Agreement and the Transaction.

 

5.           E2open Parent Representations and Warranties. E2open Parent represents and warrants to the Investor that:

 

a.           E2open Parent is duly incorporated, validly existing as a corporation and in good standing under the laws of the State of Delaware. E2open Parent has all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

3 

 

 

b.           As of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights created under E2open Parent’s certificate of incorporation (as amended on the Closing Date) or under the General Corporation Law of the State of Delaware. Assuming the accuracy of the Investor’s representations and warranties set forth in Section 6, in connection with the offer, sale and delivery of the Shares in the manner contemplated by this Subscription Agreement, it is not necessary to register the offer and sale of the Shares under the Securities Act of 1933, as amended, (the “Securities Act”). The Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws.

 

c.           This Subscription Agreement has been duly authorized, executed and delivered by E2open Parent and, assuming that this Subscription Agreement constitutes the valid and binding agreement of the Investor, this Subscription Agreement constitutes the valid and binding agreement of the Company and is enforceable against E2open Parent in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law or equity.

 

d.           The issuance and sale of the Shares and the compliance by E2open Parent with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of E2open Parent or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which E2open Parent or any of its subsidiaries is a party or by which E2open Parent or any of its subsidiaries is bound or to which any of the property or assets of E2open Parent is subject that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the Shares or the legal authority of E2open Parent to timely comply in all material respects with the terms of this Subscription Agreement; (ii) result in any violation of the provisions of the organizational documents of E2open Parent; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over E2open Parent or any of their properties that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the Shares or the legal authority of E2open Parent to timely comply in all material respects with this Subscription Agreement.

 

4 

 

 

e.           As of their respective dates, all SEC Reports complied in all material respects with the applicable requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of E2open Parent included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects the financial position of E2open Parent as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited financial statements, to normal, year-end audit adjustments. A copy of each SEC Report is available to the Investor via the SEC’s EDGAR system. To the knowledge of E2open Parent, there are no material outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Reports as of the date hereof.

 

f.            Other than the Other Subscription Agreements, the Share Purchase Agreement and any other agreement expressly contemplated by the Share Purchase Agreement or described in the SEC Reports, E2open Parent has not entered into any side letter or similar agreement with any investor in connection with such investor’s direct or indirect investment in E2open Parent or with any other investor. Except for any alternative settlement procedures that apply to certain Other Investors due to their status as a mutual fund, no Other Subscription Agreement includes terms and conditions that are materially more advantageous to any such Other Investor than Investor hereunder, and such Other Subscription Agreements have not been amended in any material respect following the date of this Subscription Agreement (other than certain subscription agreements for investors that submit an indication of interest for more than $75 million).

 

g.           Except for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, as of the date hereof, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of E2open Parent, threatened against E2open Parent or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against E2open Parent.

 

h.           As of the date of this Subscription Agreement, E2open Parent’s certificate of incorporation authorizes the issuance of 2,554,000,000 shares, consisting of (i) 1,000,000 shares of preferred stock, par value $0.0001 per share; (ii) 2,500,000,000 Shares; (iii) 9,000,000 shares of Series B-1 common stock, par value $0.0001 per share; (iv) 4,000,000 shares of Series B-2 common stock, par value $0.0001 per share; and (v) 40,000,000 shares of Class V common stock, par value $0.0001 per share. As of the date of this Subscription Agreement, (A) 187,051,142 Shares are issued and outstanding, (B) 8,120,367 shares of Series B-1 common stock are issued and outstanding, (C) 3,372,184 shares of Series B-2 common stock are issued and outstanding, (D) 35,636,680 shares of Class V common stock are issued and outstanding, and the Company holds 4,363,320 shares of Class V common Stock in treasury, (E) 29,079,972 warrants to purchase Shares of E2open Parent are issued and outstanding, consisting of: (a) 13,799,972 public warrants, (b) 10,280,000 private placement warrants, and (c) 5,000,000 forward purchase warrants, and (F) no preference shares are issued and outstanding. All (1) issued and outstanding Shares, shares of Series B-1 common stock, shares of Series B-2 common stock and shares of Class V common stock of E2open Parent have been duly authorized and validly issued, are fully paid and are non-assessable, and (2) outstanding warrants of E2open Parent have been duly authorized and validly issued. Except as set forth above and pursuant to the Other Subscription Agreements, the Share Purchase Agreement and the other agreements and arrangements referred to therein or in the SEC Reports, as of the date hereof, there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from E2open Parent any Shares or other equity interests in E2open Parent, or securities convertible into or exchangeable or exercisable for such equity interests. As of the date hereof, E2open Parent has no subsidiaries, other than Amber Road, Inc., E2open, LLC, Inttra, Inc and Zyme Solutions, Inc. and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no stockholder agreements, voting trusts or other agreements or understandings to which E2open Parent is a party or by which it is bound relating to the voting of any securities of E2open Parent, other than (1) as set forth in the SEC Reports and (2) as contemplated by the Share Purchase Agreement.

 

5 

 

 

i.            As of the date hereof, the issued and outstanding Shares of E2open Parent are registered pursuant to Section 12(b) of the Exchange Act, and are listed for trading on the New York Stock Exchange (“NYSE”) under the symbol “ETWO”. Except as disclosed in E2open Parent’s filings with the SEC, as of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of E2open Parent, threatened against E2open Parent by NYSE or the SEC, respectively, to prohibit or terminate the listing of E2open Parent’s Shares on NYSE or to deregister the Shares under the Exchange Act. E2open Parent has taken no action that is designed to terminate the registration of the Shares under the Exchange Act.

 

j.            E2open Parent acknowledges and agrees that, notwithstanding anything herein to the contrary, the Shares may be pledged by Investor in connection with a bona fide margin agreement, provided such pledge shall be (i) pursuant to an available exemption from the registration requirements of the Securities Act or (ii) pursuant to, and in accordance with, a registration statement that is effective under the Securities Act at the time of such pledge, and Investor effecting a pledge of Shares shall not be required to provide E2open Parent with any notice thereof; provided, however, that neither E2open Parent, the Company or their respective counsels shall be required to take any action (or refrain from taking any action) in connection with any such pledge, other than providing any such lender of such margin agreement with an acknowledgment that the Shares are not subject to any contractual prohibition on pledging or lock up, the form of such acknowledgment to be subject to review and comment by E2open Parent in all respects.

 

k.           E2open Parent is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by E2open Parent of this Subscription Agreement (including, without limitation, the issuance of the Shares), other than (i) filings with the SEC, (ii) filings required by applicable state securities laws, (iii) filings required in accordance with Section 11 of this Subscription Agreement, (iv) filings required by the NYSE, or such other applicable stock exchange on which E2open Parent’s common stock is then listed, and (v) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect.

 

l.            Other than the Placement Agent (as defined below), E2open Parent has not engaged any broker, finder, commission agent, placement agent or arranger in connection with the sale of the Shares, and E2open Parent is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Shares other than to the Placement Agent.

 

6 

 

 

6.            Investor Representations and Warranties. The Investor represents and warrants to E2open Parent that:

 

a.           The Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act), a “qualified purchaser” (as defined in Section 2(a)(51) of the Investment Company Act) or an institutional “accredited investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the applicable requirements set forth on Schedule A, (ii) is acquiring the Shares only for his, her or its own account and not for the account of others, or if the Investor is subscribing for the Shares as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information set forth on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the Shares and is an “institutional account” as defined by FINRA Rule 4512(c).

 

b.           The Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act and that the Shares have not been registered under the Securities Act. The Investor acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under the Securities Act except (i) to E2open Parent or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and in each of clauses (i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates representing the Shares shall contain a restrictive legend to such effect and, as a result, the Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares will not immediately be eligible for resale pursuant to Rule 144 promulgated under the Securities Act. The Investor acknowledges and agrees that it has been advised to consult legal counsel and tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of any of the Shares. The Investor acknowledges that the sale of the Shares meets the exemptions from filing under FINRA Rule 5123(b)(1)(A) and FINRA Rule 5123(b)(1)(C) or (J), and the institutional customer exemptions from filing under FINRA Rule 2111(b).

 

c.           The Investor acknowledges and agrees that the Investor is purchasing the Shares from E2open Parent. The Investor further acknowledges that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of E2open Parent, the Company, the Placement Agent, any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and agreements of E2open Parent expressly set forth in Section 5 of this Subscription Agreement.

 

7 

 

 

d.           The Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended, or any applicable similar law.

 

e.           The Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make an investment decision with respect to the Shares, including, with respect to E2open Parent, the Transaction and the business of the Company and its subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that he, she or it has reviewed E2open Parent’s filings with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares.

 

f.            The Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and E2open Parent or a representative of E2open Parent, and the Shares were offered to the Investor solely by direct contact between the Investor and E2open Parent or a representative of E2open Parent. The Investor did not become aware of this offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered by any form of general advertising or, to its knowledge, general solicitation and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, E2open Parent, the Company, the Placement Agent, any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing) or any other person or entity, other than the representations and warranties of E2open Parent contained in Section 5 of this Subscription Agreement, in making its investment or decision to invest in E2open Parent.

 

g.           The Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including those set forth in E2open Parent’s filings with the SEC. The Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision and the Investor has made its own assessment and has satisfied itself concerning relevant tax and other economic considerations relative to its purchase of the Shares. The Investor will not look to the Placement Agent for all or part of any such loss or losses the Investor may suffer and is able to sustain a complete loss on its investment in the Shares.

 

h.           Alone, or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in E2open Parent. The Investor acknowledges specifically that a possibility of total loss exists.

 

8 

 

 

i.            In making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor. Without limiting the generality of the foregoing, the Investor has not relied on any statements or other information provided by or on behalf of the Placement Agent or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing concerning E2open Parent, the Company, the Transaction, the Share Purchase Agreement, this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

j.            The Investor acknowledges that the Placement Agent: (i) has not provided the Investor with any information or advice with respect to the Shares, (ii) has not made or make any representation, express or implied as to E2open Parent, the Company, the Company’s credit quality, the Shares or the Investor’s purchase of the Shares, (iii) has not acted as the Investor’s financial advisor or fiduciary in connection with the issue and purchase of Shares, (iv) may have acquired, or during the term of the Shares may acquire, non-public information with respect to the Company, which, subject to the requirements of applicable law, the Investor agrees need not be provided to it, (v) may have existing or future business relationships with E2open Parent and the Company (including, but not limited to, lending, depository, risk management, advisory and banking relationships) and will pursue actions and take steps that it deems necessary or appropriate to protect its interests arising therefrom without regard to the consequences for a holder of Shares, and that certain of these actions may have material and adverse consequences for a holder of Shares.

 

k.           The Investor acknowledges that it has not relied on the Placement Agent in connection with its determination as to the legality of its acquisition of the Shares or as to the other matters referred to herein and the Investor has not relied on any investigation that the Placement Agent or any person acting on its behalf have conducted with respect to the Shares, E2open Parent or the Company. The Investor further acknowledges that it has not relied on any information contained in any research reports prepared by the Placement Agent.

 

l.            The Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or made any findings or determination as to the fairness of this investment.

 

m.          The Investor, if not an individual, has been duly formed or incorporated and is validly existing and is in good standing under the laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

9 

 

 

n.           The execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Investor is a party or by which the Investor is bound, and, if the Investor is not an individual, will not violate any provisions of the Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same or, if the Investor is not an individual, the signatory has been duly authorized to execute the same, and, assuming that this Subscription Agreement constitutes the valid and binding obligation of E2open Parent, this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

o.           The Investor is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (each, a “Prohibited Investor”). The Investor agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Investor is permitted to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), the Investor maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs, including the OFAC List. To the extent required by applicable law, the Investor maintains policies and procedures reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived and were not obtained, directly or indirectly, from a Prohibited Investor.

 

p.           No disclosure or offering document has been prepared by Credit Suisse Securities (USA) LLC or any of its respective affiliates (the “Placement Agent”) in connection with the offer and sale of the Shares.

 

q.           The Placement Agent or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing have not made any independent investigation with respect to E2open Parent, the Company or its subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any information supplied to the Investor by E2open Parent.

 

r.            In connection with the issue and purchase of the Shares, the Placement Agent has not acted as the Investor’s financial advisor or fiduciary.

 

s.           The Investor has or has commitments to have and, when required to deliver payment to E2open Parent pursuant to Section 2 above, will have, sufficient funds to pay the Subscription Amount and consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

10 

 

 

t.            The Investor acknowledges and agrees that it is not an underwriter within the meaning of Section 2(a)(11) of the Securities Act.

 

u.           The Investor agrees that, from the date of this Subscription Agreement until the Closing or the earlier termination of this Subscription Agreement, none of Investor, its controlled affiliates, or any person or entity acting on behalf of the Investor or any of its controlled affiliates or pursuant to any understanding with the Investor or any of its controlled affiliates will engage in any Short Sales with respect to securities of the E2open Parent. For the purposes hereof, “Short Sales” shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), including through non-U.S. broker dealers or foreign regulated brokers. Notwithstanding the foregoing, (A) nothing herein shall prohibit (x) other entities under common management with the Investor with whom the Investor is not acting in concert with respect to any trading in securities of E2open Parent, this Subscription Agreement or the Investor’s participation in this offering of the Shares including the Investor’s controlled affiliates and/or affiliates, or (y) in the case of an Investor that is externally managed, advised or sub-advised by another person, any other person that is not directly controlled or managed by such manager, adviser or sub-adviser, in each case from entering into any Short Sale and (B) in the case of an Investor that is a multi-managed investment bank or vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing other portions of such Investor’s assets, this Section (u) shall apply only with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Subscription Agreement. For the avoidance of doubt, nothing in this Section (u) shall restrict any transactions with respect to securities of E2open Parent other than transactions that are Short Sales including the exercise of any redemption with respect to securities of the E2open Parent.

 

v.           The Investor acknowledges the SEC’s issuance of the Statement and the Investor agrees that any actions taken by E2open Parent in connection with, or as may be necessary or advisable to address the potential implications of, such Statement or review shall not be deemed to constitute a breach of any of the representations, warranties or covenants in this Subscription Agreement; provided, however, that any such actions may not materially and adversely affect the rights of the Investor (in its capacity as such) under this Subscription Agreement. For the avoidance of doubt, any restatement or the financial statements of E2open Parent and any amendments to previously filed SEC Reports or delays in filing SEC Reports, in connection with the Statement or any subsequent related agreements or other guidance from the SEC with respect to the Statement shall not be considered to materially and adversely affect the rights of the Investor (in its capacity as such) under this Subscription Agreement.

 

11 

 

 

7.            Registration Rights.

 

a.            In the event that the Shares are not registered in connection with the consummation of the Transaction, E2open Parent agrees that, within thirty (30) calendar days after the Closing Date, it will file with the SEC (at the its sole cost and expense) a registration statement registering the resale of the Shares (the “Registration Statement”), and it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) sixty (60) calendar days after the filing thereof (or ninety (90) calendar days after the filing thereof if the SEC notifies E2open Parent that it will “review” the Registration Statement) and (ii) ten (10) Business Days after E2open Parent is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review. In connection with the foregoing, Investor shall not be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Shares. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement unless requested by the SEC. E2open Parent agrees to cause such Registration Statement, or another shelf registration statement that includes the Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (i) the third anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares issued pursuant to this Subscription Agreement, or (iii) on the first date on which the Investor is able to sell all of its Shares issued pursuant to this Subscription Agreement (or shares received in exchange therefor) under Rule 144 promulgated under the Securities Act (“Rule 144”) within 90 days without the public information, volume or manner of sale limitations of such rule (such date, the “End Date”). Prior to the End Date, E2open Parent will use commercially reasonable efforts to qualify the Shares for listing on the applicable stock exchange. The Investor agrees to disclose its ownership to E2open Parent upon request to assist it in making the determination with respect to Rule 144 described in clause (iii) above. E2open Parent may amend the Registration Statement so as to convert the Registration Statement to a Registration Statement on Form S-3 at such time after E2open Parent becomes eligible to use such Form S-3. The Investor acknowledges and agrees that E2open Parent may suspend the use of any such registration statement if it determines that in order for such registration statement not to contain a material misstatement or omission, an amendment thereto would be needed to include information that would at that time not otherwise be required in a current, quarterly, or annual report under the Exchange Act, provided, that, (I) E2open Parent shall not so delay filing or so suspend the use of the Registration Statement for a period of more than ninety (90) consecutive days or more than a total of one hundred-twenty (120) calendar days in any three hundred sixty (360) day period and (II) E2open Parent shall use commercially reasonable efforts to make such Registration Statement available for the sale by the Investor of such securities as soon as practicable thereafter. E2open Parent’s obligations to include the Shares issued pursuant to this Subscription Agreement (or shares issued in exchange therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to E2open Parent such information regarding the Investor, the securities of E2open Parent held by the Investor and the intended method of disposition of such Shares, which shall be limited to non-underwritten public offerings, as shall be reasonably requested by E2open Parent to effect the registration of such Shares, and shall execute such documents in connection with such registration as E2open Parent may reasonably request that are customary of a selling stockholder in similar situations.

 

12 

 

 

b.           If the SEC prevents E2open Parent from including any or all of the Shares proposed to be registered for resale under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable stockholders or otherwise, (i) such Registration Statement shall register for resale such number of Shares which is equal to the maximum number of Shares as is permitted by the SEC and (ii) the number of Shares to be registered for each selling stockholders named in the Registration Statement shall be reduced pro rata among all such selling stockholders.

 

c.            E2open Parent agrees to indemnify and hold harmless, to the extent permitted by law, the Investor, its directors, and officers, employees, and agents, and each person who controls the Investor (within the meaning of the Securities Act or the Exchange Act) and each affiliate of the Investor (within the meaning of Rule 405 under the Securities Act) from and against any and all losses, claims, damages, liabilities and expenses (including, without limitation, any reasonable and documented attorneys’ fees and expenses incurred in connection with defending or investigating any such action or claim) caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to E2open Parent by or on behalf of the Investor expressly for use therein.

 

d.           The Investor agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements, to indemnify and hold harmless E2open Parent, its directors and officers and agents and each person who controls E2open Parent (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable and documented attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by or on behalf of the Investor expressly for use therein. In no event shall the liability of the Investor be greater in amount than the dollar amount of the net proceeds received by the Investor upon the sale of the Shares purchased pursuant to this Subscription Agreement giving rise to such indemnification obligation.

 

e.           Any person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent. An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

13 

 

 

f.            The indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director, employee, agent, affiliate or controlling person of such indemnified party and shall survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

 

g.           If the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by or on behalf of, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 10(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7 from any person who was not guilty of such fraudulent misrepresentation. Any contribution pursuant to this Section 7(f) by any seller of Shares shall be limited in amount to the amount of net proceeds received by such seller from the sale of such Shares pursuant to the Registration Statement. Notwithstanding anything to the contrary herein, in no event will any party be liable for consequential, special, exemplary or punitive damages in connection with this Subscription Agreement.

 

h.           With a view to making available to the Investor the benefits of Rule 144 that may, at such times as Rule 144 is available to stockholders of the Company, permit the Investors to sell securities of the Company to the public without registration, E2open Parent agrees to:

 

(i)              make and keep public information available, as those terms are understood and defined in Rule 144;

 

(ii)             file with the SEC in a timely manner all reports and other documents required of E2open Parent under the Securities Act and the Exchange Act so long as E2open Parent remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and

 

14 

 

 

(iii)            furnish to the Investor so long as such Investor owns the Shares acquired hereunder, promptly upon request, (A) a written statement by E2open Parent, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (B) a copy of the most recent annual or quarterly report of E2open Parent and such other reports and documents so filed by E2open Parent (it being understood that the availability of such report on the SEC’s EDGAR system shall satisfy this requirement) and (C) such other information as may be necessary to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

i.            In connection with any sale, assignment, transfer or other disposition of the Shares by the Investor pursuant to Rule 144 or pursuant to any other exemption under the Securities Act such that the Shares held by the Investor become freely tradable and upon compliance by the Investor with the requirements of this Subscription Agreement, if requested by the Investor, E2open Parent shall cause the transfer agent for the Shares (the “Transfer Agent”) to remove any restrictive legends related to the book entry account holding such Shares and make a new, unlegended entry for such book entry Shares sold or disposed of without restrictive legends upon any such request therefor from the Investor, provided that E2open Parent and the Transfer Agent have timely received from the Investor customary representations, opinion and other documentation reasonably acceptable to E2open Parent and the Transfer Agent in connection therewith.

 

8.           Termination. This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such date and time as the Share Purchase Agreement is terminated in accordance with its terms without being consummated, (b) upon the mutual written agreement of each of the parties hereto and the Company to terminate this Subscription Agreement, (c) 20 days after the Longstop Date (in accordance with the Share Purchase Agreement), if the Closing has not occurred by such date other than as a result of a breach of Investor’s obligations hereunder, or (d) if any of the conditions to Closing set forth in Section 3 of this Subscription Agreement are (i) not satisfied or waived prior to the Closing (and if the failure to so satisfy such condition is capable of being cured prior to the Closing, such failure shall not have been cured by the date that is thirty calendar days following receipt of written notice from the party claiming such condition has not been satisfied) or (ii) not capable of being satisfied on the Closing and, in each case of (i) and (ii), as a result thereof, the transactions contemplated by this Subscription Agreement will not be and are not consummated at the Closing (the termination events described in clauses (a)–(d) above, collectively, the “Termination Events”); provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach. E2open Parent shall notify the Investor in writing of the termination of the Share Purchase Agreement promptly after the termination of such agreement. Upon the occurrence of any Termination Event, this Subscription Agreement shall be void and of no further effect and any monies paid by the Investor to E2open Parent in connection herewith shall promptly (and in any event within one business day) following the Termination Event be returned to the Investor.

 

15 

 

 

9.            Miscellaneous.

 

a.           Neither this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares acquired hereunder, if any) may be transferred or assigned without the prior written consent of each of the other parties hereto; provided that (i) this Subscription Agreement and any of the Investor’s rights and obligations hereunder may be assigned to any fund or account managed by the same investment manager as the Investor or by an affiliate (as defined in Rule 12b-2 of the Exchange Act) of such investment manager without the prior consent of E2open Parent and (ii) the Investor’s rights under Section 7 may be assigned to an assignee or transferee of the Shares; provided further that prior to such assignment any such assignee shall agree in writing to be bound by the terms hereof; provided, that no assignment pursuant to clause (i) of this Section 9 shall relieve the Investor of its obligations hereunder.

 

b.           E2open Parent may request from the Investor such additional information as E2open Parent may deem necessary to register the resale of the Shares and evaluate the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be requested to the extent readily available; provided, that, E2open Parent agrees to keep any such information provided by Investor confidential other than as necessary to include in any registration statement E2open Parent is required to file hereunder. The Investor acknowledges and agrees that if it does not provide E2open Parent with such requested information, E2open Parent may not be able to register the Investor’s Shares for resale pursuant to Section 7 hereof. The Investor acknowledges that E2open Parent may file a copy of this Subscription Agreement with the SEC as an exhibit to a periodic report or a registration statement of E2open Parent.

 

c.           The Investor acknowledges that E2open Parent, the Company, the Placement Agent and others will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Subscription Agreement, including Schedule A hereto. Prior to the Closing, the Investor agrees to promptly notify E2open Parent, the Company and the Placement Agent if any of the acknowledgments, understandings, agreements, representations and warranties set forth in Section 6 above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations and warranties qualified by materiality, in which case the Investor shall notify E2open Parent and the Placement Agent if they are no longer accurate in any respect). The Investor acknowledges and agrees that each purchase by the Investor of Shares from E2open Parent will constitute a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such notice) by the Investor as of the time of such purchase.

 

d.           E2open Parent, the Company and the Placement Agent are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby; provided, however, that the foregoing clause of this Section 9(d) shall not give the Company or the Placement Agent any rights other than those expressly set forth herein and, without limiting the generality of the foregoing and for the avoidance of doubt, in no event shall the Company be entitled to rely on any of the representations and warranties of E2open Parent set forth in this Subscription Agreement.

 

e.           All of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

16 

 

 

f.            This Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above) except by an instrument in writing, signed by each of the parties hereto, provided, however, that no modification or waiver by E2open Parent of the provisions of this Subscription Agreement shall be effective without the prior written consent of the Company (other than modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or any other material term of this Subscription Agreement). No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

g.           This Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth in Section 6(c), Section 6(f), Section 8, Section 9(c), Section 9 (d), Section 9 (f), this Section 9(g), the last sentence of Section 9(k) and Section 10 with respect to the persons specifically referenced therein, and Section 6 with respect to the Placement Agent, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successors and assigns, and the parties hereto acknowledge that such persons so referenced are third party beneficiaries of this Subscription Agreement for the purposes of, and to the extent of, the rights granted to them, if any, pursuant to the applicable provisions; provided, that, notwithstanding anything to the contrary contained in this Subscription Agreement, the Company is an intended third party beneficiary of each of the provisions of this Subscription Agreement.

 

h.           Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

 

i.            If any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

j.            This Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

k.           The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. The parties hereto acknowledge and agree that the Company shall be entitled to specifically enforce the Investor’s obligations to fund the Subscription Amount and the provisions of the Subscription Agreement, in each case, on the terms and subject to the conditions set forth herein.

 

17 

 

 

l.            This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters (including any action, suit, litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit, investigation or reviews by or before any governmental entity related hereto), including matters of validity, construction, effect, performance and remedies.

 

m.          Each party hereto hereby, and any person asserting rights as a third party beneficiary may do so only if he, she or it, irrevocably agrees that any action, suit or proceeding between or among the parties hereto, whether arising in contract, tort or otherwise, arising in connection with any disagreement, dispute, controversy or claim arising out of or relating to this Subscription Agreement or any related document or any of the transactions contemplated hereby or thereby (“Legal Dispute”) shall be brought only to the exclusive jurisdiction of the courts of the State of Delaware or the federal courts located in the State of Delaware, and each party hereto hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period a Legal Dispute that is filed in accordance with this Section 9(m) is pending before a court, all actions, suits or proceedings with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court. Each party hereto and any person asserting rights as a third party beneficiary may do so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a) such party is not personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding may not be brought or is not maintainable in such court, (c) such party’s property is exempt or immune from execution, (d) such action, suit or proceeding is brought in an inconvenient forum, or (e) the venue of such action, suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this Section 9 (m) following the expiration of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

18 

 

 

10.          Non-Reliance and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, the Placement Agent, the Company (or any of its affiliates) or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the statements, representations and warranties of E2open Parent expressly contained in Section 5 of this Subscription Agreement, in making its investment or decision to invest in E2open Parent. The Investor acknowledges and agrees that none of (i) any other investor pursuant to this Subscription Agreement or any other subscription agreement related to the private placement of the Shares (including the investor’s respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), (ii) the Placement Agent or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing, or (iii) any other party to the Share Purchase Agreement or any Non-Party Affiliate (other than E2open Parent with respect to the previous sentence), shall have any liability to the Investor, or to any other investor, pursuant to, arising out of or relating to this Subscription Agreement or any other subscription agreement related to the private placement of the Shares, the negotiation hereof or thereof or its subject matter, or the transactions contemplated hereby or thereby, including, without limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Shares or with respect to any claim (whether in tort, contract or otherwise) for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged to be made in connection herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished by E2open Parent, the Company, the Placement Agent or any Non-Party Affiliate concerning E2open Parent, the Company, the Placement Agent, any of their affiliates, this Subscription Agreement or the transactions contemplated hereby. For purposes of this Subscription Agreement, “Non-Party Affiliates” means each former, current or future officer, director, employee, partner, member, manager, direct or indirect equityholder or affiliate of E2open Parent, the Company, any Placement Agent or any of E2open Parent’s, the Company’s or any Placement Agent’s affiliates or any family member of the foregoing.

 

19 

 

 

11.          Disclosure. E2open Parent shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date of this Subscription Agreement, issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements, the Transaction and any other material, nonpublic information that E2open Parent has provided to the Investor at any time prior to the filing of the Disclosure Document. Upon the issuance of the Disclosure Document, to the actual knowledge of E2open Parent, the Investor shall not be in possession of any material, non-public information received from E2open Parent or any of its officers, directors, or employees or agents, and the Investor shall no longer be subject to any confidentiality or similar obligations under any current agreement, whether written or oral, with E2open Parent or any of its affiliates, relating to the transactions contemplated by this Subscription Agreement. Notwithstanding anything in this Subscription Agreement to the contrary, E2open Parent shall not publicly disclose the name of the Investor or any of its affiliates or advisers, or include the name of the Investor or any of its affiliates or advisers in any press release or in any filing with the SEC or any regulatory agency or trading market, without the prior written consent of the Investor, except (i) as required by the federal securities law or pursuant to other routine proceedings of regulatory authorities, (ii) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory agency or under the regulations of any national securities exchange on which E2open Parent’s securities are listed for trading or (iii) to the extent such announcements or other communications contain only information previously disclosed in a public statement, press release or other communication previously approved in accordance with this Section 11.

 

[SIGNATURE PAGES FOLLOW]

 

20 

 

 

IN WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set forth below.

 

Name of Investor: State/Country of Formation or Domicile:
   
By:                               

 

Name:                                           

 

Title:                  
     
Name in which Shares are to be registered (if different):   Date: May 27, 2021
     
Investor’s EIN:    
     
Business Address-Street:   Mailing Address-Street (if different):
     
City, State, Zip:   City, State, Zip:
     
Attn:     Attn:
     
     
Telephone No.:   Telephone No.:
Facsimile No.:   Facsimile No.:
Email:    
     
Number of Shares subscribed for:    
     
Aggregate Subscription Amount: $   Price Per Share: $      

  

You must pay the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account specified by E2open Parent in the Closing Notice.

 

21 

 

 

IN WITNESS WHEREOF, E2open Parent has accepted this Subscription Agreement as of the date set forth below.

 

E2OPEN PARENT HOLDINGS, INC.
     
  By:                                  
  Name:
  Title:
   
Date: May 27, 2021  

 

22 

 

 

SCHEDULE A

ELIGIBILITY REPRESENTATIONS OF THE INVESTOR

 

A.            QUALIFIED INSTITUTIONAL BUYER STATUS

 

(Please check the applicable subparagraphs):

 

¨ We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)).

 

B.            INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

(Please check the applicable subparagraphs):

 

1.            ¨We are an institutional “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

2.            ¨We are not a natural person.

 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly qualifies as an “accredited investor.”

 

¨ Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment company;

 

¨ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

¨ Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

¨ Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

¨ Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

¨ Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should be completed by the Investor
and constitutes a part of the Subscription Agreement.